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**1**   **Paradoxical Bronchospasm With a Near-Fatal Reaction to Albuterol-HFA and Levalbuterol inhalation solution leading to Intubation in an Adult Asthmatic**

**S. Amara**, N. Gupta, B. Silverman, Y. A. K. Rao, A. T. Schneider; Long Island College Hospital, Brooklyn, NY.

**2**   **Gata-3-specific Dnazyme As An Appraoch For Asthma-therapy**

**T. Dicke**, M. Wegmann, S. Sel, H. Renz, H. Garn; Medical Faculty, Philipps University, Marburg, GERMANY.

**3**   **Bronchial Thermoplasty in Refractory Asthma: Interim Results in a Severe Asthma Population (Research in Severe Asthma (RISA) Trial)**

**R. Niven** ^1^, I. Pavord^2^, M. Laviolette^3^, N. Thomson^4^, P. Corris^5^, G. Cox^6^, K. Fan-Chung^7^, A. Sperb-Rubin^8^; ^1^South Manchester University Hospitals NHS Trust, Manchester, UNITED KINGDOM, ^2^Glenfield General Hospital, University of Leicester, Leicester, UNITED KINGDOM, ^3^Laval University, Sainte-Foy, PQ, CANADA, ^4^Gartnaval General Hospital, Glasgow, UNITED KINGDOM, ^5^Freeman Hospital, Newcastle upon Tyne, UNITED KINGDOM, ^6^McMaster University, Hamilton, ON, CANADA, ^7^NHLI-Royal Brompton, London, UNITED KINGDOM, ^8^Irmandade Santa Casa de Misericordia, Porto Alegre, BRAZIL.

**4**   **Compatability of Levalbuterol Inhalation Solution Mixed with Budesonide, Ipratropium Bromide, Cromolyn Sodium or Acetylcysteine Sodium**

**W. K. McVicar**, P. Bonasia, S. Ong; Sepracor Inc., Marlborough, MA.

**5**   **A Comparison of Bronchodilator Expressions to Identify the Asthmatic Child**

**S. P. Galant** ^1,2^, T. Morphew^3^, S. Amaro^1,4^, O. Liao^1,5^; ^1^Children\'s Hospital of Orange County, Orange, CA, ^2^Southern California Chapter of Asthma and Allergy Foundation of America (AAFA), Los Angeles, CA, ^3^Southern California Chapter of Asthma and Allergy Foundation of America (AAFA), Los Anges, CA, ^4^Breathmobile TM Orange County, Orange, CA, ^5^Breathmboile TM Orange County, Orange, CA.

**6**   **Adrenergic β2 Receptor Genotyping in Asthma: Case Reports**

**S. E. Leonard**; Virginia Commonwealth University, Richmond, VA.

**7**   **Effect of Budesonide and Formoterol Administered Via One Pressurized Metered-dose Inhaler on Lung Function in Adults and Adolescents With Moderate to Severe Persistent Asthma**

**M. J. Noonan** ^1^, L. J. Rosenwasser^2^, P. Martin^3^, C. D. O\'Brien^3^, L. O\'Dowd^3^; ^1^Allergy Associates Research Center, Portland, OR, ^2^Children\'s Mercy Hospital, Kansas City, MO, ^3^AstraZeneca, Wilmington, DE.

**8**   **Efficacy and Safety of Intravenous Aminophylline in Children with Acute Exacerbation of Asthma: A Multicenter Randomized Trial**

**M. Nagao** ^1,2^, T. Katsunuma^3,2^, C. K. Kim^4,2^, T. Fujisawa^1,2^; ^1^Mie National Hospital, Tsu, JAPAN, ^2^Mie-Jikei-Inje theophylline study group, Tsu, JAPAN, ^3^Jikei University, Tokyo, JAPAN, ^4^University, Seoul, REPUBLIC OF KOREA.

**9**   **Funtional Role Of Glucocorticoid Receptor β In The Steroid-induced Suppression Of Il-8 In Airway Epithelial Cells**

**Y. Jee** ^1^, J. Park^1^, Y. Kim^1^, M. Kim^2^, Y. Cho^2^, P. Lavender^3^; ^1^College of Medicine, Dankook university, Cheonan, REPUBLIC OF KOREA, ^2^College of Medicine, Ewha Woman\'s university, Seoul, REPUBLIC OF KOREA, ^3^King\'s College, London, UNITED KINGDOM.

**10**   **Development of Asthma Study Technologies in an Environmental Chamber (ASTEC)**

**A. Salapatek** ^1,2^, P. Patel^1^, N. Mec^1^, L. Nimraj^1^, A. Ramoutar^1^, M. D. Chapman^3^, J. D. Freihaut^4^; ^1^Allied Research International, Mississauga, ON, CANADA, ^2^Centre of Mathematics and Medicine, Fields Institute, Toronto, ON, CANADA, ^3^INDOOR Biotechnologies Inc., Charlottesville, VA, ^4^Pennsylvania State University, University Park, PA.

**11**   **Cutaneous CpG Administration Reduces Th2-type Airway Inflammation But Induces Airway Hyperreactivity**

**R. Haapakoski** ^1^, N. Fyhrquist-Vanni^1^, T. Savinko^1^, H. Wolff^2^, K. Turjanmaa^3^, T. Palosuo^4^, T. Reunala^3^, A. Lauerma^5^, H. Alenius^1^; ^1^Unit of Excellence in Immunotoxicology, Finnish Institute of Occupational Health, Helsinki, FINLAND, ^2^Team for Biological Mechanisms and Prevention of Work-related Diseases, Finnish Institute of Occupational Health and Department of Pathology, Helsinki University Central Hospital, Helsinki, FINLAND, ^3^Department of Dermatology, Tampere University and University Hospital, Tampere, FINLAND, ^4^Laboratory of Immunobiology, National Public Health Institute, Helsinki, FINLAND, ^5^Control of Hypersensitivity Diseases, Finnish Institute of Occupational Health, Helsinki, FINLAND.

**12**   **New Treatments for Suppression of Ongoing Human and Murine IgE Responses**

**H. G. Durkin**, T. A. Smith-Norowitz, M. Pincus, M. Nowakowski, M. H. Bluth, R. Joks; Center for Allergy and Asthma Research, SUNY Downstate, Brooklyn, NY.

**13**   **Formoterol Treatment plus Tiotropium Results in Greater Improvements in Lung Function Compared with Tiotropium Administered Alone in Patients with COPD**

**D. Tashkin** ^1^, S. Varghese^2^; ^1^David Geffen School of Medicine, Los Angeles, CA, ^2^Schering-Plough, Kenilworth, NJ.

**14**   **Montelukast Added to Usual Therapy during the September Epidemic of Asthma Exacerbations in Children**

**N. W. Johnston**, P. J. Mandhane, J. Dai, J. M. Duncan, J. M. Greene, K. Lambert, M. R. Sears; Firestone Institute for Respiratory Health, Hamilton, ON, CANADA.

**15**   **Addition of Omalizumab Improves Quality of Life in Moderate-Severe Asthmatics Receiving Fluticasone 500 μg/Salmeterol 50 μg**

**M. Massanari**, R. J. Maykut, F. Kianifard, R. K. Zeldin, G. P. Geba; Novartis Pharmaceuticals Corporation, East Hanover, NJ.

**16**   **Effects Of MN-001 In Patients With Mild-to-moderate Asthma In A Randomized, Double-blind And Placebo-controlled Phase II Study**

**W. W. Busse** ^1^, H. S. Nelson^2^, P. E. Korenblat^3^, M. J. Noonan^4^, K. W. Locke^5^, M. S. Munsey^5^, R. E. Gammans^5^; ^1^University of Wisconsin, Madison, WI, ^2^National Jewish Medical Research Center, Denver, CO, ^3^Associated Specialists In Internal Medicine, St. Louis, MO, ^4^Allergy Associates Research Center, Portland, OR, ^5^MediciNova, Inc., San Diego, CA.

**17**   **Safety of Budesonide and Formoterol Administered Via One Pressurized Metered-dose Inhaler (Budesonide/Formoterol pMDI) in Patients (≥2 Years) With Moderate to Severe Persistent Asthma**

**L. J. Rosenwasser** ^1^, M. J. Noonan^2^, P. Martin^3^, L. O\'Dowd^3^, C. D. O\'Brien^3^; ^1^Children\'s Mercy Hospital, Kansas City, MO, ^2^Allergy Associates Research Center, Portland, OR, ^3^AstraZeneca, Wilmington, DE.

**18**   **The Effects of Mometasone DPI on Airway Hyperresponsiveness and Markers of Airway Inflammation**

**F. A. Romero**, V. Mehta, A. I. Berro, J. Stokes, T. B. Casale; Creighton University, Omaha, NE.

**19**   **Objective evidence of omalizumab treatment assessed by Forced Oscillation (FO)**

**C. Saadeh**, M. D. Goldman, C. K. Saadeh, J. R. Lemert, Jr.; Amarillo Center for Clinical Research, Amarillo, TX.

**20**   ***Saccharomyces (S.) Cerevisiae* Mannan Facilitates Airway Epithelial Repair**

**C. F. Michael**, K. Chapman, B. Lew, C. Waters; UT Health Science Center, Memphis, Memphis, TN.

**21**   ***Streptomyces cerevisiae* 1,3/1,6 Beta-glucan Prevents Airway Hyperreactivity and Pulmonary Inflammation in a Murine Asthma Model**

**M. Oh** ^1^, T. Zhang^1^, R. Seljelid^2^, X. Li^1^; ^1^Mt. Sinai School of Medicine, New York, NY, ^2^University of Tromso, Tromso, NORWAY.

**22**   **The Effect of Discontinuing Omalizumab Therapy on Free IgE Concentration**

**P. Lowe** ^1^, J. Jaffe^2^, C. Martin^3^, L. Brookman^3^, H. Fox^3^; ^1^Novartis Pharmaceuticals AG, Basel, SWITZERLAND, ^2^Novartis Pharmaceuticals Corporation, East Hanover, NJ, ^3^Novartis Horsham Research Centre, Horsham, UNITED KINGDOM.
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**23**   **Quality of Life of Caregivers of Underserved Children with Asthma**

**D. Sztein** ^1^, M. Streett^2^, M. Foster^3^, C. Vibbert^2^, T. Morphew^4^, M. E. Bollinger^2^; ^1^Haverford College, Philadelphia, PA, ^2^University of Maryland School of Medicine, Baltimore, MD, ^3^University of Maryland Hospital for Children, Baltimore, MD, ^4^Southern CA Asthma and Allergy Foundation, Los Angeles, CA.

**24**   **Asthma Control Test: reliability, validity, and responsiveness in Korean patients**

**K. Hyouk-Soo** ^1,2^, K. Deok-In^1,2^, P. Chang-Han^1,2^, S. Seong-Wook^1,2^, L. Sang-Min^1,2^, S. Woo-Jung^1,2^, K. Yong-Eun^3^, P. Heung-Woo^1,2^, K. Sun-Sin^1,2^, C. Sang-Heon^1,2^, M. Kyoung-Up^1,2^, K. You-Young^1,2^, C. Yoon-Seok^1,4^; ^1^Department of Internal Medicine, Seoul National University College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Instutute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, REPUBLIC OF KOREA, ^3^Department of Internal Medicine, Chosun University College of Medicine, Gwangju, REPUBLIC OF KOREA, ^4^Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, REPUBLIC OF KOREA.

**25**   **Self Reported Provider Adherence to NAEPP Guidelines for Control of Factors Contributing to Asthma Severity**

**P. J. Warrier** ^1^, S. Dever^1^, M. Shah^2^, D. M. O\'Sullivan^3^, J. E. Thomas^1^; ^1^Hartford Hospital, University of Connecticut, Hartford, CT, ^2^Bridgeport Hospital, Bridgeport, CT, ^3^Hartford Hospital, Hartford, CT.

**26**   **Race, Asthma Exacerbations and Leaving against Medical Advice**

**B. D. Tano**; University of Texas Health Center at Tyler, Tyler, TX.

**27**   **Use of a Validated Asthma Symptom Questionnaire to Predict Obstructive Flow Volume Loop in School-Aged Children**

**M. Michelis**, J. F. Hirsh, A. Oughourli, D. J. Lee; Hackensack University Medical Center, Hackensack, NJ.

**28**   **Real-World Evaluation of Asthma Control and Treatment (REACT): Findings from a National Web-Based Survey**

**S. P. Peters** ^1^, C. A. Jones^2^, T. Haselkorn^3^, D. R. Mink^4^, D. J. Valacer^3^, S. T. Weiss^5^; ^1^Wake Forest University School of Medicine, Winston-Salem, NC, ^2^University of Southern California Medical Center, Los Angeles, CA, ^3^Genentech, Inc., South San Francisco, CA, ^4^Ovation Research Group, San Francisco, CA, ^5^Brigham & Women\'s Hospital, Harvard Medical School, Boston, MA.

**29**   **Keeping Asthmatics Out of the Emergency Department and Hospital: Evidence for Asthma Controller Medication Usage for Intermittent Asthmatics**

**C. C. Spagnola** ^1^, W. W. Crawford^2^, M. Schatz^3^, R. K. Nakahiro^4^; ^1^Southern California Permanente Medical Group, Los Angeles, CA, ^2^Southern California Permanente Medical Group, Harbor City, CA, ^3^Southern California Permanente Medical Group, San Diego, CA, ^4^Kaiser Permanente Medical Care Program, Los Angeles, CA.

**30**   **Childhood Asthma Control Test: Reliability, Validity And Responsiveness**

**R. Jan** ^1,2^, I. Liu^1^, S. Chen^1^, C. Shieh^3^, J. Wang^1^; ^1^Dept of Ped, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, ^2^Dept of Ped,College of Medicine, National Cheng Kung University, Tainan, TAIWAN, ^3^Dept of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, TAIWAN.

**31**   **Achieving and Maintaining Control of Asthma with Regular Participation in an Urban Pediatric Disease Management Program: The Breathmobile® Program**

**C. A. Jones** ^1^, L. T. Clement^2^, T. Morphew^3^, J. Hanley-Lopez^1^, K. Y. C. Kwong^1^, F. Lifson^3^, L. Opas^1^, J. J. Guterman^4^; ^1^Los Angeles County + University of Southern California Medical Center and the Keck School of Medicine at the University of Southern California, Los Angeles, CA, ^2^University of South Alabama College of Medicine, Mobile, AL, ^3^Southern California Chapter of the Asthma and Allergy Foundation of America, Los Angeles, CA, ^4^Los Angeles County Department of Health Services, Olive-View UCLA Medical Center and the Geffin School of Medicine at the University of California at Los Angeles, Los Angeles, CA.

**32**   **Implementation of GINA Guidelines in Poor Countries May Have Resulted in an Unnecessary Expenditure on Pharmacotherapy**

**J. E. Gereda;** Clinica Ricardo Palma, Lima, PERU.

**33**   **No Correlation Between Airway Obstruction Measured by FEV~3~/FVC and Asthma Control Test Scores**

**E. C. Swartz**, M. K. Bossard, K. McCarthy, R. López, D. M. Lang; Cleveland Clinic, Cleveland, OH.

**34**   **Does A Www-based Interactive Computer Program change asthma Outcomes, Quality of Life and Asthma Knowledge**

**U. M. Andersen** ^1,2^; ^1^Aalborg Sygehus Nord, Aalborg, DENMARK, ^2^Pediatric Department, Aalborg Sygehus Nord, Aalborg, DENMARK.

**35**   **Update on the Effect of a Multidisciplinary Team Clinic on Asthma Outcome for Medicaid-Eligible Inner City Children with Moderate to High-Risk Asthma**

**P. P. Patel**, P. Munzenberger, R. Marocco, S. Taormina, W. Alame, J. Montejo, M. Pansare, E. A. Secord; Carman and Ann Adams Department of Pediatrics, Children\'s Hospital of Michigan-Wayne State University, DETROIT, MI.

**36**   **Effect of Omalizumab on Measures of Control in Adolescents with Moderate-Severe Persistent Asthma**

**S. J. Pollard** ^1^, R. J. Maykut^2^, M. Massanari^2^, F. Kianifard^2^, R. K. Zeldin^2^, G. P. Geba^2^; ^1^Family Allergy and Asthma, Louisville, KY, ^2^Novartis Pharmaceuticals Corporation, East Hanover, NJ.

**37**   **Assessment of Asthma Control in a United States Population**

M. Blaiss^1^, **R. Manjunath** ^2^, A. Dalal^2^, P. Jhingran^2^; ^1^Allergy and Asthma Care, Germantown, TN, ^2^GlaxoSmithKline, RTP, NC.

**38**   **Risk Factors for Asthma-Related Emergency Hospital Utilization Differ Between High and Low Users of Asthma Medications**

**R. T. Hsu** ^1^, W. W. Crawford^2^, W. B. Klaustermeyer^1^, M. Schatz^3^; ^1^VA Greater Los Angeles Healthcare System, Los Angeles, CA, ^2^Kaiser Permanente, Southern California, Harbor City Medical Center, CA, ^3^Kaiser Permanente, Southern California, San Diego Medical Center, CA.

**39**   **Change (Δ) in Percent Forced Expiratory Volume in the First Second (FEV1) in 10 patients on Omalizumab Over 23 Months**

**K. Shamir**, A. Hersh, H. Aguila, J. Pepe, A. Wolff, L. Bielory; UMDNJ Medical School, Newark, NJ.

**40**   **Pulmonary Function Test Values Predictive of Success in Decreasing Inhaled Corticosteroid Doses in Asthmatics: A Chart Review**

**L. M. Miller** ^1^, M. V. White^2^; ^1^Washington Hospital Center, Washington, DC, ^2^Institute for Asthma & Allergy, Wheaton, MD.
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**41**   **Evaluation and Standardization of Enzyme-Linked ImmunoSpot (ELISPOT) Assay for Measurement of Pathogen-Specific T-cell Responses in Normal Donors**

**G. V. Yamshchikov**, J. A. Franklin, C. D. Williams, L. K. Wathen, J. F. Halsey; IBT Reference Laboratory, Lenexa, KS.

**42**   **Comèl-Netherton Syndrome - New Insight Into The Molecular Basis of this Rare Syndrome Characterized by Atopic Diathesis and Immune Deficiency**

**E. D. Renner** ^1,2^, S. Rylaarsdam^1^, S. Anover^1^, D. Hartl^2^, A. Jayakumar^3^, B. H. Belohradsky^2^, U. Ermer^4^, Y. Jin^1^, G. Kleiner^5^, F. Nagel^2^, Q. Zhu^1^, G. L. Claymann^3^, T. R. Torgerson^1^, H. D. Ochs^1^; ^1^University of Washington, Seattle, WA, ^2^Dr. v. Haunersches Kinderspital, Ludwig Maximilian University, Munich, GERMANY, ^3^The University of Texas M. D. Anderson Cancer Center, Houston, TX, ^4^Children\'s Hospital, Neuburg, GERMANY, ^5^University of Miami Bachelor Children\'s Research Center, Miami, FL.

**43**   **European Consensus for Gynecologycal and Obstetric Management of Women with Hereditary Angioedema due to C1-Inhibitor Deficiency (HAE): PREHAEAT**

**T. Caballero** ^1,2^, L. Bouillet^3,4^, K. Bork^5,6^, C. Bucher^7,8^, A. Bygum^9,10^, C. De Carolis^11,12^, H. Farkas^13,14^, H. Longhurst^15,16^, E. Nielsen^17,18^, R. Perricone^19,12^, N. Prior^1^, M. Cicardi^20,21^; ^1^University Hospital La Paz, Madrid, SPAIN, ^2^PREHAEAT Member, Coordinator of Consensus, Madrid, SPAIN, ^3^Grenoble University Hospital, Grenoble, FRANCE, ^4^PREHAEAT Member, Coordinator Work Package 5, Grenoble, FRANCE, ^5^Johannes-Gutenberg-University of Mainz, Mainz, GERMANY, ^6^PREHAEAT Member (alphabetic order), Mainz, GERMANY, ^7^University of Zurich, Zurich, SWITZERLAND, ^8^PREHAEAT Member (alphabetic order), Zurich, SWITZERLAND, ^9^Odense University Hospital, Odense C, DENMARK, ^10^PREHAEAT Member (alphabetic order), Odense, DENMARK, ^11^San Giacomo Hospital, Rome, ITALY, ^12^PREHAEAT Member (alphabetic order), Rome, ITALY, ^13^Semmelweis University, Budapest, HUNGARY, ^14^PREHAEAT Member (alphabetic order), Budapest, HUNGARY, ^15^Barts and the London NHS Trust, London, UNITED KINGDOM, ^16^PREHAEAT Member (alphabetic order), London, UNITED KINGDOM, ^17^Norland Hospital and University of Tronsø, Bodø, NORWAY, ^18^PREHAEAT Member (alphabetic order), Bodø, NORWAY, ^19^PTV and University of Rome "Tor Vergata", Rome, ITALY, ^20^Università degli Studi de milano; Ospedale S. Giuseppe, Milan, ITALY, ^21^Coordinator of PREHAEAT Group, Milan, ITALY.

**44**   **Tolerance To Allogeneic Thymus Transplantation In Complete DiGeorge Syndrome**

**I. K. Chinn**, B. H. Devlin, M. J. Alexieff, J. Li, S. E. Gupton, E. A. McCarthy, M. L. Markert; Duke University Medical Center, Durham, NC.

**45**   **Development Of A Newborn Screening Test For Severe Combined Immunodeficiency Using ELISA And Dried Blood Spots**

**K. Chen**, S. A. McGhee, E. R. B. McCabe; David Geffen School of Medicine at UCLA, Los Angeles, CA.

**46**   **Use of Wiskostatin to Recapitulate the Wiskott-Aldrich Syndrome Phenotype in-vitro**

**S. Roy-Ghanta**, E. P. Williams, R. P. Deering, J. S. Orange; University of Pennsylvania/Children\'s Hospital of Philadelphia, Philadelphia, PA.

**47**   **Defective Pneumococcal Polysaccarides-induced Cytokine Production in Common Variable Immunodeficiency**

**R. Hong**, S. Gupta; University of California, Irvine, CA.

**48**   ***Helicobacter Pylori* Infection As A Triggering Factor Of Attacks In Patients With Hereditary Angioedema**

**B. Visy** ^1^, G. Füst^2^, A. Bygum^3^, K. Bork^4^, H. J. Longhurst^5^, C. Bucher^6^, L. Bouillet^7^, M. Cicardi^8^, H. Farkas^2^; ^1^Madarász street Hospital of Heim Pál\' Pediatric Hospital, Budapest, HUNGARY, ^2^Semmelweis University, Budapest, HUNGARY, ^3^Odense University Hospital, Odense, DENMARK, ^4^Johannes Gutenberg University, Mainz, GERMANY, ^5^Barts and the London NHS Trust, London, UNITED KINGDOM, ^6^University Hospital, Zurich, SWITZERLAND, ^7^CHU de Grenoble, Grenoble, FRANCE, ^8^Università degli Studi di Milano, Milan, ITALY.

**49**   **Genetic Analysis of Autosomal Dominant Common Variable Immunodeficiency**

**A. Marks** ^1^, H. Meyerson^1^, B. Grimbacher^2^, R. W. Hostoffer, Jr.^1^; ^1^Case Western Reserve University, Cleveland, OH, ^2^University Of Friedburg, Friedburg, GERMANY.

**50**   **Role of Toll-like Receptor Signalling Defects in Human Susceptibility to Invasive Infection by Streptococcus Pneumoniae**

**S. E. Turvey** ^1^, A. F. Hirschfeld^1^, R. E. Victor^1^, J. S. Orange^2^, J. A. Bettinger^1^; ^1^BC Children\'s Hospital and University of British Columbia, Vancouver, BC, CANADA, ^2^Children\'s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA.

**51**   **Guidelines for "10 Warning Signs of Primary Immunodeficiency" Neither Sensitive Nor Specific**

**F. P. Aloi**, S. S. Mishra, A. J. MacGinnitie; Children\'s Hospital of Pittsburgh, Pittsburgh, PA.

**52**   **Reimbursement Driven Medicare Patients Receiving IVIgG in the Hospital vs. the Physician\'s Office**

**M. Eagam** ^1^, R. W. Hostoffer, Jr.^2^; ^1^Lake Erie College of Osteopathic Medicine, Erie, PA, ^2^Case Western Reserve University, Cleveland, OH.

**53**   **Hypo-IgM Syndrome: A Secretion Defect?**

**S. P. Silverman**, D. W. Rosenthal, P. Ponda, V. R. Bonagura; North Shore-Long Island Jewish Medical Center, Great Neck, NY.

**54**   **Allergic Reaction and Anaphylaxis to IVIg when Administered Through Bromobutyl Vial Closure**

**M. Solomon**, R. W. Hostoffer, Jr.; Case Western Reserve University, Cleveland, OH.

**55**   **NEMO (IKKγ) Mutation Can Be Associated With Opportunistic Infection Without Impairing TLR Function**

**E. W. Gelfand** ^1^, B. Salt^1^, A. Jain^2^, J. E. Niemela^2^, R. Deering^3^, R. Pandey^3^, R. Quinones^4^, J. Orange^3^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^National Institutes of Health, Bethesda, MD, ^3^Children\'s Hospital of Philadelphia, Philadelphia, PA, ^4^Children\'s Hospital of Denver, Denver, CO.

**56**   **Primary Immunodeficiency Disorders: 30 Years of Experience in Shanghai, China**

**T. Chen**, D. Ying; Shanghai Jiao Tong University School of Medicine, Shanghai, CHINA.

**57**   **Antibody Deficiency Disorders in Recurrent/persistent pneumonia and Chronic Sinusitis in Thai Children at Queen Sirikit National Institute of Child Health.**

**P. Lerdluedeeporn, IV** ^1^, C. Thanee^2^, N. Pupugdee^2^, S. Nanthapisal^2^, G. Phongsamart^2^, M. Vangveeravong^2^; ^1^Bangkok International Hospital, Bangkok, THAILAND, ^2^Queen Sirikit National Intitute of Child Health, Bangkok, THAILAND.

**58**   **Subcutaneous Bioavailability of Gamunex® in Rabbits**

M. Pamarthi, G. Taylor, P. Scuderi, **V. Arora**; Talecris Biotherapeutics, Research Triangle Park, NC.

**59**   **Infants With Decreased Immunoglobulin Levels**

**S. J. McGeady**, S. Kung; Thomas Jefferson University, Philadelphia, PA.

**60**   **Idiopathic CD4+ T-Lymphocytopenia (ICL) in a Child with Persistent Cryptococcal Meningitis**

Y. Yilmaz^1^, B. Wilson^2^, M. Lowery-Nordberg^3^, J. A. Bocchini, Jr.^4^, **S. L. Bahna** ^2^; ^1^Department of Pediatrics, Louisiana State University Health Sciences Center, Shreveport, LA, ^2^Allergy/Immunology Section, Louisiana State University Health Sciences Center, Shreveport, LA, ^3^Department of Pathology, Louisiana State University Health Sciences Center, Shreveport, LA, ^4^Pediatric Infectious Disease Section, Louisiana State University Health Sciences Center, Shreveport, LA.

**61**   **Novel CYBA Gene Mutation in a Patient with Chronic Granulomatous Disease Associated with Autoimmune Hepatitis**

**A. Bagg** ^1^, R. Gonzalez-Peralta^2^, A. Petrovic^3^, J. W. Sleasman^4^; ^1^Division of Allergy and Immunology, James A Haley Veterans Hospital, Tampa, FL, ^2^University of Florida Pediatric Gastroenterology, Gainesville, FL, ^3^Department of Pediatrics, University of South Florida College of Medicine, St. Petersburg, FL, ^4^Department of Pediatrics, Division of Allergy and Immunology, University of South Florida College of Medicine, St. Petersburg, FL.

**62**   **Mannose-Binding Lectin Deficiency in a Family with Frequent Respiratory Infections**

**W. Zheng** ^1,2^, J. Hester^3^, C. Kirkpatrick^2^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^University of Colorado Health Sciences Center, Denver, CO, ^3^IBT Reference Laboratory, Lenexa, KS.

**63**   **Pediatric Patients With Refractory Autoimmune Cytopenias Displaying Autoimmune Lymphoproliferative Syndrome (ALPS) Phenotypes - Role For Anti-cd20(Rituximab ™) Therapy**

**T. Chang**, D. Schauer, W. Grossman; Medical College of Wisconsin, Milwaukee, WI.
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**64**   **β-tubulin Induced Murine Model of Autoimmune Hearing Loss and Regulation of T Cell Cytokines of the Mice**

**S. H. Cho**, B. Zhou, J. Glickstein, M. H. Kermany, C. Cai, Q. Cai, W. Liu, T. J. Yoo; University of Tennessee Health Science Center, Memphis, TN.

**65**   **The Clinical Significance Of Isolated Antinucleolar Antibodies**

**S. Khan** ^1^, S. Holding^2^, A. Alvi^3^, S. Saravana^4^, W. A. C. Sewell^1,5^; ^1^Scunthorpe General Hospital, Scunthorpe, UNITED KINGDOM, ^2^Hull Royal Infirmary, Hull, UNITED KINGDOM, ^3^Diana Princess of Wales Hospital, Grimsby, UNITED KINGDOM, ^4^Worcester Royal Hospital, Worcester, UNITED KINGDOM, ^5^University of Lincoln, Lincoln, UNITED KINGDOM.

**66**   **Prostate Specific Antigen: Responsible Allergen In Human Seminal Plasma Allergy**

**M. Basagaña** ^1^, C. Pastor^2^, B. Bartolomé^3^, R. Alonso^1^, M. San Miguel^1^, A. Cisteró-Bahíma^1^; ^1^Institut Universitari Dexeus, Barcelona, SPAIN, ^2^Fundación Jimenez-Díaz, Madrid, SPAIN, ^3^I+D Bial-Aristegui, Bilbao, SPAIN.

**67**   **Development of Hypocomplementemic Urticarial Vasculitis Syndrome Following Intracoronary Stent Placement**

**S. L. Cole**, D. K. Ledford; University of South Florida, Tampa, FL.

**68**   **Treatment of Hypoglycemia with Intramuscular Immunoglobulin in Insulin Dependent-Diabetics with Insulin Antibodies**

**S. A. MacLeish**, S. Wallace, Z. Madhun, R. Hostoffer, Jr.; Case Western Reserve University, Cleveland, OH.

**69**   **A Case of a Child with Autoimmune Polyglandular Syndrome(APS-1) associated with Metaphyseal Dysplasia**

**T. J. Pitt**, N. K. Maclaren; St Vincent Hospital Manhattan, Department of Pediatrics, New York, NY.

**70**   **Behçet Disease in a Patient with Autoimmune Polyendocrine Syndrome -Type 1**

**Ö. Özdemir**; Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**71**   **Autoimmune Neonatal Chondrodysplasia Punctata and Maternal Lupus**

**R. Herzog** ^1^, L. J. Bernstein^1^, A. L. Shanske^2^; ^1^Division of Allergy and Immunology, Children\'s Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY, ^2^Center for Craniofacial Disorders, Children\'s Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY.

**72**   **Hyperinsulinemia Hyperammonemia Syndrome in a patient with autoimmune disease**

**R. V. Basavaraju**; Kansas University Medical Center, Kansas City, KS.

**73**   **Fever of Unknown Origin (FUO) and Anemia as Sole Presenting Features of Sarcoid**

**T. Chacko**, D. Ledford, R. F. Lockey; University of South Florida Collge of Medicine, Tampa, FL.

**74**   **Pancytopenia and Myelofibrosis in Autoimmune Polyglandular Syndrome Type I**

**M. Braskett**, M. I. Garcia-Lloret, S. Howenstine, D. McCurdy, S. McGhee; UCLA, Los Angeles, CA.

**75**   **Autoimmune Thyroiditis Developing In A Survivor Of Catastrophic Antiphospholipid Syndrome: A Case Report**

**C. C. Ocampo**, L. T. A. Aleta, M. W. Sumpaico; Section of Allergy and Immunology, Department of Medicine, University of the Philippines - Philippine General Hospital, Manila, PHILIPPINES.

**76**   **Ischemic Events in Pacients with Systemic Lupus Erythematosus**

M. E. Flores^1,2^, **M. E. Contreras** ^1^, I. A. Bello^1^, L. A. Aranguren^1^, E. Marti^1^; ^1^Universidad de Carabobo, Valencia, VENEZUELA, ^2^Ciudad Hospitalaria Dr. Enrique Tejera, Valencia, VENEZUELA.

**77**   **Antibodies Anti-cmv In Patient With Myocardial Ischemia**

**M. E. Flores Chávez** ^1^, M. Chacón de Petrola^2^, C. Celis^3^, A. Chiquito^3^, N. Figueroa^3^, I. Petrola^4^; ^1^Unidad de Inmunologia. Ciudad Hospitalaria Enrique Tejera, Valencia, VENEZUELA, ^2^Unidad de Investigaciones en Inmunologia Clinica. UC., Valencia, VENEZUELA, ^3^Universidad de Carabobo, Valencia, VENEZUELA, ^4^Unidad de Cuidados Coronarios. Ciudad Hospitalaria Enrique Tejera, Valencia, VENEZUELA.

**78**   **A 54 Year-Old Woman with Acquired Angioedema, Coagulopathy, and Lymphoma**

**E. L. Pratt**, S. Chegini, T. Craig; Penn State Milton S. Hershey Medical Center, Hershey, PA.

**79**   **Abdominal pain, Nausea, and Vomiting as the Initial Presenting Symptoms of Systemic Lupus Erythematosus**

**B. Shin**, D. K. Ledford, R. F. Lockey; Division of Allergy and Clinical Immunology, University of South Florida College of Medicine, Tampa, FL.

**80**   **Mucosal administration of *Escherichia coli* Heat-labile toxin B and Classical swine fever E2 Chimeric antigen inhibits collagen-induced rheumatoid arthritis**

**D. Kim**; Chonnam national university, Gwang-ju, REPUBLIC OF KOREA.
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**81**   **IgE-Mediated Hypersensitivity Reactions to Cannabis in Laboratory Personnel**

**T. Herzinger**, F. Ruëff, P. Schöpf, B. Przybilla; Ludwig-Maximilians-Universität, Munich, GERMANY.

**82**   **Multiple Chemical Sensitivity: an Unusual Case of Vocal Disorder**

**M. Medeiros, Jr.**, H. B. Santos, C. Salles, H. Rosa; Allergic Center Diseases, Salvador - Bahia, BRAZIL.

**83**   **Effect of Training on Asthma and Allergy Symptoms in Recreational Roadrunners**

**C. C. R. Randolph** ^1^, D. Dreyfus^1^, D. Bangalore^2^, L. Wall^1^; ^1^Center for Allergy, Asthma and Immunology, Waterbury, CT, ^2^Waterbury Hospital, Waterbury, CT.

**84**   **Occupational Mouse Allergen Exposure and Incident Skin Test Sensitivity**

**E. C. Matsui** ^1^, B. J. Paigen^2^, E. A. O\'Neil^2^, K. A. Hagberg^2^, P. A. Eggleston^1^; ^1^Johns Hopkins University School Medicine, Baltimore, MD, ^2^The Jackson Laboratory, Bar Harbor, ME.

**85**   **Hypersensitivity Pneumonitis Caused by Trichoderma Viride**

**A. Enríquez-Matas** ^1^, S. Quirce^1^, R. Melchor^1^, M. J. Rodríguez-Nieto^1^, J. Carnés^2^, M. Madero^1^, J. A. Torres^1^, J. Sastre^1^; ^1^Fundación Jiménez Díaz, Madrid, SPAIN, ^2^Leti, Madrid, SPAIN.

**86**   **An Age-stratified Assessment Of The Incidence Allergic Diseases Among Patients From Western Hungary**

**L. Sóti** ^1^, Z. Petz^1^, L. Endre^2^, L. Réthi^3^, L. M. DuBuske^4^; ^1^Szombathely Allergy-Asthma Outpatient Clinic, Szombathely, HUNGARY, ^2^Budapest National Health Institute, Budapest, HUNGARY, ^3^Svábhegy National Institute of Pediatrics, Budapest, HUNGARY, ^4^Immunology Research Institute of New England, Gardner, MA.

**87**   **Occupational Asthma Secondary To Enzymes Used In Cheese Production**

**R. M. Casper**, M. C. Zacharisen, J. N. Fink; Medical College of Wisconsin, Milwaukee, WI.

**88**   **IgE and Skin Test Reactivity in relation to Anti-parasitic treatment**

**E. E. Fouda** ^1^, A. I. Ali^1^, M. Emam^2^, A. S. Abdel Khalek^1^; ^1^Al-Azhar Allergy & Immunology University Center, Cairo, EGYPT, ^2^Al-Azhar University faculty of medicine, Cairo, EGYPT.

**89**   **Occupational Contact Urticaria Syndrome Caused By Handling Lettuce And Chicory: Cross-reactivity Between Lettuce And Chicory**

**A. Morita** ^1^, N. Inomata^1^, M. Kondou^2^, T. Shirai^3^, Z. Ikezawa^1^; ^1^Department of Dermatology,Yokohama City University, Yokohama, JAPAN, ^2^Kondou Dermatology Clinic, Yokohama, JAPAN, ^3^Department of Internal Medicine, Fujinomiya City Hospital, Japan, Fujinomiya, JAPAN.

**90**   **Asthma Prevalence and Morbidity Among Rural Schoolchildren in the Mississippi Delta**

**T. T. Perry**, S. M. Jones, J. R. Stalnaker, K. R. Nichols, P. A. Vargas; University of Arkansas for Medical Sciences, Little Rock, AR.

**91**   **Asthma and Mycoplasma pneumoniae infection**

**Y. Park**; Wonkwang University Sanbon Medical Center, Gunpo City, REPUBLIC OF KOREA.

**92**   **Is Obesity Related To Severity And Frequency Of Asthma Symptoms?**

**F. Hassan** ^1,2^, P. Patel^2^, E. Secord^2^; ^1^Woodhull medical center, Brooklyn, NY, ^2^The Carmen and AnAdams Dept. of Pediatrics, Children hospital of Michigan, Wayne State University, Detroit, MI.

**93**   **Characteristics of Asthma Programs with Positive Health Outcomes**

**A. R. Friedman**, L. L. Lachance, S. C. Stoll, D. F. Awad, N. M. Clark; University of Michigan School of Public Health, Ann Arbor, MI.

**94**   **Detection of Underdiagnosed and Poorly Controlled Asthma in a Hospital-Based Outpatient Pediatric Clinic using a Health Risk Assessment (HRA) System**

**B. Nichols** ^1^, L. Scott^1^, S. Jones^2^, K. Kwong^1^, T. Morphew^3^, L. T. Clement^1^, F. Lifson^3^, C. A. Jones^1,3^; ^1^LAC+USC Medical Center, Los Angeles, CA, ^2^LAC+USC Medical Center Volunteer Program, Los Angeles, CA, ^3^Southern California Chapter of the Asthma and Allergy Foundation of America, Los Angeles, CA.

**95**   **The Asthma Day Care Project: Identifying and Managing Asthma in Brooklyn Preschools**

**A. R. Padi**, K. Garrett-Szymanski, C. Willis, B. Silverman, R. Giusti, A. Schneider; Long Island College Hospital, Brooklyn, NY.

**96**   **Dust And Airborne Concentrations Of Endotoxins In Strasbourg And In A Rural Environment (Haut-Doubs)**

**F. de Blay** ^1^, G. Reboux^2^, A. Casset^1^, S. Roussel^2^, K. Humbert^2^, B. Sudre^2^, R. Piarroux^2^, J. Dalphin^2^; ^1^Asthma and Allergy Division, Department of Chest Diseases, University Hospital, Strasbourg, FRANCE, ^2^University Hospital, Besançon, FRANCE.

**97**   **Allergy To Cumaru (*Dipterix micrantha Harms*) Tropical Wood**

**F. de la Losa, Sr.**; DIATER Laboratories, San Martin de la Vega, SPAIN.

**98**   **Impact of Absences due to Asthma on Total School Absences in Upstate New York Elementary Schools**

**E. Simons**, A. Reddy, M. Gomez, C. Kielb, S. Lin; New York State Department of Health, Center for Environmental Health, Albany, NY.

**99**   **Effects of Cigarette Smoke Extract and Rhinovirus on Expression of B7H1 and B7H3 in Human Airway Epithelial Cells**

**E. Schafer**, S. Favoreto, J. Shen, R. Dave, P. C. Avila; Northwestern University, Chicago, IL.

**100**   **The Long-term Effects Of Diesel Exhaust Particles On Airway Inflammation And Responsiveness In A Mouse Model**

**A. Jang**; Soonchunhyang University Hospital, Bucheon, REPUBLIC OF KOREA.

**101**   **Quantity of Rhinovirus in Nasal Lavage Does Not Predict Illness Severity**

**J. D. Bufford** ^1^, K. A. Roberg^1^, T. E. Pappas^1^, R. F. Vrtis^1^, M. D. Evans^2^, R. E. Gangnon^2^, R. F. Lemanske, Jr.^1^, J. Gern^1^; ^1^University of Wisconsin School of Medicine and Public Health, Madison, WI, ^2^University of Wisconsin-Madison, Madison, WI.
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**102**   **Elucidating The Cause Of Peri-operative Allergic Reactions-Correlation Between Clinical Features, Skin Testing Data And Serum Tryptase Levels**

**C. H. Katelaris**; Westmead Hospital, Westmead, AUSTRALIA.

**103**   **Dose-Dependant Angioedema Due to Sirolimus**

**A. Kleiner**, R. Srinivasan, R. J. Looney; Allergy/Immunology and Rheumatology Unit, University of Rochester Medical Center, Rochester, NY.

**104**   **Differences in the Allergic Response Induced by Live or Dead Anisakis Simplex Larvae in C3H/HeJ Mice**

**M. L. Baeza**, Y. Higaki, L. Conejero, A. Torrecilla, M. Vazquez de la Torre, M. Rubio, J. M. Zubeldia; Hospital General Universitario Gregorio Marañón, Allergy Service and Experimental Medicine Unit, Madrid, SPAIN.

**105**   **Drug Anaphylaxis As Presentation of Systemic Mastocytosis: About 7 Case Reports**

**F. Codreanu**, M. Morisset, J. M. Renaudin, A. Schuller, J. Mouzita, E. Beaudouin, D. A. Moneret-Vautrin, G. Kanny; University Hospital, Nancy, FRANCE.

**106**   **The Availability of EpiPens® Used by Students with Severe Food allergies in Michigan Schools**

**D. Kassab** ^1^, E. A. Robinson^2^, A. Russell^1^, M. McMorris^1^; ^1^University of Michigan, Ann Arbor, MI, ^2^St. Joseph Mercy Hospital, Ann Arbor, MI.

**107**   **Prevalence of Allergy and Anaphylaxis in 210 Patients with Mastocytosis**

**A Study From The Spanish Network on Mastocytosis (REMA)**

**D. González de Olano** ^1^, M. B. de la Hoz Caballer^1^, R. Nuñez López^1^, L. Sánchez Muñoz^1^, M. Cuevas Agustín^1^, M. Dieguez^1^, M. Castells^2^, L. Escribano Mora^1^; ^1^Hospital Ramón y Cajal, Madrid, SPAIN, ^2^Brigham and Women\'s Hospital, Harvard Medical School, Boston, MA.

**108**   **Anaphylaxis As An Initial Manifestation Of Cholangiocarcinoma**

**P. Ngamjanyaporn** ^1^, S. Janwityanujit^1^, P. Dekumyoy^2^; ^1^Department of Internal Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND, ^2^Department of Helminthology, Faculty of Tropical Medicine, Mahidol University, Bangkok, THAILAND.

**109**   **Superior Vena Cava Syndrome: A Masquerader of Anaphylaxis**

**B. Khalili** ^1^, P. B. Boggs^2^, S. L. Bahna^1^, A. J. Marsala^3^, M. Tapolyai^3^, R. O. Bryn^3^; ^1^LSUHSC Allergy & Immunology Section, Shreveport, LA, ^2^Asthma and Allergy Clinic and Center of Excellence, Shreveport, LA, ^3^Willis-Knighton Medical Center, Shreveport, LA.

**110**   **Use Of Epinephrine In Food-induced Anaphylaxis In Children**

**K. M. Jarvinen**, W. G. Shreffler, H. A. Sampson, S. Noone, A. Nowak-Wegrzyn; Mt. Sinai Hospital, New York, NY.

**111**   **Food-Dependent Exercise-Induced Anaphylaxis Associated with Clonal Mast Cells Carrying an Activating c-Kit Mutation**

**S. I. Hungness**, A. M. Singer, C. Akin; University of Michigan, Ann Arbor, MI.

**112**   **Maturation of the IgE and IgG response to Imported Fire Ant Venom during natural exposure**

**M. Partridge** ^1^, D. Ownby^1^, R. Hamilton^2^, P. Young^1^, J. Ford^1^; ^1^Medical College of Georgia, Augusta, GA, ^2^Johns Hopkins Hospital, Baltimore, MD.

**113**   **Recent Trends in Hymenoptera Sensitivity Evaluation**

**L. C. Cary** ^1^, J. Temprano^2^; ^1^Department of Internal Medicine, Divison of Allergy, Asthma and Immunology, Univeristy of Kentucky, Lexington, KY, ^2^Department of Internal Medicine, Division of Allergy, Asthma, and Immunology, Univeristy of Kentucky, Lexington, KY.

**114**   **The Uses of MALDI-TOF Mass Spectrometry in Characterization of Allergens**

**D. R. Hoffman**; Brody School of Medicine at East Carolina University, Greenville, NC.

**115**   **IgE Reactivity to Recombinant Omega-5 Gliadin in Wheat-Dependent Exercise-Induced Anaphylaxis**

**H. Matsuo** ^1^, J. Dahlström^2^, K. Kohno^3^, H. Takahashi^3^, E. Morita^3^; ^1^Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JAPAN, ^2^Research and Development, Phadia, Uppsala, SWEDEN, ^3^Department of Dermatology, Shimane University School of Medicine, Shimane, JAPAN.

**116**   **Production and Analysis of the Allergenic Venom Serine Protease from Polistes dominulus**

C. D. Fitch^1^, M. Schmidt^2^, **D. R. Hoffman** ^3^; ^1^Brody School of Medicine, Greenville, NC, ^2^E. Carolina University, Greenville, NC, ^3^Brody School of Medicine, Greenville, NC.

**117**   **New Diagnostic Approaches for Wasps Venom Allergy**

**R. I. Monsalve** ^1^, R. Gutierrez^1^, F. Polo^1^, M. Lombardero^1^, A. Galan^1^, T. P. King^2^, L. Marques^3^, D. Barber^1^; ^1^ALK-ABELLO, Madrid, SPAIN, ^2^Rockefeller University, New York, NY, ^3^SEAIC Hymenoptera Committee, Lleida, SPAIN.

**118**   **Identification of an Allergenic Lipid Transfer Protein in Pomegranate-Induced Anaphylaxis**

**M. San Miguel-Moncín** ^1^, M. Lombardero^2^, D. Barber^2^, E. Enrique^3^, R. Alonso^1^, M. Basagaña^1^, A. Cisteró-Bahima^1^; ^1^Allergy Department. Institut Universitari Dexeus, Barcelona, SPAIN, ^2^R & D Dept. ALK-Abello S. A., Madrid, SPAIN, ^3^Servicio de Alergia. Hospital General de Castellón, Castellón, SPAIN.

**119**   **Anaphylaxis Due To Buckwheat Skin Testing**

**Y. K. Cheng**; Tan Tock Seng Hospital, Singapore, SINGAPORE.

**120**   **Sensitization to Egg Via Inhalation of Egg Aerosol Resulting in Anaphylaxis**

**J. E. Yoo**; University CA-San Francisco, San Francisco, CA.

**121**   **Comparison of a Modified Yellow Jacket Venom Extract (Allergoid) with Conventional Yellow Jacket Venom (Aluminium hydroxide bounded) for the Treatment of Yellow Jacket Allergy by Sting Challenges**

**H. N. G. Oude Elberink** ^1^, H. A. Kleinjans^2^, H. de Groot^3^; ^1^University Medical Center of Groningen, Groningen, THE NETHERLANDS, ^2^HAL Allergy, Haarlem, THE NETHERLANDS, ^3^Erasmus Medical Center, Rotterdam, THE NETHERLANDS.

**122**   **Hospitalizations for Anaphylaxis in Florida: Epidemiologic Analysis of a Population-Based Dataset**

**Z. D. Mulla** ^1^, M. R. Simon^2^; ^1^Texas Tech University HSC School of Medicine at El Paso, El Paso, TX, ^2^Wayne State University School of Medicine, Detroit, MI.

**123**   **Prevalence of Latex Sensitization and Allergy among handicapped patients**

**I. Kobayashi** ^1,2^, K. Kitsuki^3,2^, S. Yamamoto^2^, T. M. Horiuti^1^, R. M. Goldblum^1^, Y. Hamasaki^2^; ^1^University of Texas Medical Branch, Galveston, TX, ^2^Medical University of Saga, Saga city, JAPAN, ^3^Saga seishi-gakuen Child Development Medical Center, Saga city, JAPAN.

**124**   **Fast-Disintegrating Sublingual Epinephrine Tablets: High Temperature Stability Study**

M. M. Rawas-Qalaji, F. E. R. Simons, **K. J. Simons**; University of Manitoba, Winnipeg, MB, CANADA.

**125**   **Latex Allergy: Low Prevalence of IgE to Highly Purified Hev b 2 and Hev b 13**

**T. Palosuo** ^1^, M. Lehto^2^, A. Kotovuori^3^, N. Kalkkinen^3^, C. Blanco^4^, P. Poza^4^, T. Carrillo^4^, R. G. Hamilton^5^, H. Alenius^2^, T. Reunala^6^, K. Turjanmaa^6^; ^1^National Public Health Institute, Helsinki, FINLAND, ^2^Finnish Institute of Occupational Health, Helsinki, FINLAND, ^3^Institute of Biotechnology, University of Helsinki, Helsinki, FINLAND, ^4^Servicio de Alergia, Hospital Universitario de Gran Canaria, Las Palmas de Gran Canaria, SPAIN, ^5^Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, ^6^Department of Dermatology, Tampere University and University Hospital, Tampere, FINLAND.

**126**   **Imported Fire Ant Sublingual Immunotherapy for Large Local Reactions**

**M. H. Tucker**, C. W. Calabria, L. L. Hagan, J. P. Dice; Wilford Hall Medical Center, San Antonio, TX.

**127**   **Single Intragastric Peanut Feeding Leads To Anaphylactic Shock In C3H/HeJ But Not In BALB/c Or C57BL/6 Mice**

**B. Proust** ^1^, C. M. N. Astier^2^, S. Jacquenet^3^, V. Ogier^3^, E. Magueur^3^, B. Thouvenot^3^, M. Morisset^1^, D. A. Moneret-Vautrin^1^, H. A. Sampson^4^, A. W. Burks^5^, B. E. Bihain^3^, G. Kanny^1^; ^1^University Hospital, Vandoeuvre-Les-Nancy, FRANCE, ^2^INPL, Vandoeuvre-Les-Nancy, FRANCE, ^3^Laboratory of Molecular Medicine and Therapeutics, Vandoeuvre-Les-Nancy, FRANCE, ^4^Mount Sinaï Hospital, New-York, NY, ^5^Duke University Medical Center, Durham, NC.

**128**   **Methylene Blue as a Treatment for Refractory Anaphylaxis**

**S. S. Sheth**, D. Del Duca, P. Ergina, A. E. Clarke; McGill University Health Centre, Montreal, PQ, CANADA.

**129**   **Anaphylaxis: Report of Two Fatal Yellow Jacket (YJ) Stings in Alaska (AK)**

**M. L. Oswalt** ^1^, J. T. Foote^2^, S. F. Kemp^1^; ^1^University of Mississippi Medical Center, Jackson, MS, ^2^Tanana Valley Clinic, Fairbanks, AK.

**130**   **Anaphylaxis Caused by Younger Garlic: Two Cases Report in China**

**J. Yin**, H. Li; Allergy Department, Peking Union Medical College Hospital, Beijing, CHINA.

**131**   **Recurrent Panic/Anxiety Attacks: Masquerader of Anaphylaxis and Challenge to Comprehensive History Taking**

**C. D. Friesen** ^1^, R. J. M. Engler^2^; ^1^Carl R. Darnall Army Medical Center, Fort Hood, TX, ^2^Walter Reed Army Medical Center-VHC, Washington, DC.

**132**   **Anaphylaxis in a Patient with Long QT Syndrome**

**P. Permaul**, L. C. Schneider, J. Triedman; Children\'s Hospital Boston, Boston, MA.

**133**   **A Case Report on Immunotherapy in Recurrent Anaphylaxis using the Whole-Body Extract of Fire Ant**

**P. Rojponpradit** ^1^, S. Benjaponpitak^1^, W. Kamchaisatian^1^, C. Direkwattanachai^1^, C. Sasisakulporn^2^; ^1^Division of Pediatric Allergy and Immunology, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND, ^2^Center of Research, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND.

**134**   **Anaphylaxis to Honey in a Patient Sensitized to Compositae Pollen**

**N. Fuiano** ^1^, G. Riario-Sforza^2^, C. Incorvaia^2^; ^1^Pediatric Allergy Service, A.USL Fg1, San Severo, ITALY, ^2^Allergy and Pulmonary rehabilitation, ICP Hospital, Milano, ITALY.

**135**   **Successful Desensitization in a Severe Hemophilia B patient with IgE-mediated Anaphylaxis to Factor IX**

**Y. Moonsup** ^1^, S. Benjaponpitak^1^, A. Chuansumrit^2^, W. Kamchaisatian^1^, C. Direkwattanachai^1^; ^1^Division of Allergy and Clinical Immunology, Department of Pediatrics, Ramathibodi hospital, Mahidol University, Bangkok, THAILAND, ^2^Division of Hematology, Department of Pediatrics, Ramathibodi hospital, Mahidol University, Bangkok, THAILAND.
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**136**   **Humoral Immune Responses to Cosmetically-Administered Hyaluronic Acid (Perlane and Restylane)**

**R. G. Hamilton** ^1^, J. Strobos^2^, N. F. Adkinson, Jr.^1^; ^1^Johns Hopkins University School of Medicine, Baltimore, MD, ^2^Medicis Pharmaceutical Corporation, Scottsdale, AZ.

**137**   **Safety of a Single Day Aspirin Desensitization Protocol**

**B. L. Buchmiller**, D. A. Khan; University of Texas Southwestern Medical School at Dallas, Dallas, TX.

**138**   **Rapid Oral Aspirin Challenge-Desensitization in Patients With Symptomatic Acute Coronary Syndrome**

**M. Michelis**, K. Bianco, T. Selvaggi, A. Oughourli; Hackensack University Medical Center, Hackensack, NJ.

**139**   **Severe Drug-Induced Anaphylaxis: Survey of Case Reports by Allergy Vigilance Network**

**J. M. C. Renaudin**, G. Kanny, F. Codreanu, E. Beaudouin, D. A. Moneret-Vautrin; University Hospital, Nancy, FRANCE.

**140**   **Specific Subpopulation Involved in Allergic Delayed Responses to Amoxicillin in an *in Vitro* System with Autologous Dendritic Cells**

**R. R-Pena** ^1^, S. Lopez^1^, C. Antunez^1^, P. Chaves^1^, C. Mayorga^1^, M. J. Torres^2^, T. D. Fernandez^1^, J. A. Cornejo-Garcia^1^, M. Blanca^2^; ^1^Research Laboratory, Fundacion IMABIS-Carlos Haya Hospital, Málaga, SPAIN, ^2^Allergy Service, Carlos Haya Hospital, Málaga, SPAIN.

**141**   **Coexistence of Atopic Diseases and Idiosyncratic Reactions to Aspirin**

**A. A. Nowak** ^1,2^, M. Nowak^2^, A. Muszyñska^3,2^, A. M. Fal^4^; ^1^1st Department of Paediatrics, Allergology and Cardiology, Medical University, Wroclaw, POLAND, ^2^Allergology and Clinical Immunology Students Scientific Research Group, Medical University, Wroclaw, POLAND, ^3^Department of Family Medicine, Medical University, Wroclaw, POLAND, ^4^Department of Internal Medicine and Allergology, Medical University, Wroclaw, POLAND.

**142**   **Exudative Erythema Multiforme With Hydroxyzine**

**A. Losada**, E. Gonzalez, A. Henriquez, B. Huertas, P. Berges, E. Alvarez; Servicio de Alergia. Hospital Ramon y Cajal, Madrid, SPAIN.

**143**   **Reliability of Drug Allergy History in Foreign Tourists**

**M. OKADA**; St. Luke\'s International Hosiptal, 104-8560 Tokyo, JAPAN.

**144**   **Putative B-cell Apoptosis as a Cause of Hypogammaglobulinemia in Carbamazepine Hypersensitivity: A Case Report**

**J. A. Bird**, D. M. Anmuth, E. Muscal, M. K. Dishop, C. L. Nance, S. L. Abramson; Baylor College of Medicine, Houston, TX.

**145**   **Cross-reactivity Between Penicillins and Cephalosporins with the Same Side Chain: Amoxicillin and Cefadroxil**

**M. J. Torres** ^1^, N. Blanca-Lopez^2^, E. Martin^1^, C. Mayorga^3^, J. L. Rodriguez-Bada^3^, I. Doña^1^, G. Canto^2^, C. Antunez^3^, J. J. Romero^1^, M. Blanca^1^; ^1^Allergy Service, Carlos Haya Hospital, Málaga, SPAIN, ^2^Allergy Service, Doce de Octubre Hospital, Madrid, SPAIN, ^3^Research Laboratory, Fundacion IMABIS-Carlos Haya Hospital, Málaga, SPAIN.

**146**   **Stevens-Johnson Syndrome From Oral Acetazolamide In A 19-Year Old Male**

**G. B. Velez** ^1^, K. S. Estrellado^2^, R. G. Tabigo-on^2^, C. J. Gloria^1^, M. W. Sumpaico^1^; ^1^University of the Philippines-Philippine General Hospital Section of Allergy and Immunology, Manila, PHILIPPINES, ^2^University of the Philippines-Philippine General Hospital Department of Medicine, Manila, PHILIPPINES.

**147**   **Metronidazole-Induced Encephalopathy in a Pediatric Patient**

A. Gaye, **A. Sanghavi**; Loyola University Medical Center, Maywood, IL.

**148**   **Sequential Drug Provocation Testing in Diagnosis of an Unusual Fixed Drug Eruption to Pseudoephedrine**

**Y. K. Cheng**; Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, SINGAPORE.

**149**   **Eosinophilia During Piperacillin-Tazobactam (Pip/Taz) IV Desensitization**

**J. G. Kemp**, N. L. Rider, G. Ghaffari, E. L. Pratt, J. G. Gibbs, S. Chegini, T. J. Craig; Penn State College of Medicine Milton S. Hershey Medical Center, Hershey, PA.

**150**   **New Orleans Seniors on Polypharmacy: The Impact of Intervention on Adverse Drug Reactions (ADR) and Cost of Medications**

P. Kumar, **K. Elshatory**, C. Vital, S. Kamboj; LSU medical center, New Orleans, LA.

**151**   **Optimising the Lymphocyte Transformation Test in Drug Allergy Diagnosis**

**E. M. M. Tomaz**, M. R. Viseu, A. F. Ferrão, S. H. Correia, M. J. Peres, R. P. Reis, L. A. Patricio, F. C. Inacio; Hospital S. Bernardo, Setúbal, PORTUGAL.

**152**   **Persistent Eosinophilia Following Aspirin Desensitization in a Patient with Aspirin Exacerbated Respiratory Disease**

**N. M. Vogel**, D. M. Lang, F. H. Hsieh; The Cleveland Clinic Foundation, Cleveland, OH.

**153**   **Type I Allergy to Benzoimidazole Antihelmintics**

**R. González-Mendiola** ^1^, T. Palomeque Rodríguez^1^, N. Martínez Borque^1^, M. Torrecillas Toro^1^, D. Martínez Bohigas^1^, J. Solera^2^; ^1^Complejo Hospitalario Universitario de Albacete. Allergy Department, Albacete, SPAIN, ^2^Complejo Hospitalario Universitario de Albacete. Internal Medicine Department, Albacete, SPAIN.

**154**   **Immediate Hypersensitivity Reactions to Methylprednisolone in Children**

**A. Nahum** ^1,2^, B. Garty^1^, Y. Levy^1^; ^1^Kipper Institute of Immunology, Schneider Children\'s Medical Center of Israel, Petah Tiqva, ISRAEL, ^2^Department of Pediatrics, Kaplan Medical Center, Rehovot, ISRAEL.

**155**   **Prevalence of Drug Adverse Reactions in Out-Patients**

**M. Palma-Carlos**, M. Medina, A. G. Palma-Carlos; Clinical Allergy Immunology Center, Lisbon, PORTUGAL.

**156**   **Skin Reaction after Desensitization Not Predict the Outcome of Short Course Sulfa Desensitization Protocol among AIDS Patients**

**W. Maek-A-Nantawat** ^1^, H. Chantaphakul^2^, K. Ruxrungtham^2^; ^1^Mahidol University, Bangkok, THAILAND, ^2^Chulalongkorn University, Bangkok, THAILAND.

**157**   **Monitoring the Peripheral Blood Lymphocyte Subtypes in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)**

**M. Yazicioglu** ^1^, R. Elmas^1^, T. Genchallacoglu^1^, S. Yildirim^1^, B. Turgut^2^; ^1^Trakya University, Department of Pediatrics, Edirne, TURKEY, ^2^Trakya University, Department of Internal Medicine, Edirne, TURKEY.

**158**   **Allergy To Multiple Local Anesthetics**

**A. B. Caron**; Clinique Concorde, Laval, PQ, CANADA.
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**159**   **Development of Health-Related Quality of Life Questionnaires for Children, Adolescents and Adults with Food Allergy: the Item Reduction**

**B. M. J. de Blok** ^1^, A. DunnGalvin^2^, J. N. G. Oude Elberink^3^, B. J. Vlieg-Boerstra^1^, E. J. Duiverman^1^, J. B. Hourihane^2^, A. E. J. Dubois^1,3^; ^1^University Medical Center Groningen, University of Groningen, Beatrix Children\'s Hospital, Department of Paediatric Pulmonology and Allergology, Groningen, THE NETHERLANDS, ^2^Cork University Hospital, Department of Paediatrics and Child Health, Cork, IRELAND, ^3^University Medical Center Groningen, University of Groningen, Department of Allergology, Groningen, THE NETHERLANDS.

**160**   **Impact of Pediatric Asthma and Treatment on Care-givers Visiting Specialist Clinics in Japan**

**Y. Ohya** ^1^, H. Watanabe^1^, N. Kojima^1^, T. Katsunuma^2^, N. Kondo^3^, A. Akasawa^1^; ^1^National Center for Child Health and Development, Tokyo, JAPAN, ^2^The Jikei University, Tokyo, JAPAN, ^3^Gifu University, Gifu, JAPAN.

**161**   **Once-A-Day Olopatadine Improves the Health-Related Quality-Of-Life of Allergic Conjunctivitis Patients**

**G. J. Berdy** ^1^, S. V. Scoper^2^, S. J. Lichtenstein^3^, J. M. Rubin^4^, C. Waycaster^5^, T. Pasquine^5^, R. D. Gross^5^, S. Robertson^5^; ^1^Ophthalmology Associates, St. Louis, MO, ^2^Virginia Eye Consultants, Norfolk, VA, ^3^Louisville Children\'s Eye Specialists, Louisville, KY, ^4^Eye Clinics of South Texas, San Antonio, TX, ^5^Alcon Research Ltd., Fort Worth, TX.

**162**   **Health Related Quality of Life in Lithuanian Children with Asthma**

**E. Vaitkaitiene**; Biomedical Research Institute of Kaunas University of Medicine, Kaunas, LITHUANIA.

**163**   **Developmental Trajectories in Food Allergy: Sex and Age Differences**

**J. O. B. Hourihane**, A. DunnGalvin; University College Cork, Cork, IRELAND.

**164**   **Does Childhood Asthma Affect The Quality Of Life Of Caregivers?**

**Z. Tamay** ^1^, A. Akcay^2^, N. Guler^1^, A. Suleymanoglu^1^, G. Kilic^1^, U. Ones^1^; ^1^Istanbul Medical Faculty, Istanbul, TURKEY, ^2^Pamukkale Medical Faculty, Denizli, TURKEY.

**165**   **Adverse Effects of Danazol in the Prophylactic Treatment of Hereditary or Acquired C1-Inhibitor Deficiency**

**W. Kreuz**, E. Aygören-Pürsün, I. Martinez-Saguer, E. Rusicke, T. Klingebiel; University Hospital Frankfurt, Frankfurt, GERMANY.
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**166**   **T-Cell Receptor (TCR)-Mediated Upregulation of BLT1 (LTB4 Receptor) Expression and Activation of Human T Cells by LTB4**

A. Ahuja, A. Dakhama, H. Ohnishi, J. J. Lucas, **E. W. Gelfand**; National Jewish Medical and Research Center, Denver, CO.

**167**   **The Role Of Th1 And Th2 Response In Allergic Rhinitis Children With Or Without Sensitization To Food Allergens**

**A. Nakonechna** ^1^, T. Umanetz^2^, V. Lapshin^2^, A. R. D. van Bergen^3^; ^1^National Medical University, Kiev, UKRAINE, ^2^Institute of Pediatry, Obstetrics and Gynaecology, Kiev, UKRAINE, ^3^Novidec Ltd, Neston, UNITED KINGDOM.

**168**   **CD4+CD25+ Cells and Laboratory Animal Allergy**

**H. Jeal**, A. Newman Taylor, M. Jones; NHLI @ Imperial College, London, UNITED KINGDOM.

**169**   **IL-5 production In Response To *Candida Albicans* Secretory Aspartic Protease 2 Is Associated With Isolated Late-phase Bronchial Response Upon Inhalation Challenge**

**A. Mori**, N. Kitamura, T. Hashimoto, M. Taniguchi, M. Otomo, Y. Maeda, M. Hasegawa, K. Akiyama; National Sagamihara Hospital, Clinical Research Center, Sagamihara, JAPAN.

**170**   **Critical Role For Adaptive T Cell Immunity In Experimental Eosinophilic Esophagitis In Mice**

**A. Mishra**, J. Schlotman, M. Wang, M. E. Rothenberg; Childrens Hospital Medical Center, Cincinnati, OH 45229, Cincinnati, OH.

**171**   **Allergen-specific CD4 T & B Cells in Allergic Patients are NOT Increased Compared to Nonallergic Individuals**

**A. Ueno**, C. Lu, B. Serushago, T. Bowen, J. Storek; University of Calgary, Calgary, AB, CANADA.

**172**   **Profound Lymphopenia in Two Immunocompetant Children With Allergic Fungal Sinusitis**

**D. R. Naimi**, J. M. Spergel; The Children\'s Hospital of Philadelphia, Philadelphia, PA.

**173**   **Association Between Second Hand Smoke Exposure (SSE) and T-Helper Type 2 (TH2) Cytokine Production During Early Childhood**

**A. Patel**, D. A. Gentile, J. M. Koehrsen, D. P. Skoner, M. Varga, C. A. Schad, T. J. Schaffner; Allegheny General Hospital, Pittsburgh, PA.

**174**   **Activation Of Allergen-specific T Cells In Vivo During Specific Immunotherapy With Depigoid Allergen Extracts**

E. O. Luger, H. Lee, D. Ernst, **M. Worm**; Dept. of Dermatology and Allergy, Berlin, GERMANY.

**175**   **EBI3 Deficient Naive T cells Show Increase in Expression of Th2 Mediated Cytokines In-vitro**

**E. Dokmeci** ^1^, L. Xu^1^, R. Blumberg^2^, K. Bottomly^1^; ^1^Yale University, New Haven, CT, ^2^Brigham & Womens Hospital, Boston, MA.

**176**   **The Tyrosine Kinase Txk/Rlk Rescues The Development Of Allergic Asthma In Mice Lacking Tec Kinase Itk**

**N. SAHU**; PENNSTATE UNIVERSITY, State college, PA.

**177**   **Mast Cell Mediated LTB4-BLT1 Pathway in Asthma and the Therapeutic Role of Zileuton in Regulating Early T Cell Trafficking in Airways**

**Z. Mikhak**, M. Fukui, P. Hesterberg, A. D. Luster; Massacusetts General Hospital, Charlestown, MA.

**178**   **Living in Farming Communities (FC) Provides Children Greater Protection Against Asthma Attacks than Living in Poor Hygienic Conditions (PHC)**

**S. Sur** ^1^, S. Chitranshi^2^, S. Ganesh^3^, R. Moona^3^, M. Sharma^3^, S. Bajpai^3^, S. K. Katiyar^4^; ^1^University TX Medical Branch, Galveston, TX, ^2^RAMA Hospital, Kanpur, INDIA, ^3^Indian Institute of Technology, Kanpur, INDIA, ^4^GSVM Medical College, Kanpur, INDIA.

**179**   **Pharmacological Effects of ASM8, an Antisense Oligonucleotide to CCR3 and the Common Beta Chain Receptor in Mild Asthmatics**

**G. M. Gauvreau** ^1^, L. P. Boulet^2^, D. W. Cockcroft^3^, M. Duong^1^, H. D\'Anjou^4^, P. M. Renzi^4,5^, P. M. O\'Byrne^1^; ^1^McMaster University, Hamilton, ON, CANADA, ^2^Hopital Laval, Université Laval, Quebec City, PQ, CANADA, ^3^University of Saskatchewan, Saskatoon, SK, CANADA, ^4^Topigen Pharmaceuticals Inc, Montreal, PQ, CANADA, ^5^University of Montreal, Montreal, PQ, CANADA.

**180**   **Adoptive Transfer of Splenocytes from Immunotherapy Group Ameliorating the Histopathological Changes and Increased IL-10 and IFN-g Levels in the Recipient Mice**

**T. Akkoc**; Marmara University, Istanbul, TURKEY.

**181**   **Airway Exposures to House Dust Extracts Provide Th2 Adjuvant Activity with Intermittent Delivery and Long Term Tolerogenic Activity with Daily Delivery**

**G. M. Batzer**, N. Ng, D. P. Lam, A. A. Horner; UCSD, La Jolla, CA.

**182**   **Neonatal Education of Dendritic and T Cells by LPS results in Tolerance in an Adoptive Transfer Model of Airways Allergy**

**Y. Wang**, C. T. McCusker; McGill University, Montreal, PQ, CANADA.

**183**   **Peripherally-Induced Allergen-Specific Foxp3+ Regulatory T Cells are Essential for the Control of Chronic Allergic Lung Inflammation**

**M. A. Curotto de Lafaille**, N. Kutchukhidze, Y. Ding, S. Shen, J. J. Lafaille; New York University School of Medicine, New York, NY.

**184**   **Sublingual Immunotherapy Induce Systemic T-cell Tolerance in Naive Mice**

**J. Brimnes**, J. Kildsgaard, H. Jacobi, K. Lund; ALK-Abello, Hoersholm, DENMARK.

**185**   **Mast Cells Promote the Development of CD103+ Regulatory T cells**

**Z. Allakhverdi**, G. Delespesse; CHUM Research Center, Montreal, PQ, CANADA.

**186**   **An Environmental Fungus, *Alternaria*, Stimulates OX40L and CCR7 Expression by Dendritic Cells (DCs)**

**T. Kobayashi** ^1^, S. Radhakrishnan^2^, L. R. Pease^2^, H. Kita^1^; ^1^Division of Allergic Diseases, Mayo Clinic College of Medicine, Rochester, MN, ^2^Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN.

**187**   **The Major Allergen From Peanut, Ara h 1, Induces Transcription Of Genes In Dcs That Are Important For Th2 Priming**

**Z. Y. Kucuk**; Mount Sinai School of Medicine, New York, NY.

**188**   **Eosinophils Modulate the Allergen-Indcued Th2 Pulmonary Immune Microenvironment**

**E. A. Jacobsen**, S. Ochkur, A. G. Taranova, R. Pero, C. Protheroe, J. J. Lee; Mayo Clinic Arizona, Scottsdale, AZ.

**189**   **Concomitant Use Of Glucocorticoids During Allergen Immunotherapy Upregulates Il-10 Production By Peripheral Blood Mononuclear Cells (pbmc)**

**P. Majak** ^1^, J. Jerzyńska^1^, W. Stelmach^1^, P. Kuna^2^, I. Stelmach^1^; ^1^N.Copernicus Hospital, Lodz, POLAND, ^2^Medical University, Lodz, POLAND.

**190**   **The Effect Of Allergen-pulsed Bone Marrow-derived Dendritic Cells In Mouse Asthma Mod Dose Not Depends On The Route Of Administration**

**M. Kim** ^1^, Z. Hahn^2^, Y. Hahn^1^; ^1^Chungbuk National University, Cheongjoo, REPUBLIC OF KOREA, ^2^Chungbuk National University, Postgraduate School, Cheongjoo, REPUBLIC OF KOREA.
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**191**   **Conservation of Connective Tissue Mast Cells (MCs) for \>500 Million Years of Evolution**

**R. L. Stevens** ^1^, L. Zhuo^2^, B. Lam^1^, K. Kimata^2^, G. W. Wong^3^; ^1^Brigham and Women\'s Hospital, Boston, MA, ^2^Aichi Medical University, Aichi, JAPAN, ^3^Whitehead Institute of Biomedical Research, Cambridge, MA.

**192**   **Environmental Estrogens Induce Mast Cell Degranulation and Enhance IgE-mediated Release of Allergic Mediators**

**S. Narita**, R. M. Goldblum, E. G. Brooks, C. S. Watson, M. D. Estes, E. M. Curran, T. Midoro-Horiuti; University of Texas Medical Branch, Galveston, TX.

**193**   **Induction of Suppressor of Cytokine Signaling (SOCS)-1/3 by IFN-alpha in Suppressing IL-3- but not IgE- Dependent Signaling in Human Basophils**

**J. T. Schroeder**, A. P. Bieneman, K. L. Chichester; Johns Hopkins University, Baltimore, MD.

**194**   **Short Term Culture of Functional Human Mast Cells from Buffy Coat Preparations**

**M. Holm** ^1,2^, H. B. Andersen^1^, C. Dahl^1^, H. J. Hoffmann^3^, S. Junker^2^, P. O. Schiotz^1^; ^1^Aarhus University Hospital, Aarhus, DENMARK, ^2^Institute of Human Genetics-University of Aarhus, Aarhus, DENMARK, ^3^Aarhus University Hospital-Resp. Dept, Aarhus, DENMARK.

**195**   **Ras Guanine Nucleotide Releasing Protein 4 (RasgrP4) Dependent Pathways and Genes that Reversibly Control the Development, Phenotype, and Function of Human Mast Cells (MCs)\]**

G. P. Katsoulotos^1^, K. Tanaka^2^, T. J. Molloy^3^, R. L. Stevens^4^, **S. A. Krilis** ^5^; ^1^St. George Hospital, University of New South Wales, Sydney, AUSTRALIA, ^2^St. George Hospital, University of, Sydney, AUSTRALIA, ^3^St. Vincent\'s Hospital, Sydney, AUSTRALIA, ^4^Harvard Medical School and Brigham and Women\'s Hospital, Boston, MA, ^5^St. George Hospital, Sydney, AUSTRALIA.

**196**   **Trans-basement Membrane Migration of Human Basophils: Role of Matrix Metalloproteinase-9**

**M. Suzukawa** ^1^, A. Komiya^1^, M. Iikura^1^, H. Nagase^2^, C. Yoshimura-Uchiyama^1^, H. Yamada^1^, H. Kawasaki^3^, K. Ohta^2^, K. Matsushima^1^, K. Hirai^1^, K. Yamamoto^1^, M. Yamaguchi^1^; ^1^University of Tokyo Graduate School of Medicine, Bunkyo-ku, Tokyo, JAPAN, ^2^University of Teikyo School of Medicine, Tokyo, JAPAN, ^3^University of Tokyo, Bunkyo-ku, Tokyo, JAPAN.

**197**   **NGF-β-Induced Enhancement of FcɛRI-Mediated Activation in Human Basophils is Associated with Reduced SHIP Activity**

**B. F. Gibbs** ^1,2^; ^1^Medway School of Pharmacy, Chatham Maritime, Kent, UNITED KINGDOM, ^2^Department of Dermatology, University of Lübeck, GERMANY.

**198**   **Identification and Characterization of *Cis*-Acting Regulatory Elements of the PAI-1 Gene in Human Mast Cells**

**C. K. Oh**, Z. Ma; Harbor-UCLA Medical Center, Torrance, CA.

**199**   **Mast Cells Stimulate Cytokine Release from Fibroblasts of Asthmatic Airways**

**L. C. K. Lau**, P. N. Sanders, P. H. Howarth, A. F. Walls; Southampton General Hospital, Southampton, UNITED KINGDOM.

**200**   **Role of Mast Cells in the Development of Pulmonary Allergic Inflammation of SHP-1 Deficient Mice**

**S. Oh**, T. Zheng, J. Schroeder, B. Vonakis, O. Choi, Z. Zhu; The Johns Hopkins University, Baltimore, MD.

**201**   **Abnormal Expression of Fcγ Receptors by Human Bone Marrow Mast Cells in Systemic Mastocitosis**

**L. B. Sanchez-Muñoz** ^1^, A. Prados^1^, R. Nuñez^1^, C. Ruiz^1^, C. Teodosio^2^, A. Lopez^2^, M. Jara^2^, J. Almeida^2^, A. Orfao^2^, L. Escribano^1^; ^1^Mast Cell Unit and K. Frank Austen Laboratory, Hospital Ramón y Cajal, Madrid, SPAIN, ^2^Servicio General de Citometría, Centro de Investigación del Cáncer, Universidad de Salamanca, Salamanca, SPAIN.

**202**   **The 4G/5G-Genotype-Specific Regulation of Plasminogen Activator Inhibitor (PAI)-1 Expression in Human Mast Cells**

**Z. Ma**, C. K. Oh; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA.

**203**   **Susceptibility to Cow\'s Milk Allergy (CMA) in C3H/HeJ Mice and Oral Tolerance in BALB/c Mice are Associated With Different Mast Cell Profiles**

**I. Kirman**, R. Du, H. Sampson, X. Li; Mount Sinai School of Medicine, New York, NY.

**204**   **Mature hyphae of *Aspergillus fumigatus* Induce IgE-Independent Mast Cell Degranulation**

**M. Urb**, P. Pouliot, M. Olivier, D. C. Sheppard; McGill University, Montreal, PQ, CANADA.

**205**   **Leukotriene E4 (LTE4) Is More Potent Than LTD4 For Inducing Cytokine Generation And Proliferation Of Human Mast Cells**

**S. Paruchuri**, J. A. Boyce; Division of Rheumatology, Immunology and Allergy, Brigham and Women\'s Hospital, Boston, MA.

**206**   **IgE Reversibly Enhances FcɛRI levels on the Surface of Human Skin Mast Cells and Increases Sensitivity to Low Levels of FcɛRI Cross-Linking**

**G. V. Gomez**, S. Jogie-Brahim, M. Shima, L. B. Schwartz; Virginia Commonwealth University, Richmond, VA.

**207**   **Cigarette Smoke Exposure Activates Human Mast Cells (MC) In Vitro**

**L. H. Bellehsen**; Hebrew University of Jerusalem, Jerusalem, ISRAEL.

**208**   **Atrial Natriuretic Peptide is Released from Human Mast Cells following IgE-Mediated Activation**

**M. C. Glaum**, S. Nimal, R. F. Lockey, S. S. Mohapatra; University of South Florida College of Medicine, Tampa, FL.

**209**   **When is a Mouse Basophil not a Basophil?**

**J. J. Lee**, M. P. McGarry; Mayo Clinic Arizona, Scottsdale, AZ.

**210**   **Immunological Response to Cat Allergen: A Comparison of the Effects of Environmental Exposure vs Specific Immunotherapy**

**C. T. Cady** ^1,2^, R. J. Harbeck^1^, P. C. Giclas^1^, J. R. Murphy^1^, R. K. Katial^1^, R. W. Weber^1^, J. C. Cambier^1,2^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^University of Colorado at Denver Health Sciences Center, Denver, CO.

**211**   **Human Lung Mast Cells Express Functional Receptors for Extracellular Adenosine 5′-Diphosphate (ADP)**

**H. Nishi**, A. Pelleg, E. Schulman; Drexel University College of Medicine, Philadelphia, PA.

**212**   **Role of Hydrogen Peroxide in *Mycoplasma pneumoniae*-induced Mast Cell IL-4 Production**

**T. P. Atkinson**, Y. Dai, L. B. Duffy; Univ of Alabama at Birmingham, Birmingham, AL.

**213**   **Atrial Natriuretic Peptide Can Modulate Human Mast Cell Gene Expression**

**S. Nimal**, M. C. Glaum, P. K. Jena, R. F. Lockey, S. S. Mohapatra; University of South Florida, Tampa, FL.

**214**   **Inhibition of Message for FcɛRI α Chain in RBL Cells Blocks IL-4 Production Induced by Co-Culture with Mycoplasma pneumoniae**

**D. Luo**, Y. Dai, L. B. Duffy, T. P. Atkinson; Univ of Alabama at Birmingham, Birmingham, AL.
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**215**   **\[Withdrawn\]**

**216**   **Aggressive Anti-Leukotriene (LT) Prophylaxis Decreases Anaphylaxis Severity during Rush Desensitization (RD)**

**A. B. Vegh**; Puget Sound Allergy Asthma and Imm., Tacoma, WA.

**217**   **Immunomodulator Adjunctive Effects in Treatment of Allergic Diseases**

**M. Rudenko** ^1^, L. Siziakina^1^, E. Urban^1^, L. Du Buske^2^; ^1^Research Institute of Clinical Immunology and Allergology, Rostov-on-Don, RUSSIAN FEDERATION, ^2^Immunological Research Institute of New England, Gardner, MA.

**218**   **Influence Of Anti-IgE On Nasal Polyps**

**G. Rasp**; Katharinenhospital, Stuttgart, GERMANY.

**219**   **Use of a Multimedia Presentation to Increase Knowledge and Safety of Allergen Immunotherapy**

**P. Hemmers**, S. Amara, B. Silverman, A. T. Schneider; Long Island College Hospital, Brooklyn, NY.

**220**   **Sublingual Immunotherapy with Allergoid Tablets: A Double Blind Placebo Controlled Assay**

**A. G. Palma-Carlos**; Clinical Allergy Immunology Center, Lisbon, PORTUGAL.

**221**   **The Glycerin Induced Large Local Reaction (GILL) study**

**C. Calabria**, M. Tankersley; Wilford Hall Medical Center, San Antonio, TX.

**222**   **Tree Pollen Allergoids in Pollinex Quattro Tree Immunotherapy Reduce the Residual Allergenicity as Assessed with Skin Prick Tests (SPTs)**

**M. Chudak** ^1^, P. Patel^1^, A. Salapatek^1^, K. Jethwa^1^, K. J. Fischer von Weikersthal-Drachenberg^2^, J. Amersdorffer^2^; ^1^Allied Research International, Mississauga, ON, CANADA, ^2^Allergy Therapeutics plc, Worthing, UNITED KINGDOM.

**223**   **Quantitative Measurements of Allergen Specific IgG4 and IgG Antibodies using ImmunoCAP Technology**

**A. Kober**, P. Lundin, L. Söderström, I. Cressy; Phadia AB, Uppsala, SWEDEN.

**224**   **Comparision of Compositional Differences and Relative Potency Between Different Manufacturers of Ragweed Pollen Extracts**

**P. S. Creticos** ^1^, S. Balcer-Whaley^1^, P. Moldt^2^, O. Pedersen^2^; ^1^Johns Hopkins Asthma and Allergy Center, Baltimore, MD, ^2^Curalogic, Copenhagen, DENMARK.

**225**   **Systemic Reactions to Percutaneous (P) and Intradermal (ID) Skin Tests (ST)**

**T. Chacko**, M. Glaum, D. Ledford, R. Fox, R. F. Lockey; University of South Florida Collge of Medicine, Tampa, FL.

**226**   **Effects of a Novel Symbiotic, ImmuBalance, as a Food Supplement in Relieving Clinical Symptoms of Japanese Cedar Pollonosis: A Pilot Study**

**W. PAN** ^1,2^, Y. Otsuka^3^; ^1^Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, ^2^Nichimo Co., Ltd., Tokyo, JAPAN, ^3^Tokorozawa Otolaryngology, Saitama, JAPAN.

**227**   **Segmental Laryngeal Dystonia: A Difficult Differential of Vocal Cord Dysfunction Presenting During Immunotherapy**

**R. P. Harvey**, J. Poole, W. S. Silvers; Allergy Asthma & Immunology Clinic of Colorado, Englewood, CO.

**228**   **Allergy Tests Available over the Internet;'Caveat emptor!'**

**A. J. Frew**, J. Wade, H. Smith; Brighton & Sussex Medical School, Brighton, UNITED KINGDOM.

**229**   **Allergen-specific Immunotherapy Using A Highly Modified Allergen And The Immunomodulator Polyoxidonium In A Murine Model Of Allergic Asthma**

**A. A. Babakhin** ^1^, L. S. Litvin^1^, S. M. Andreev^1^, O. N. Stetzenko^1^, L. N. Voronkova^1^, M. R. Khaitov^1^, G. G. Barsegyan^2^, I. V. DuBuske^3^, L. M. DuBuske^3^; ^1^National Research Center - Institute of Immunology, Moscow, RUSSIAN FEDERATION, ^2^All-Russia Research Center for Molecular Diagnostics and Treatment, Moscow, RUSSIAN FEDERATION, ^3^Immunology Research Institute of New England, Gardner, MA.

**230**   **Immunotherapy with *Dermatophagoides pteronyssinus*. Monitoring with Western-blot technique**

**F. Pineda**; DIATER Laboratories, San Martin de la Vega, SPAIN.

**231**   **Aeroallergens in the Valley of Mexico (Frequency)**

**D. Aguilar**, M. I. Rojo, M. A. Bermejo, M. Gonzalez, K. Lopez, K. E. Lopez, T. Sandoval; Juarez Hospital, Mexico, MEXICO.

**232**   **IgE Mediated Sensitization to Weeds Pollen in Saudi Arabia**

**A. R. Al Frayh**; College of Medicine and KKUH, Riyadh, SAUDI ARABIA.

**233**   **A Strategy For Absolute Quantification Of Allergens: Quantification Of Group 2 Isoallergens From A Mixture Of Two Different House Dust Mite Species**

**U. Seppälä**, H. Ipsen, M. D. Spangfort; Research Department, ALK-Abelló, Horsholm, DENMARK.
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**234**   **Effect of Montelukast on Collagen Deposition of the Eyes in a Murine Model of Chronic Allergic Eye Disease**

**E. Marzo**, Z. Ma, C. Oh; Harbor UCLA, Torrance, CA.

**235**   **A Single-Center, Double Masked, Randomized, Placebo Controlled Study to Evaluate the Efficacy of Multiple Doses of 10 mg Montelukast Sodium (Singulair®) on the Signs and Symptoms of Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model**

**P. J. Gomes**, M. B. Abelson; Ophthalmic Research Associates, North Andover, MA.

**236**   **Intravenous Immune Globulin (IVIG) in the Treatment of Ocular-Cicatricial Pemphigoid (OCP)**

**J. A. Lagos**, S. F. Kemp, G. D. Marshall; University of Mississippi Medical Center, Jackson, MS.

**237**   **Ocular Symptoms of Seasonal Allergic Rhinitis Can Be Treated Effectively With An Inhaled Corticosteroid (Mometasone Furoate Nasal Spray)**

**L. Bielory** ^1^, M. Danzig^2^, D. Gates^2^; ^1^UMDNJ-New Jersey Medical School, Newark, NJ, ^2^Schering-Plough Research Institute, Kenilworth, NJ.

**238**   **Total Ocular Symptom Scores in Patients With Seasonal Allergic Rhinitis are Reduced With Mometasone Furoate Nasal Spray**

**G. Sussman** ^1^, M. Danzig^2^, D. Gates^2^; ^1^University of Toronto Faculty of Medicine, Toronto, ON, CANADA, ^2^Schering-Plough Research Institute, Kenilworth, NJ.

**239**   **Mometasone Furoate Nasal Spray Improves Nasal and Ocular Symptoms of Seasonal Allergic Rhinitis in Adolescent Patients**

**R. Anolik** ^1^, D. Pearlman^2^, M. Danzig^3^, D. Gates^3^; ^1^Allergy & Asthma Specialists, PC, Blue Bell, PA, ^2^Colorado Allergy and Asthma Centers, PC, Denver, CO, ^3^Schering-Plough Research Institute, Kenilworth, NJ.

**240**   **Mometasone Furoate Improves Total Ocular Symptom Score in Patients With Allergic Rhinitis**

**J. Hébert** ^1^, M. Danzig^2^, D. Gates^2^; ^1^Université Laval Faculté de Médecine, Québec City, PQ, CANADA, ^2^Schering-Plough Research Institute, Kenilworth, NJ.

**241**   **Safety and Tolerability of Repeated Nasal Allergen Challenges**

**I. Hussain** ^1^, P. Sayre^1^, F. Romero^2^, W. W. Busse^3^, J. N. Kline^4^, T. B. Casale^2^; ^1^University of California San Francisco, San Francisco, CA, ^2^Creighton University, Omaha, NE, ^3^University of Wisconsin, Madison, WI, ^4^University of Iowa, Iowa City, IA.

**242**   **Comparative Responses to Nasal Allergen Challenge in Allergic Rhinitic Subjects With or Without Asthma**

**M. Rousseau**; Centre de recherche de l\'hôpital Laval, Québec, PQ, CANADA.

**243**   **Effect of Antibiotic Treatment on Nasal and Maxillary Sinus Nitric Oxide in Patients with Acute Bacterial Sinusitis**

**M. J. Lanz**, S. Prendes, G. Toledo, C. M. Ferrer; Allergy, Asthma, Rhinitis & Sinusitis CRC, Coral Gables, FL.

**244**   **Criterion for Eosinophilic Nasal Polyp: A Clinicopathologic Correlation**

**C. Rhee**, W. Jeong, J. Kim, S. Kim, T. Won, Y. Kim, C. Lee, S. Cho, Y. Min; Seoul National University College of Medicine, Seoul, REPUBLIC OF KOREA.

**245**   **Efficacy of Mometasone Furoate Nasal Spray in Seasonal Allergic Rhinitis According to Baseline Symptom Severity**

**M. J. Derebery**; House Clinic, Los Angeles, CA.

**246**   **Evaluation Of Respiratory Pressure Meter In Atopic And Non-atopic Rhinitis**

**Y. Park** ^1^, H. Park^2^, J. Lee^3^; ^1^Department of Pediatrics, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Department of Pediatrics, Konkuk University Hospital, Seoul, REPUBLIC OF KOREA, ^3^Department of Pediatrics, Samsung Masan Hospital, Sungkyunkwan University School of Medicine, Masan, REPUBLIC OF KOREA.

**247**   **Use of Acoustic Rhinometry In Allergic Children**

**C. Nunes**, S. Ladeira; Center of Allergy of Algarve, Portimao, PORTUGAL.

**248**   **Improvement of Symptoms in Children 6 to 12 Years With Allergic Rhinitis Seen With Desloratadine Therapy With or Without Concomitant Corticosteroids**

**P. Tassinari** ^1^, N. R. Suárez^2^, J. Centeno^3^, J. Vergara Velásquez^4^, H. Aguirre-Mariscal^5^, S. N. Gonzàlez Dìaz^6^, A. Fernández de Córdova Jerves^7^; ^1^Universidad Central de Venezuela, Caracas, VENEZUELA, ^2^Policlínica Metropolitana, Caracas, VENEZUELA, ^3^Universidad Peruana Cayetano Heredia, Lima, PERU, ^4^Centro Especializado San Fernando, Panama City, PANAMA, ^5^Hospital Angeles Pedregal, Mexico City, MEXICO, ^6^Hospital Universitario, Monterrey, MEXICO, ^7^Hospital Universitario del Rio, Cuenca, ECUADOR.

**249**   **Improved Symptom Relief and Quality of Life With Desloratadine in Pollen-Induced Allergic Rhinitis**

**D. Dumitrascu**; University of Medicine and Pharmacy Iuliu Hatieganu, Cluj Napoca, ROMANIA.

**250**   **Efficacy and Safety of Desloratadine in Combination with Mometasone Furoate in Patients With Moderate-to-Severe SAR**

**G. Grevers** ^1^, B. Karmann^2^; ^1^Nose and Sinus Center, Starnberg, GERMANY, ^2^Medical Affairs, Essex Pharma GmbH, Munich, GERMANY.

**251**   **Mometasone Furoate Nasal Spray Rapidly and Enduringly Relieves Nasal Congestion and Other Symptoms of Seasonal Allergic Rhinitis**

**G. N. Gross** ^1^, M. R. Danzig^2^, D. Gates^2^; ^1^Dallas Allergy and Asthma Center, Dallas, TX, ^2^Schering-Plough Research Institute, Kenilworth, NJ.

**252**   **Desloratadine Treatment Improves Symptoms in Patients With Seasonal Allergic Rhinitis**

**I. Braverman** ^1^, M. Beiser^2^, Z. Gilad^3^; ^1^Hillel Yaffe Medical Center, Hadera, ISRAEL, ^2^The Tel Aviv Sourasky Medical Center, Tel Aviv, ISRAEL, ^3^Schering-Plough Israel AG, Petach Tikva, ISRAEL.
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**253**   **Respiratory Protection and Incident Skin Test Sensitivity Among Laboratory Mouse Workers**

**J. M. Curtin-Brosnan** ^1^, P. A. Eggleston^1^, B. J. Paigen^2^, E. A. O\'Neil^2^, K. A. Hagberg^2^, E. C. Matsui^1^; ^1^Johns Hopkins University, Baltimore, MD, ^2^The Jackson Laboratory, Bar Harbor, ME.

**254**   **Once Daily Fluticasone Furoate^∗^ Nasal Spray (FFNS), a Novel Enhanced Affinity Steroid, Provides 24-hour Relief for the Nasal Symptoms of Perennial Allergic Rhinitis (PAR)**

**R. Nathan** ^1^, W. Berger^2^, W. Yang^3^, A. Cheema^4^, M. J. Silvey^5^, W. Wu^5^, M. Faris^5^, E. Philpot^5^; ^1^Asthma & Allergy Associates, P.C., Colorado Springs, CO, ^2^Southern California Research, Mission Viejo, CA, ^3^Allergy & Asthma Research Centre, Ottawa, ON, CANADA, ^4^Private Practice, Mississauga, ON, CANADA, ^5^GlaxoSmithKline, Research Triangle Park, NC.

**255**   **Identification Of Ige-mediated Drug Allergy In Patients With Adverse Drug Reactions Categorized By World Health Organization-the Uppsala Monitoring Centre (who-umc) System**

**C. Tantikul**, N. Dhana, K. Jongjareornprasert, S. Rithikot, N. Visitsunthorn, P. Vichyanond, O. Jirapongsananuruk; Siriraj Hospital, Bangkok, THAILAND.

**256**   **A Survey of Community Physicians\' Perceptions Related to Asthma Education**

**C. A. Gillespie**, A. B. Becker; Health Sciences Centre, Winnipeg, MB, CANADA.

**257**   **Improving Asthma Communication With Inner City Parents: Does It Work?**

**A. Butz** ^1^, C. Land^1^, J. Walker^1^, M. E. Bollinger^2^; ^1^Johns Hopkins University, Baltimore, MD, ^2^University of Maryland, Baltimore, MD.

**258**   **Innovative Reporting of Penicillin Allergy in an Integrated Electronic Medical Record**

**P. J. Markus**, D. M. Erickson, J. T. C. Li, R. R. Bessette, J. E. Rueter, D. R. Osmon, N. J. Larson, K. E. Kloos, M. A. Park; Mayo Clinic and Foundation, Rochester, MN.

**259**   **Unusual Side Effect Of Treatment To Large Local Reaction To Immunotherapy**

**C. W. Wagner** ^1,2^, A. G. Mery^1^; ^1^Allergy and Asthma Associates, Houston, TX, ^2^Texas Woman\'s University, Houston, TX.

**260**   **Comparison Of Efficacy Of Once Daily Zyrtec^R^(cetirizine), Cetrizin^R^(cetirizine), Desloratadine And Placebo: Suppressive Effects On Allergen And Histamine Induced Wheal And Flare Responses In Allergic Rhinitis Patients**

**A. Sukkul**, K. Ruxrungtham; Chulalongkorn Hospital, Bangkok, THAILAND.

**261**   **Pyrimethamine Desensitization In Cerebral Toxoplasmosis And Aids**

**E. Gonzalez**, A. Henriquez, A. Losada, B. Huertas, J. Gonzalez, P. Berges, E. Alvarez; Servicio de Alergia Hospital Ramon y Cajal, Madrid, SPAIN.

**262**   **Evolution of Asthma Population Management**

**C. A. Martin** ^1^, C. Tacinas^2^, C. Lamb^2^, K. Baldwin^2^, S. Hay^2^, S. Heermann^2^, J. Hoban^2^, V. Perry^2^, B. J. Spiecher^2^; ^1^Kaiser Permanente, Westminster, CO, ^2^Kaiser Permanente, Denver, CO.

**263**   **Evaluation of Penicillin Allergy in an Allergy Immunology Practice**

**C. S. Wright**; Allergy Medical Clinic, Los Angeles, CA.

**264**   **A Comparison of Peak Pollen Times in the Missoula Valley from 1978 and 2006**

**K. L. Crispen** ^1^, D. N. Gillespie^2^, T. J. Ward^3^, A. Holian^4^; ^1^University of Montana Center for Environmeantal Health Sciences, Missoula, MT, ^2^Allergist, Missoula, MT, ^3^University of Montana Center for Environmental Health Sciences, Missoula, MT, ^4^University of Montana Center for Environmental Health Sciences, Missoula, MT.

**265**   **Frontal Sinusitis Complicated by an Epidural Abscess and Seizures**

**D. C. Wirth**, S. B. Tanner; Vanderbilt Univeristy Medical Center: Asthma, Sinus, Allergy Program, Nashville, TN.

**266**   **Respiratory Health of Kentucky Farm Children**

**P. V. Burkhart** ^1^, S. R. Browning^2^, S. Westneat^3^, C. A. Knox^4^, D. Abshire^1^; ^1^University Of Kentucky, Lexington, KY, ^2^University Of Kentucky College of Public Health, Lexington, KY, ^3^University Of Kentucky College of Nursing, Lexington, KY, ^4^Kosair Children\'s Hospital, Louisville, KY.

**267**   **Do Parents Follow Breastfeeding And Weaning Recommendations Given By The Pediatric Nurses? A Study With Emphasis On Introduction Of Cow\'s Milk Protein In Allergy Risk Families**

**A. Mikkelsen** ^1^, L. Rinné-Ljungqvist^2^, M. P. Borres, Sr.^3^, J. van Odijk^4^; ^1^Dep. of Primary Health Care, Göteborg, SWEDEN, ^2^Primary Health Care Services of Partille, Partille, SWEDEN, ^3^Dep. of Pediatrics, Sahlgrenska Academy, Göteborg University, Göteborg, SWEDEN, ^4^Dep. of Clinical Nutrition, Sahlgrenska Academy, Göteborg University, Göteborg, SWEDEN.
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**268**   **Effect Of Age And Aeroallergen Sensitivities On Acquisition Of Aeroallergen Sensitivities Among Children With Asthma In The Childhood Asthma Management Program (CAMP)**

**K. A. DeMuth** ^1^, R. Strunk^1^, G. Bloomberg^1^, A. Liu^2^, L. Bacharier^1^; ^1^Washington University in St. Louis, Saint Louis, MO, ^2^National Jewish Hospital Medical & Research., Boulder, CO.

**269**   **Asthma at Age 6 is Associated with an Early and Variable Pattern of Allergic Sensitization in Childhood**

**C. J. Tisler** ^1^, K. A. Roberg^1^, E. L. Anderson^1^, L. E. Salazar^1^, R. A. Grabher^1^, D. F. DaSilva^1^, T. E. Pappas^1^, K. Sullivan Dillie^1^, R. E. Gangnon^2^, M. D. Evans^2^, J. E. Gern^1^, R. F. Lemanske, Jr.^1^; ^1^University of Wisconsin School of Medicine and Public Health, Madison, WI, ^2^University of Wisconsin-Population Health Sciences Biostatistics and Medical Informatics, Madison, WI.

**270**   **Allergen Sensitization as a Predictor of Wheezing Phenotype at Age Six Years**

**C. M. Virnig**, K. Roberg, E. Anderson, L. E. P. Salazar, R. A. Grabher, C. Tisler, D. F. DaSilva, T. E. Pappas, K. Sullivan Dillie, M. D. Evans, R. E. Gargnon, J. E. Gern, R. F. Lemanske, Jr.; UW School of Medicine and Public Health, Madison, WI.

**271**   **Association Of The Genetic Polymorphism Of The Surfactant Protein (SP)-D With Mite-sensitization In Childhood Asthma**

**M. Lei** ^1,2^, W. Dai^1^, C. Tan^1^, J. Wang^1^; ^1^Dept of Ped, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, ^2^Institude of molecular medicine, Tainan, TAIWAN.

**272**   **Effect of a Single Nucleotide Polymorphism in the Surfactant Protein D Gene on Atopy and Asthma Susceptibility**

**E. B. Brandt**, N. Wang, E. Grube, M. Stevenson, G. K. Khurana Hershey, M. E. Rothenberg; Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**273**   **Allergen and Endotoxin Exposure, Infection, and Breastfeeding in Early Life, and Recurrent Wheezing in Infants: 18-month Follow-up of a Cohort Study**

**V. E. V. Rullo** ^1^, D. Solé^1^, V. Valente^1^, C. Nakamura^1^, A. S. Zampolo^2^, L. K. Arruda^2^, R. C. Cardoso^3^, F. J. Nóbrega^4^, C. K. Naspitz^1^; ^1^Pediatrics, Federal University of São Paulo, São Paulo, BRAZIL, ^2^Medicine, School of Medicine of Ribeirão Preto-USP, Ribeirão Preto, BRAZIL, ^3^School of Public Health-USP, São Paulo, BRAZIL, ^4^Pediatrics, Albert Einstein Hospital, São Paulo, BRAZIL.
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**274**   **T-B+NK+ Severe Combined Immunodeficiency Caused by Complete Deficiency of the CD3zeta Subunit of the T Cell Antigen Receptor Complex**

**J. L. Roberts** ^1^, J. P. H. Lauritsen^2^, M. Cooney^1^, R. E. Parrott^1^, E. O. Sajaroff^1^, C. M. Win^1^, M. D. Keller^1^, J. H. Carpenter^1^, M. Sarzotti^1^, X. Zhong^1^, D. L. Wiest^2^, R. H. Bucley^1^; ^1^Duke University Medical Center, Durham, NC, ^2^Fox Chase Cancer Center, Philadelphia, PA.

**275**   **Lysophosphatidylserine (Lyso-PS), a Signaling Phospholipid, is Deficient in Models of Chronic Granulomatous Disease (CGD)**

**D. L. Bratton** ^1^, K. Zemski-Berry^2^, R. C. Murphy^3^, P. M. Henson^1^, S. C. Frasch^1^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^Univeristy of Colorado at Denver and Health Science Center, Aurora, CO, ^3^University of Colorado at Denver and Health Science Center, Aurora, CO.

**276**   **Immunologic and Clinical Features of 21 Amish Patients with Cartilage-Hair Hypoplasia**

**N. L. Rider** ^1^, D. Morton^2^, K. A. Strauss^2^; ^1^Penn State Milton S. Hershey Medical Center, Hershey, PA, ^2^The Clinic for Special Children, Strasburg, PA.

**277**   **Lymphocyte Proliferation to Antigens Develops Over Time in Partial DiGeorge Syndrome**

**V. S. Kancherla**, A. P. Reddy, L. M. Noroski, J. Chinen, H. W. Yeh, C. M. Davis; Baylor College of Medicine, Houston, TX.

**278**   **Association Between Mannose-Binding Lectin Deficiency and Immunoglobulin Subclass 4 Deficiency in Children with Recurrent Infections**

**M. M. Dowd** ^1^, N. Tangsinmankong^2^, D. D. Siri^2^, A. S. Hartel^2^, K. S. Brauer^1^, I. N. Umeh^1^, N. K. Day^2^, J. W. Sleasman^2^; ^1^Department of Pediatrics, University of South Florida College of Medicine, St. Petersburg, FL, ^2^Division of Allergy and Immunology, University of South Florida College of Medicine, St. Petersburg, FL.

**279**   **Specialist Physician Perspectives On Primary Immunodeficiency Diseases: A 2006 Survey Of The AAAAI Membership**

**J. S. Orange** ^1^, J. Boyle^2^; ^1^Children\'s Hospital of Philadelphia, Philadelphia, PA, ^2^Immune Deficiency Foundation, Towson, MD.
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**280**   **Monocyte Chemotactic Protein-4 (MCP-4; CCL-13) and the CC chemokine Receptor 3 (CCR3) in Sputum of Asthmatic Children**

**Y. M. El-Gamal** ^1^, N. M. Heshmat^1^, K. S. Awwad^1^, M. H. M. Ezzat^1^, M. M. Abd Al-Aziz^2^, Z. M. El-Gabbas^1^; ^1^Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, EGYPT, ^2^Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, EGYPT.

**281**   **Exhaled Nitric Oxide as a Predictor of Response to Anti-inflammatory Treatment in Asthma**

**A. Michils**, S. Baldassarre, A. Van Muylem; Erasme University Hospital, Brussels, BELGIUM.

**282**   **Impact and Use of Asthma Control Test (ACT™) on Healthcare Resource Use (HCRU) in a Managed Care (MC) Setting**

**J. R. CarranzaRosenzweig**, P. M. Jhingran, A. A. Dalal; GlaxoSmithkline, RTP, NC.

**283**   **Improving Asthma Care in Disadvantaged Elderly: A Randomized, Controlled Trial Using Telephone Intervention Conducted by Non-Medically Trained Personnel**

**R. R. Patel**, W. L. Gray, C. A. Saltoun, L. C. Grammer; Department of Medicine, Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL.

**284**   **Longitudinal Patterns of Predominant Disease Activity (PDA) in Pediatric Patients Receiving Care in an Inner City Asthma Disease Management Program: The Breathmobile Program™**

**L. Scott** ^1^, B. Nichols^1^, K. Y. Kwong^1^, T. Morphew^2^, L. T. Clement^1^, F. Lifson^2^, C. A. Jones^1^; ^1^LAC+USC, Los Angeles, CA, ^2^Southern California Chapter of the Asthma and Allergy Foundation of America (AAFA), Los Angeles, CA.

**285**   **Development and Validation of 'Asthma Control in Paediatrics' Questionnaire (CAN)**

**M. Ibero** ^1^, X. Badia^2^, N. Cobos^3^, J. Garde^4^, E. G. Pérez-Yarza^5^, J. Villa^6^, C. Badiola^7^; ^1^Hospital de Terrassa, Terrassa, SPAIN, ^2^Healt Outcomes Research Europe, Barcelona, SPAIN, ^3^Hospital Vall d\'Hebró, Barcelona, SPAIN, ^4^Hospital General d\'Elx, Elx, SPAIN, ^5^Hospital de Donostia, San Sebastián, SPAIN, ^6^Hospital del Niño Jesús, Madrid, SPAIN, ^7^Medical Department GSK, Madrid, SPAIN.
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**286**   **The Natural History of Cow\'s Milk Allergy (CMA)**

**J. M. Skripak**; Johns Hopkins Medical School, Baltimore, MD.

**287**   **Clinical Manifestations and Natural History of Egg Allergy in Infants and Children**

**R. G. Heine** ^1,2^, N. Laske^1^, D. J. Hill^2^; ^1^Royal Children\'s Hospital, Melbourne, AUSTRALIA, ^2^Murdoch Childrens Research Institute, Melbourne, AUSTRALIA.

**288**   **The Utility of Combining Skin Prick and Specific IgE Antibody Testing as a Predictor of Clinical Reactivity to Milk, Egg, and Peanut**

**D. R. Naimi**, N. M. Paranich, J. M. Spergel, J. L. Beausoleil; The Children\'s Hospital of Philadelphia, Philadelphia, PA.

**289**   **Consumer Awareness and Response Following the Food Allergen Labeling and Consumer Protection Act (FALCPA)**

**H. Lemon-Mule** ^1^, T. J. Furlong^2^, S. H. Sicherer^1^; ^1^Mt Sinai School Of Medicine, New York, NY, ^2^Food Allergy & Anaphylaxis Network, Fairfax, VA.

**290**   **Preliminary Support for a Group Intervention for Children with Food Allergy and Their Parents**

**J. S. LeBovidge**, K. G. Timmons, C. Rich, A. Rosenstock, K. Fowler, L. C. Schneider; Children\'s Hospital Boston, Boston, MA.

**291**   **Oral Desensitization Therpy In Children With Egg Allergy**

**M. Akashi**, M. Narita, A. Saito, T. Suda, I. Nomura, A. Akasawa, Y. Ohya; National Center for Child Health and Development, Tokyo, JAPAN.
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**292**   **Prevalence of Obesity in Severe Asthma Differs by the Anthropometric Measure**

**S. M. Musaad** ^1,2^, G. K. Hershey^2^; ^1^University of Cincinnati, Cincinnati, OH, ^2^Cincinnati Childrens Hospital Medical Center, Cincinnati, OH.

**293**   **The Role of Allergy Treatment in Asthma Management among Urban Children**

**J. A. Stingone**, L. Claudio; Mount Sinai School of Medicine, New York, NY.

**294**   **Utilization of Non-Traditional and Alternative Therapies (CAM) in Inner City Under-Served Children with Asthma**

**K. Tai** ^1^, M. Tsoukleris^1,2^, V. Hsu^1^, I. H. Zuckerman^1^, M. E. Bollinger^2^, K. Mudd^3^, M. Donithan^4^, A. M. Butz^3^; ^1^University of Maryland School of Pharmacy, Baltimore, MD, ^2^University of Maryland School of Medicine, Baltimore, MD, ^3^The Johns Hopkins University School of Medicine, Baltimore, MD, ^4^The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.

**295**   **Patterns of Asthma Mortality in Ohio: 1999-2003 Compared with 1990-98**

**D. R. Stukus** ^1^, N. Nock^2^, D. M. Lang^1^; ^1^The Cleveland Clinic, Cleveland, OH, ^2^Case Western Reserve University, Cleveland, OH.

**296**   **Characteristics and Outcomes of Asthmatics Who Leave Against Medical Advice (AMA)**

**A. P. Baptist**, J. Ager, M. Massanari; Wayne State University, Detroit, MI.

**297**   **Population Density and Race as Factors in Asthma Mortality**

**N. M. Lebak**, L. B. Schwartz; Medical College of Virginia, Virginia Commonwealth University, Richmond, VA.
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**298**   **Effects of Lipoxin A4 (LX) on Glucocorticoid Receptor (gr) Function**

**J. M. Terasaki** ^1^, N. N. Bulayeva^1^, B. D. Levy^2^, W. J. Calhoun^1^; ^1^Division of Allergy, Pulmonary, Immunology, CCM, & Sleep (APICS), University of Texas Medical Branch, Galveston, TX, ^2^Department of Internal Medicine and Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women\'s Hospital and Harvard Medical School, Boston, MA.

**299**   **Blockage of IL-10 Modulates Airway Inflammation-Associated Eosinophilia And IL-4 Levels in C57Bl6 Mice**

**Y. Ogawa**, E. A. Duru, J. L. Parks, IV, W. J. Calhoun, B. T. Ameredes; University of Texas Medical Branch, Galveston, TX.

**300**   **CysLT1 Receptor Signaling Induces Transcriptional Upregulation of Proprotein Convertase Furin Expression: Potential Implications in Airway Remodeling**

**M. Rola-Pleszczynski**, C. Thompson, S. McMahon, Y. Bossé, C. M. Dubois, J. Stankova; Université de Sherbrooke, Sherbrooke, PQ, CANADA.

**301**   **Fractional Exhaled Nitric Oxide (FeNO) is Elevated in School Aged Children who have Culture-Documented Frequent Viral Respiratory Illnesses during Infancy**

**L. E. Salazar**, M. D. Evans, E. L. Anderson, D. F. DaSilva, R. A. Grabher, T. E. Pappas, K. A. Roberg, K. Sullivan Dillie, C. J. Tisler, R. E. Gangnon, J. E. Gern, R. F. Lemanske, Jr.; University of Wisconsin-Madison, Madison, WI.

**302**   **A *Anisakis Simplex* Homolog of Macrophage Migration Inhibitory Factor Inhibits Allergic Airway Responses in Mice**

**H. Park** ^1^, J. Lee^1^, K. Kim^1^, H. Jeong^2^, Y. Jeong^3^, J. Jeong^4^, Y. Kim^1^, M. Lee^1^, S. Park^1^, H. Yu^2^; ^1^Internal Medicine, Pusan National University School of Medicine, Busan, REPUBLIC OF KOREA, ^2^Department of Parasitology, Pusan National University School of Medicine, Busan, REPUBLIC OF KOREA, ^3^Internal Medicine, Gyeonsang National University School of Medicine, Jinju, REPUBLIC OF KOREA, ^4^Internal Medicine, Iilsan Paik Hospital, Kyungki-do, REPUBLIC OF KOREA.

**303**   **Sensitization to Multiple Allergens Breaks Through Tolerance and Establishes Chronic Asthma That is Unresponsive to Anti-Cytokine Therapy**

**R. Alam**, N. Goplen, Q. Liang, S. Rozario, Y. Morimoto, M. Gorska; National Jewish Medical and Research Center, Denver, CO.
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**304**   **Stability of Protease Rich *Periplaneta americana* Allergen Extract During Storage: Formulating Preservatives to Enhance Shelf life**

**V. Thangam Sudha** ^1,2^, N. Arora^1^, S. N. Gaur^3^, B. P. Singh^1^; ^1^Institute of Genomics and Integrative Biology, Delhi, INDIA, ^2^Department of Biotechnology, University of Pune, Pune, INDIA, ^3^V. P. Chest Institute, Delhi, INDIA.

**305**   **Usefulness Of Specific Ige Determination To Recombinant Grass Pollen Allergens (cap-feia) In Pollinic Patients**

**J. M. de la Borbolla**, R. Escudero, J. Antón, M. J. Goikoetxea, M. L. Sanz, M. Ferrer; University Clinic, School of Medicine, University of Navarra, Pamplona, SPAIN.

**306**   **Correlation Between SIT Induced Inhibition of IgE Binding, Histamine Release and Facilitated Allergen Presentation**

**P. A. Würtzen** ^1^, G. Lund^1^, J. Holm^1^, M. Arvidsson^2^, K. Lund^1^, S. Rak^3^, H. Ipsen^1^; ^1^ALK-Abello, Hørsholm, DENMARK, ^2^Department of Medical Sciences, Clinical Chemistry, University Hospital, Uppsala, SWEDEN, ^3^Asthma and Allergy Research Group, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Goteborg, SWEDEN.

**307**   **Safety and Efficacy of the Novel Vaccine TOLAMBA™ in Ragweed Allergic Adults, a Dose Finding Study**

**D. I. Bernstein** ^1^, N. Segall^2^, A. Nayak^3^, T. Casale^4^, P. Korenblatt^5^, E. Martins^6^; ^1^Bernstein Allergy Group, Cincinnati, OH, ^2^Clinical Research of Atlanta, Stockbridge, GA, ^3^Sneeze, Wheeze and Itch Associates, Normal, IL, ^4^Creighton U., Omaha, NE, ^5^Clinical Re-search Center, St. Louis, MO, ^6^Dynavax Technologies, Berkeley, CA.

**308**   **Venom Immunotherapy (VIT) Reduces Large Local Reactions (LLR) to Insect Stings**

**D. Kelly** ^1^, D. B. K. Golden^1^, R. G. Hamilton^1^, T. J. Craig^2^; ^1^Johns Hopkins University, Baltimore, MD, ^2^Penn State Hershey Medical Center, Hershey, PA.

**309**   **Prolonged Pre-seasonal Treatment Phase with Sublingual Immunotherapy Increases Clinical Efficacy**

**M. A. Calderon** ^1^, A. O. Birk^2^, J. S. Andersen^2^, S. R. Durham^1^; ^1^Imperial College, National Heart and Lung Institute, London, UNITED KINGDOM, ^2^ALK-Abelló, Hörsholm, DENMARK.
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**310**   **Predicting Outcome of Repeated Oral Food Challenges**

**K. E. Mudd**, M. Paterakis, J. Curtin-Brosnan, R. A. Wood; Johns Hopkins University, School of Medicine, Baltimore, MD.

**311**   **Analysis of a System to Provide Consistent Care of Patients with Fatality-Prone Asthma (FPA)**

**L. C. Kertz**, R. C. Strunk, L. B. Bacharier; Washington University School of Medicine, St. Louis, MO.

**312**   **The Integration of Web-based Asthma Education with Nurse Case Management**

**K. Kelly-Shanovich** ^1^, A. D. Pulvermacher^1^, C. A. Sorkness^2^, A. Bhattacharya^3^, D. H. Gustafson^1^; ^1^Center for Health Enhancement Systems Studies, University of Wisconsin - Madison, Madison, WI, ^2^Schools of Pharmacy and Medicine, University of Wisconsin - Madison, Madison, WI, ^3^Center for the Study of Cultural Diversity in Healthcare, University of Wisconsin - Madison, Madison, WI.

**313**   **A Needs Assessment Project to Enhance Patient and Provider Asthma Communication**

**P. M. Fritz**, F. L. Schottenfeld, C. Spampinato, G. Gallinger; NYS Dept of Health, Troy, NY.

**314**   **The Impact of Home Visits on Retention in a Low-Income School Based Mobile Asthma Clinic**

**C. M. Carcel** ^1^, S. Amaro^1^, F. Sowa^2^, T. Morphew^3^, S. P. Galant^1^; ^1^Children\'s Hospital of Orange County, Orange, CA, ^2^Latino Health Access, Santa Ana, CA, ^3^AAFA, Los Angeles, CA.

**315**   **Does Use of Asthma Controllers Really Indicate Asthma "Control?"**

**C. L. Vibbert** ^1^, A. Butz^2^, M. Tsoukleris^3^, V. D. Hsu^3^, M. E. Bollinger^1^; ^1^University of Maryland School of Medicine, Baltimore, MD, ^2^Johns Hopkins University School of Medicine, Baltimore, MD, ^3^University of Maryland School of Pharmacy, Baltimore, MD.
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**316**   **Sputum Mediators in Children with Mild Persistent Asthma Indicate Immune Dysregulation and Correlate with Lower Lung Function**

**N. Patel** ^1^, A. M. Schiltz^1^, R. Harbeck^1^, R. A. Covar^1,2^, S. M. Wood^3^, S. J. DeMichele^3^, E. W. Gelfand^1,2^, S. J. Szefler^1,2^, A. H. Liu^1,2^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^University of Colorado School of Medicine, Denver, CO, ^3^Ross Products Division/Abbott Laboratories, Columbus, OH.

**317**   **Clinical Implication of Vascular Endothelial Growth Factor (VEGF) in Childhood Asthma**

**K. Kim** ^1^, E. Kim^1^, J. Park^1^, G. Jang^2^, C. Kim^3^, H. Lee^3^, M. Sohn^1^, K. Kim^1^; ^1^Department of Pediatrics and Institute of Allergy, Severance Children\'s Hospital, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Department of Pediatrics, NHIC Ilsan Hospital, Goyang, REPUBLIC OF KOREA, ^3^Department of Pediatrics, Kwandong University, Goyang, REPUBLIC OF KOREA.

**318**   **The Predictive Power of Frequent eNO Measurements in Patients with Asthma**

**J. D. Wolfe** ^1^, D. M. Dreon^2^, B. R. Parikh^2^, E. E. Hutchins^2^, M. N. Bates^3^; ^1^Asthma and Allergy Associates of Northern California, San Jose, CA, ^2^Aperon Biosystems Corp., Menlo Park, CA, ^3^University of California - Berkeley, Berkeley, CA.

**319**   **Exhaled Nitric Oxide and Pulmonary Function Tests in Children with Asthma**

**S. Choi** ^1^, H. Koh^2^, C. Bae^2^, Y. Rha^2^; ^1^Department of Pediatrics, College of Medicine, Seoul National University, Seoul, REPUBLIC OF KOREA, ^2^Department of Pediatrics, College of Medicine, Kyung Hee University, Seoul, REPUBLIC OF KOREA.

**320**   **Diagnostic Value of Eosinophil Cationic Protein (ECP) in Children with Asthma Undergoing Food Challenges**

**A. Krogulska**, K. Wasowska-Królikowska, J. Dynowski; Medical University Lodz, Poland, Lodz, POLAND.

**321**   **Longitudinal Changes in Bronchial Hyperresponsiveness and Exposure to High Levels of Domestic Pet Allergens**

**S. J. Fowler** ^1,2^, N. Truman^1^, A. Simpson^1^, A. A. Woodcock^1^, S. J. Langley^1^, A. Custovic^1^; ^1^University of Manchester, Manchester, UNITED KINGDOM, ^2^Lancashire Teaching Hospitals, Preston, UNITED KINGDOM.

**322**   **Roc Curve Analysis Of Serum-specific Ige Levels To Predict Airway Reactivity To Dog Allergens In Asthmatic Subjects**

**A. Matito**, S. Blanco, P. Gajate, L. Martín, R. Vives, C. Ortega, C. Fernandez; Hospital 12 de Octubre, Madrid, Spain.

**323**   **Correlation between Clinical Parameters of Asthma and Airway Dimension, Air Trapping and Airway Collapsibility Measured by Volumetric Inspiration and Expiration CT**

**H. Moon** ^1,2^, T. Kim^1,2^, E. Chae^3,2^, N. Kim^3^, Y. Lee^3^, C. Park^1,2^, B. Yoo^1^, J. Seo^3,2^, Y. Cho^1,2^; ^1^Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Clinical Research Center for Chronic Obstructive Airway Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, REPUBLIC OF KOREA, ^3^Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, REPUBLIC OF KOREA.

**324**   **Effect of Emergency Room Treatment of Acute Asthma on Plasma Levels of Complement Split Products**

**D. Dure** ^1^, I. Kalampokis^1^, E. Monk, Jr.^1^, C. Charlot^1^, E. Gilbert^1^, M. Nowakowski^1^, R. Sinert^2^, R. Joks^1^; ^1^Center for Allergy and Asthma Research, SUNY, Brooklyn, NY, ^2^Kings County Hospital Center, Brooklyn, NY.

**325**   **Standard Range Of Peak Expiratory Flow Rate Of Korean Children In Seoul**

**W. H. Seo** ^1^, H. K. Shin^1^, S. H. Ahn^2^, S. H. Park^2^, K. M. Ahn^2^, S. I. Lee^2^; ^1^College of Medicine, Korea University, Seoul, REPUBLIC OF KOREA, ^2^Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, REPUBLIC OF KOREA.

**326**   **Airflow Obstruction Of Adolescent Asthmatics Without Current Respiratory Symptoms**

**H. Nishimura** ^1^, K. Tokuyama^2^, M. Suzuki^1^, T. Mizuno^3^, H. Koyama^3^, H. Arakawa^3^, H. Mochizuki^3^, A. Morikawa^3^; ^1^Tone Central Hospital, Numata, JAPAN, ^2^Takasaki Univ. of health and Welfare, Takasaki, JAPAN, ^3^Gunma Univ., Maebashi, JAPAN.

**327**   **Dynamic Oxygen-Enhanced Magnetic Resonance Imaging is Not Useful in Assessing Severity or Airway Inflammation in Asthmatic Children**

**T. F. Leung** ^1^, W. C. W. Chu^2^, C. W. Y. Kam^1^, D. T. Yeung^2^, C. Y. Li^1^, G. W. K. Wong^1^, P. C. Ng^1^; ^1^Department of Pediatrics, The Chinese University of Hong Kong, Hong Kong, HONG KONG, ^2^Department of Diagnostic Radiology and Organ Imaging, The Chinese University of Hong Kong, Hong Kong, HONG KONG.

**328**   **Measurement of Specific IgE Levels in Korean Allergic Disease Children by Using CAP system**

**J. Lee** ^1^, J. Jung^2^, J. Kim^3^, C. Kim^4^, Y. Park^5^; ^1^Masan samsung hospital, Masan si, REPUBLIC OF KOREA, ^2^Dong A university, Busan, REPUBLIC OF KOREA, ^3^Ulsan university, Ulsan, REPUBLIC OF KOREA, ^4^Kwan Dong University, Seoul, REPUBLIC OF KOREA, ^5^Konkuk university, Seoul, REPUBLIC OF KOREA.

**329**   **The Impact of Electronic Medical Records on Timeliness of Diagnosis of Asthma**

**K. H. Yoo** ^1^, S. Bagniewski^2^, A. L. Weaver^2^, S. V. Pankrantz^2^, R. M. Jacobson^2^, Y. J. Juhn^2^; ^1^Mayo Clinic/Konkuk University, Rochester, MN, ^2^Mayo Clinic, Rochester, MN.

**330**   **Cutaneous Sensitization to Indoor allergens in children with Asthma and Rhinitis in Chiclayo, Peru**

**F. V. Maticorena Agramonte**, L. Suarez, W. Presentacion; Hospital Belen, Chiclayo, PERU.

**331**   **Cell-specific Activation of ERK1/2 and p38 MAPK in Airway Biopsy Samples from Asthmatic patients**

Q. Liang, S. Balzar, S. Wenzel, M. Gorska, **R. Alam**; National Jewish Medical and Research Center, Denver, CO.

**332**   **The Severity of Historical ASA/NSAID-Induced Asthma Attacks Does Not Correlate with Severity of Asthma Induced During Oral ASA Challenges**

**A. N. Williams**, R. A. Simon, K. M. Woessner, D. D. Stevenson; Scripps Clinic, San Diego, CA.

**333**   **Serum TGF-β1 in Allergic Asthma**

**W. Manuyakorn** ^1^, S. Benjaponpitak^1^, W. Kamchaisatian^1^, C. Setthaudom^2^, K. Atamasirikul^2^, C. Sasisakulporn^3^, C. Direkwattanachai^1^; ^1^Division of Allergy/Immunology, Department of Pediatrics, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND, ^2^Department of Pathology, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND, ^3^Research Center, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND.
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**334**   **Systemic Autoimmunity Significance in Patients with Asthma**

**I. Agache** ^1^, L. Duca^1^, M. Anghel^2^; ^1^Transylvania University Brasov, Faculty of Medicine, Brasov, ROMANIA, ^2^Brasov County Hospital, Brasov, ROMANIA.

**335**   **Allergy, Serum IgE, and Lung Function in Children and Adolescents With Severe or Difficult-to-Treat Asthma**

**T. Haselkorn** ^1^, S. J. Szefler^2^, F. E. R. Simons^3^, D. R. Mink^4^, B. E. Chipps^5^, D. A. Wong^1^, L. Borish^6^; ^1^Genentech, Inc., South San Francisco, CA, ^2^Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO, ^3^Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, CANADA, ^4^Ovation Research Group, San Francisco, CA, ^5^Capital Allergy and Respiratory Disease Center, Sacramento, CA, ^6^University of Virginia Health Systems, Charlottesville, VA.

**336**   **Asthma and Lung Dysfunction Among Disadvantaged Wheezing Infants Followed to Age 7 Years**

**M. D. Klinnert** ^1,2^, A. H. Liu^1,2^, G. Herrera-Garcia^1^, K. Walsh^1^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^University of Colorado Health Sciences Center, Denver, CO.

**337**   **Short-term Growth Suppression assessed by Knemometry may predict Height Growth Suppression in Children with Asthma treated with Inhaled Glucocorticoids**

**O. D. Wolthers**; Asthma and Allergy Clinic, Children\'s Clinic Randers, Randers, DENMARK.

**338**   **IRF-1 Interferes with Steroid Function in Airway Smooth Muscle Cells**

**O. Tliba**, H. Baidouri, Y. Amrani; University of Pennsylvania, Philadelphia, PA.

**339**   **Predictive Factors for Air Trapping Measured by CT Scan in Asthma**

**A. A. Busacker** ^1,2^, C. Kotaru^2^, T. Keefe^1^, J. Newell^2^, E. Hoffman^3^, S. E. Wenzel^4^; ^1^Colorado State University, Fort Collins, CO, ^2^National Jewish Medical and Research Center, Denver, CO, ^3^University of Iowa, Iowa City, IA, ^4^University of Pittsburgh Medical Center, Pittsburgh, PA.

**340**   **Exhaled Nitric Oxide Decreases during Acetylcholine-induced Bronchoconstriction in Children with Asthma**

**Y. Noma**, M. Nagao, T. Fujisawa; Mie National Hospital, Tsu, JAPAN.

**341**   **Forced Expiratory Maneuvers - Most Of Healthy Children Do Not Meet ATS Criteria For Spirometry**

**G. Siergiejko** ^1^, B. E. Nowowiejska^2^, M. G. Kaczmarski^2^, Z. Siergiejko^2^; ^1^Children Hospital, Bialystok, POLAND, ^2^Medical University, Bialystok, POLAND.

**342**   **Diurnal Assessment of Airways Inflammation in Patients with Asthma Utilizing eNO**

**J. D. Wolfe** ^1^, D. M. Dreon^2^, B. R. Parikh^2^, E. E. Hutchins^2^, M. N. Bates^3^; ^1^Asthma and Allergy Associates of Northern California, San Jose, CA, ^2^Aperon Biosystems Corp., Menlo Park, CA, ^3^University of California - Berkeley, Berkeley, CA.

**343**   **Detection of Tissue Eosinophils and Evidence of Extensive Degranulation in Archived Clinical Biopsies Using a Novel Anti-Eosinophil Peroxidase Monoclonal Antibody**

**C. Protheroe**, J. C. Lewis, T. N. Lunsford, G. DePetris, M. P. McGarry, N. A. Lee, J. J. Lee; Mayo Clinic Arizona, Scottsdale, AZ.

**344**   **Adiposity May Enhance Pulmonary Dysfunction in Obese Asthmatics Adolescents**

**P. Rojas**, P. Sakali, J. Estrada, R. Pasternak, C. Moore; louisiana state university, New Orleans, LA.

**345**   **Gastroesophageal Reflux (GER) Cause Increase In Bronchial Reactivity**

**B. E. Nowowiejska** ^1^, G. Siergiejko^2^, M. G. Kaczmarski^1^, Z. Siergiejko^1^; ^1^Medical University, Bialystok, POLAND, ^2^Children Hospital, Bialystok, POLAND.

**346**   **Effect of Smoking Cessation on AMP and Methacholine Airway Hyperresponsiveness in Cigarette Smokers**

**C. Russo**, G. Piccillo, P. Caponnetto, A. Origlio, A. Bonaccorsi, A. Di Maria, R. Polosa; University Of Catania, Catania, ITALY.

**347**   **Exhaled Breath Condensate (EBC) pH in the Evaluation of Asthma**

**C. A. Coop**, L. L. Hagan, J. P. Dice; Wilford Hall Medical Center, San Antonio, TX.

**348**   **Monitoring the Fractional Concentration of Exhaled Nitric Oxide (FE~NO~) in Uncontrolled Asthma Before and After Steroid Therapy Using a New Portable Monitor**

**W. E. Berger**; Allergy and Asthma Associates of Southern California, Mission Viejo, CA.

**349**   **Is Spirometry a Better Tool Than Measurement of Peak Flow Rate for Monitoring a Rub-Test for Screening Exercise-Induced Asthma?**

**C. A. Charpin-Kadouch** ^1^, J. Ercoli^1^, J. Quéralt^1^, A. Palot^2^, F. Pelleing^3^, D. Charpin^2^; ^1^Maison de l\'Allergie et de l\'Environnement, Marseille, FRANCE, ^2^Assistance publique-Hôpitaux de Marseille, Marseille, FRANCE, ^3^Inspection d\'Académie des Bouches-du-Rhône, Marseille, FRANCE.

**350**   **Nitric Oxide Metabolites In Asthma And Copd**

**J. V. Garmendia** ^1^, D. Moreno, Jr.^2^, N. E. Larocca^1^, C. Tálamo^3^, J. B. De Sanctis^1^; ^1^Instituto de Inmunología. Universidad Central de Venezuela, Caracas, VENEZUELA, ^2^Cátedra de Fisiopatología del Instituto de Medicina Experimental y Servicio de Neumonología del Hospital Universitario de Caracas. Facultad de Medicina, Universidad Central de Venezuela., Caracas, VENEZUELA, ^3^IServicio de Neumonología. Hospital Universitario. Universidad Central de Venezuela, Caracas, VENEZUELA.

**351**   **Performance Characteristics of a New Device for Assessment of Asthmatic Inflammation by Measurement of Exhaled Breath Temperature, the Dunev Thermometer, a Unique Tool for Asthma Management**

**T. A. Popov** ^1^, S. Dunev^1^, T. Kralimarkova^1^, S. Kraeva^1^, L. M. DuBuske^2^; ^1^Sofia Medical University, Sofia, BUL-GARIA, ^2^Immunology Research Institute of New England, Gardner, MA.
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**352**   **Kainic Acid Treatment of B Cells Causes Increased CD23 Shedding**

**J. L. Sturgill**; Virginia Commonwealth University, Richmond, VA.

**353**   **Eosinophilic Fasciitis Associated with X-Linked Agammaglobulinemia: Report of Two Cases**

**P. Sriaroon** ^1^, N. Tangsinmankong^1^, S. Skoda-Smith^2^, M. E. Elder^2^, J. W. Sleasman^1^; ^1^University of South Florida College of Medicine, St. Petersburg, FL, ^2^University of Florida College of Medicine, Gainesville, FL.

**354**   **An Uncommon Familial Presentation of Long Standing Diarrhea and Common Variable Immunodeficiency Improved with IVIG Therapy**

**V. VELAZQUEZ**, C. A. Camacho, C. A. Camacho; Hospital Episcopal San Lucas, Ponce, PR.

**355**   **MR1, a Class Ib Molecule, Utilizes a MHC Class II Like Pathway to Activate Mucosal Associated Invariant T Cells**

**S. Huang** ^1^, A. Sant^2^, T. Hansen^1^; ^1^Washington University in St. Louis, St. Louis, MO, ^2^University of Rochester, New York, NY.

**356**   **Analysis of T Cell Skewing by a Receptor Targeted Allergen Variant Reveals Selective Enhancement of Th1-Promoting Cytokines at the APC Level**

**K. Hulse** ^1^, A. J. Reefer^1^, S. M. Satinover^1^, M. D. Chapman^2^, V. Engelhard^1^, J. A. Woodfolk^1^; ^1^University of Virginia, Charlottesville, VA, ^2^Indoor Biotechnologies Inc., Charlottesville, VA.

**357**   **Synergy Between LPS and Immobilized anti-human CD3 mAb for Activation of Cord Blood CD3+ T cells**

**Y. Katz**, M. Goldberg, N. Luknar-Gabor, G. Zadik-Mnuhin, P. Koch, J. Tovbin; Assaf-Harofeh Medical Center, Zerifin, ISRAEL.

**358**   **Impaired Corticosteroid-induced Transactivation In Human CD8+ T Cells**

**L. Li**, D. Y. M. Leung, E. Goleva; National Jewish Medical and Research Center, Denver, CO.

**359**   **Circulating Foxp3^+^CD4^+^ regulates both Th1 and Th2 responses in vivo**

**K. Orihara** ^1,2^, M. Narita^3^, T. Tobe^2^, A. Akasawa^3^, Y. Ohya^3^, K. Matsumoto^1^, H. Saito^1^; ^1^National Research Institute for Child Health and Development, Tokyo, JAPAN, ^2^Showa University, Tokyo, JAPAN, ^3^National Center for Child Health and Development, Tokyo, JAPAN.

**360**   **Delivery Of Augmented Il-2 Receptor Signals To Cd8+ T Cells Replaces The Requirement For Helper Function In The Generation Of Primary But Not Secondary Cd8+ T Cell Responses**

**L. E. Cheng** ^1^, P. D. Greenberg^2^; ^1^University of California, San Francisco, San Francisco, CA, ^2^University of Washington, Seattle, WA.

**361**   **Up-regulation of Granzyme B Gene Expression by Chemical Allergens**

**R. J. Dearman**, H. T. Caddick, C. J. Betts, I. Kimber; Syngenta CTL, Macclesfield, UNITED KINGDOM.

**362**   **The MAb CHO-131 Identifies a Subset of Cutaneous Lymphocyte-Associated Antigen T cells Enriched in P-Selectin Binding Cells**

**Z. Ni**; University of Minnesota, St. Paul, MN.

**363**   **IL-12/TGF-β1 Regulation of TCR Signal Transduction in Human Memory T Cells Associated with Malignant and Non-malignant Chronic Inflammatory Microenvironments**

**L. Broderick**, R. B. Bankert; University at Buffalo, Buffalo, NY.

**364**   **Activated CD4+ And CD4- Subsets Of T Lymphocytes Increase In Experimentally Induced Eosinophilic Esophagitis (EE)**

**M. Wang**, E. B. Brandt, M. E. Rothenberg, A. Mishra; Division of Allergy and Immunology, Cincinnati Children Hospital Medical Center, Cincinnati, OH.

**365**   **Effects of Stress Hormones on Regulatory T cell (Treg) and Intracellular TH1/TH2 Cytokine Levels in Normal Human PBMC**

**G. D. Marshall**, D. D. Montgomery, S. R. Roy, J. B. Brock; University MS Medical Center, Jackson, MS.

**366**   **Regulatory T Lymphocytes Distribution And Eosinophilic Gastroenteropathy**

**P. Vannelli**, T. Yan, C. Barone, S. McGeady; Thomas Jefferson University, Philadelphia, PA and A.I. duPont Hospital for Children, Wilmington, DE.

**367**   **Complete DiGeorge Syndrome Due to CHD7 Mutation**

**M. Sanka**, N. Tangsinmankong, M. Loscalzo, J. W. Sleasman, M. J. Dorsey; University of South Florida College of Medicine, St. Petersburg, FL.

**368**   **Factors Inducing Development of Childhood-onset Myasthenia Gravis by CD3 Spectratyping Analysis**

**H. Dokai**, Y. Fujikawa, K. Nihei, N. Shinomiya; Toho University Medical Center, Tokyo, JAPAN.

**369**   **Identification of Cytokine Heterogeneity within the Th2 Subset**

**N. Kim**, B. A. Foster, C. Prussin; Laboratory of Allergic Diseases, NIAID/NIH, Bethesda, MD.

**370**   **Variable Effects of Combination Corticosteroids and Catecholamines on Total β2-Adrenergic Receptors in Human CD4+ T-Lymphocytes**

**A. N. Salicru** ^1^, B. E. Crucian^2^, M. A. Nelman-Gonzales^2^, J. K. Actor^1^, C. F. Sams^3^, G. D. Marshall, Jr.^4^; ^1^Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, TX, ^2^NASA-Johnson Space Center Bioastronautics Team Inc, Houston, TX, ^3^NASA Human Adaptation and Countermeasures Office, Houston, TX, ^4^Division of Clinical Immunology and Allergy, The University of Mississippi Medical Center, Jackson, MS.

**371**   **Idiopathic CD4 Lymphocytopenia With Cryptococcal Pneumonia: A Case Report In Literature In Review**

**R. W. Hostoffer, Jr.** ^1^, M. Eagam^2^; ^1^Case Western Reserve University, Cleveland, OH, ^2^Lake Erie College of Osteopathic Medicine, Erie, PA.

**372**   **Evaluation of NKT Cells in Leishmaniasis**

**R. A. Campos**, J. M. Cunha, O. F. Jesus, O. Bacellar, F. C. C. Figueiredo, R. G. D. Lima, R. S. Matos, E. M. Carvalho; Universidade Federal da Bahia, Salvador-BA, BRAZIL.

**373**   **B Cell Superantigen-induced Immune Complex Lung Inflammation**

**A. L. Anderson**, A. I. Levinson; University of Pennsylvania, Philadelphia, PA.
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**374**   **Long-term Clinical Outcomes Following Vaccinia Associated Myopericarditis**

**M. R. Nelson** ^1^, L. C. Collins^1^, J. E. Atwood^1^, R. E. Eckert^2^, E. A. Shry^2^, D. J. Shelton^1^, W. Scott^1^, R. J. M. Engler^1^; ^1^Walter Reed Army Medical Center, Washington, DC, ^2^Brooke Army Medical Center, Fort Sam Houston, TX.

**375**   **Does Early BCG (Tokyo Strain) Vaccination have Potency to Prevent Allergy in Infants?**

**R. Ito**, H. Saito, K. Matsumoto; National Research Institute for Child Health & Development, Tokyo, JAPAN.

**376**   **A Pilot Study: Trivalent Inactivated Influenza Vaccine (TIV) and Myopericarditis**

**M. I. Slingluff** ^1^, M. M. Klote^1^, B. A. Hemann^1^, M. R. Nelson^1^, M. A. Yacavone^1^, J. E. Atwood^1^, S. Black^2^, R. J. M. Engler^1^; ^1^Walter Reed Army Medical Center, Washington, DC, ^2^Kaiser Permanente Vaccine Study Center, Oakland, CA.

**377**   **Headache After Trivalent Inactivated Influenza Vaccine (TIV): Gender Differences and Severity**

**S. Kim-Delio** ^1^, M. M. Klote^1^, M. R. Nelson^1^, W. W. Carr^2^, R. D. Deguzman^1^, C. P. Mikita^1^, B. L. Martin^1^, R. J. M. Engler^1^; ^1^Walter Reed Army Medical Center, Washington, DC, ^2^Walter Reed Army Medical Ctr-WRAIR, Washington, DC.

**378**   **Adverse Reactions To Pneumovax Pneumococcal Vaccine-cases Of Hyperimmunization?**

**S. E. Mannan**, E. Yousef; A. I. duPont Hospital for Children/Thomas Jefferson University Hospital, Wilmington, DE.

**379**   **Knowledge, Attitudes and Beliefs (KAB) Regarding Reporting of Adverse Events Following Immunizations (AEFI)**

**P. A. Hutchinson** ^1^, M. R. Nelson^1^, S. L. Hill^1^, L. L. Duran^2^, R. J. M. Engler^1^; ^1^Walter Reed Army Medical Center, Washington, DC, ^2^Walter Reed Army Medical Center-VHC, Washington, DC.

**380**   **Primary Smallpox Vaccination Temporally Associated with New Onset Urticaria-Angioedema (UrtAng) Evolving to Chronic Disease**

**R. J. M. Engler, MD** ^1^, A. Marini^2^, J. Green^3^, M. Klote^1^, L. Collins^4^, P. V. Belandres^4^, S. T. Chang^3^, J. F. Williams^5^, M. R. Nelson^1^; ^1^Walter Reed Army Med Ctr.; Uniformed Services University of the Health Sciences, Washington, DC, ^2^Uniformed Services University of the Health Sciences, Bethesda, MD, ^3^Walter Reed Army Med Ctr, Washington, DC, ^4^Walter Reed Army Med Ctr., Washington, DC, ^5^Walter Reed Army Med Ctr-VHC, Washington, DC.

**381**   **Thrombocytopenia and Measles-Mumps-Rubella (MMR) Vaccine: Managing Loss Of Immunity to MMR**

**L. C. Collins, Jr.** ^1,2^, M. C. Minor^1,2^, N. C. Blacker^3,4^, G. J. Robinson^3,4^, R. J. M. Engler^1,2^; ^1^Walter Reed Army Medical Center, Washington, DC, ^2^Vaccine Healthcare Centers Network, Washington, DC, ^3^Womack Army Medical Center, Fayetteville, NC, ^4^Vaccine Healthcare Centers Network, Fayetteville, NC.

**382**   **Pre-transplant Cellular Alloimmunity as Assessed by a Panel of Reactive T-Cells (PRT) and Risk of Post-transplant Allograft Rejection**

**M. R. Gupta** ^1^, M. Vieyra^1^, D. E. Hricik^2^, J. J. Augustine^2^, L. Coleman^1^, R. Starling^1^, E. Poggio^1^, P. S. Heeger^1^; ^1^Cleveland Clinic Foundation, Cleveland, OH, ^2^University Health Systems, Cleveland, OH.

**383**   **Chimeric EGF Receptor That Detects IgE-binding/crosslinking**

**R. Nakamura;** Natl Inst Health Sci, Tokyo, JAPAN.

**384**   **Low Values of Allergen Specific IgE Antibodies are Clinically Useful and Give Predictive Information for Very Young Children**

**L. Soderstrom** ^1^, M. Nordlund^2^, C. Nilsson^2^, G. Lilja^21^Phadia AB, Uppsala, SWEDEN, ^2^Sachs\' Children\'s Hospital, Sodersjukhuset, Stockholm, SWEDEN.

**385**   **Development of a Clinical Flow Cytometry Assay to Measure in Vitro Lymphocyte Responses**

**E. C. Chenworth** ^1^, V. Nandakumar^2^, R. S. Abraham^2^; ^1^Division of Allergic Diseases, Mayo School of Graduate Medical Education, Rochester, MN, ^2^Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

**386**   **Component Resolved IgE, IgG and IgG4 Antibody Levels for Grass Pollen Allergic Patients in Specific Immunotherapy. A Pilot Study**

J. Arnved^1^, S. Ronborg^1^, B. Kristensen^2^, **L. Soderstrom** ^3^; ^1^Lung and Allergy Clinic, Copenhagen, DENMARK, ^2^Sweden Diagnostics Denmark, Copenhagen, DENMARK, ^3^Phadia AB, Uppsala, SWEDEN.

**387**   **Comparison of Skin Prick Tests and Allergen-specific IgE by MAST-CLA Technique in Allergic Thai Children**

**P. Vilaiphan**, S. Numkiatwongsa, P. Chatchatee, J. Ngamphaiboon; King Chulalongkorn Memorial Hospital, Bangkok, THAILAND.

**388**   **Allergen Recognizing Pattern in Patients Sensitized to *Dermatophagoides pteronyssinus* and *Lepidoglyphus destructor***

**R. P. Reis** ^1^, A. P. Pires^1^, T. Fonseca^2^, R. Murta^2^, A. F. Ferrão^1^, L. A. Patrício^1^, E. M. Tomaz^1^, F. C. Inácio^1^; ^1^Hospital S. Bernardo, Setúbal, PORTUGAL, ^2^Amerlab DPC, Lisboa, PORTUGAL.
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**389**   **Airborne Spore Levels and Skin Test Reactivity in New Orleans following Hurricane Katrina**

**E. Levetin** ^1^, E. Horner^2^, E. Davis^3^, S. B. Lehrer^4^; ^1^University of Tulsa, Tulsa, OK, ^2^Air Quality Science, Marietta, GA, ^3^Ochsner Clinic Foundation, New Orleans, LA, ^4^Tulane University, New Orleans, LA.

**390**   **Indoor Molds and Allergic Potential**

**M. D. W. Ward** ^1^, Y. Chung^1^, L. B. Copeland^1^, M. K. Selgrade^1^, S. Vesper^2^; ^1^US EPA, Research Triangle Park, NC, ^2^US EPA, Cincinnati, OH.

**391**   **Seasonal Distribution of Airborne Alternaria Spores**

**J. D. K. McNairn**; Children\'s Mercy Hospital, Kansas City, MO.

**392**   **A Comparative Study of Airborne Grass Pollen and Grass Pollen Hypersensitivity in Tulsa and Sorrounding Areas in Northeast Oklahoma**

**R. S. Medagoda** ^1^, E. Levetin^2^, J. Purser^3^, D. Stewart^1^; ^1^University of Ok, College of Medicine, Tulsa, OK, ^2^University of Tulsa, Tulsa, OK, ^3^Allergy Clinic of Tulsa, Tulsa, OK.

**393**   **Respiratory Allergy and Airborne Pollen Concentrations in Italy from 1992 to 2004**

**E. Ridolo**, R. Albertini, D. Giordano, L. Soliani, I. Usberti, P. Dall\'Aglio; University of Parma, Parma, ITALY.

**394**   **An Eight Year Survey (1998-2005) of the Major Tree Pollens in the Washington, DC Area**

**J. Yoon**, M. R. Nelson, M. S. Marks, S. E. Kosisky; Walter Reed Army Medical Center, Washington, DC.

**395**   **Typical Outdoor Levels of Airborne Fungal Spores Collected at Ground Level During Both The Rainy and Dry Seasons in Florida**

**R. Codina**, L. S. Cohen, Jr., J. J. Mele; SDII Global Corporation, Tampa, FL.

**396**   **The Air Spora Surrounding a Compost Facility in Northeast, Oklahoma**

**S. Gillum**, E. Levetin; The University of Tulsa, Tulsa, OK.

**397**   **Influence of Meteorological Conditions on Early Spring Pollen in the Tulsa Atmosphere from 1987-2006**

**E. Lo**, E. Levetin; University of Tulsa, Tulsa, OK.

**398**   **Predominant Weed and Grass Aeroallergens of the Washington, DC Area: an Eight Year Survey (1998-2005)**

**S. E. Kosisky, Sr.**; Walter Reed Army Medical Center, Washington, DC.

**399**   **Effect of Trimming Cypress Tree on Pollination**

**D. A. Charpin** ^1^, M. Calleja^2^, C. Pichot^3^; ^1^Assistance publique-Hôpitaux de Marseille, Marseille, FRANCE, ^2^Ecole Supérieure d\'Agronomie de Montpellier, Montpellier, FRANCE, ^3^Institut National de la Recherche Agronomique, Avignon, FRANCE.

**400**   **Characteristics of the Casuarina Pollen Season in the Sydney District, NSW**

**P. K. Burton**, C. H. Katelaris; Institute of Immunology and Allergy Research, Westmead, AUSTRALIA.

**401**   **September Asthma Spikes And Mold Aeroallergen Levels In A Southwestern Ontario Community: Correlation Or Coincidence?**

**J. Ohayon** ^1^, J. Anderson^2^; ^1^McMaster University, Hamilton, ON, CANADA, ^2^London Health Sciences, London, ON, CANADA.

**402**   **Seasonal Pollinosis Symptoms, Atmosphere Conditions And Pollens Count**

**C. Nunes**, S. Ladeira; Center of Allergy of Algarve, Portimao, PORTUGAL.

**403**   **"Farmhouse Mycosis": Mold Assessment**

**J. J. Anderson** ^1^, P. J. Pityn^2^; ^1^London Health Sciences Centre, London, ON, CANADA, ^2^Oshtech Inc., London, ON, CANADA.

**404**   **Concordance Rates of Allergen Sensitization Amongst Family Members at an Inner City Asthma Center**

**F. Hajee**, H. Solomon, M. Castro, C. Bowser, M. Rao, R. Joks; Center for Allergy and Asthma Research, SUNY Downstate Medical Center, Brooklyn, NY.

**405**   **Risk Factors for Asthma in Adolescents: ISAAC Phase II in a Brazilian Coast City**

L. M. Spinelli, **N. A. Rosario**, C. A. Riedi, A. V. Schmidt, J. J. Jorge, M. Malucelli, M. S. Cramer, J. C. Correa-Celi, A. Albanus; Federal University of Parana, Curitiba, BRAZIL.

**406**   **Allergic Asthma and Rhinitis Caused by Household Rabbit Exposure: Identification of Seum-Specific IgE and Its Allergens**

**J. Choi** ^1^, H. Kim^2^, H. Park^2^; ^1^Bundang JeSaeng General Hospital, Seongnam-si, Kyunggido, REPUBLIC OF KOREA, ^2^Ajou University Hospital, Suwon-si, Kyunggido, REPUBLIC OF KOREA.

**407**   **The Relationship Between Obesity, Menstrual Cycle, And Lung Function In Korean Adolescent Girls**

**H. J. Yang**, Y. H. Jeon, B. Y. Pyun; Department of Pediatrics, College of Medicine, Soonchunhyang Univ Hospital, Seoul, REPUBLIC OF KOREA.

**408**   **Development of a Murine Model for Assessment of Chronic Beryllium Disease**

**F. Salehi** ^1^, S. Audusseau^1^, N. Karp^1^, J. Zayed^2^, B. Mazer^1^; ^1^McGill University, Montreal, PQ, CANADA, ^2^University of Montreal, Montreal, PQ, CANADA.

**409**   **Tobacco Smoke Relation With Chronic Sinusitis And Nasal Polips**

**J. Martín-Lázaro** ^1^, D. D. Stevenson^2^; ^1^Hospital Juan Canalejo, La Coruna, SPAIN, ^2^Scripps Clinic, La Jolla, CA.
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**410**   **Cockroach Allergen Bla g 2 Dimerizes in a Crystal Complex with an Antibody Fragment**

**A. Pomés** ^1^, M. Li^2^, S. Wünschmann^1^, M. D. Chapman^1^, A. Wlodawer^3^, A. Gustchina^3^; ^1^INDOOR Biotechnologies, Inc., Charlottesville, VA, ^2^Basic Research Program, SAIC-Frederick, Frederick, MD, ^3^Macromolecular Crystallography Laboratory, National Cancer Institute, Frederick, MD.

**411**   **Purification And Characterization Of Allergens From *Harmonia Axyridis* (asian Lady Beetle): An Evolving Indoor Allergen**

**T. NAKAZAWA** ^1^, B. Dragulev^1^, L. Goddard^1^, J. Shannon^1^, E. Peters^2^, T. A. Platts-Mills^1^; ^1^University of Virginia, Charlottesville, VA, ^2^Asthma and Allergy Consultants, Austin, TX.

**412**   **Mapping of Antigenic Determinants on Bla g 2 surface**

**S. Wünschmann** ^1^, M. Li^2^, A. Gustchina^3^, A. Wlodawer^3^, M. Chapman^1^, A. Pomés^1^; ^1^INDOOR Biotechnologies Inc., Charlottesville, VA, ^2^Basic Research Program, SAIC, Frederick, MD, ^3^Macromolecular Crystallography Laboratory, NCI, Frederick, MD.

**413**   **IgE Recognition Pattern of Homologous Allergens Tested by Microarray-based Nanotechnology**

**E. Scala**, A. Zaffiro, D. Quaratino, C. D\'Ambrosio, M. Bernardi, P. Palazzo, M. Giani, A. Mari; Center for Clinical and Experimental Allergology, IDI-IRCCS, Rome, ITALY.

**414**   **Stability of Major Allergen Proteins in Extract Mixes Diluted in Human Serum Albumin (HSA), Normal Saline (NSP), or Glycerin (GLY)**

**G. Plunkett**; ALK-Abelló, Inc., Round Rock, TX.

**415**   **Mapping Conformational Epitopes On Jun A 1, The Major Allergen Of Mountain Cedar Pollen**

**R. Tiwari**, B. Ning, S. Negi, M. Endsley, D. Estes, C. Schein, W. Braun, T. Midoro-Horiuti, R. Goldblum; University of Texas Medical Branch, Galveston, TX.

**416**   **Natural and Recombinant Amb a 1: Immunologic Analysis of IgE and Monoclonal Antibody Epitopes**

**N. Wopfner** ^1,2^, R. Bauer^1^, J. Thalhamer^1,2^, F. Ferreira^1,2^, M. Chapman^3^; ^1^University of Salzburg, Department of Molecular Biology, Salzburg, AUSTRIA, ^2^Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Salzburg, AUSTRIA, ^3^Indoor Biotechnologies, Charlottesville, VA.

**417**   **Proteomics Of The Major Pollen Allergen From Birch (Bet v 1), Hazel (Cor a 1), Oak (Que a 1), And Hornbeam (Car b 1)**

**A. M. Erler** ^1,2^, F. Ferreira^1,2^, P. Briza^1^; ^1^University of Salzburg, Department of Molecular Biology, Salzburg, AUSTRIA, ^2^Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Salzburg, AUSTRIA.

**418**   **Molecular Cloning of *Chortoglyphus arcuatus* Allergens**

**E. Fernandez-Caldas** ^1^, L. Vailes^2^, O. Troubina^2^, E. King^2^, L. Arlian^3^, M. Boquete^4^, V. Iraola^1^, S. Lafosse-Marin^5^, M. Chapman^2^; ^1^Laboratorios LETI S. L., Tres Cantos, SPAIN, ^2^Indoor Biotechnologies Inc., Charlottesville, VA, ^3^Wright State University, Dayton, OH, ^4^Hospital Xeral, Lugo, SPAIN, ^5^Cabinet d\'Immuno-allergologie, Fort de France, MARTINIQUE.

**419**   **Identification of an Allergen of *Harmonia Axyridis* (Multicolor Asian Lady Beetle)**

**J. E. Knuffman** ^1,2^, M. A. Opsahl^1^, B. H. Gern^1^, A. S. Pratt^1^, H. Sanchez^1^, R. K. Bush^1,2^; ^1^William S. Middleton Veterans Affairs Hospital, Madison, WI, ^2^University of Wisconsin Hospital and Clinics, Madison, WI.

**420**   **N-terminus Amino Acid Analysis Of Four Independently Produced Recombinant Alt a1**

**H. Sanchez** ^1^, R. K. Bush^1,2^; ^1^William S. Middleton VA Hospital, Madison, WI, ^2^University of Wisconsin-Madison, Madison, WI.

**421**   **Extraction and Purification of Art v 1, the Mugwort Pollen Major Allergen**

**M. Egger**, P. Gruber, F. Ferreira; Department of Molecular Biology, Division of Allergy and Immunology, University of Salzburg, Salzburg, AUSTRIA.

**422**   **Characterization of *Ascaris lumbricoides* Tropomyosin: Use of Recombinant Protein to Investigate IgE Antibody Responses**

A. B. R. Santos^1^, G. C. Arruda^1^, A. S. Zampolo^1^, M. C. Rodrigues^1^, V. P. L. Ferriani^1^, C. Oliver^1^, M. S. Palma^2^, V. S. Sales^3^, **L. K. Arruda** ^1^; ^1^School of Medicine of Ribeirão Preto-University of São Paulo, Ribeirão Preto, BRAZIL, ^2^Bioscience Institute, State University of São Paulo, Rio Claro, BRAZIL, ^3^Federal University of Rio Grande do Norte, Natal, BRAZIL.

**423**   **The Cross-allergenecity of Pollens from *Compositae* Family: *Dendranthema grandiflorum, Artemisia vulgaris* and *Taraxacum officinale***

**Y. W. Lee** ^1^, S. Y. Choi^2^, E. K. Lee^2^, J. H. Sohn^2^, J. W. Park^1^, C. S. Hong^1^; ^1^Dept of Int Med & Institute of Allergy, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Institute of Allergy, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA.

**424**   **Biochemical Characterization Of Intact Allergen Extracts Vaccine (Alutard SQ®) And Chemically Modified Allergoid Vaccines Representing Birch, Grass And House Dust Mite**

**H. Henmar**, K. Meno, L. Friberg, H. Ipsen; ALK-Abelló A/S, Hørsholm, DENMARK.

**425**   ***Senecio jacobea* Pollen: A New Allergenic Source**

**O. Luengo** ^1^, R. Mollá^2^, V. Pozo^2^, V. Cardona^1^, C. Geller-Bernstein^3^, Y. Waysel^4^, C. Lahoz^2^, A. Cadahia^1^; ^1^Allergy Unit. Hospital Universitari Vall d\'Hebron., Barcelona, SPAIN, ^2^Department of Immunology. Fundación Jiménez Díaz, Madrid, SPAIN, ^3^Kaplan Medical Center, Rehovot, ISRAEL, ^4^Tel Aviv University, Tel Aviv, ISRAEL.

**426**   **Physicochemical and Immunochemical Characterization of Cyn d 24 from Bermuda Grass Pollen**

**S. Su** ^1^, l. chiu^2^, s. yang^1^, S. Huang^3^, L. Chou^2^; ^1^Veterans General Hospital-Taipei, Taipei, TAIWAN, ^2^National Taiwan University, Taipei, TAIWAN, ^3^University of Florida, Gainesville, FL.

**427**   **Epidemiological Evaluation of Allergenic Molecules IgE Reactivity Detected by means of a Proteomic Microarray Method**

**M. Giani**, E. Guerra, M. Locanto, C. Mondino, L. Pirrotta, D. Pomponi, E. Scala, A. Mari; Center for Clinical and Experimental Allergology, IDI-IRCCS, Rome, ITALY.

**428**   **Identification of the Russian Hamster Allergens (*Phodopus sungorus*)**

**J. A. Torres**, M. de las Heras, C. Pastor, M. Fernandez-Nieto, S. Quirce, M. Madero, A. Enriquez-Matas, J. Sastre; Fundacion Jimenez Diaz, Madrid, SPAIN.

**429**   **Assessment of the Potential Cross-Allergenicity between Hen\'s Egg Lysozyme and Recombinant Human Lysozyme**

**D. A. Moneret-Vautrin** ^1^, C. M. N. Astier^2^, P. Franck^1^, M. Morisset^1^, F. Codreanu^1^, O. Roitel^3^, S. L. Taylor^4^, D. R. Bethell^5^; ^1^University Hospital, Nancy, FRANCE, ^2^INPL, Vandoeuvre-Les-Nancy, FRANCE, ^3^Laboratory of Molecular Medicine and Therapeutics, Vandoeuvre-Les-Nancy, FRANCE, ^4^University of Nebraska, Lincoln, NE, ^5^Ventria Bioscience, Sacramento, CA.

**430**   **Specific IgE levels to Der p 1 and Der p 2 in patients sensitized to *Dermatophagoides* spp.**

**M. Boquete** ^1^, F. Carballada^1^, C. Carballas^1^, J. Carnés^2^, V. Iraola^2^, E. Fernández-Caldas^2^, M. Chapman^3^; ^1^Hospital Xeral de Calde, Lugo, SPAIN, ^2^Laboratorios LETI, SL, Tres Cantos, SPAIN, ^3^Indoor Biotechnologies Inc., Charlottesville, VA.

**431**   **Production of Purified Native Alt a 1 at an Industrial Scale**

**M. Osterberg** ^1^, S. Jabbari^1^, E. Hogbom^2^, P. Brostedt^2^; ^1^Allergon AB, Angelholm, SWEDEN, ^2^Phadia AB, Uppsala, SWEDEN.
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**432**   **Fig Allergy: Not Just Oral Allergy Syndrome (OAS)**

**N. V. Cruz**, S. L. Bahna, A. K. Knight; Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA.

**433**   **A Case Series of Eosinophilic Esophagitis: Importance of Allergy Evaluation, Detection of Food Allergy and Avoidance Diet**

**V. Patel**, S. Kearney; Lehigh Valley Hospital, Allentown, PA.

**434**   **Prevalence of Sensitization to Food Allergens Among Food Allergy Index and Control Families**

**D. Caruso**, F. Ouyang, J. A. Pongracic, R. Kumar, A. Schroeder, J. Costello, X. Wang; Children\'s Memorial Hospital, Chicago, IL.

**435**   **Trends in Sensitisation to Aero and Food Allergens-Comparison between different Birth Cohorts**

**T. Dean** ^1,2^, C. Venter^2^, R. Kurukuralaatchy^2^, B. Pereira^2^, S. Matthews^2^, J. Grundy^2^, C. B. Clayton^2^, M. Fenn^2^, B. Higgins^1^, S. H. Arshad^2^; ^1^University of Portsmouth, Portsmouth, UNITED KINGDOM, ^2^The David Hide Asthma and Allergy Research Centre, Isle of Wight, UNITED KINGDOM.

**436**   **Racial Differences in Early Introduction of Solid foods, IgE and Incidence of Atopic Dermatitis and Wheeze**

**C. L. M. Joseph** ^1^, D. R. Ownby^2^, S. L. Havstad^1^, E. M. Zoratti^3^, C. C. Johnson^1^; ^1^Dept of Biostatistics and Research Epidemiology, Henry Ford Hospital & Health System, Detroit, MI, ^2^Medical College of Georgia, Augusta, GA, ^3^Section of Allergy & Clinical Immunology, Henry Ford Hospital & Health System, Detroit, MI.

**437**   **Prevalence of Peanut and Shellfish Allergy in Singapore Children Estimated from a Questionnaire Survey**

**L. P. Shek** ^1^, J. Y. Soh^2^, P. Z. Ng^1^, E. A. Morales^1^, S. Ma^3^, B. W. Lee^1^; ^1^National University of Singapore, Singapore, SINGAPORE, ^2^National University Hospital, Singapore, SINGAPORE, ^3^Ministry of Health, Singapore, SINGAPORE.

**438**   **Food Allergen Sensitization is Independently Associated with Decreased Lung Function in Children**

**R. Kumar** ^1^, Y. Yu^2^, J. A. Pongracic^1^, A. Schroeder^2^, B. Wang^2^, X. Liu^3^, H. Xing^3^, X. Wang^2^; ^1^Division of Allergy, Children\'s Memorial Hospital, Chicago, IL, ^2^The Mary Ann and J. Milburn Smith Child Health Research Program, Children\'s Memorial Hospital and Children\'s Memorial Research Center, Chicago, IL, ^3^Biomedical Institute, Anhui Medical University, Hefei, CHINA.

**439**   **Demographic Information for Patients with Eosinophilic Esophagitis**

**M. L. Heltzer**, J. P. Franciosi, M. Shuker, C. A. Liacouras, J. M. Spergel; Children\'s Hospital of Philadelphia, Philadelphia, PA.

**440**   **Food Hypersensitivity (FHS) And Sensitisation To Food Allergens Over The First Three Years Of Life**

**C. Venter** ^1^, B. N. Pereira^1^, J. Grundy^1^, C. B. Clayton^1^, B. Higgins^2^, T. Dean^1,2^; ^1^The David Hide Asthma and Allergy Research Centre, Isle of Wight, UNITED KINGDOM, ^2^University of Portsmouth, Portsmouth, UNITED KINGDOM.

**441**   **Cookies and Avoidance Diets - Impact of the Food Allergen Labeling and Consumer Protection Act (FALCPA) and Other Industry Practices on Ingredient Labeling of Cookies**

**S. L. Taylor** ^1^, G. A. Knudsen^1^, S. L. Hefle^1^, T. J. Furlong^2^; ^1^Food Allergy Research and Resource Program (FARRP) at University of Nebraska, Lincoln, NE, ^2^Food Allergy & Anaphylaxis Network (FAAN), Fairfax, VA.

**442**   **Transfer of Shrimp Allergens to Other Foods Through Cooking Oil?**

**S. B. Lehrer** ^1^, L. Kim^1^, T. Rice^1^, J. Saidu^2^, J. Bell^2^, R. Martin^3^; ^1^Tulane University Health Sciences Center, New Orleans, LA, ^2^LSU Ag Center, Baton Rouge, LA, ^3^National Fisheries Institute, McLean, VA.

**443**   **Familial Aggregation of Total and Food-Specific IgE**

**H. Tsai**, R. Kumar, J. Pongracic, Y. Yu, J. Costello, M. O\'Gorman, X. Wang; Children\'s Memorial Hospital and Children\'s Memorial Research Center, Chicago, IL.

**444**   **ELISA and HPLC Comparison of Pediatric Amino Acid-based Nutritionals**

**G. O. Duska-McEwen**; Abbott Laboratories, Columbus, OH.

**445**   **Peanut Allergic Child Increases Risk for Peanut Allergy in Siblings**

**S. Huq** ^1,2^, J. Liem^1,2^, A. Kozyrskyj^1,2^, A. Becker^1,2^; ^1^University of Manitoba, Winnipeg, MB, CANADA, ^2^Manitoba Institute of Child Health, Winnipeg, MB, CANADA.

**446**   **Study and Development of Food Allergy Herbal Formula (FAHF-2)**

**Y. Chen**, K. Srivastava, H. Sampson, X. Li; Mt. Sinai School of Medicine, New York, NY.

**447**   **Cross Reactivity in Mountain Cedar-Tomato Oral Allergy Syndrome**

**R. S. Bonds**, R. Tiwari, B. Ning, E. W. Czerwinski, R. G. Goldblum, T. Midoro-Horiuti; University of Texas Medical Branch, Galveston, TX.

**448**   **Investigation of the Safety to Allergic Patients of Biotechnologically Derived Enzymes used in the Food Industry**

**C. Bindslev-Jensen** ^1^, P. Skov^2^, E. Roggen^3^, E. Friis^3^, T. Gehring^3^, P. Hvass^3^, D. Brinch^3^; ^1^Odense University Hospital, Odense, DENMARK, ^2^RefLab, Copenhagen, DENMARK, ^3^Novozymes A/S, Bagsvaerd, DENMARK.

**449**   **Food-Induced Anaphylaxis and Repeat Epinephrine Treatments**

**E. Oren**, A. Banerji, S. Clark, C. A. Camargo, Jr.; Massachusetts General Hospital, Boston, MA.

**450**   **Evaluation of Pediatric Patients Admitted with Adverse Food Reactions to an Inner-City Pediatric ED**

**S. Kiratiseavee**, S. Ramesh; University of Buffalo, Buffalo, NY.

**451**   **Roasted Peanuts Are More Likely to Sensitize Mice than Raw Peanuts**

**S. J. Maleki** ^1^, K. Yamaki^2^; ^1^USDA-Agricultural Research Service, New Orleans, LA, ^2^National Food Research Institute, Tsukuba, JAPAN.

**452**   **Children with Multiple Food Allergies are Not More Likely to be Underweight than Other Children**

**J. L. P. Protudjer**, J. J. Liem, A. L. Kozyrskyj, A. B. Becker; University of Manitoba, Winnipeg, MB, CANADA.

**453**   **The Natural History of Egg Allergy**

**J. H. Rabe**, E. C. Matsui, K. E. Mudd, J. M. Skripak, R. A. Wood; Johns Hopkins Hospital, Baltimore, MD.

**454**   **Identification of a MnSOD-like Protein as a New Major Pistachio Allergen**

**R. Ayuso**, G. Grishina, K. Ahn, L. Bardina, K. Beyer, H. Sampson; Mt Sinai Medical Center, New York, NY.

**455**   **Immunochemical and Biological Methods for Estimation of Allergen Content Used for Soy Allergy Risk Assessments of Biotechnologically Derived Products**

**M. H. Pedersen** ^1^, P. S. Skov^1^, T. Holzhauser^2^, C. Bindslev-Jensen^3^, D. S. Brinch^4^, L. K. Poulsen^1^; ^1^National university hospital of Denmark, Copenhagen, DENMARK, ^2^Paul-Ehrlich-Institut, Langen, GERMANY, ^3^Odense university hospital, Odense, DENMARK, ^4^Novozymes A/S, Bagsvœrd, DENMARK.

**456**   **Basophil Activation In Food Allergic Patients**

**M. Worm**; Dept. of Dermatology and Allergy, Berlin, GERMANY.

**457**   **Association Between Milk Allergy, Steroid Use, And Rate Of Hospitalizations In Children With Asthma**

A. B. Sympson^1,2^, **E. Yousef** ^1,2^; ^1^DuPonts Children\'s Hospital, Wilmington, DE, ^2^Thomas Jefferson Uiniversity, Philadlephia, PA.

**458**   **Epicutaneous Testing Using Peanut Extracts Prepared by a Variety of Cooking Methods**

**M. Peng** ^1^, G. Hubbard^1^, J. A. Nordlee^2^, S. L. Hefle^2^, M. B. Levy^1^; ^1^Medical College of Wisconsin, Milwaukee, WI, ^2^University of Nebraska, Food Allergy Research and Resource Program, Lincoln, NE.

**459**   **Sunflower Seed Food Allergy as a Co-allergy With Peanut**

**S. S. Comstock**, C. Kath, S. S. Teuber; Univ CA-Davis School Medicine, Davis, CA.

**460**   **Identification of a New Sesame Seed Allergen - Ses i 7, an 11 S Globulin belonging to the Seed Storage Proteins**

**K. Beyer** ^1^, G. Grishina^2^, L. Bardina^2^, H. A. Sampson^2^; ^1^Charité, Berlin, GERMANY, ^2^Mount Sinai School of Medicine, New York, NY.
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**461**   **A Phase II, Randomized, Double-Blind, Parallel-group, Placebo-Controlled, Oral Food Challenge Trial of XOLAIR® (omalizumab) in Peanut Allergy (TOPS)**

**H. A. Sampson**; Mount Sinai School of Medicine, New York, NY.

**462**   **Relative Potency of Oral Antigens in Provoking Food Allergy in the Mouse**

**C. C. Bowman**, M. K. Selgrade; USEPA, Research Triangle Park, NC.

**463**   **Increased Prevalence of Vitamin D Deficiency Rickets Due to Inadequate Dietary Restrictions for the Treatment for Allergic Diseases**

**T. Muto** ^1^, S. Morii^1^, R. Kimura^1^, M. Futamura^2^, K. Ito^2^, T. Sakamoto^1^; ^1^Nagoya University Graduate School of Medicine, Nagoya, JAPAN, ^2^Aichi Children\'s Health and Medical Center, Obu, JAPAN.

**464**   **Recognition of Clinical Tolerance to Baked Milk Products in Milk-Allergic Children**

**K. A. Bloom**, A. Nowak-Wegrzyn, S. M. Walsh, E. D. Robinson, M. Mishoe, H. A. Sampson; The Mount Sinai Medical Center, New York, NY.

**465**   **Novel Clinical Course Of IgE-mediated, Late-onset Anaphylaxis After Ingestion *Bacillus Subtilis*-Fermented Soybeans (natto): Clinical Review Of 7 Patients**

**N. Inomata**, H. Osuna, K. Kawano, J. Yamaguchi, M. Yanagimachi, Z. Ikezawa; Yokohama City University Hosipital, Yokohama, JAPAN.

**466**   **Cherry Allergy: How To Decrease The Allergenicity Of Cherry Industrial Derivatives**

**V. Pravettoni** ^1^, O. Brenna^2^, L. Farioli^3^, L. Primavesi^2^, S. Bonomi^1^, S. Tonoli^1^, C. Pompei^2^, E. Pastorello^3^; ^1^Operative Unit of Allergy and Clinical Immunology, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena Foundation, IRCCS, Milan, Italy, ^2^Department of Food Science and Technology and Microbiotechnology, University of Milan, Milan, Italy, ^3^Operative Unit of Allergy and Clinical Immunology, Niguarda Ca\' Granda Hospital, Milan, Italy.

**467**   **Treatment of Natural Peanut Butter with Phytic Acid**

**S. CHUNG**, E. T. Champagne; USDA-ARS, New Orleans, LA.

**468**   **Multifaceted Food Allergy Education Program: Healthcare Provider Educational Resource Development**

**J. E. Yu** ^1^, S. Teuber^2^, S. H. Sicherer^1^; ^1^Mt Sinai School Of Medicine, New York, NY, ^2^University of California, San Diego, San Diego, CA.

**469**   **Assessment of Hypoallergenic Properties of the Santana Apple**

**H. S. Kootstra** ^1^, B. J. Vlieg-Boerstra^1^, M. P. van der Maas^2^, A. E. J. Dubois^1^; ^1^University Medical Center Groningen, Groningen, THE NETHERLANDS, ^2^Applied Plant Research, Wageningen UR, Wageningen, THE NETHERLANDS.

**470**   **Can Egg-Allergic Children Recognize Egg Proteins In Breast Milk?**

**I. Cerecedo** ^1^, C. Alonzi^2^, J. Wang^3^, L. Bardina^3^, A. Nowak-Wegrzyn^3^; ^1^Hospital Ramon y Cajal, Madrid, SPAIN, ^2^Policlinico Gemelli, Università Cattolica del Sacro Cuore, Rome, ITALY, ^3^Mount Sinai School of Medicine, New York, NY.

**471**   **Assessment of Oral Allergy to Apple with Rat Basophil Leukemia (RBL) Cells Transfected with Human Fcɛ Receptor and Passively Sensitized with Sera from Apple- and Birch-Allergic Individuals**

**R. Bencharitiwong**, A. Nowak-Wegrzyn; Mount Sinai School of Medicine, New York, NY.

**472**   **A New Murine Model of beta-Lactoglobulin-Specific IgE-Mediated Cow\'s Milk Hypersensitivity**

**K. Dairiki**, N. Shimizu, T. Kaneko; Food Science Institute, Meiji Dairies Corporation, Odawara, Kanagawa, JAPAN.

**473**   **Weaning to a Partially Hydrolyzed Whey Formula at Three Months of Age Protects Against the Later Development of Anti-Cow Milk IgE Antibodies in Comparison to Whole Cow\'s Milk or Extensively Hydrolyzed Whey Formulas**

**R. U. Sorensen** ^1^, J. Inostroza^2^, E. Hebel^2^, A. M. Vinet^2^, J. Fierro^2^, A. Roman^2^, K. Mason^1^; ^1^LSU Health Sciences Center, New Orleans, LA, ^2^University of La Frontera, Temuco, CHILE.

**474**   **Specific IgE Antibodies To ω-5 Gliadin - Indicator Of Wheat Anaphylaxis And Its Tolerance In Wheat Sensitized Children**

**R. Shibata** ^1^, S. Nishima^1^, K. Kohno^2^, E. Morita^2^, H. Matsuo^3^, A. Tanaka^4^; ^1^Fukuoka National Hospital, Fukuoka, JAPAN, ^2^Department of Dermatology, Shimane University School of Medicine, Shimane, JAPAN, ^3^Graduate School of Biomedical Scineces, Hiroshima University, Hiroshima, JAPAN, ^4^Phadia KK, Tokyo, JAPAN.

**475**   **Food Allergy Symptoms As A Consequence Of Subconscious Stress Responses**

**K. Nekam** ^1^, K. Toth^2^, L. M. DuBuske^3^; ^1^Hospital of the Hospitaller Brothers of St. John of God, Budapest, HUNGARY, ^2^Institute of Psychology, University of Pécs, Pecs, HUNGARY, ^3^Immunology Research Institute of New England, Gardner, MA.

**476**   **Cashew Allergy Demographics, Presentation and Cross Reactivity in a US Cohort**

**A. W. Grigg** ^1^, I. C. Hanson^1,2^, C. M. Davis^1,2^; ^1^Baylor College of Medicine, Houston, TX, ^2^Section of Allergy and Immunology, Department of Pediatrics,Texas Children\'s Hospital, Houston, TX.

**477**   **Identification of Pistachio (*Pistacia vera*) Allergens of 11s Globulin and 2s Albumin Family**

**K. Ahn**; Samsung Medical Center, Sunkyunkwan University School of Medicine, Seoul, REPUBLIC OF KOREA.

**478**   **Accidental Allergic Reactions (AAR) In Children With Cow\'s Milk Allergy (CMA)**

**M. Boyano**; Hospital Infantil La Paz, Madrid, SPAIN.

**479**   **Associations of Prick Skin Tests and Allergen Specific IgE in Children and Adults**

**J. A. Pongracic** ^1^, F. Ouyang^2^, J. S. Kim^1^, D. Caruso^2^, H. Wang^2^, X. Wang^2^; ^1^Division of Allergy, Children\'s Memorial Hospital, Chicago, IL, ^2^The Mary Ann and J. Milburn Smith Child Health Research Program, Children\'s Memorial Hospital and Children\'s Memorial Research Center, Chicago, IL.

**480**   **Utility of the Direct Basophil Activation Test in Predicting Tolerance to Dietary Milk Protein in Children With a History of Cow\'s Milk Allergy**

**N. Wanich**, A. Nowak-Wegrzyn, S. Walsh, B. Robinson, S. Noone, H. A. Sampson, W. G. Shreffler; Mount Sinai School of Medicine, New York, NY.

**481**   **Establishing Objective Detection Limits for the Pepsin Digestion Assay Used in the Assessment of Genetically Modified Foods**

**A. O. Ofori-Anti**, L. Chen, H. L. Lee, R. E. Goodman; University of Nebraska, Lincoln, Lincoln, NE.

**482**   **Bird-egg Syndrom In A 80 Years Old Patient**

**A. Losada** ^1^, M. Dieguez^1^, E. González^1^, B. de Valdés^1^, J. Carnes^2^, M. Díez^1^; ^1^Servicio de Alergia Hospital Ramon y Cajal, Madrid, SPAIN, ^2^Laboratorios LETI I+D, Madrid, SPAIN.

**483**   **Egg-bird Syndrome In A Five Year Old Patient**

**B. de Valdés** ^1^, E. Gonzalez^1^, M. Diéguez^1^, J. Carnés^2^, B. De la Hoz^1^, S. Terrados^1^; ^1^Allergy Department. Hospital Ramon y Cajal, Madrid, SPAIN, ^2^I+D Laboratorios LETI, Madrid, SPAIN.

**484**   **IgE Mediated Food Allergy in Childhood: Novel Concepts in Allergic Immune Response**

**S. Donnanno** ^1^, M. Rosado^2^, G. Trimarco^3^, F. Capolunghi^2^, S. Cascioli^2^, M. C. Artesani^1^, R. Carsetti^2^, G. Cavagni^1^; ^1^C.O.U. of Allergy, Pediatric Medicine Department, IRCCS, Osp. Pediatrico Bambino Gesù, Rome, Roma, ITALY, ^2^Research Laboratory of Flow Cytometry and B cells Development, IRCCS, Osp. Pediatrico Bambino Gesù, Rome, Roma, ITALY, ^3^O.U. of Allergy, Pediatric Department, University of Parma, Roma, ITALY.

**485**   **Analysis of Peanut Allergenic Components for Chinese Patients**

**H. Li**; Peking Union Medical College Hospital, Beijing, CHINA.

**486**   **Allergic Proctocolitis Associated With Cow\'s Milk With An Unusual Evolution**

**C. M. A. Jacob**, D. L. A. Pitarello, A. C. Pastorino, M. M. F. Trevisan, Y. L. Koda, E. Vidolin, A. P. B. M. Castro; Depto. of Pediatrics, São Paulo, BRAZIL.

**487**   **Presence, Loss, and Recurrence of Walnut Allergy after Chemotherapy**

**W. L. Ebbeling**; William L. Ebbeing, MD, INC, APMC, Fresno, CA.

**488**   **Egg\'s allergy: an experience from Brazilian Food Allergy Reference Center**

**C. M. A. Jacob**, A. C. Pastorino, D. Munhoz, R. G. Ramos, T. Batelochio, A. C. Brandão, A. K. F. Gushken, G. H. Yonamine, A. P. B. M. Castro; Faculty of Medicine of University of Sao Paulo, Sao Paulo, BRAZIL.
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**489**   **The Effect of Increasing Study Enrollment on Willingness to Adopt Newly Validated Asthma Therapies**

**P. Khoury**, J. O\'Brien, S. K. Aberegg; The Ohio State University, Columbus, OH.

**490**   **Adherence To Immunotherapy Protocols, SLIT Vs. SCIT**

**R. Garcia-Ibanez**, D. M. Pollina; The AllergiGroup, Tampa, FL.

**491**   **Low Temperature is a Strong Risk Factor for the Onset of Atopic Dermatitis in Children in Japan**

**K. Matsumoto**, H. Saito; National Research Institute for Child Health and Development, Tokyo, JAPAN.

**492**   **Prevalence of Self-reported Adverse Drug Reaction/Drug Allergy in a Singaporean Paediatric Population**

**T. Tan** ^1^, H. Van Bever^2^; ^1^National University of Singapore, Singapore, SINGAPORE, ^2^Department of Paediatrics, National University of Singapore, Singapore, SINGAPORE.

**493**   **Locating Evidence-based Literature in Immunology Using PubMed/MEDLINE**

**K. E. Deeney**, A. F. Carr; NN/LM Pacific Southwest Region, UCLA, Los Angeles, CA.

**494**   **Childhood Obesity as a Possible Aggravating Factor of Atopic Dermatitis**

**T. Kusunoki** ^1,2^, T. Morimoto^3^, R. Nishikomori^2^, T. Heike^2^, M. Ito^1^, S. Hosoi^4^, T. Nakahata^2^; ^1^Shiga Medical Center for Children, Moriyama, Shiga, JAPAN, ^2^Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, JAPAN, ^3^Medical Education Center, Kyoto University, Kyoto, JAPAN, ^4^Ako City Hospital, Ako, Hyogo, JAPAN.

**495**   **Prevalence of Atopy in Rural China among Children and Adults**

**J. S. Kim** ^1^, F. Ouyang^2^, J. A. Pongracic^1^, B. Wang^2^, X. Liu^3^, H. Xing^3^, D. Caruso^2^, X. Wang^2^; ^1^Division of Allergy, Children\'s Memorial Hospital, Chicago, IL, ^2^The Mary Ann and J. Milburn Smith Child Health Research Program, Children\'s Memorial Hospital and Children\'s Memorial Research Center, Chicago, IL, ^3^Biomedical Institute, Anhui Medical University, Hefei, CHINA.

**496**   **Risk Factors of Atopy in the First Two Years of Life in Indonesian Children**

**B. Setiabudiawan**, C. B. Kartasasmita; Hasan Sadikin General Hospital, Bandung, INDONESIA.

**497**   **Does Breastfeeding (BF) Prevent Allergic Sensitization? Results of Probit II**

**B. D. Mazer** ^1,2^, L. Matush^3^, R. Platt^1^, I. Vanilovich^3^, M. Kramer^1^; ^1^McGill University/Montreal Children\'s Hosp., Montreal, PQ, CANADA, ^2^Meakins Christie Laboratories, Montreal, PQ, CANADA, ^3^National Research and Applied Medicine Mother and Child Centre, Minsk, BELARUS.

**498**   **Association of Parental Gender and Allergic Sensitization with the Patterns of Sensitization in 18 year-old Offspring in the Detroit Area Childhood Allergy Study**

**R. T. Misiak** ^1^, G. Wegienka^1^, S. Havstad^1^, D. R. Ownby^2^, C. C. Johnson^1^, E. M. Zoratti^1^; ^1^Henry Ford Health System, Detroit, MI, ^2^Medical College of Georgia, Augusta, GA.
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**499**   **Plasmacytoid Dendritic Cells from Asthmatic Patients Exhibit Increased FcERI Expression**

**M. A. Gill**, T. A. George, V. Gan, K. Long, I. Dougherty, R. Gruchalla; UT Southwestern Medical Center at Dallas, Dallas, TX.

**500**   **The Anti-Inflammatory Effect of Ciglitazone is Partially Mediated by Glucocorticoid Induced Leucine Zipper in Human Airway Epithelial Cells**

**A. L. Wagelie-Steffen** ^1^, J. Eddleston^1,2^, J. Herschbach^1,2^, B. L. Zuraw^1,2^; ^1^University of Califonia, San Diego, San Diego, CA, ^2^Veterans Medical Research Foundation, La Jolla, CA.

**501**   **Mice Deficient in Atrial Natriuretic Peptide Receptor A (NPRA) Exhibit Decreased Lung Inflammation: Implication of NPRA Signaling in Asthma Pathogenesis**

**X. Kong** ^1,2^, X. Wang^1^, G. Hellermann^1^, R. F. Lockey^1^, S. Mohapatra^1^; ^1^University of South Florida, Tampa, FL, ^2^James A. Haley Veterans Hospital, Tampa, FL.

**502**   **\[Withdrawn\]**

**503**   **The Effect of Daily Apolipoprotein A-I Mimetic Therapy on T15-Type Autoantibodies Against Oxidized Phosphatidylcholine in a Murine Model of Asthma**

**K. S. Konduri** ^1^, S. D. Nandedkar^1^, D. Weilrauch^1^, D. A. Rickaby^1^, N. Duzgunes^2^, K. A. Pritchard^1^; ^1^Medical College of Wisconsin and Zablocki VA Medical Center, Milwaukee, WI, ^2^University of Pacific School of Dentistry, San Franscisco, CA.

**504**   **LILRB4 Suppresses the Development of Th2 Allergic Airway Inflammation**

**J. J. Rao**, N. A. Barrett, F. I. Hsu, Y. Kanaoka, K. F. Austen, H. R. Katz; Brigham and Women\'s Hospital, Brookline, MA.

**505**   **Inhibiting Pollen Nadph Oxidase-induced Signal By Intrapulmonary Administration Of Antioxidants Blocks Allergic Airway Inflammation**

**N. G. Dharajiya** ^1^, B. K. Choudhury^1^, A. Bacsi^2^, I. Boldogh^1^, R. Alama^3^, S. Sur^1^; ^1^University of Texas Medical Branch, Galveston, TX, ^2^Institute of Immunology, University of Debrecen, Debrecen, HUNGARY, ^3^National Jewish Medical & Research Center, Denver, CO.

**506**   **IL-4 Bypasses Innate Immune Signals in Inhalational Priming**

**A. Dittrich**, K. Bottomly; Yale University School of Medicine, New Haven, CT.

**507**   **A Murine Model Of Childhood Asthma**

**H. Mayuzumi** ^1^, Y. Ohki^2^, K. Tokuyama^3^, T. Mizuno^2^, H. Arakawa^2^, H. Mochizuki^2^, A. Morikawa^2^; ^1^Gunma Children\'s Medical Center, Shibukawa, JAPAN, ^2^Gunma University Graduate School of Medicine, Maebashi, JAPAN, ^3^Takasaki University of Health and Welfare, Takasaki, JAPAN.

**508**   **Nerve Growth Factor Induces Goblet Cell Hyperplasia And Muc5ac Production In A Human Epithelial Cell Line**

**A. Micera** ^1,2^, B. Stampachiacchiere^1^, A. Lambiase^2^, S. Bonini^2^, S. Bonini^3,4^; ^1^IRCCS-G.B. Bietti Eye Foundation, Rome, ITALY, ^2^Dept. of Ophthalmology, University Campus Bio-Medico, Rome, ITALY, ^3^Internal Medicine, Second University of Naples, Naples, ITALY, ^4^CNR, Institute of Neurobiology and Molecular Medicine, Rome, ITALY.

**509**   **Role of Insulin-like Growth Factor (IGF)-I in Human and Experimental Asthma**

**H. Yoshihara** ^1^, T. Adachi^1^, H. Nagase^1^, N. Yamashita^2^, K. Ohta^1^; ^1^Teikyo University School Medicine, Tokyo, JAPAN, ^2^Musashino University, Tokyo, JAPAN.

**510**   **Effect of Inflammatory Cytokines on the Expression of Tie-2 Receptors in Structural Cells of the Lung**

**T. O. Makinde** ^1^, D. K. Agrawal^2^; ^1^Creighton University, Department of Biomedical Sciences, Omaha, NE, ^2^Creighton University, Departments of Biomedical Sciences, Internal Medicine, Medical Microbiology and Immunology., Omaha, NE.

**511**   **Role of Protein Tyrosine Phosphatase SHP-1 in Oxidative Stress and Development of Allergic Airway Inflammation**

**Y. Cho**, S. Oh, Z. Zhu; Johns Hopkins Asthma and Allergy Center, Baltimore, MD.

**512**   **Comparison of Central and Peripheral Airway Inflammation between Cough Variant Asthma and Mild Asthma by Examination of Hypertonic Saline Inhalation-Induced Sputum**

**T. Shimoda** ^1^, Y. Obase^2^, R. Kishikawa^1^, S. Shoji^1^, S. Nishima^1^; ^1^Fukuoka National Hospital, Fukuoka, JAPAN, ^2^Kawasaki Medical School, Kurashiki, JAPAN.

**513**   **Role of Inducible Nitric Oxide Synthase Pathway in the Development of Non-eosinophilic Asthma**

**H. Park** ^1^, S. Sohn^1^, C. Park^1^, H. Kwon^1^, D. Kim^1^, S. Kim^1^, Y. Chang^2^, S. Lee^3^, D. Choi^4^, S. Cho^1^, S. Chang^5^, K. Min^1^, Y. Kim^1^; ^1^Seoul National University Hospital, Seoul, REPUBLIC OF KOREA, ^2^Seoul National University Bundang Hospital, Seongnam, REPUBLIC OF KOREA, ^3^Cheongju St. Mary\'s Hospital, Cheongju, REPUBLIC OF KOREA, ^4^Samsung Medical Center, Seoul, REPUBLIC OF KOREA, ^5^Sungae General Hospital, Gwangmyung, REPUBLIC OF KOREA.

**514**   **Increase of Amphiregulin Level in Sputum during Exacerbation of Acute Asthma Attacks in Children**

**Y. Enomoto** ^1,2^, T. Takamasu^2^, M. Nakazawa^3^, K. Kurihara^2^, M. Minami^3^, H. Saito^1^, Y. Okayama^1^; ^1^RIKEN Yokohama Institute, Yokohama, JAPAN, ^2^Kanagawa Children\'s Medical Center, Yokohama, JAPAN, ^3^Yokohama City University Graduate School of Medicine, Yokohama, JAPAN.

**515**   **siRNA Targeting the Natriuretic Peptide Receptor-A Prevents Airway Inflammation in a Mouse Model of Allergic Asthma**

**X. Wang** ^1,2^, W. Xu^1^, X. Kong^1^, S. Shirley^1^, R. Lockey^1,2^, S. Mohapatra^1,2^; ^1^University of South Florida, Tampa, FL, ^2^James A. Haley Veterans Hospital, Tampa, FL.

**516**   **Volume-regulated Chloride Channel-3 in PDGF-Induced Proliferation of Human Bronchial Smooth Muscle Cells**

**A. Ramanathan Arumugham** ^1^, D. K. Agrawal^1,2^; ^1^Dept of Biomedical Sciences, Creighton University School of Medicine, Omaha, NE, ^2^Dept of Internal Medicine, Creighton University School of Medicine, Omaha, NE.

**517**   **Microsomal Prostaglandin E Synthase-1 Deficiency Increases Dust Mite Antigen-Induced Airway Inflammation**

**S. N. Nallamshetty** ^1^, S. Uematsu^2^, S. Akira^2^, J. A. Boyce^1^; 11Division of Rheumatology, Immunology, and Allergy, Brigham and Women\'s Hospital, Boston, MA, ^2^Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, JAPAN.

**518**   **Role of Glycogen Synthase Kinase 3 in regulating Vascular Permeability associated with Asthma**

**Y. Morimoto**, N. Goplen, R. Alam; National Jewish Medical and Research Center, Denver, CO.

**519**   **Towards Systems Biology In Allergy Research**

**R. Renkonen**; Biomedicum & Haartman Institute, University of Helsinki, Helsinki, FINLAND.

**520**   **Effect Of Tnf-α (-308g/a) Polymorphism And Combined Effect With Il-13 Polymorphisms In Bronchial Responsiveness Of Korean Children With Asthma**

**H. Kim** ^1^, M. Kang^2^, S. Lee^3^, J. Kim^1^, B. Kim^1^, S. Jang^2^, M. Sohn^4^, K. Kim^4^, S. Hong^1^; ^1^Asan Medical Center, Seoul, REPUBLIC OF KOREA, ^2^Asan Institute for Life Science, Seoul, REPUBLIC OF KOREA, ^3^Hallym Medical Center, Seoul, REPUBLIC OF KOREA, ^4^Yonsei University, Seoul, REPUBLIC OF KOREA.

**521**   **Internalization of CysLT1 Receptor Through the Clathrin Endocytic Pathway**

**K. Audette**, J. Larrivee, C. Thompson, M. Rola-Pleszczynski, J. Stankova; Universite de Sherbrooke, Sherbrooke, PQ, CANADA.

**522**   **Clearance of *Mycoplasma Pneumoniae* Is Impaired in Mice with Established Allergic Airway Inflammation**

**D. D. Chaplin**, C. L. Zindl, L. B. Duffy, T. P. Atkinson, J. Lai; University of Alabama at Birmingham, Birmingham, AL.

**523**   **Ascaris Antigens Suppress Experimental Allergic Inflammation**

**S. Trivedi** ^1^, M. G. Hodges^1^, V. Bundoc^1^, H. H. Norris^2^, A. Boesen^1^, S. Madala^1^, J. F. Urban^3^, A. Keane-Myers^1^; ^1^LAD/NIAID/NIH, Rockville, MD, ^2^NIAID/NIH, Rockville, MD, ^3^NRFL, USDA, Beltsville, MD.

**524**   **Hookworm Protein Necator Americanus - Ancyclostoma Secreted Protein 2 (na-asp-2) Inhibits Allergic Airway Inflammation**

**J. G. Patel** ^1^, P. J. Hotez^2^, N. G. Dharajiya^1^, S. Sur^1^; ^1^University of Texas Medical Branch, Galveston, TX, ^2^George Washington University, Washington, DC.
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**525**   **Tumour Necrosis Factor Alpha (TNFα) Peptide-based Vaccines Suppress Murine Airway Allergic Responses**

**A. G. Ma**, Y. Ma, T. Zhang, A. B. Becker, Z. Peng; University of Manitoba, Winnipeg, MB, CANADA.

**526**   **Role of the RNA-binding Protein HuR in Posttranscriptional Regulation of IL-13 in T Cells**

**C. Stellato** ^1^, X. Fang^1^, B. Tancowny^1^, J. Fan^1^, F. Wu^1^, S. Y. Asaki^1^, U. De Fanis^1^, S. Huang^1^, M. Gorospe^2^, U. Atasoy^3^, V. Casolaro^1^; ^1^Johns Hopkins University School of Medicine, Baltimore, MD, ^2^National Institute of Aging, NIH, Baltimore, MD, ^3^University of Missouri-Columbia, Columbia, MO.

**527**   **A New Immunotherapy Approach: Mucosal Immunization With An Il-13 Vaccine Suppresses Murine Airway Allergic Responses**

**Y. Ma**, A. G. Ma, S. Basu, Y. Zhou, A. J. Halayko, K. T. HayGlass, A. B. Becker, F. E. R. Simons; University of Mnitoba, Winnipeg, MB, CANADA.

**528**   **Role of the RNA-binding Protein Tristetraprolin (TTP) in Glucocorticoid (GC)-mediated Gene Regulation**

**F. T. Ishmael** ^1^, X. Fang^1^, N. Heller^1^, J. Fan^1^, P. J. Blackshear^2^, U. Atasoy^3^, C. Cheadle^1^, C. Stellato^1^; ^1^Johns Hopkins University School of Medicine, Baltimore, MD, ^2^National Institute of Environmental Health Sciences, Research Triangle Park, NC, ^3^University of Missouri-Columbia, Columbia, MO.

**529**   **Comparison of Expression and Cellular Provenance of Thymic Stromal Iymphopoietin and Chemokines in Patients with Severe Asthma, COPD and Controls**

**Q. Meng** ^1^, B. O\'Connor^1^, J. Ratoff^1^, D. Cousins^1^, G. Z. Zhang^2^, S. Y. Gu^2^, J. S. Zhao^2^, T. H. Lee^1^, C. J. Corrigan^1^, S. Ying^1^; ^1^King\'s College London, London, UNITED KINGDOM, ^2^Third Clinical College, Jilin University, Jilin, CHINA.

**530**   **The Role Of Il-25 In Airway Allergic Response**

**P. Angkasekwinai** ^1^, H. Park^2^, Y. Wang^1^, Y. Wang^1^, Y. Liu^1^, Z. Zhu^3^, C. Dong^1^; ^1^MD Anderson Cancer Center, Universtiy of Texas Health Science Center, Houston, TX, ^2^University of Washington, Seattle, WA, ^3^Johns Hopkins University School of Medicine, Baltimore, MD.

**531**   **Humanized Anti-IL-5 Therapy (Mepolizumab) Reduces Eosinophil Responsiveness to the Eotaxins**

**M. L. Stein**, B. K. Buckmeier, M. E. Rothenberg; Cincinnati Childrens Hospital Medical Center, Cincinnati, OH.

**532**   **Effect Of Breast Milk Feeding From Allergic And Non-allergic Mothers On Infant During The First 4-years Of Life**

**W. Kim** ^1^, H. Yoon^2^; ^1^Inje University, Seoul, REPUBLIC OF KOREA, ^2^Hallym University, Seoul, REPUBLIC OF KOREA.

**533**   **Synergistic Effect of Double-Stranded RNA and TGF-α on MUC5AC production in Human Bronchial Epithelial Cells**

**H. Tadaki**, H. Arakawa, T. Mizuno, T. Suzuki, H. Mochizuki, K. Tokuyama, A. Morikawa; Gunma University, maebashi, JAPAN.

**534**   **Nitric Oxide (NO) Inhibits Human Rhinovirus (HRV)-16-Induced Transcription of IP-10 (CXCL10) in Human Airway Epithelial Cells (HAE)**

**R. Koetzler**, D. Proud; University of Calgary, Calgary, AB, CANADA.

**535**   **Role of Th2-molecules in OVA-Induced Intestinal Anaphylaxis**

**E. E. Forbes** ^1,2^, K. R. Groschwitz^1^, R. Ahrens^1^, E. B. Brandt^1^, M. E. Rothenberg^1^, P. S. Foster^2,3^, K. I. Matthaei^2^, S. P. Hogan^1^; ^1^Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^2^John Curtin School of Medical Research, Australian National University, Canberra, AUSTRALIA, ^3^Asthma, Allergy and Inflammation Research Center, University of Newcastle, Newcastle, AUSTRALIA.

**536**   **Sputum Epithelial Cell-Derived Neutrophil-Activating Peptide-78 (ENA-78/CXCL5) in Asthmatic Children**

**N. M. Heshmat** ^1^, G. A. Mostafa^1^, M. M. Abd Al-Aziz^2^, E. M. Abd El-Bary^1^; ^1^Pediatrics Department, Ain Shams University, Cairo, EGYPT, ^2^Clinical Pathology Department, Ain Shams University, Cairo, EGYPT.

**537**   **Small-interfering RNA Decreases IL-13 Receptor α1 (IL-13Rα1) Expression and Signalling in Human Tonsillar B Cells**

**O. Hajoui**, J. Guay, A. Banville-Langelier, B. Mazer; Meakins Christie Laboratories, Montreal, PQ, CANADA.

**538**   **Effect of IL-13 and IL-13 Mutant (IL-13E13K) on Airway Hyperresponsiveness (AHR) and Airway Smooth Muscle (ASM) In Mice**

**P. R. Gendapodi** ^1^, M. Kioi^2^, R. K. Puri^2^, P. Abel^1^, R. G. Townley^1^; ^1^Creighton University, Omaha, NE, ^2^NIH, Bethesda, MD.

**539**   **Protein Microarray Analysis in Patients with Asthma: Elevation of the Chemokine PARC/CCL18 in Sputum**

**C. Kim** ^1,2^, H. Kim^1^, T. Kurian^1^, T. Kobayashi^2^, K. Hirohito^2^; ^1^Inje University, Seoul, REPUBLIC OF KOREA, ^2^Mayo Clinic, Rochester, MN.

**540**   **Level Of Cytokine In Children Of Acute *Mycoplasma Pneumoniae* Infection And Wheeze**

**H. Yoon** ^1^, W. Kim^2^; ^1^Hallym University, Seoul, REPUBLIC OF KOREA, ^2^Inje University, Seoul, REPUBLIC OF KOREA.

**541**   **Aspartate Protease From *Alternaria* Induced Cytokine Production, And Calcium Signaling In Human Airway Epithelial Cells Through A Protease-activated Receptor-2 (par-2)**

**Y. Matsuwaki** ^1,2^, T. White^1^, K. Hotta^1^, Y. Inoue^1^, C. B. Lawrence^3^, H. Kita^1^; ^1^Mayo Clinic, Rochester, MN, ^2^Jikei university, school of medicine, Tokyo, JAPAN, ^3^Virginia Biotech Institute, Blacksburg, VA.

**542**   **CXCR2 Chemokines Regulate Tube Formation of Human Lung Microvascular Endothelial Cells**

**A. Matsuda**, H. Saito, K. Matsumoto; National Research Institute for Child Health and Development, Tokyo, JAPAN.

**543**   **Oxidative Stress Regulates IL-4 Gene Expression In Mast Cells Through Reduction Of Histone Deacetylase (HDAC)**

**Y. Nakamaru** ^1^, D. Takagi^1^, M. Maeda^1^, P. J. Barnes^2^, S. Fukuda^1^, K. Ito^2^; ^1^Hokkaido univ. graduate school of med., Sapporo, JAPAN, ^2^NHLI, Imperial College, London, UNITED KINGDOM.

**544**   **Targeted Disruption of Smad3 Affects the IL-13 Expression of Lung in a Mouse Model of Asthma**

**M. Anthoni** ^1^, G. Wang^1,2^, M. Leino^1^, A. Lauerma^1^, H. Alenius^1^, H. Wolff^1,3^; ^1^Finnish Institution of Occupational Health, Helsinki, FINLAND, ^2^Department of Dermatology and Venereology, Qingdao University Medical College Hospital, Qingdao, CHINA, ^3^Department of Pathology, Helsinki University Central Hospital, Helsinki, FINLAND.

**545**   **Immunomodulating Properties of Stored Product Mite Extracts on Human Dermal Fibroblasts**

**L. G. Arlian**, M. S. Morgan, K. T. Peterson, D. Vyszenski-Moher; Wright State University, Dayton, OH.

**546**   **Inhibition Of Airway Inflammation And HIV Entry By NNY-CCL14 Treatment: Role Of CCR1 And CCR5**

**S. Gupta** ^1^, B. Fuchs^2^, S. Schulz-Maronde^1^, A. Heitland^1^, S. E. Escher^1^, J. Münch^3^, F. Kirchhoff^3^, M. Mack^4^, H. C. Tillmann^5^, A. Braun^2^, W. G. Forssmann^1^, U. Forssmann^6^, J. Elsner^7^; ^1^Hannover Medical School, Hannover, GERMANY, ^2^Fraunhofer Institute of Toxicology & Experimental Medicine, Hannover, GERMANY, ^3^University of Ulm, Ulm, GERMANY, ^4^University of Regensburg, Regensburg, GERMANY, ^5^VIRO Pharmaceuticals GmbH & Co. KG, Hannover, GERMANY, ^6^IPF PharmaCeuticals GmbH, Affiliated Institute of Hannover Medical School, Hannover, GERMANY, ^7^Fachklinik Bad Bentheim, Bad Bentheim, GERMANY.

**547**   **IP-10 Moderates Rhinovirus Induced IFN-α Production and Stimulates IL-10**

**S. Kakumanu**, W. W. Busse, J. E. Gern; University of Wisconsin Hospital and Clinics, Madison, WI.

**548**   **Effects Of Intranasal TNFα On Granulocyte Recruitment In Healthy Individuals And Patients With Allergic Rhinitis**

**H. D. Widegren** ^1^, M. Korsgren^1^, J. Erjefalt^2^, M. Andersson^1^, L. Greiff^1^; ^1^Lund University Hospital, Lund, SWEDEN, ^2^Lund University, Lund, SWEDEN.

**549**   **Plasma Concentration of CCR4 Ligands in Asthma Patients During Bronchial Challenge with Dermatophagoides Pteronyssinus (Dp) Allergen**

**K. Kowal** ^1^, S. Zukowski^1^, L. DuBuske^2^, A. Bodzenta-Lukaszyk^1^; ^1^University Medical School of Bialystok, Bialystok, POLAND, ^2^Immunology Research Institute of New England, Gardner, MA.

**550**   **Determination of mRNA Expression and Serum Levels for IL-4 and IL-13 in Asmathic Patients**

**R. Farid**, J. Tavakol Afshari, M. Boskabadi; Mashad University Medical Sciences, Mashad, IRAN (ISLAMIC REPUBLIC OF).
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**551**   **Prevalence of Nonallergic Triggers among Seasonal Allergic Rhinitics and Normals**

**D. Shusterman** ^1^, M. Murphy^2^; ^1^University of Washington, Seattle, WA, ^2^University of California, San Francisco, CA.

**552**   **Role Of Prostaglandin D2 And E2 Terminal Synthases In Chronic Rhinosinusitis**

**M. Okano** ^1^, T. Fujiwara^1^, M. Yamamoto^1^, H. Hattori^1^, K. Nishizaki^1^, Y. Sugata^1^, Y. Urade^2^; ^1^Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JAPAN, ^2^Osaka Bioscience Institute, Osaka, JAPAN.

**553**   **Cytokines and Chemokines in NARES and Nasal Polyposis**

**C. Klemens** ^1^, F. Jund^1^, A. Klemens^2^, C. Devens^1^, M. F. Kramer^1^; ^1^Oto-Rhino-Laryngology, Head and Neck Surgery, Ludwig-Maximilians-University Munich, Munich, GERMANY, ^2^Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Zentralklinikum Augsburg, Augsburg, GERMANY.

**554**   **Population-Based Association Study Of TLR Gene Polymorphisms In Chronic Rhinosinusitis**

**M. A. Tewfik** ^1^, Y. Bossé^2^, T. J. Hudson^2^, M. Desrosiers^1^; ^1^McGill University, Montreal, PQ, CANADA, ^2^McGill University and Genome Quebec Innovation Centre, Montreal, PQ, CANADA.

**555**   **The Role Of Fungi In Sinus Polyposis**

**A. M. Hofman**, T. Hofman, W. Skrobisz; Center of Allergology, Poznan, POLAND.

**556**   **Remodelling in Nasal Polyposis is Independent of TH-Cell Polarisation**

**N. Zhang**, T. v. Zele, P. Gevaert, G. Holtappels, P. v. Cauwenberge, C. Bachert; Universitair Ziekenhuis Gent, Ghent, BELGIUM.

**557**   **Correlations between Rhinitis associated Impairment of Quality of Life and Levels of ECP and Tryptase**

**F. Jund** ^1^, C. Klemens^1^, R. Jund^2^, C. Devens^1^, M. F. Kramer^1^; ^1^Oto-Rhino-Laryngology, Head and Neck Surgery, Ludwig-Maximilians-University Munich, Munich, GERMANY, ^2^ENT Clinic, Puchheim, GERMANY.

**558**   **The Correlation between Allergen Skin Prick Test (SPT) Wheal Diameters and Nasal Symptoms to Aeroallergen Challenge in Environmental Exposure Chamber (EEC)**

**D. Wilson**, A. Salapatek, P. Tanna, P. Patel; Allied Research International, Mississauga, ON, CANADA.

**559**   **Investigation Of Olfactory Threshold Responses In Chronic Rhinitis Subtypes**

**M. Rezvani** ^1^, L. Hastings^2^, D. Brandt^1^, J. Bernstein^1^; ^1^University of Cincinnati, Cincinnati, OH, ^2^Osmic Enterprises, Cincinnati, OH.

**560**   **A Pilot, Prospective, Double Blind, Placebo-Controlled Treatment Trial with Itraconazole Orally in Patients with Chronic Rhinosinusitis and Asthma**

**E. Frigas**; Mayo Clinic, Rochester, MN.

**561**   **Intranasal Corticosteroids That Provide Sustained Efficacy May Improve Patient Satisfaction and Adherence to Therapy**

**E. Meltzer** ^1^, J. Boyle^2^, J. Droar^3^; ^1^Allergy and Asthma Medical Group and Research Center, San Diego, CA, ^2^Schulman, Ronca and Bucuvalas, Inc., New York, NY, ^3^Altana Pharma US, Florham Park, NJ.

**562**   **Coadministration of Intranasal Ciclesonide and Inhaled Fluticasone Propionate-Salmeterol in Perennial Allergic Rhinitis (PAR)**

**K. Kim** ^1^, J. Quesada^1^, M. A. Wingertzahn^2^, N. Szmaydy-Rikken^2^, P. Darken^2^, T. Shah^2^; ^1^West Coast Clinical Trials, LLC, Long Beach, CA, ^2^Altana Pharma US, Florham Park, NJ.

**563**   **The Pharmacokinetics (PK), Safety and Tolerability of Fexofenadine HCl 6mg/mL Suspension in Children with Allergic Rhinitis (AR): a Multicenter, Open-label, Single-dose Study**

**R. E. Grubbe** ^1^, A. S. Nayak^2^, B. Kittner^3^, N. Segall^4^; ^1^Center Of Research Excellence, L.L.C., Oxford, AL, ^2^Sneeze, Wheeze & Itch Associates, LLC, Normal, IL, ^3^sanofi-aventis U.S. Inc., Bridgewater, NJ, ^4^Clinical Research Atlanta, Atlanta, GA.

**564**   **The 30mg Dose of Fexofenadine HCl 6mg/mL Suspension is Bioequivalent to the Marketed 30mg Tablet in Healthy Adult Subjects under Fasted Conditions: a Randomized, Crossover, Open-label Study**

**D. N. Morrison** ^1^, S. Sahasranaman^2^; ^1^Bio-Kinetic Clinical Applications, Inc., Springfield, IL, ^2^sanofi-aventis U.S. Inc., Bridgewater, NJ.

**565**   **How Effective Are New Generation Antihistamines In Combination With Nasal Steroids In Patients Suffering From Severe Allergic Rhinitis And Concomitant Asthma?**

**R. Mosges**, J. Koberlein; University of Cologne, Cologne, GERMANY.

**566**   **Long-term Efficacy of Ciclesonide in Adult and Adolescent Patients With Perennial Allergic Rhinitis**

**P. Chervinsky** ^1^, S. Kunjibettu^2^, D. Miller^1^, B. Prenner^3^, G. Raphael^4^, T. Shah^5^; ^1^Northeast Medical Research Associates, North Dartmouth, ME, ^2^Altana Pharma US, Florham Park, NJ, ^3^Allergy Associates Medical Group, Inc., San Diego, CA, ^4^Bethesda, MD, Bethesda, MD, ^5^Altana Pharma, Florham Park, NJ.

**567**   **Onset of Action of Azelastine Nasal Spray Compared to Mometasone Nasal Spray and Placebo in Patients with Seasonal Allergic Rhinitis (SAR)**

**P. Patel** ^1^, D. Wilson^1^, C. D\'Andrea^2^, H. Sacks^2^; ^1^Allied Research International, Mississauga, ON, CANADA, ^2^MedPointe Pharmaceuticals, Somerset, NJ.

**568**   **A Case of Chronic Rhinosinusitis**

**S. Sattar**, A. Casillas; UCLA Medical Center, Los Angeles, CA.

**569**   **Evidence for Elevated IL-6 and its Signaling Components in Chronic Rhinosinusitis with Nasal Polyps**

**A. T. Peters**, B. Tancowny, L. Suh, M. Agashe, K. Harris, D. Conley, R. Kern, L. Grammer, R. Schleimer; Northwestern University Medical School, Chicago, IL.

**570**   **Nasal and Airway Inflammatory Features of Subjects with Nasal Polyposis With or Without Asthma**

**M. Boulay**; Centre de recherche, Hôpital Laval, Quebec, PQ, CANADA.
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**571**   **Absence of Relationship between History of Tuberculosis Infection, Skin Tuberculin Responses and Development of Adult Bronchial Asthma, Allergic Rhinitis and Atopy**

**J. Li**, S. Y. Li, Z. M. Zhou, D. F. Luo, J. Y. An, B. Q. Sun, N. S. Zhong; Guangzhou Institute of Respiratory Disease, Guangzhou, CHINA.

**572**   **Viral Etiology and Rhinovirus Serotypes of Recurrent Respiratory Illnesses during Infancy**

**T. Jartti** ^1^, T. Pappas^1^, W. Lee^1^, R. F. Lemanske, Jr.^2^, J. E. Gern^1^; ^1^Department of Pediatrics, University of Wisconsin, Madison, WI, ^2^Department of Medicine, University of Wisconsin, Madison, WI.

**573**   **Respiratory Syncytial Virus-Induced Gene Expression Profiles in Human Respiratory Epithelial Cells: Effect of pretreatment with Th1/Th2-type cytokines**

**Y. Yamada** ^1^, S. Yoshihara^1^, K. Matsumoto^2^, M. Saikusa^3^, N. Hashimoto^2^, T. Homma^2^, O. Arisaka^1^, H. Saito^2^; ^1^Dokkyo University School of Medicine, Mibu, Tochigi, Japan, ^2^National Research Institute for Child Health and Development, Department of Allergy and Immunology, Tokyo, Japan, ^3^Yokohama Health Research Institute, Kanagawa, Japan.

**574**   ***Coronavirus NL63* Illnesses in Infancy are a Risk Factor for Asthma at Age Six**

**T. E. Pappas** ^1^, K. T. Sullivan Dille^1^, W. Lee^1^, K. A. Grindle^1^, K. A. Roberg^1^, D. F. Da Silva^1^, C. J. Tisler^1^, E. L. Anderson^1^, K. M. Hansen^1^, R. A. Grabher^1^, L. E. Pleiss Salazar^1^, M. D. Evans^2^, R. Gagnon^2^, J. E. Gern^1^, R. F. Lemanske, Jr.^1^; ^1^University of Wisconsin School of Medicine and Public Health, Madison, WI, ^2^University of Wisconsin Population Health Sciences Biostatistics and Medical Informatics, Madison, WI.

**575**   **Seasonal Distribution Of Respiratory Viruses In Pediatric Asthma In Trinidad West Indies**

**J. Matthew** ^1^, L. M. PintoPereira^1^, T. E. Pappas^2^, C. Swenson^2^, K. Grindle^2^, K. Roberg^2^, R. F. Lemaske, Jr.^2^, W. Lee^2^, J. E. Gern^2^; ^1^The University of the West Indies, St Augustine, TRINIDAD AND TOBAGO, ^2^University of Wisconsin-Madison, Madison, WI.

**576**   **Analysis of Airway Immune System Responses to Rhinovirus Infection in Children and Resultant Tendency to Wheeze**

**B. K. Smith** ^1^, C. J. Tisler^2^, T. E. Pappas^2^, D. Mueller^2^, D. F. DaSilva^3^, J. E. Gern^4^, R. F. Lemanske, Jr.^4^; ^1^University of Wisconsin School of Medicine and Public Health, Madison, WI, ^2^University of Wisconsin Hospital, Madison, WI, ^3^University of Wisconsin Hospital, Madison, WI, ^4^University of Wisconsin, Madison, WI.
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**577**   **Myosin Light Chain Kinase (MYLK) Variants that Confer Increased Risk of Sepsis and Acute Lung Injury are Associated with Asthma and Associated Phenotypes**

**L. Gao** ^1^, A. Grant^1^, P. Chi^1^, P. Gao^1^, M. Stockton^1^, H. Watson^2^, N. N. Hansel^3^, G. Diette^3^, G. Dunston^4^, R. A. Mathias^5^, A. Togias^1^, R. Brower^3^, J. Sevransky^3^, J. P. Maloney^6^, M. Moss^6^, C. Shanholtz^7^, J. G. N. Garcia^8^, T. H. Beaty^9^, K. C. Barnes^1^; ^1^Johns Hopkins Asthma and Allergy Ctr., Baltimore, MD, ^2^University of the West Indies, West Indies, BARBADOS, ^3^Division of Pulmonary and Critical Care Medicine, The Johns Hopkins University, Baltimore, MD, ^4^National Human Genome Center at Howard University, Washington, DC, DC, ^5^National Human Genome Research Institute, Baltimore, MD, ^6^Division of Pulmonary and Critical Medicine, University of Colorado Health Sciences Center, Denver, CO, ^7^University of Maryland School of Medicine, Baltimore, MD, ^8^Department of Medicine, The University of Chicago Biological Sciences, Chicago, IL, ^9^Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD.

**578**   **Comprehensive Analysis of Mannan-Binding Lectin (MBL) Status in a Cohort of Healthy Donors as Determined by MBL Protein Concentration, MBL Complement Pathway Function and MBL and MASP-2 Genotypes**

**J. Yu**, D. Sheets, J. F. Halsey, J. D. Hester; IBT Reference Laboratory, Lenexa, KS.

**579**   **Clara Cell secretory 10-Kd Protein Sequence Variation Is Associated with the Severity of Asthma and Glucocorticoid Responsiveness**

**L. Chen** ^1,2^, J. Huang^2^, M. Kuo^3^, K. Yeh^2^, S. Huang^4^; ^1^Chang Gung Children\'s Hospital, Taiwan, LA, ^2^Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Children\'s Hospital, and Chang Gung University, Taoyuan, TAIWAN, ^3^Chang Gung University, Taoyuan, TAIWAN, ^4^Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, MD.

**580**   **Ethnicity Plays a Role in Differential Human Toll-like Receptor Responsiveness**

**K. T. HayGlass**, Y. Lissitsyn, A. Kozyrskyj, A. B. Becker; Univ Manitoba, Winnipeg, MB, CANADA.

**581**   **Single Nucleotide Polymorphism in IL-9 Promoter Influences Promoter Strength**

P. Huyett, S. Early, E. Barekzi, L. Borish, **J. W. Steinke**; Asthma and Allergic Diseases Center, Charlottesville, VA.

**582**   **A Polymorphism In Human CD40 Correlates With Autoimmunity And Enhances B Cell Activation**

**A. L. Peters** ^1^, P. M. Gaffney^2^, G. A. Bishop^1,3^; ^1^University of Iowa, Iowa City, IA, ^2^University of Minnesota, Minneapolis, MN, ^3^VA Medical Center, Iowa City, IA.
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**583**   **Anaphylactic Mechanisms in Sudden Unexpected Infant Death: Elevated Concentrations of Mast Cell Carboxypeptidase in the Serum**

**X. Zhou** ^1^, M. G. Buckley^1^, J. Lucas^1^, S. Variend^2^, A. F. Walls^1^; ^1^Southampton General Hospital, Southampton, UNITED KINGDOM, ^2^Children\'s Hospital, Sheffield, UNITED KINGDOM.

**584**   **HLA Class I and Class II Associations with Bee and Wasp Venom Allergy**

**B. A. Sin** ^1,2^, H. Tutkak^3^, G. Pasaoglu^4^, K. Köse^5^, Z. Misirligil^6^; ^1^Ankara University School of Medicine, Ankara, TURKEY, ^2^Ankara University School of Medicine Department of Allergic Diseases, Ankara, TURKEY, ^3^Ankara University School of Medicine, Dept.of Rheumatology and Immunology, Ankara, TURKEY, ^4^Ankara University School of Medicine, Dept. of Allergic Diseases, Ankara, TURKEY, ^5^Ankara University School of Medicine, Dept. of Biostatistics, Ankara, TURKEY, ^6^Ankara University School of Medicine, Dept.of Allergic Diseases, Ankara, TURKEY.

**585**   **Seafood Allergy & Risk of Adverse Reactions to Radiocontrast Media: Are Physicians Unwittingly Propagating A Medical Myth?**

**A. D. Beaty** ^1^, P. L. Lieberman^2^, R. G. Slavin^1^; ^1^Division of Allergy & Immunology, Saint Louis University School of Medicine, St. Louis, MO, ^2^University of Tennessee Center for the Health Sciences, Memphis, TN.

**586**   **Immunologic Characteristics Correlate With Reactions to Sting Challenge**

**D. B. K. Golden** ^1^, J. S. Schroeder^1^, R. G. Hamilton^1^, L. B. Schwartz^2^, T. J. Craig^3^, A. Kagey-Sobotka^1^; ^1^Johns Hopkins University, Baltimore, MD, ^2^Virginia Commonwealth University, Richmond, VA, ^3^Penn State Hershey Medical Center, Hershey, PA.

**587**   **A 1-Day Rush Immunotherapy Schedule for Imported Fire Ant Hypersensitivity**

**J. J. Dietrich**, L. M. Moore, S. Nguyen, L. L. Hagan, M. S. Tankersley; Department of Allergy and Immunology, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, TX.

**588**   **Parental Use of EpiPen for Inner-City Children with Food Allergy**

**J. A. Sinacore** ^1^, J. S. Kim^2^, A. S. Murthy^2^, J. A. Pongracic^2^; ^1^Department of Preventive Medicine and Epidemiology, Loyola University Stritch School of Medicine, Maywood, IL, ^2^Division of Allergy, Children\'s Memorial Hospital, Chicago, IL.
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**589**   **Parental Anxiety Before And After Food Challenges In Children With Suspected Peanut And Hazelnut Allergy**

**W. T. Zijlstra**; UMC Utrecht, Utrecht, THE NETHERLANDS.

**590**   **Addition of Omalizumab Reduces School Absenteeism in Children with Moderate-Severe Persistent Asthma**

**H. Milgrom** ^1^, M. Massanari^2^, R. J. Maykut^2^, F. Kianifard^2^, R. K. Zeldin^2^, G. P. Geba^2^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^Novartis Pharmaceuticals Corporation, East Hanover, NJ.

**591**   **Numerical Skills and Asthma Outcomes**

**A. J. Apter**, J. Cheng, D. Small, I. M. Bennett, C. Albert, D. G. Fein, M. George, S. Van Horne; University of Pennsylvania, Philadelphia, PA.

**592**   **Reliability and Validity of the Paediatric Food Allergy Questionnaire (PFAQ;Parent Form): A New Scientific Measure of HRQoL**

**A. DunnGalvin** ^1^, A. DuBois^2^, B. De Blok^2^, H. Oude-Elberink^2^, J. O. B. Hourihane^1^; ^1^University College Cork, Cork, IRELAND, ^2^Groningen Universiteit, Groningen, THE NETHERLANDS.

**593**   **Assessment of the Psychometric Properties of the Paediatric Asthma Quality of Life Questionnaire (PAQLQ) in Moderate to Severe Pediatric Asthma Patients**

**F. S. Lobo** ^1^, D. Revicki^2^, W. Grant^3^, F. Turk^4^, M. Massanari^1^; ^1^Novartis Pharmaceuticals, East Hanover, NJ, ^2^UnitedBioSource, Bethesda, MD, ^3^James Madison University, Harrisonburg, VA, ^4^Novartis Pharmaceuticals, Basel, SWITZERLAND.

**594**   **Tracking Quality of Life Changes in Asthma Requires Disease-Specific Measure for Optimal Sensitivity**

**K. M. Shanovich**, K. T. Sullivan Dillie, M. D. Evans, K. A. Roberg, E. L. Anderson, K. M. Hanson, R. A. Grabher, D. F. DaSilva, T. E. Pappas, L. E. P. Salazar, C. J. Tisler, R. E. Gangnon, J. E. Gern, R. F. Lemanske; University of Wisconsin, School of Medicine and Public Health, Madison, WI.
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**595**   **Co-Expression of IL-5 and Eotaxin-2 in Mice Creates a Novel and Eosinophil-dependent Pulmonary Model of Respiratory Inflammation Characteristic of Human Disease**

**S. I. Ochkur** ^1^, T. Biechele^1^, E. Jacobsen^1^, B. McElhinney^2^, C. Protheroe^1^, R. S. Pero^1^, M. T. Borchers^3^, K. R. O\'Neill^1^, D. C. Colbert^1^, M. P. McGarry^1^, Y. Janssen-Heininger^2^, C. Irvin^2^, H. H. Shen^4^, J. J. Lee^1^, N. A. Lee^1^; ^1^Mayo Clinic Arizona, Scottsdale, AZ, ^2^Vermont Asthma Center, Burlington, VT, ^3^University of Cincinnati College of Medicine, Cincinnati, OH, ^4^Second Hospital, Zhejiang University, Hangzhou, PR, CHINA.

**596**   **A Causative Link Exists Between Eosinophil Major Basic Protein-2 and Allergen-Induced Airway Hyperresponsiveness**

**K. O\'Neill** ^1^, C. Protheroe^1^, S. I. Ochkur^1^, E. Jacobsen^1^, D. C. Colbert^1^, L. Rinaldi^2^, C. Irvin^2^, M. P. McGarry^1^, J. J. Lee^1^, N. A. Lee^1^; ^1^Mayo Clinic Arizona, Scottsdale, AZ, ^2^Vermont Asthma Center, Burlington, VT.

**597**   **Inducible Expression of the IL-13 Transgene in the Lung Results in IL-13 Accumulation, Eosinophilia, and Tissue Remodeling in the Esophagus**

**L. Zuo**, P. C. Fulkerson, C. Blanchard, M. E. Rothenberg; Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**598**   **Extra-vasation of Leukocytes from Circulation is Controlled by Gαi2 Signaling Events in the Endothelium**

**R. S. Pero** ^1^, M. T. Borchers^2^, K. Spicher^3^, S. I. Ochkur^1^, L. Sikora^4^, S. P. Rao^5^, K. R. O\'Neill^1^, H. Abdala-Valencia^6^, H. Shen^7^, M. I. Simon^8^, M. P. McGarry^1^, N. A. Lee^1^, J. M. Cook-Mills^6^, P. Sriramarao^9^, L. Birnbaumer^10^, J. J. Lee^1^; ^1^Mayo Clinic Arizona, Scottsdale, AZ, ^2^University of Cincinnati College of Medicine, Cincinnati, OH, ^3^Heinrich Heine University, Dusseldorf, GERMANY, ^4^La Jolla Institute for Molecular medicine, San Diego, CA, ^5^La Jolla Institute for Molecular Medicine, San Diego, CA, ^6^Northwestern University Feinberg School of Medicine, Chicago, IL, ^7^Zhejiang University College of Medicine, Hangzhou, CHINA, ^8^California Institute of Technology, Pasadena, CT, ^9^La Jolla Institute of Melecular Medicine, San Diego, CA, ^10^National Institute of Environmental Health Sciences, Triangle Park, NC.

**599**   **T-Cell Death-Associated Gene 8 Critically Regulates Airway Eosinophilia in Allergen-Challenged Mice**

**A. R. Collier** ^1^, C. G. Radu^2^, O. N. Witte^3^, M. E. Rothenberg^1^, N. Zimmermann^1^; ^1^Cincinnati Children\'s Hospital, Cincinnati, OH, ^2^University of California - Los Angeles, Los Angeles, CA, ^3^University of California - Los Angeles and Howard Hughes Medical Institute, Los Angeles, CA.

**600**   **Eosinophils are Required for T Cell Infiltration of Lungs During Allergic Asthma Responses**

**E. Walsh**, N. Sahu, A. August; The Pennsylvania State University, University Park, PA.
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**601**   **Anticholinergic Effects of Antihistamine Drugs Used in the Clinic**

**S. C. Wolff**, K. Brubaker, T. Navratil, E. H. Fulcher, J. R. Lankford, J. L. Boyer; Inspire Pharmaceuticals, Durham, NC.

**602**   **Vernal Keratoconjunctivitis (vkc) Treated With 0.1% Fk-506 Ophthalmic Ointment: Result Of A Three Years Follow-up**

**P. Pacharn**, N. Visitsunthorn, O. Jirapongsananuruk, P. Vichyanond; Siriraj Hospital, Bangkok, THAILAND.

**603**   **Shedding of the Soluble Receptor for TNFα, TNFR1, is Inhibited by the TACE Inhibitor TAPI2 in Conjunctival Epithelial Cells**

**E. B. Cook**, J. L. Stahl, N. P. Barney, F. M. Graziano; University of Wisconsin-Madison, Madison, WI.

**604**   **Ocular Allergy: A National Epidemiologic Study**

**K. Singh**, L. Bielory; UMDNJ, Newark, NJ.

**605**   **Symptoms of Allergic Rhinitis in Mothers during Early Pregnancy are Associated with Higher Prevalence of Allergic Rhinitis in their Offspring**

**M. Shinohara** ^1,2^, H. Wakiguchi^1^, H. Saito^2^, K. Matsumoto^2^; ^1^Kochi University, Kochi Medical School, Department of Pediatrics, Kochi, JAPAN, ^2^National Research Institute for Child Health and Development, Tokyo, JAPAN.

**606**   **Allergic Rhinitis and Inner-City Children --- Is There a Relationship to Sleep-Disordered Breathing?**

**N. Gupta** ^1^, U. Emre^1^, S. Kearney^2^, R. A. Fermo^1^, B. Silverman^1^, A. T. Schneider^1^; ^1^Long Island College Hospital, Brooklyn, NY, ^2^Lehigh Valley Hospital, Allentown, PA.
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**607**   **Haplotype Tagging SNPs in the Beta Adrenergic Receptor (*ADRB2*) Gene are Associated with Pre and Post-bronchodilator Lung Function in Preschool Children**

**A. Simpson**, J. Hankinson, S. Borg-Bartolo, L. Lowe, S. John, A. Woodcock, W. Ollier, A. Custovic; University of Manchester, Manchester, UNITED KINGDOM.

**608**   **Effect of Anti-IgE Antibody Omalizumab on Airway Remodeling and the Expression of Interleukins in Asthma**

**O. Korzh**, S. Krasnokutskiy, E. Lavrova; Kharkov Medical Academy of Postgraduate Education, Kharkov, UKRAINE.

**609**   **Exhaled Nitric Oxide Levels are Associated with Daily Lung Function Declines and Increased Medication Usage in Urban Children with Moderate to Severe Asthma Despite Use of Inhaled Corticosteroids and Long-acting Bronchodilators**

**N. Rabinovitch** ^1^, L. Zhang^2^, E. W. Gelfand^1^; ^1^Department of Pediatrics, NJMRC, Denver, CO, ^2^Division of Biostatistics, NJMRC, Denver, CO.

**610**   **Airway Remodeling and Lack of Bronchodilator Response in Steroid Resistant (SR) Asthma**

**E. Goleva**, P. J. Hauk, J. Boguniewicz, R. J. Martin, D. Y. M. Leung; National Jewish Medical and Research Ctr., Denver, CO.
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**611**   **IL-4 and IL-13 Induction of SOCS-3 Negatively Regulates TNF-α and IFN-γ Induced Human β Defensin (HBD)-3 Expression in Keratinocytes**

**H. R. Fairchild**, D. Y. M. Leung, M. D. Howell; National Jewish Medical and Research Center, Denver, CO.

**612**   **Tumour Necrosis Factor Alpha (TNFα) Vaccines in the Downregulation of Bowel Inflammatory Responses in Mice**

**Y. Zhou**, A. G. Ma, Y. Ma, G. Qing, T. Zhang, Z. Peng; University of Manitoba, Winnipeg, MB, CANADA.

**613**   **A Novel Card-Card Interaction is revealed by the Crystal Structure of Nod1-Card**

**N. P. Coussens**; University of Iowa, Iowa City, IA.

**614**   **Txk, A Nonreceptor Tyrosine Kinase of The Tec Family, Selectively Downregulates TRIF-Dependent Activation Program in LPS-Stimulated Mast Cells**

**T. Ohno** ^1^, J. Kashiwakura^1,2^, H. Saito^3,1^, Y. Okayama^1^; ^1^RIKEN Yokohama Institute, Yokohama, JAPAN, ^2^La Jolla Institute for Allergy and Immunology, San Diego, CA, ^3^National Research Institute for Child Health and Development, Tokyo, JAPAN.

**615**   **Regulatory Role for Gr-1^+^ Cells and CD11b^+^ Cells in Lungs of Mice**

**J. Lai**, C. L. Zindl, Y. Jung, L. Duffy, T. P. Atkinson, D. D. Chaplin; University of Alabama at Birmingham, Birmingham, AL.
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**616**   **High Environmental Tobacco Smoke Exposure and Presence of IL4 Polymorphism (C-589T) Increases Risk of Infant Wheezing: the Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS)**

**A. M. Smith** ^1^, D. I. Bernstein^1^, G. K. LeMasters^2^, N. L. Huey^3^, G. K. Khurana Hershey^3^; ^1^University of Cincinnati, Department of Internal Medicine, Cincinnati, OH, ^2^University of Cincinnati, Department of Environmental Health, Cincinnati, OH, ^3^Cincinnati Children\'s Hospital Center for Translational Research in Allergy and Asthma, Cincinnati, OH.

**617**   **BASE a Major Cat Allergen**

**S. E. O\'Neil**, W. Smith, T. K. Heinrich, B. J. Hales, W. R. Thomas; Telethon Institute for Child Health Research, West Perth, AUSTRALIA.

**618**   **Cockroach Allergen Reduction by Extermination Alone in Low-Income, Urban Homes-A Randomized Control Trial**

**M. L. Sever** ^1^, S. J. Arbes, Jr.^1^, D. C. Zeldin^1^, C. Schal^2^, R. G. Santangelo^2^, J. C. Gore^2^, B. Vaughn^3^, H. Mitchell^3^; ^1^NIEHS, Research Triangle Park, NC, ^2^NCSU, Raleigh, NC, ^3^Rho, Inc., Chapel Hill, NC.

**619**   **Wheezing Severe Rhinovirus Illnesses During Infancy Predict Childhood Asthma at Age 6 Years**

**K. A. Roberg** ^1^, K. T. Sullivan-Dillie^2^, M. D. Evans^2^, T. E. Pappas^2^, E. L. Anderson^2^, K. M. Hanson^2^, D. F. DaSilva^2^, C. J. Tisler^2^, L. E. P. Salazar^2^, R. E. Gangnon^2^, J. E. Gern^2^, R. F. Lemanske, Jr.^2^; ^1^University of Wisconsin School of Medicine and Public Health, Madison, WI, ^2^UW School of Medicine and Public Health, Madison, WI.

**620**   **Epigenetic Regulation of Th1/Th2- Recall Responses in Atopic Asthmatic Individuals**

**R. Su** ^1^, A. Becker^1,2^, A. L. Kozyrskyj^2,3^, K. T. HayGlass^1,2^; ^1^CIHR National Training Program in Allergy and Asthma Research, Departments of Immunology, University of Manitoba, Winnipeg, MB, CANADA, ^2^Community Health Sciences, Winnipeg, MB, CANADA, ^3^Pediatrics/Child Health, Winnipeg, MB, CANADA.
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**621**   **Peanut Allergy in Infant: is Breastfeeding a Risk Factor?**

**A. Des Roches** ^1^, L. Paradis^1^, J. Paradis^1^, C. Infante-Rivard^2^; ^1^Allergy Section, Hôpital Sainte-Justine, Montréal, PQ, CANADA, ^2^Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, PQ, CANADA.

**622**   **Oral Peanut Immunotherapy For Peanut Allergic Patients**

**S. D. Nash** ^1^, P. H. Steele^1^, J. S. Kamilaris^1^, L. Pons^1^, M. Kulis^1^, L. A. Lee^1^, K. Althage^2^, L. Christie^2^, A. M. Scurlock^2^, S. M. Jones^2^, A. W. Burks^1^; ^1^Duke University Medical Center, Durham, NC, ^2^University of Arkansas Medical Sciences, Little Rock, AR.

**623**   **Minimum Elicitation Dose Determination Using Roasted Peanut-Low Dose Challenges**

**J. A. Nordlee** ^1^, S. L. Hefle^1^, S. L. Taylor^1^, A. C. Knulst^2^, K. A. B. M. Peeters^2^, R. K. Bush^3^, J. O. Hourihane^4^, D. A. Moneret-Vautrin^5^, M. Morisset^5^, P. S. Smailes^3^, C. A. Swenson^3^, J. B. T. Trewin^6^; ^1^University of Nebraska, Lincoln, NE, ^2^University Medical Center, Utrecht, THE NETHERLANDS, ^3^University of Wisconsin Medical School, Madison, WI, ^4^University of Southampton School of Medicine, Southampton, UNITED KINGDOM, ^5^Hopital Universitaire, Nancy, FRANCE, ^6^Wellcome Trust Clinical Research Facility, Southampton, UNITED KINGDOM.

**624**   **Clinical Features and Outcomes of Peanut-Allergic Patients Who Underwent Follow-up Oral Food Challenges**

**J. M. Maloney**, W. G. Shreffler, S. H. Sicherer, H. A. Sampson; Mount Sinai Medical Center, New York, NY.

**625**   **Clinical Predictors of Peanut Allergy Remission in Children**

**K. J. Allen** ^1^, M. Ho^1^, R. Heine^1^, W. Wong^2^, C. Hosking^1^, D. Hill^1^; ^1^Royal Children\'s Hospital, Parkville, AUSTRALIA, ^2^The University of Hong Kong, Hong Kong SAR, CHINA.
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**626**   **Allergy Immunotherapy Practice Patterns and Associated Outcomes of Care**

**C. S. Hankin** ^1^, L. Cox^2^, Z. Wang^1^, A. Bronstone^1^; ^1^BioMedEcon, South San Francisco, CA, ^2^Nova Southeastern University School of Osteopathic Medicine, Davie, FL.

**627**   **Physician and Patient Perception Differ for Symptoms Associated with Allergic Rhinitis (AR)**

**A. E. Williams** ^1^, M. Schatz^2^, S. Kay^3^; ^1^GlaxoSmithKline R&D, London, UNITED KINGDOM, ^2^Allergy Department, Kaiser-Permanente Medical Center, San Diego, CA, ^3^Adelphi Group Products, Macclesfield, UNITED KINGDOM.

**628**   **Corticosteroid-Sparing Effects of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody, in Patients With Hypereosinophilic Syndrome**

**L. J. Rosenwasser** ^1^, L. B. Schwartz^2^, J. Sheikh^3^, A. D. Klion^4^, M. E. Rothenberg, on behalf of the Mepolizumab HES Study^5^; ^1^Allergy-Immunology Division, Children\'s Mercy Hospital, Kansas City, MO, ^2^Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, ^3^Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, ^4^Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, MD, ^5^Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**629**   **Persistence and Compliance with Omalizumab in a Managed-Care Population**

**B. Gutierrez**; Partnership for Health Analytic Research, Los Angeles, CA.

**630**   **How Readable are our Patient Information Leaflets?**

**H. E. Smith**, J. Wade, A. Frew; Brighton & Sussex Medical School, Brighton, UNITED KINGDOM.
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**631**   **Onset of Clinical Tolerance to Milk Protein is Associated with Increased CD25+ CD27+ Casein Specific T Cells**

**W. G. Shreffler**, N. Wanich, S. Noon, A. Nowak-Wegrzyn, H. A. Sampson; Mount Sinai School of Medicine, New York, NY.

**632**   **Human Airway Epithelial Cells Produce Thymic Stromal Lymphopoietin (TSLP) after Stimulation with Th2 Cytokines and TLR3 Ligand**

**A. Kato**, R. P. Schleimer; Allergy-Immunology Division, Northwestern University Feinberg School of Medicine, Chicago, IL.

**633**   **Programmed Death One (PD1): Friend or a Foe of Regulatory T cells in the Modulation of Immune Response in Allergic Asthma**

**H. S. McGee** ^1^, H. Yagita^2^, D. K. Agrawal^3^; ^1^Creighton University, Department of Biomedical Sciences, Omaha, NE, ^2^Juntendo University School of Medicine, Department of Immunology, Toyko, JAPAN, ^3^Creighton University, Departments of Biomedical Sciences, Internal Medicine, Medical Microbiology and Immunology, Omaha, NE.

**634**   **A Novel Adhesion Molecule Plays a Critical Role in T Cell Migration to Inflamed Skin**

**M. E. Gainers** ^1,2^, L. Descheny^1,2^, C. J. Dimitroff^1,2^; ^1^Harvard Skin Disease Research Center, Boston, MA, ^2^Brigham and Women\'s Hospital, Boston, MA.

**635**   **IL-4 Upregulates FceRI-Mediated TSLP Expression by Human Mast Cells**

**Y. Okayama** ^1^, H. Sagara^2^, S. Okumura^1,3^, K. Yuki^1^, T. Fukuda^2^, H. Saito^1^; ^1^RIKEN Yokohama Institute, Yokohama, JAPAN, ^2^Dokkyo University School of Medicine, Mibu, JAPAN, ^3^Stanford University School of Medicine, Stanford, CA.
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**636**   **Effect of Allergen Challenge on Key Inflammatory Mediator Receptors Expression in Rat Nasal Tissues**

**N. Ferrari** ^1^, J. Brault^1^, J. G. Wagner^2^, M. Fortin^1^, J. R. Harkema^2^, P. M. Renzi^1^, L. Paquet^1^; ^1^Topigen Pharmaceuticals Inc., Montreal, PQ, CANADA, ^2^Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI.

**637**   **Nasal Ocular Reflexes Occur After Nasal Challenge With Allergen**

**F. M. Baroody**, K. Foster, A. Markarian, M. deTineo, R. Naclerio; The University of Chicago, Chicago, IL.

**638**   **Cytokines, Growth Factors And MMPs In Tears Of Vernal Keratoconjunctivitis (VKC) Patients**

**A. Leonardi** ^1^, M. Bortolotti^1^, V. Calder^2^, J. S. Curnow^3^, S. Sathe^4^, R. Sack^4^; ^1^University of Padua, Padova, ITALY, ^2^UCL, London, UNITED KINGDOM, ^3^University of Birmingham, Birmingham, UNITED KINGDOM, ^4^SUNY College of Optometry, New York, NY.

**639**   **Is Allergic Fungal Sinusitis A Distinct Form Of Chronic Rhinosinusitis?**

**P. S. Hutcheson** ^1^, M. S. Schubert^2^, R. G. Slavin^1^; ^1^Saint Louis University Medical School, Saint Louis, MO, ^2^Allergy Asthma Clinic, Ltd., Phoenix, AZ.

**640**   **Non Allergic Rhinitis In Competitive Swimmers**

**M. Gelardi** ^1^, M. Bonini^2,3^, S. Bonini^3,4^, T. Candreva^1^, M. Fiorella^1^, M. Ventura^5^; ^1^Dept. of Ophthalmology and Otolaryngology, University of Bari, Bari, ITALY, ^2^Institute of Sports Medicine, UCSC, Rome, ITALY, ^3^CNR, Institute of Neurobiology and Molecular Medicine, Rome, ITALY, ^4^Chair of Allergy and Clinical Immunology, Second University of Naples, Naples, ITALY, ^5^Dept. of Internal Medicine, MIDIM, University of Bari, Bari, ITALY.
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**641**   **The Growing Gender Gap In Adult Asthma Hospitalizations: New York State 1990-2004**

**R. Y. Lin** ^1,2^; ^1^St Vincents Hospital, Manhattan-SVCMC, New York, NY, ^2^New York Medical College, Valhalla, NY.

**642**   **The Relationship Between Wheezing Patterns During Early Childhood and Six Year Asthma Diagnosis in a High Risk Birth Cohort**

**K. M. Hanson**, M. D. Evans, C. J. Tisler, D. F. DaSilva, T. E. Pappas, R. A. Grabher, L. E. P. Salazar, K. T. Sullivan Dillie, E. L. Anderson, K. A. Roberg, R. E. Gangnon, J. E. Gern, R. F. Lemanske, Jr.; University of Wisconsin School of Medicine and Public Health, Madison, WI.

**643**   **Caesarean Delivery Could Be A Risk Factor For Asthma?**

**C. Nunes**, S. Ladeira; Center of Allergy of Algarve, Portimao, PORTUGAL.

**644**   **Dog Ownership: A Risk Factor Of Corticosteroid-Resistant (CR) Asthma?**

**P. J. Hauk**, E. Goleva, A. H. Liu, C. F. Hall, R. J. Martin, D. Y. M. Leung; National Jewish Medical and Research Center, Denver, CO.

**645**   **Development of a Specific Questionnaire for the Suspicion of DPV**

**P. Giavina-Bianchi**, L. Eduardo Pinto, S. Sayed, A. Cukier, J. Kalil; FMUSP, São Paulo, BRAZIL.

**646**   **The Effect of Body Mass Index on Asthma Related Quality of Life Measurements in Children**

**B. Catalina**; Long Island College Hospital, Brooklyn, NY.

**647**   **Asthma, Obesity, And The Effect On Airway Inflammation**

**P. Sakali**, A. Arreh-mensah, J. Estrada, P. Rojas, O. Ozdemir, K. Paris, C. Moore; Louisiana State University, New Orleans, LA.

**648**   **Demographic Characteristics of Males and Females With Acute Asthma**

**I. Warrier**, A. P. Baptist; Wayne State University, Detroit, MI.

**649**   **Perinatal outcomes (PO), potencial pregnancy variables (PPV), comorbidity occurence (CO) and asthma severity in two successive pregnancies (2SP)**

**B. Novotna** ^1,1^, T. Pavlik^2^; ^1^University Hospital, Brno, CZECH REPUBLIC, ^2^The Center of Biostatistics and Analyses Masaryk University, Brno, CZECH REPUBLIC.

**650**   **The Role Of Fungi In Patient With Chronic Sinusitis And Bronchial Asthma**

**T. Hofman**, A. M. Hofman, J. Michalik; Center of Allergology, Poznan, POLAND.

**651**   **The Correlation Between Skin Prick Tests and Bronchial Hyperresponsiveness in Children with Atopic Conditions**

**J. J. Liem** ^1^, R. Rabbani^2^, A. L. Kozyrskyj^1^, A. B. Becker^1^; ^1^University of Manitoba, Winnipeg, MB, CANADA, ^2^The Manitoba Institute of Child Health, Winnipeg, MB, CANADA.

**652**   **Comparison Of ΔFVC (% Fall In FVC At The Methacholine PC20) Between Asymptomatic And Symptomatic BHR**

**Y. Yoo** ^1^, J. Choung^1^, J. Yu^2^, S. Choi^3^, Y. Koh^3^; ^1^Korea University Anam Hospital, Seoul, REPUBLIC OF KOREA, ^2^Dongguk University International Hospital, Goyang, REPUBLIC OF KOREA, ^3^Seoul National University Hospital, Seoul, REPUBLIC OF KOREA.

**653**   **Respiratory Symptoms, Spirometry and Skin-Prick Tests in Patients with a Family History of Asthma: A 12-year Follow-up**

**J. P. Raasch**; University of Minnesota, Minneapolis, MN.

**654**   **Prevalence of Asthma among Childrend and Teenagers in Quito Ecuador**

**S. F. Barba, Jr.**; Hospital General FF AA, QUITO, ECUADOR.

**655**   **Prevalence and Factors affecting Asthma and Allergic Rhinitis among Adolescent children in Mysore, South India**

**P. A. Mahesh** ^1^, R. Bharath^2^, A. D. Holla^2^, A. K. Prabhakar^2^, P. K. Vedanthan^3^; ^1^JSS Medical College, Mysore, Karnataka, INDIA, ^2^Allergy Asthma and Chest Center, Mysore, Karnataka, INDIA, ^3^University of Colorado Health Sciences, Denver, CO.

**656**   **Prevalence Of Asthma And Allergic Rhinitis In Children And Adolescents Of Nuevo Leon, Mexico**

**A. Arias-Cruz**, M. Zárate-Hernández, S. N. González-Díaz, S. N. González-Díaz; Hospital Universitario, Monterrey, MEXICO.

**657**   **Persistent Cough: The Link Between Asthma and *Chlamydia pneumoniae* Respiratory Infections**

**M. G. Ghoshhajra**, A. A. Petrov; University of Pittsburgh Medical Center, Pittsburgh, PA.

**658**   **Asthma at 6 Yrs is Not Associated with Overweight Status or Pro-Inflammatory Markers in a High-Risk-for-Asthma Birth Cohort**

**S. L. Friedlander**, K. A. Roberg, M. D. Evans, R. E. Gangnon, Z. Zhang, H. J. Lai, J. E. Gern, R. F. Lemanske, Jr.; University WI - Madison, Madison, WI.

**659**   **Children with Viral Respiratory Infections in the First Year of Life and Food Allergy at Age 5 Years**

**E. L. Anderson**, K. S. Dillie, M. D. Evans, K. A. Roberg, L. E. P. Salazar, D. F. DaSilva, T. E. Pappas, C. J. Tisler, R. Gangnon, C. Ober, J. E. Gern, R. F. Lemanske, Jr.; University of Wisconsin School of Medicine and Public Health, Madison, WI.

**660**   **Parental Smoking Modifies Effects Of Genetic Variation In Tumor Necrosis Factor-α On Childhood Asthma**

**H. Wu** ^1^, I. Romieu^2^, J. Sienra-Monge^3^, B. Rio-Navarro^3^, D. M. Anderson^1^, E. W. Dunn^1^, L. L. Steiner^4^, I. Lara-Sanchez^2^, S. London^1^; ^1^National Institute of Environmental Health Sciences, Research Triangle Park, NC, ^2^National Institute of Public Health, Cuernavaca, MEXICO, ^3^Hospital Infantil de Mexico Federico Gomez, Mexico City, MEXICO, ^4^Roche Molecular Systems, Alameda, CA.

**661**   **Interactions Between Rhinovirus-Induced IFN-alpha Production at Birth and the Severity of Rhinovirus Illnesses in the First Year of Life**

**D. F. G. DaSilva**, C. J. Tisler, T. E. Pappas, M. D. Evans, K. T. Sullivan Dillie, K. A. Roberg, E. L. Anderson, L. E. P. Salazar, R. A. Grabher, K. M. Hanson, R. E. Gangnon, J. E. Gern, R. F. Lemanske, Jr.; University of Wisconsin - Madison, Madison, WI.

**662**   **Frequent Moderate to Severe Viral Respiratory Illnesses During Infancy Significantly Influence the Development of Asthma but Not Immunologic and Clinical Markers of Atopy During Early Childhood**

**R. A. Grabher**, K. T. Sullivan Dillie, T. E. Pappas, D. F. DaSilva, K. A. Roberg, E. L. Anderson, K. M. Hanson, L. E. P. Salazar, C. J. Tisler, M. D. Evans, R. E. Gangnon, J. E. Gern, R. F. Lemanske, Jr.; University of Wisconsin School of Medicine and Public Health, Madison, WI.

**663**   **Association of Environmental Allergen Sensitization with Asthma Morbidity**

**J. Wang** ^1^, C. M. Visness^2^, A. Calatroni^2^, P. J. Gergen^3^, H. E. Mitchell^2^, H. A. Sampson^1^; ^1^Mount Sinai Medical Center, New York, NY, ^2^Rho Federal Systems Division, Inc, Chapel Hill, NC, ^3^National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD.

**664**   **Factors Associated with Asthma Mortality: a National United Kingdom Database Analysis**

**L. Watson** ^1^, F. Turk^2^, S. T. Holgate^3^; ^1^Phimap, Bollington, Cheshire, UNITED KINGDOM, ^2^Novartis Pharma, Basel, SWITZERLAND, ^3^Southampton University Hospital, Southampton, UNITED KINGDOM.

**665**   **Influence of Body Mass Index on Lung Function in Korean Children With No Asthma Symptoms Residing in Urban Area**

**Y. H. Shin** ^1^, K. W. Kim^2^, K. E. Kim^1^, H. Y. Yum^1^, K. E. Lee^2^, T. W. Song^2^, E. S. Kim^2^, M. H. Sohn^2^, K. E. Kim^2^; ^1^Pochon CHA University College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA.

**666**   **The First Nationwide Survey of Asthma Prevalence in Japan using ISAAC and ECRHS questionnaire**

**A. Akasawa** ^1^, M. Akashi^1^, A. Aota^1^, A. Saito^1^, N. Kojima^1^, M. Futamura^1^, Y. Ohya^1^, Y. Adachi^2^, H. Odajima^3^, K. Takahashi^4^, T. Nakagawa^5^, K. Akiyama^6^; ^1^National Ctr for Child Health and Development, Tokyo, JAPAN, ^2^Toyama Medical and Pharmaceutical University, Toyama, JAPAN, ^3^NHO Fukuoka National Hospital, Fukuoka, JAPAN, ^4^NHO Minami-Okayama Medical Center, Okayama, JAPAN, ^5^Kawasaki Municipal Tama Hospital, Kanagawa, JAPAN, ^6^NHO Sagamihara National Hospital, Kanagawa, JAPAN.

**667**   **Risk Factors for Fatal Asthma in Three U.S. States, 2004**

**C. A. Camargo, Jr.** ^1^, A. J. Pelletier^1^, R. Hammel^2^, D. Vasas^3^, D. M. Lang^3^; ^1^Massachusetts General Hospital, Boston, MA, ^2^University of Arkansas Medical Sciences, Little Rock, AR, ^3^Cleveland Clinic, Cleveland, OH.

**668**   **Advair Prescribing Patterns in a State Medicaid and Child Health Insurance Program**

**M. E. Helm** ^1^, P. A. Vargas^2^, S. M. Jones^2^; ^1^University of Arkansas for Medical Sciences, Little Rock, AR, ^2^University of Arkansas for Medical Sciences/Arkansas Children\'s Hospital Research Institute, Little Rock, AR.

**669**   **Comorbidity of Life-Threatening Arrhythmia in Children with Asthma**

**Y. Ito**, Y. Adachi, T. Itazawa, K. Saito, K. Uese, F. Ichida, T. Miyawaki; University of Toyama, Toyama, JAPAN.

**670**   **Electrocardiograph (ekgs) And Echocardiograph (ecos) Alterations Determined And Compared In Obese Adolescents With Asthma (oa) And Without Asthma (ona) (preliminary Results)**

**J. S. Calderon Rivera**, B. E. del Rio Navarro, J. J. L. Sienra Monge; Hospital Infantil de Mexico, Federico Gomez, Mexico City, MEXICO.
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**671**   **Genetic Association between Asthma and Atopy and *CD14* Promoter Variants in Chinese Children**

Y. S. Wong^1^, **T. F. Leung** ^1^, C. Y. Li^1^, I. H. S. Chan^2^, E. Yung^1^, C. W. K. Lam^2^, G. W. K. Wong^1^; ^1^Department of Pediatrics, The Chinese University of Hong Kong, Hong Kong, HONG KONG, ^2^Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, HONG KONG.

**672**   **TNFA -308 G/A Polymorphism And Asthma In Different Ethnicities: Systematic Review and Meta-analysis**

**I. R. Genov**, A. Gonçalves-Primo, D. Solé, C. K. Naspitz; UNIFESP, São Paulo, BRAZIL.

**673**   **Synergistic Modulation Of Eotaxin And Il-4 Secretion By Constituents Of An Anti-asthma Herbal Formula (ashmi) In Vitro**

**J. Bolleddula**; Mount Sinai School of Medicine, New York, NY.

**674**   **Development of a Cell Culture Model for the Study of Genes Regulated by Inhaled Corticoids During Asthma Treatment**

**C. J. Pantoja**; University of California, San Francisco, San Francisco, CA.

**675**   **Safety and Tolerance of a Novel Medical Food (NMF) in Children with Mild Persistent Asthma**

**S. J. Szefler** ^1^, R. Covar^1^, B. Macomber^1^, L. Stewart^1^, M. Gleason^1^, K. Engelhardt^1^, J. Murphy^1^, A. Liu^1^, S. Wood^2^, S. DeMichele^2^, A. Wennberg^2^, E. Gelfand^1^; ^1^National Jewish Med Res Ctr, Denver, CO, ^2^Ross Products, Abbott Laboratories, Columbus, OH.

**676**   **Harnessing the RNA-interference for Anti-inflammatory Therapeutics**

**P. N. Pushparaj** ^1^, J. J. Aarthi^2^, S. D. Kumar^1^; ^1^National University of Singapore, Singapore, SINGAPORE, ^2^Singapore General Hospital, Singapore, SINGAPORE.

**677**   **Rescue-Free and Symptom-Free Days With Mometasone Furoate Dry Powder Inhaler Used Once or Twice Daily in the Evening by Patients With Persistent Asthma**

**G. W. Bensch** ^1^, J. Corren^2^, R. Lockey^3^, R. Yao^4^, H. Staudinger^4^; ^1^Allergy, Immunology and Asthma Medical Group, Stockton, CA, ^2^Allergy Research Foundation, Inc., Los Angeles, CA, ^3^University of South Florida College of Medicine, Tampa, FL, ^4^Schering-Plough Research Institute, Kenilworth, NJ.

**678**   **A Case Study; Extracorporeal Gas Exchange for Severe Asthma Treatment**

**Y. Ogawa**, E. G. Brooks, L. Williams, J. Lynch, J. B. Zwischenberger; University of Texas Medical Branch, Galveston, TX.

**679**   **Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) in a Patient with Cough and Dyspnea Resistant to Standard Therapy**

**N. Singhania**, Q. Liang, C. Cool, R. Tate, R. Alam; National Jewish Medical and Research Center, Denver, CO.

**680**   **Management of Asthma Exacerbation in a Patient with Wiskott Aldrich Syndrome**

**M. A. Rank**, J. B. Hagan; Mayo Clinic, Rochester, MN.

**681**   **A Tale of Two Pediatric Patients: Using High Resolution CT (HRCT) to Distinguish Severe Asthma and Bronchiolitis Obliterans (BO)**

**P. A. Szefler**, M. E. Krawiec, J. D. Newell, S. J. Szefler, R. W. Hendershot; National Jewish Medical and Research Center, Denver, CO.

**682**   **A Case Study Utilizing Exhaled Nitric Oxide - An Aid in Determining Asthma Treatment**

**J. Bishop**, B. Miller; Univeristy of Kentucky, Lexington, KY.
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**683**   **Correlation of Plasma Ghrelin And Serum Immunoglobulin Levels: A Hormonal Link Between Immunity and Obesity?**

**K. Matsuda**, Y. Okamatsu, H. Tani, K. Kimura, T. Matsuishi; Kurume university school of medicine, Kurume ciry, Fukuoka, JAPAN.

**684**   **Association of a Haplotype Related to TGFb1 with Allergy and Its Potential Race Dependent Effect**

**J. Meng**; Children\'s Mercy Hospital, UMKC School of Medicine, Kansas City, MO.

**685**   **A Genetic Variant in the Promoter of the Siglec8 Gene is Associated with Wheeze in a Brazilian Population**

**A. V. Grant** ^1,2^, B. S. Bochner^2^, J. P. Guo^2^, M. I. Araujo^3^, E. V. Ponte^4^, A. A. Cruz^4^, T. H. Beaty^1^, P. S. Gao^2^; ^1^Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, ^2^Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, MD, ^3^Servico de Imunologia, Hospital Universitario Professor Edgard Santos, Salvador, BRAZIL, ^4^Brazil Center for Respiratory Diseases, Federal University of Bahia, Salvador, BRAZIL.

**686**   **A Network-based Analysis Of Lung From A Novel Mouse Model Of Experimental Asthma**

**S. B. Sarpong** ^1^, S. Ghimbovschi^2^, E. Hoffman^2^; ^1^Howard University, Washington, DC, ^2^Childrens National Medical Center, Washington, DC.

**687**   **A G-protein-coupled Receptor 154 *(GPRA)* Gene Polymorphism is Associated with Asthma in a Colombian population**

**C. Vergara** ^1^, N. Acevedo^1^, S. Jiménez^1^, B. Martínez^1^, L. Gusmão^2^, D. Mercado^1^, L. Caraballo^1^; ^1^Institute for Immunological Research, University of Cartagena, Cartagena, COLOMBIA, ^2^IPATIMUP, Instituto de Patologia e Inmunologia Molecular da Universidade do Porto, Portugal, Porto, PORTUGAL.

**688**   **The Interleukin 1β Gene (IL1B) is Upregulated in CD14+ Monocytes But Not Alveolar Macrophages after Lipopolysaccharide (LPS) Stimulation by Genomic Expression Profiling**

**Y. J. Tsai** ^1^, P. Gao^1^, M. A. Williams^2^, D. Grigoryev^1^, M. Stockton^1^, T. Watkins^1^, C. Cheadle^1^, S. Georas^2^, M. C. Liu^1^, L. Breslin^1^, K. C. Barnes^1^; ^1^Johns Hopkins University, Baltimore, MD, ^2^University of Rochester, Rochester, NY.

**689**   **GATA-3 Induces Transcriptional Activation of CRTh2**

R. Quapp, T. Seibert, N. Madsen, K. Madsen, **L. Cameron**; University of Alberta, Edmonton, AB, CANADA.

**690**   **Keratins: Important Candidate genes for Asthma and Immune Responsiveness to Cockroach**

**P. Gao** ^1^, D. Grigoryev^1^, L. Breslin^1^, C. Cheadle^1^, R. A. Mathias^2^, T. H. Beaty^3^, A. Togias^1^, K. Barnes^1^; ^1^JHAAC, Baltimore, MD, ^2^Center for Inherited Disease Research, NIH, Baltimore, MD, ^3^Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.

**691**   **Copy Number Variations in del22q11.2 Syndrome**

**S. A. McGhee**, M. Suchard, U. Bhardwaj, Y. Zhang, E. R. B. McCabe; David Geffen School of Medicine at UCLA, Los Angeles, CA.

**692**   **Effect of Montelukast on IL6, IL12 from Inflamatory Exudation in Gouty Arthritis Model**

J. A. Corado, **M. Bermudez**, A. Linares, L. Ponce, Z. Mora, J. Lucar, A. Acosta, R. Tovar; Universidad de Carabobo, Valencia, VENEZUELA.

**693**   **Hydrodynamics Based in vivo siRNA Transfection: Legal or Lethal?**

**P. N. Pushparaj**, H. S. Chen, A. J. Melendez; National University of Singapore, Singapore, SINGAPORE.

**694**   **Prevalence Of IgE Anti-parvovirus B19 Antibodies In Asymptomatic Healthy Adult Humans**

**M. H. Bluth**, H. G. Durkin, L. Wright, M. Nowakowski, T. A. Smith-Norowitz; SUNY Downstate Medical Center, Brooklyn, NY.

**695**   **Detection Of IgE Anti-Parvovirus B19 Antibodies In Human Breast Millk: A Case Study**

**T. A. Smith-Norowitz**, K. B. Norowitz, H. Drew, M. Nowakowski, E. F. Bluth, H. G. Durkin, M. H. Bluth; SUNY Downstate Medical Center, Center for Allergy and Asthma Research, Brooklyn, NY.

**696**   **The Role of Surfactant Protein D (SP-D) and IgA in Schaedler\'s *E.coli* Induced Diminished Translocation of *Lactobacillus salivarius* Into the Lung: Crosstalk Between Innate and Adaptive Immunity**

**K. Krytska** ^1,2^, N. V. Boyko^2^, N. Kushnir^1^, D. Kobuley^1^, S. A. Keilbaugh^1^, G. D. Wu^1^, Y. Yu^1^, J. J. Cebra^1^, A. Haczku^1^; ^1^University of Pennsylvania, Philadelphia, PA, ^2^Uzhgorod National University, Uzhgorod, UKRAINE.

**697**   **Changes in Cytokine Levels in The First Year of Life in WHEALS Cohort Infants**

**K. R. Bobbitt**, K. J. Woodcroft, S. Havstad, L. K. Williams, C. C. Johnson; Henry Ford Hospital, Detroit, MI.

**698**   **Effect Of Nasal And Bronchial Grass Pollen Challenges On Plasma Cytokine Levels**

**C. Barnig** ^1^, B. Uring-Lambert^2^, A. Purohit^1^, C. Donnay^1^, A. Casset^1^, S. Bahram^2^, F. de Blay^1^; ^1^Asthma and Allergy Division, Department of Chest Diseases,University Hospital, Strasbourg, FRANCE, ^2^Laboratory of Immunology, University Hospital, Strasbourg, FRANCE.

**699**   **Influence Of H1, H2 And H3 Antagonists On Apoptosis Of Lymphoid Cells**

**I. Kaidashev** ^1^, I. Yastremskaya^1^, N. Kutzenko^1^, L. M. DuBuske^2^; ^1^Ukrainian Medical Stomatological Academy, Poltava, UKRAINE, ^2^Immunology Research Institute of New England, Gardner, MA.

**700**   **Leukemoid Reaction in Children: Lymphocytes Flow Cytometry Characterization and Clinical Etiologies**

**A. Beigelman** ^1,2^, J. Kapelushnik^1^, G. Shubinsky^1^, A. Haim^1^, A. M. Moser^1^; ^1^Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, ISRAEL, ^2^Washington University School of Medicine, Saint Louis, MO.

**701**   **Inhibition of Phosphoinositide 3 Kinase by Masoprocol Ameliorates IgE-mediated Anaphylaxis in vivo and ex vivo**

**J. J. A. Aarthi** ^1^, P. N. Pushparaj^2^, S. D. Kumar^2^; ^1^Singapore General Hospital, Singapore, SINGAPORE, ^2^National University of Singapore, Singapore, SINGAPORE.

**702**   **Altered Histone Acetylation in Monocytes in Response to Polarization with IFN-gamma and IL-4**

**S. L. Garrett** ^1,2^, K. Sullivan^1^; ^1^Children\'s Hospital of Philadelphia, Philadelphia, PA, ^2^University of Pennsylvania, Philadelphia, PA.

**703**   **Macrophages Accumulation in Visceral and Subcutaneous Adipose Tissue Correlates with Age**

**E. Jerschow** ^1^, S. Anwar^2^, N. Barzilai^1^, D. Rosenstreich^1^; ^1^Albert Einstien College Medicine, Bronx, NY, ^2^Montefiore Medical Center, Bronx, NY.

**704**   **The Role Of c-FLIP Isoform II In Il-2 Production**

**B. K. Al-Saud**, Z. Alli, M. Abdelhaleem; the hospital for sick children, Toronto, ON, CANADA.
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**705**   **Pattern Of Cd28 Expression On Cd8+ T Cells In A Group Of Coinfected And Monoinfected HIV And HCV Patients**

**A. Paravisini** ^1^, M. S. Cianchetta^1^, R. Garcia^1^, S. Raso^2^, P. Llorente^1^, M. Fernandez-Guerrero^3^, M. Gorgolas^3^; ^1^Immunology.Fundacion Jimenez Diaz Capio, Madrid, SPAIN, ^2^Immunology.Fundacion Jimenez Diaz Unilabs, Madrid, SPAIN, ^3^Infectious Diseases.Fundacion Jimenez Diaz Capio, Madrid, SPAIN.

**706**   **Multidrug-Resistant (MDR) HIV Transmission to a Third Generation Offspring**

**D. W. Rosenthal** ^1,2^, C. Colter^1^, L. Maroldo^3^, E. Coakley^3^, S. J. Schuval^1^; ^1^Long Island Jewish Medical Center, Schneider Children\'s Hosptial, New Hyde Park, NY, ^2^Feinstein Institute for Medical Research at North Shore Long Island Jewish Health System, Manhasset, NY, ^3^Mongram Biosciences, South San Francisco, CA.

**707**   **A Protocol for the Desensitization to Intravenous Immunoglobulin (IVIg)**

**M. Salomon**, R. Hostoffer, Jr.; Case Western Reserve University, Cleveland, OH.

**708**   **3 Cases of Common Variable Immune Deficiency Associated With Absence of CD19+ B Lymphocytes**

**J. R. Sigmon**, E. Kasabeh, G. Krishnaswamy; Division of Allergy and Immunology, Department of Internal Medicine, East Tennessee State University, College of Medicine, Johnson City, TN.

**709**   **Intrathoracic Disease and Nontuberculous Mycobacteria (NTM) in a 6 Month Old Female: Immunodeficiency or Bad Luck? Case Report/Proposal**

**D. M. Anmuth** ^1^, M. S. Edwards^1^, N. Tatevian^1^, S. M. Holland^2^, I. C. Hanson^1^; ^1^Baylor College of Medicine/Texas Children\'s Hospital, Houston, TX, ^2^National Institute of Allergy and Infectious Diseases, Bethesda, MD.

**710**   **Lymphomatoid Granulomatosis in a Young Male with Hypogammagobulinemia**

**M. A. Netravali** ^1^, A. J. MacGinnitie^1^, L. Teot^2^, D. R. Nash^1^; ^1^Children\'s Hospital of Pittsburgh, Pittsburgh, PA, ^2^University of Pittsburgh Medical Center, Pittsburgh, PA.

**711**   **Myocardial Infarction After Replacement-Dose Intravenous Immunoglobulin**

**J. M. Klein** ^1^, A. Tevrizian^2^, D. Adelman^1^, P. Avila^3^; ^1^University of California, San Francisco, San Francisco, CA, ^2^Allergy and Asthma Medical Group of the Bay Area, Pleasanton, CA, ^3^Northwestern University, Chicago, IL.

**712**   **Specific Antibody Deficiency in a Patient with Factor IX Deficiency**

**M. A. Travassos**, S. W. Alexander, J. E. Arnold, A. K. Chouksey; Rainbow Babies & Children\'s Hospital, Cleveland, OH.

**713**   **Mannose Binding Lectin Deficiency In An Adolescent With Recurrent Infections And Idiopathic Thrombocytopenic Purpura**

**S. M. Nyenhuis**, J. E. Gern; Department of Medicine, Section of Allergy and Clinical Immunology, University of Wisconsin, Madison, WI.

**714**   **Atypical Presentation of DiGeorge Syndrome in an 14 Year Old Male**

**S. Najm Masoud**, W. Blouin, R. A. Stoudt, J. Carro, V. P. Hernandez-Trujillo; Miami Children\'s Hospital, Miami, FL.

**715**   **Cystic Fibrosis and Associated Common Variable Immunodeficiency**

**M. M. Sikora**, R. Bansal, J. El-Dahr; Tulane University, New Orleans, LA.

**716**   **Improved Tolerability with IVIG Switch in Patients With Common Variable Immunodeficiency**

**H. N. Taki** ^1,2^, H. Karen^1^; ^1^Fort Wayne Medical Institute, Fort Wayne, IN, ^2^Medical Universilty of Ohio, Toledo, OH.

**717**   **Neutropenia And Primary Immunodeficiency Disease (PID)**

**S. N. Mathew**; University of New Mexico, Albuquerque, NM.

**718**   **Food Allergy in a Patient with Hyper-IgE Syndrome (HIE) in Exclusive Breast-Feeding**

**A. M. S. Neves** ^1^, P. A. Cunha^2^, T. Lawrence^1^, S. S. Lima^3^, M. C. Mallozi^4^, B. T. Costa-Carvalho^4^, D. Solé^5^; ^1^Fellow in Training of the Division of Allergy, Clinical Immunology, and Rheumatology of the Department of Pediatrics, Federal University of São Paulo-Escola Paulista de Medicine, São Paulo, BRAZIL, ^2^Felow in Training of the Division of Pediatric DermatologyHospital Darcy Vargas, São Paulo, BRAZIL., São Paulo, BRAZIL, ^3^Professor of the Division of Pediatric Dermatology, Hospital Darcy Vargas, São Paulo, BRAZIL, ^4^Associate Professor of the Division of Allergy, Clinical Immunology, and Rheumatology of the Department of Pediatrics, Federal University of São Paulo-Escola Paulista de Medicine, São Paulo, BRAZIL, ^5^Full Professor of the Division of Allergy, Clinical Immunology, and Rheumatology of the Department of Pediatrics,Federal University of São Paulo-Escola Paulista de Medicine, São Paulo, BRAZIL.

**719**   **Relationship Of Immune Response To Endotoxin And Candida To Clinical Status Of Patients With Combined Bacterial And Candidal Periodontitis**

**V. A. Beloglazov** ^1^, N. S. Lukojanova^1^, A. I. G_rdienko^1^, N. V. Khimich^1^, A. A. Bakova^1^, I. V. DuBuske^2^, L. M. DuBuske^2^; ^1^Crimean Medical State University, Simferopol, UKRAINE, ^2^Immunology Research Institute of New England, Gardner, MA.

**720**   **Transient Neonatal Hypocalcemic Seizures Identifying Partial DiGeorge Syndrome**

**S. Ramanuja**, D. C. Jerome, M. R. Baskin; University of California at Irvine, Irvine, CA.

**721**   **The Role of IVIG in Treatment of Hyper-IgE Syndrome (HIES)**

**S. I. Krassilnikova**, M. Davies, J. Rosch; Penn State\'s Milton S. Hershey Medical Center, Hershey, PA.

**722**   **Primary Selective IgM Deficiency (SIgMD) Associated With Functional Antibody Deficiency In Two Boys**

**F. I. Khan**, M. Pansare, E. A. Secord; Carman and Ann Adams Department of Pediatrics, Children\'s Hospital of Michigan, Detroit, MI.

**723**   **14 Year Old Boy With ill-defined Immunodeficiency**

**R. S. Watkins** ^1^, A. L. MacDowell^1^, M. Fontana-Penn^1^, S. De Ravin^2^, H. L. Malech^2^; ^1^Wake Forest University Baptist Med. Ctr., Winston Salem, NC, ^2^National Institute of Allergy and Infectious Diseases; National Institutes of Health, Bethesda, MD.

**724**   **An Adolescent Patient with Chronic Granulomatous Disease (CGD) Presenting with Renal Failure**

**P. D. Niolet**, K. Paris, C. Moore; LSU Health Sciences Center, New Orleans, LA.

**725**   **Positive Prick Test in an X-Linked Agammaglobulinemia Patient**

**T. C. Lawrence**; UNIFESP-EPM, São Paulo, BRAZIL.

**726**   **A 3 Years Old Female With SCID T(-) B(-) Nk(+) Treated With Halogenic Bone Marrow Transplantation. Case Report**

**H. Del Olmo Tellez**, G. Treviño Garza, N. Ramire, C. Ramos Becerril, F. Rivas Larrauri; National Institute of Pediatrics Mexico, Mexico City, MEXICO.

**727**   **Case Report. Recessive Pediatric Hyper Ige Syndrome**

**K. I. G. C. Giron, II**, A. A. S. Alcantara, III, H. G. C. Campos, IV, S. E. E. P. Espinosa, Jr.; National Institute of Pediatric, Mexico D.F, MEXICO.
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**728**   **A Quantitative Exposure Assessment for Eight Indoor Allergens by Fluorescent Multiplex Array**

**C. D. Earle** ^1^, A. Tsay^1^, K. Pittman^1^, L. Vailes^1^, R. Godbout^2^, K. G. Oliver^3^, M. D. Chapman^1^; ^1^Indoor Biotechnologies Inc., Charlottesville, VA, ^2^Radix Biosolutions Inc., Austin, TX, ^3^Radix Biosolutions Inc, Austin, TX.

**729**   **The Risk of Asthma in Children Sensitized to Alternaria**

**R. Chooniedass** ^1,2^, R. Rabbani^1,2^, J. Liem^1,2^, A. Becker^1,2^; ^1^University of Manitoba, Winnipeg, MB, CANADA, ^2^Manitoba Institute of Child Health, Winnipeg, MB, CANADA.

**730**   **Fel d 1 In The Bed Dust Of Cat Non-Owners Differs Among Ethnicities But Not Neighborhood In Two NYC Cohorts**

**K. Panjwani** ^1,2^, G. L. Chew^1^, A. Divjan^1^, A. M. Reardon^1^, F. P. Perera^1^, R. L. Miller^1^, M. S. Perzanowski^1^; ^1^Columbia\'s Center for Children\'s Environmental Health (CCCEH), New York, NY, ^2^Department of Environmental Health Sciences, Columbia University, New York, NY.

**731**   **Content of (1-3)-β-D-glucan in Common Indoor Air Fungi**

**Y. Iossifova**, C. Crawford, T. Reponen; University of Cincinnati, Cincinnati, OH.

**732**   **Comparison of Protein Antigens Among Commercially Available Dog Extracts**

**T. M. Hrabak**, J. Dice, L. Hagan, B. Whisman; Wilford Hall Medical Center, Lackland AFB, TX.

**733**   **Effects of Climate And Flooding On Mold And Pollen Sensitization**

**D. Dalan** ^1^, W. Brooks, IV^2^, E. Levetin^3^; ^1^University of North Dakota, Fargo, ND, ^2^Allergy & Asthma Care Center, Fargo, ND, ^3^Biological Science, University of Tulsa, Tulsa, OK.

**734**   **Are There House-Dust Mites on Moldy Wall Surfaces?**

**Y. Gernez** ^1^, P. Parola^1^, A. Palot^1^, G. Maurel^2^, J. Ercoli^2^, C. Charpin-Kadouch^2^, D. Charpin^1^, H. Dumon^1^; ^1^Assistance publique-Hoˆpitaux de Marseille, Marseille, FRANCE, ^2^Maison de l\'Allergie et de l\'Environnement, Marseille, FRANCE.

**735**   **Acute Asthma with High Grass Pollen in Oregon**

**K. W. Jacobson** ^1^, S. E. Zakarian^1^, J. C. Jensen^1^, J. A. Moran^1^, M. Glovsky^2^; ^1^Allergy and Asthma Research Group, Eugene, OR, ^2^California Institute of Technology, Pasadena, CA.

**736**   **IgE Reactivity to *Paecilomyces variotii* Antigens in Fungal Sensitized Patients**

**B. J. Green** ^1^, F. M. Blachere^1^, D. H. Beezhold^1^, D. N. Weissman^1^, M. B. Hogan^2^, N. W. Wilson^2^, D. Schmechel^1^; ^1^Centers for Disease Control and Prevention, Morgantown, WV, ^2^West Virginia University School of Medicine, Morgantown, WV.

**737**   **Rat and Mouse Allergens in Homes of Patients with Acute Wheezing Living in Brazil**

M. Thiesen^1^, A. S. Zampolo^1^, A. R. Santos^1^, A. A. Camara^2^, V. P. L. Ferriani^1^, **L. K. Arruda** ^1^; ^1^School of Medicine of Ribeirão Preto-University of São Paulo, Ribeirão Preto, BRAZIL, ^2^Santa Lidia Hospital, Ribeirão Preto, BRAZIL.

**738**   **Mites Whose Time Has Come: Sensitization to Blomia Tropicalis, and Other Mites in Allergic Patients in Israel**

**K. Sade**, D. Roitman, S. Kivity; Tel-Aviv Sourasky Medical Center, Tel-Aviv, ISRAEL.

**739**   **A Two-stage Personal Cyclone Sampler for the Collection of Fungal Aerosols and Direct ELISA and PCR Sample Analysis**

**D. Schmechel**, W. G. Lindsley, T. B. Chen, F. M. Blachere, B. J. Green, R. A. Brundage, D. H. Beezhold; CDC/Natl. Inst. Occup. Safety & Health, Morgantown, WV.

**740**   **Risk Factors and Distribution of Mite Allergens in Spain**

**V. Iraola**, E. Fernández-Caldas; Laboratorios LETI S.L., Tres Cantos, SPAIN.

**741**   **Relative Potency of Mold and House Dust Mite Extracts in Inducing Allergic Responses in BALB/c Mice**

**Y. Chung**, L. B. Copeland, M. D. W. Ward; US/EPA, Research Triangle Park, NC.

**742**   **Meteorological Effects May Alter the Incidence of Rye-grass Pollen Related Asthma**

**M. M. Glovsky** ^1^, K. Jacobson^2^, S. Zakarian^2^, J. Jensen^2^, J. Moran^2^, P. E. Taylor^1^; ^1^Huntington Asthma and Allergy Center, Pasadena, CA, ^2^Allergy and Asthma Research Group, Eugene, OR.

**743**   **Home Cleaning Awareness Improves Asthma Quality Of Life**

**M. Amado**, F. Pacheco, L. Gard, E. Forrest, L. Johnson, C. Barnes; Childrens Mercy Hospital, Kansas City, MO.

**744**   **Reduction in *Aspergillus* and *Penicillium* Spore Counts Results in Reduction of *Aspergillus* and *Penicillium* Antigen Level in House Dust**

**D. R. Ward**, P. Dowling, F. Hu, L. Johnson, K. Kennedy, C. Barnes; Children\'s Mercy Hospital, Kansas City, MO.

**745**   **Initial Characterization of a cDNA Encoding a Heat Shock Protein Homolog From *Stachybotrys chartarum***

**F. M. Blachere**, B. J. Green, D. Schmechel, D. H. Beezhold; Centers for Disease Control and Prevention, Morgantown, WV.

**746**   **The Relationship between Skin Test Responses and Nasal Responses to Mouse Allergen**

**H. P. Sharma**, R. A. Wood, A. R. Bravo, E. C. Matsui; Johns Hopkins University, Baltimore, MD.

**747**   **Statewide and Intrastate Assessments of Allergenic Tree, Grass and Weed Species**

**R. S. Jacobson**, T. J. Grier; Greer Laboratories, Inc., Lenoir, NC.

**748**   **Decreased Dust Antigen Levels Resulting from Specific Cleaning Practices**

**B. Jones**, C. Barnes, F. Pacheco, L. Johnson, L. Gard, E. Forrest, J. Portnoy; Children\'s Mercy Hospital, Kansas City, MO.

**749**   **The Impact of Cleaning Practices on Antigen Levels and Spirometry in an Asthmatic Population**

**C. S. Barnes**, F. Pacheco, L. Gard, E. Forrest, L. Johnson, J. Portnoy; Childrens Mercy Hospital, Kansas City, MO.
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**750**   **Sensitization to Cor a 8, a Lipid Transfer Protein, in Children with Objective Reactions to Hazelnut from a Birch Endemic Country**

**A. E. Flinterman** ^1^, J. H. Akkerdaas^2,1^, C. F. den Hartog Jager^1^, M. O. Hoekstra^1^, A. C. Knulst^1^, R. van Ree^2^, S. G. M. A. Pasmans^1^; ^1^University Medical Center, Utrecht, THE NETHERLANDS, ^2^Academic Medical Center, Amsterdam, THE NETHERLANDS.

**751**   **Omega-5-Gliadin Specific IgE as a Predictor of Wheat Allergy in Children**

**K. Ito** ^1^, Y. Takaoka^1^, M. Futamura^1^, T. Sakamoto^2^, K. Kohno^3^, E. Morita^3^, H. Matsuo^4^, A. Tanaka^5^; ^1^Aichi Children\'s Health and Medical Center, Obu, JAPAN, ^2^Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, JAPAN, ^3^Department of Dermatology, Shimane University School of Medicine, Shimane, JAPAN, ^4^Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JAPAN, ^5^Phadia KK., Tokyo, JAPAN.

**752**   **Impact of an Inpatient Program to Improve Safety of Food Allergic Patients During Hospitalization**

**A. R. Auerbach** ^1^, M. E. Bollinger^1^, E. Loreck^2^, M. Simke^2^, C. Vibbert^1^, J. Gladstein^1^, A. Kewalramani^1^; ^1^Univ. of Maryland School of Medicine, Baltimore, MD, ^2^Univ. of Maryland Medical System, Baltimore, MD.

**753**   **Contamination of Probiotic Preparations With Milk Allergen Can Cause Anaphylaxis in Cow\'s Milk Allergic Patients**

**M. Morisset** ^1^, T. T. Lee^2^, C. M. N. Astier^3^, D. A. Moneret-Vautrin^1^, V. Cordebar^1^, E. Beaudouin^1^, F. Codreanu^1^, B. E. Bihain^4^, G. Kanny^1^; ^1^University Hospital, Nancy, FRANCE, ^2^Laboratory of Molecular Medicine and Therapeutics, Vandoeuvre-Les-Nancy, FRANCE, ^3^INPL, Vandoeuvre-Les-Nancy, FRANCE, ^4^Laboratory of Molecular Medicine and Therapeutics, Nancy, FRANCE.

**754**   **Usefulness Of Serum Interleukin-10 In The Determining Food Tolerance**

**F. Pineda**; DIATER Laboratories, San Martin de la Vega, SPAIN.

**755**   **Oral Food Challenge with Boiled Egg Yolk and Boiled and Raw Egg White**

**Y. Takaoka** ^1^, K. Ito^1^, M. Futamura^1^, T. Sakamoto^2^; ^1^Aichi Children\'s Health and Medical Center, Obu, JAPAN, ^2^Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, JAPAN.

**756**   **IgE Mediated Cow\'s Milk Allergy (CMA): Evaluation of Weight and Height of Patients at Admission and After one-year Follow-up in Use of Soy Products**

**G. H. Yonamine**, G. A. Corradi, F. R. P. Afonso, A. P. B. M. Castro, A. C. Pastorino, C. M. A. Jacob; Depto. of Pediatrics, São Paulo, BRAZIL.

**757**   **Detection of Legume Proteins Cross-reactivity by Immunoblot Using Human Plasma of Individuals with Food Allergies to Peanut and/or Soybean**

**L. Chen**, A. O. Ofori-Anti, R. E. Goodman; University of Nebraska, Lincoln, NE.

**758**   **Assessment Of The Allergenicity To Raw Tuna And Canned Tuna**

**Y. Kondo** ^1^, Y. Nakajima^1^, R. Komatsubara^1^, M. Kawamura^1^, M. Kakami^1^, I. Tsuge^1^, T. Yasuda^2^, A. Urisu^1^; ^1^Fujita Health University, Toyoake, Aichi, JAPAN, ^2^Toyo Suisan Kaisha, Ltd, Tokyo, JAPAN.

**759**   **Ara H 2.02 Is A More Potent Cross-linker Of Anti-Peanut IgE Than Is Ara H 2.01**

**R. El Mezayen** ^1^, L. Pons^2^, A. W. Burks^2^, M. West^3^, S. Stanley^3^, M. El Gazzar^1^, M. W. Duncan^1^, K. C. Hansen^1^, S. C. Dreskin^1^; ^1^University of Colorado Health Sciences Center, Denver, CO, ^2^Duke University, Durham, NC, ^3^University of Arkansas Medical Center, Little Rock, AR.

**760**   **The Majority of the Effector Activity of a Crude Peanut Extract Co-purifies with Ara h 2 but not Ara h 1 or Ara h 3**

**H. S. Porterfield**, M. W. Duncan, K. C. Hansen, S. C. Dreskin; University of Colorado Health Sciences Center, Denver, CO.

**761**   **Diagnosis of Cow\'s Milk Allergy: Are Low Levels of Specific IgE Significant?**

**A. M. Plaza**, M. Piquer, M. T. Giner, M. A. Martin Mateos, J. I. Sierra; Hospital Sant Joan de Déu, Esplugues, SPAIN.

**762**   **An Objective Approach for the Assessment of Interchangeability of Cross-Reactive Food Allergens in Diagnostic Tests for Specific IgE**

**J. Lidholm** ^1^, A. Marknell DeWitt^1^, L. Mattsson^1^, J. Ostling^1^, G. Lilja^2^, M. Nordlund^2^, B. Ballmer-Weber^3^, S. Scheurer^4^, A. Wangorsch^4^, H. Kofler^5^, J. Sastre^6^, E. Enrique^7^, S. Vieths^4^, K. Andersson^1^; ^1^Phadia AB, Uppsala, SWEDEN, ^2^Sachs\' Children\'s Hospital, Stockholm, SWEDEN, ^3^University Hospital Zurich, Zurich, SWITZERLAND, ^4^Paul-Ehrlich-Institut, Langen, GERMANY, ^5^Allergieambulatorium Hall, Hall, AUSTRIA, ^6^Fundación Jiménez Díaz, Madrid, SPAIN, ^7^Hospital General de Castellón, Castellón, SPAIN.

**763**   **Seasonal Palatal Pruritus is a Risk Factor for Oral Allergy Syndrome**

**D. A. Fischer**; University of Western Ontario, Barrie, ON, CANADA.

**764**   **A Trial of a Diet Containing Baked Egg in Children with Egg Allergy**

**A. H. Nowak-Wegrzyn**, S. H. Sicherer, W. G. Shreffler, E. Thanik, S. Mofidi, S. Noone, H. A. Sampson; Jaffe Food Allergy Institute, Mount Sinai School of Medicine, New York, NY.

**765**   ***Dioscorea batatas* (Sanyak) Allergy, Identification of an IgE-binding Component**

**G. Hur** ^1^, S. Shin^2^, H. Park^1^, H. Kim^1^, Y. Ye^1^, S. Kim^3^, D. Nahm^1^, H. Park^1^; ^1^Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA, ^2^KyungHee University College of Medicine, Seoul, REPUBLIC OF KOREA, ^3^Yonsei University Wonju College of Medicine, Wonju, REPUBLIC OF KOREA.

**766**   **Severe Peripheral Eosinophilia and Failure to Thrive with Complete Resolution of Symptoms with Milk Elmination**

**H. Ahluwalia**, L. Bernstein, J. Shliozberg; Albert Einstein The Children\'s Hospital at Montefiore, Bronx, NY.

**767**   **Clinical And Laboratorial Findings From Ige Mediated Cow\'s Milk Allergy (CMA) In Brazilian Pediatric Patients**

**A. K. F. Gushken**, D. L. A. Pitarello, G. H. Yonamine, E. Ciccone, A. C. Brandão, A. P. B. M. Castro, A. C. Pastorino, C. M. A. Jacob; Depto. of Pediatrics, São Paulo, BRAZIL.

**768**   **Isolated Food Pollen Syndrome in Response to Fresh Pineapple**

**E. S. Lavine** ^1^, A. R. Atkinson^1^, A. K. Ellis^2^; ^1^University of Toronto and Division of Immunology and Allergy, The Hospital for Sick Children, Toronto, ON, CANADA, ^2^Division of Clinical Immunology and Allergy, McMaster University, Hamilton, ON, CANADA.

**769**   **Sensitization to *Cannabis sativa* in Tomato Sensitized Patients**

**C. Hernando de Larramendi** ^1^, J. García Abujeta^1^, J. Carnés^2^, E. Fernández-Caldas^2^; ^1^Hospital Marina Baixa, Villajoyosa, SPAIN, ^2^Laboratorios LETI, SL, Tres Cantos, SPAIN.

**770**   **Biological Standardization Of Hazelnut Extract In Selected Patients With Dbpcfc**

**F. Pineda**; DIATER Laboratories, San Martin de la Vega, SPAIN.

**771**   **Peanut Allergy and Peanut-specific IgG4 characteristics among Xhosa Children in Cape Town**

**G. Du Toit** ^1^, M. Levin^2^, C. Motala^2^, M. Perkin^3^, A. Stephens^4^, V. Turcanu^4^, G. Lack^1^; ^1^Children\'s Allergy Service. Evelina Children\'s Hospital, Guy\'s & St Thomas\' NHS Foundation Trust, Kings College London, UNITED KINGDOM, ^2^Red Cross Children\'s Hospital, University of Cape Town, SOUTH AFRICA, ^3^Division of Community Health Sciences, St George\'s Hospital Medical School, UNITED KINGDOM, ^4^Kings College London, London, UNITED KINGDOM.

**772**   **Angioedema Due to Blueberry Hypersensitivity**

**M. P. Wolbert**, J. Baldwin; University of Michigan, Ann Arbor, MI.

**773**   **Responses of Treatment Primary Eosinophilic Gastrointestinal Disorders with Corticosteroid, Montelukast and Ketotifen, 3 Cases Report**

**S. Nanthapisal**, N. Vithayasai, T. Dangsuwan, S. Jennuwat, J. Sirikul, G. Pongsamat, M. Vangveeravong; Queen Sirikit National Institute of Child Health, Bangkok, THAILAND.

**774**   **Atypical Presentation of Eosinophilic Gastroenteritis (EGE)**

**P. Kapur**, B. Silverman, A. T. Schneider; Long Island College Hospital, Brooklyn, NY.

**775**   **Eosinophilic Esophagogastritis In A Child With Atopy And Abdominal Pain**

**J. L. Caicedo**, R. A. Caicedo; Wake Forest University, Winston-Salem, NC.

**776**   **Anti-Allergic Effects of the Traditional Chinese Medicine Herbal Formula FAHF2 are Partially Dependent on Interferon-γ Activity**

**K. D. Srivastava**, H. A. Sampson, X. Li; The Mount Sinai School of Medicine, New York, NY.

**777**   **Severe Eosinophilia in a Pediatric Patient Following Hemolytic-Uremic Syndrome**

**G. C. Pien**, T. Brown-Whitehorn; Children\'s Hospital of Philadelphia, Philadelphia, PA.

**778**   **Total Serum Level Of Ige, Allergen-specific Ige And Blood Eosinophils In Food Allergy**

**J. T. Kim** ^1^, H. Kim^1^, J. Yoon^2^, J. Lee^2^, S. Kim^3^; ^1^Catholic University of Korea, Kyunggi-Do, REPUBLIC OF KOREA, ^2^Catholic University of Korea, Seoul, REPUBLIC OF KOREA, ^3^Pusan St.Mary\'s Hospital, Pusan, REPUBLIC OF KOREA.
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**779**   **A Case of Hemolytic Anemia Following Intravenous Immuno-globulin Administration in a Patient With Chronic Urticaria**

**S. M. Herman** ^1^, S. Betschel^2^, G. Sussman^2^; ^1^McMaster University, Hamilton, ON, CANADA, ^2^University of Toronto, Toronto, ON, CANADA.

**780**   **Localized Heat Induced Urticaria: A Case Report**

**C. O. Barnes**, A. Kulczycki; Washington University, St. Louis, MO.

**781**   **Chronic Idiopathic Urticaria May Not Be Idiopathic**

**M. E. Masching-Wright**; Sneeze, Wheeze, and Itch Associates, Normal, IL.

**782**   **Hydroxychloroquine in the Treatment of 12 Patients With Severe Chronic Idiopathic Urticaria; A Case Series**

**A. M. Ditto**; Northwestern University Feinberg School of Medicine, Chicago, IL.

**783**   **Evaluation of a Functional Assay for the Diagnosis of Autoimmune Chronic Urticaria (CU)**

**M. L. Altrich** ^1^, J. F. Halsey^1^, L. C. Altman^2^; ^1^IBT Reference Laboratory, Lenexa, KS, ^2^Dept Medicine University of Washington and Northwest Asthma and Allergy Center, Seattle, WA.

**784**   **Serological Factors in Chronic Idiopathic Urticaria (CIU) in Relation To Disease Activity Over Time**

**J. A. Eckman**, L. M. Gober, P. M. Sterba, R. G. Hamilton, S. S. Saini; Johns Hopkins Asthma and Allergy Center, Baltimore, MD.

**785**   **Association of Chronic Idiopahic Urticaria with Autoimmunity and IgE levels**

**A. Chomiciene** ^1^, L. M. DuBuske^2^, A. Blaziene^1^; ^1^Vilnius University, Vilnus, LITHUANIA, ^2^Immunology Research Institute of New England, Gardner, MA.

**786**   **Investigation Of Complement Activation In Patients with Chronic Idiopathic Urticaria**

**S. N. Sharif**, B. Goldberg; Kaiser Permanente Los Angeles, Los Angeles, CA.

**787**   **Colchicine Use in Resistant Urticaria and Angioedema Patients: A Case Series**

**B. A. Martinez**, I. C. Hanson, C. M. Davis; Baylor College of Medicine, Houston, TX.

**788**   **Eosinophilic Fasciitis Masquerading as Angioedema**

**A. M. Dowden** ^1,2^, Z. K. Ballas^1,2^; ^1^University of Iowa, Iowa City, IA, ^2^Veterans Affairs Medical Center, Iowa City, IA.

**789**   **Generalized Urticaria Due to Nickel Sensitivity**

**J. K. Lemmon**, A. P. Knutsen, R. G. Slavin; St. Louis University School of Medicine, Saint Louis, MO.

**790**   **Lymphocyte Response Pattern of Eczema Herpeticum Patients to Herpes Simplex Virus Antigen**

**H. C. Rerinck**, S. Kamann, A. Wollenberg; Ludwig-Maximilian University, Munich, GERMANY.

**791**   **A Murine Model of Eczema Vaccinatum**

**A. Elkhal** ^1^, J. Scott^1^, D. H. MacArthur^1^, R. He^1^, M. D. Howell^2^, E. Freyschmidt^1^, H. C. Oettgen^1^, D. Y. M. Leung^2^, R. S. Geha^1^; ^1^Childrens Hospital Boston, Boston, MA, ^2^National Jewish Medical and Research center, Denver, CO.

**792**   **Re Vaccination of Children with a History of an Allergic Reaction to a Vaccine After a Negative Intradermal Skin Test**

**M. Primeau**, A. Des Roches; Sainte-Justine Hospital, University of Montreal, Montreal, PQ, CANADA.

**793**   **Effects of Olopatadine on the Recovery of Skin Barrier Function and Epidermal Hyperplasia Induced by Skin Barrier Disruption in Mice**

**T. Amano**, T. Takeda, H. Yano, T. Tamura; Kyowa Hakko Kogyo Co., Ltd., Shizuoka, JAPAN.

**794**   **Olopatadine Ameliorates Rat Experimental Cutaneous Inflammation by Improving the Skin Barrier Function**

**T. Tamura**, T. Amano, M. Chida, H. Yano; Kyowa Hakko Kogyo Co., Ltd., Shizuoka, JAPAN.

**795**   **IL-13 Receptors in Cutaneous Inflammation**

**M. R. Warrier**, A. Gibson, Y. Tabata, M. O. Daines, W. Chen, H. S. Akei, M. E. Rothenberg, G. K. Khurana Hershey; Cincinnati Children\'s Hosp. Med. Center, Cincinnati, OH.

**796**   **Overexpression of Interleukin 13 (IL-13) in the Skin Induces Dermatitis and Pulmonary Inflammation and Airway Hyperresponsiveness to Allergen Challenge**

**T. Zheng**, S. Oh, M. Oh, M. Wang, A. Myers, J. Schroeder, Z. Zhu; Johns Hopkins University, Division of Allergy & Clinical Immunology, Baltimore, MD.

**797**   **Eyelid Dermatitis Due To Contact Allergy To Cocamidopropyl Betaine**

**H. D. Oei**; Albert Schweitzer Hospital, Dordrecht, THE NETHERLANDS.

**798**   **Contact Dermatitis To Atropine**

**C. A. Villanueva Alvarez-Santullano**, V. Tovar Flores, P. Tornero Molina, M. De Barrio Fernandez, M. Baeza Ocho de Ocariz, S. Perez Bustamante, A. Prieto Garcia; HospitaL Universitario Gregorio Marañon, Madrid, SPAIN.

**799**   **Perception of Factors Restricting Widely Performing Allergy Patch Testing: Comparison Between Allergists and Allergy Program Directors**

**G. Ghaffari**, T. Craig; Penn State Milton S Hershey Medical Center, Hershey, PA.

**800**   **Mast cell tryptase generate C3a from keratinocyte derived C3: Implication for allergic skin inflammation**

**R. Purwar** ^1^, M. Wittmann^1^, J. Zwirner^2^, M. Oppermann^2^, M. Kracht^1^, O. Dittrich-Breiholz^1^, R. Gutzmer^1^, T. Werfel^1^; ^1^Hannover Medical School, Hannover, GERMANY, ^2^Georg-August-University, Göttingen, GERMANY.

**801**   **Serum IgE Concentrations in Bullous Pemphigoid Correlate with Disease Activity**

**L. A. Kelly**, R. Holubkov, M. A. Campbell, K. S. Herlevi, T. Taylor, C. Hull, G. J. Gleich, J. J. Zone, K. M. Leiferman; University of Utah, Salt Lake City, UT.

**802**   **Study of the Effect of the Antihistamine Agent Fexofenadine on Pruritus Associated with Asteatotic Dermatitis in the Elderly**

**T. Yudate**; Sakai Hospital Kinki University School of Medicine, Sakai, JAPAN.

**803**   **Combination Therapy with Dapsone, Colchine and Hydroxychloroquine in the Treatment of Urticarial Vasculitis**

**J. Melamed** ^1^, H. Laznickova^2^; ^1^Allergy and Asthma Specialists, Chelmsford, MA, ^2^Allergy and Asthma Clinic P.C., Lexington, MA.

**804**   **Cutaneous Leukocytoclastic Vasculitis in a Patient with HIV**

**S. A. Hodes**, M. Carlson; University of California, Los Angeles, Los Angeles, CA.

**805**   **Tamoxifen, A Possible Novel Therapy For Systemic Mastocytosis**

**R. Mian**, P. E. Korenblat; Washington University School of Medicine, Barnes Jewish Hospital, St Louis, MO.

**806**   **Urticaria: Characterization of 375 cases**

**M. D. C. Petrola** ^1^, P. Adriana^1^, F. Maria^1^, T. Alcira^2^, Q. Velmar^2^; ^1^University of Carabobo, Valencia, VENEZUELA, ^2^Ciudad Hospitalaria Enrique Tejera, Valencia, VENEZUELA.

**807**   **The use of Danazol in the Management of Refractory Chronic Urticaria**

**M. Karakelides**, C. R. Weiler; Mayo School of Graduate Medical Education, Rochester, MN.

**808**   **A Case of Urticarial Vasculitis Associated with Chronic Lymphocytic Leukemia**

**J. C. Moore**, M. B. Fasano; University of Iowa Hospitals and Clinics, Iowa City, IA.

**809**   **Urticaria And Angioedema Caused By Currant Sauce**

**A. Rodríguez**, M. de Barrio, M. Vázquez, P. Rojas, T. Herrero, M. Baeza; Hospital General Universitario Gregorio Marañón, Madrid, SPAIN.

**810**   **Chronic Urticaria and Non Specific rash from the Herbal Product "Airborne"**

**R. M. Harris**, M. S. Johnson; Allergy & Asthma Associates, Beverly Hills, CA.

**811**   **Urticaria - A Rare Presentation of Sulfite Allergy**

**L. Yao**, R. J. Bloomberg; Generations Medical Center, Tempe, AZ.

**812**   **Contact Dermatitis Following Occupational Exposure to the New U.S. Army Combat Uniform (ACU)**

**C. B. Soltis** ^1^, C. K. Dolan^2^, M. R. Nelson^1^, S. A. Norton^3^; ^1^Walter Reed Army Medical Center, Washington, DC, ^2^National Naval Medical Center, Bethesda, MD, ^3^Uniformed Serviced University of the Health Sciences, Bethesda, MD.

**813**   **Evaluation of a Moisturizing Cream Containing Sweet Almond Oil and Gyceryl Polymethacrylate in Patients with Chronic Inflammatory Skin Diseases**

**U. Amon**, S. Erndt; PsoriSol-Center for Dermatology & Allergy, Hersbruck, GERMANY.

**814**   **Successful Treatment of Systemic Mastocytosis Associated with AML-M2, t(8:21) in a Child Using MRC-based AML Chemotherapy along with Gemtuzumab**

**D. K. Jeong**, K. Fauman, C. Ross, C. Akin, R. Mody; University of Michigan, Ann Arbor, MI.

**815**   **Tacrolimus Hydrate Ointment Inhibits Skin Plasma Extravasation Induced by Topically Applied *m*-Xylene But Not Capsaicin in Rat**

**S. Morii** ^1^, F. Kondo^2^, Y. Ikai^2^, M. Miyake^1^, M. Futamura^3^, K. Ito^3^, T. Sakamoto^1^; ^1^Nagoya University Graduate School of Medicine, Nagoya, JAPAN, ^2^Aichi Prefectural Institute of Public Health, Nagoya, JAPAN, ^3^Division of Allergology, Aichi Children\'s Health and Medical Center, Obu, JAPAN.

**816**   **Churg-Strauss Syndrome with Colonic Vasculitis**

**J. Jeong** ^1^, K. You^2^, S. Nahm^1^, E. Kim^3^; ^1^ILSAN PAIK HOSPITAL, Kyungki-do, REPUBLIC OF KOREA, ^2^Kun-Kuk University Hospital, Seoul, REPUBLIC OF KOREA, ^3^Dong-Kuk University Hospital, Kyungki-do, REPUBLIC OF KOREA.
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**817**   **Dyspnea and Obesity in African-American Females: Is It Really Asthma?**

**D. Waggoner**, J. Stokes, F. A. Romero, T. B. Casale; Creighton University, Omaha, NE.

**818**   **A Systematic Review of Randomized Control Trials Evaluating the Effectiveness of Interactive Computerized Asthma Patient Education Programs**

**K. L. Bussey-Smith** ^1^, R. D. Rossen^1,2^; ^1^Baylor College of Medicine, Houston, TX, ^2^Micheal E. DeBakey Veterans Affairs Medical Center, Houston, TX.

**819**   **Factors Associated with Increased Passive Cigarette Smoke Exposure in Inner City Asthmatic Children**

**S. J. Khiani** ^1^, S. J. Sietsema^1^, L. Curtis^2^, L. K. Sharp^3^, C. Catrambone^4^, K. B. Weiss^2,5^, J. J. Shannon^6^, J. N. Moy^7,1^; ^1^Section of Allergy and Immunology, Rush University Medical Center, Chicago, IL, ^2^Institute for Healthcare Studies, Northwestern University, Chicago, IL, ^3^Department of Medicine, University of Illinois, Chicago, IL, ^4^Rush University College of Nursing, Chicago, IL, ^5^Institute for Healthcare Studies, Hines VA, Chicago, IL, ^6^Divisions of Pulmonary and Critical Care Medicine, Stroger Hospital of Cook County, Chicago, IL, ^7^Department of Pediatrics, Stroger Hospital of Cook County, Chicago, IL.

**820**   **Recruitment Strategies in Under-Served Populatons for a Web-based Asthma Education Study Integrated with Nurse Case Management**

**A. D. Pulvermacher** ^1^, K. Kelly-Shanovich^1^, C. A. Sorkness^2^, A. Bhattacharya^3^, D. H. Gustafson^1^; ^1^Center for Health Enhancement Systems Studies, University of Wisconsin - Madison, Madison, WI, ^2^Schools of Pharmacy and Medicine, University of Wisconsin - Madison, Madison, WI, ^3^Center for the Study of Cultural Diversity in Healthcare, University of Wisconsin - Madison, Madison, WI.

**821**   **Effects of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody, on Blood Eosinophil Counts in Patients With Hypereosinophilic Syndrome**

**P. F. Weller** ^1^, G. J. Gleich^2^, W. W. Busse^3^, M. E. Rothenberg, on behalf of the Mepolizumab HES Study^4^; ^1^Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, ^2^Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT, ^3^Department of Medicine, University of Wisconsin Medical School, Madison, WI, ^4^Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.
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**822**   **The Allergic Profile Of Infants In The SAM Study: A Large Longitudinal Study Of Development Of Asthma And Allergies In Patients With Atopic Dermatitis**

**M. Boguniewicz** ^1^, L. Schneider^2^, D. Leung^1^, T. Hultsch^3^, J. Spergel^4^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^Children\'s Hospital Boston, Boston, MA, ^3^Novartis Pharmaceuticals Corp, East Hanover, NJ, ^4^Children\'s Hospital of Philadelphia, Philadelphia, PA.

**823**   **Cross-linking of FcɛRI on Dendritic Cells Skews CD4^+^ T cells towards a TH17 Phenotype**

**D. S. Cheung**, M. M. Rohlfing, R. T. Kitchens, M. J. Holtzman, M. H. Grayson; Washington University School of Medicine, Saint Louis, MO.

**824**   **Identifying the Presence and Function of the FcɛR1 Receptor in Human Normal and Small Airway Epithelium**

**E. Hochstadter** ^1^, J. Guay^1^, B. Tolloczko^1^, A. Soussi-Gounni^2^, B. D. Mazer^1^; ^1^Meakins Christie Laboratories, Montreal, PQ, CANADA, ^2^University of Manitoba, Winnipeg, MB, CANADA.

**825**   **Identification of Novel Candidate Gene/s Linked to Total Serum IgE Levels: An Integrative Genomic Approach**

**J. Batra**, M. Sharma, R. Nagarkatti, B. Ghosh; Institute of Genomics and Integrative Biology, Delhi, INDIA.

**826**   **Involvement of the High-affinity IgE Receptor (FCER1B) Gene Polymorphisms in the Susceptibility for Childhood Asthma**

**E. Kim** ^1^, K. Kim^1^, J. Park^1^, J. Hong^1^, G. Jang^2^, M. Sohn^1^, K. Kim^1^; ^1^Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^National Health Insurance Corporation Ilsan Hospital, Seoul, REPUBLIC OF KOREA.

**827**   **The Prevalence of IgE Antibodies to *Ascaris* in Asthmatic Patients Living in a Tropical Environment**

**L. Caraballo** ^1^, D. Mercado^1^, C. Vergara^1^, A. Fernández^2^, M. Gutiérrez^2^; ^1^Institute for Immunological Research, University of Cartagena, Cartagena, COLOMBIA, ^2^Departamento de Microbiología y Parasitología, Universidad Nacional Autónoma de México, México, MEXICO.

**828**   **Role Of Inhibitory Antibodies For The Prevention Of IgE-allergen Complex Formation/CD-23 Antigen Uptake: Impact Of Antibody Affinity And Clonality Using Defined Ratios Of Recombinant IgE, IgG And Der p 2**

**J. Holm**, L. H. Christensen, J. Skovsgaard, P. A. Wurtzen, K. Lund; ALK-Abelló A/S, Hørsholm, DENMARK.

**829**   **Total and Allergen Specific IgE Antibody Levels During and After Pregnancy in Relation to Maternal Allergic Disease**

**M. Sandberg**, A. Frykman, M. Persson, J. Ernerudh, G. Berg, L. Matthiesen, C. Ekerfelt, M. C. Jenmalm; Linköping University, Linköping, SWEDEN.

**830**   **IgE-dependent Activation Of Human Mast Cells Up-regulates FLIP And Mcl-1 Anti-apoptotic Proteins**

**B. Berent-Maoz**, F. Levi-Schaffer; The Hebrew University of Jerusalem, Jerusalem, ISRAEL.

**831**   **Specific IgE Response to Mites and Phenotypes of Allergic Disease in Childhood**

**M. I. Kidon** ^1,2^, S. Steinberg^1^, L. Y. S. Tiong^3^, T. C. Ong^3^, H. S. Shang^3^, F. T. Chew^3^; ^1^Children\'s Health Center, Rishon Lezion, ISRAEL, ^2^KK Children\'s Hospital, Singapore, SINGAPORE, ^3^Department of Biological Sciences, National University, Singapore, SINGAPORE.

**832**   **Omalizumab Therapy in Evolving Allergic Bronchopulmonary Aspergillosis**

**S. Dave** ^1^, W. B. Cherry^1^, D. E. Maddox^2^; ^1^Mayo School of Graduate Medical Education, Rochester, MN, ^2^Mayo Clinic College of Medicine, Rochester, MN.

**833**   **Efficacy of Omalizumab Using Extended Dose Intervals**

**R. M. Katz**, A. W. Rafi, L. Do, M. Lin, R. Mangat, N. Azad, S. Sender; Allergy Asthma Care Center/UCLA, Santa Monica, CA.

**834**   **Development Of A Monoclonal Antibody That Binds To Der P I Precursor And Blocks Serum Specific Ige Binding To Mite Allergen**

**W. Dai** ^1,1^, C. Shieh^2^, J. Wang^3^; ^1^Institude of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, ^2^Institude of Microbilogy&Immunology, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, ^3^Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, TAIWAN.

**835**   **A Systems Theory of Optimality in the Behavior of a Mast Cell**

**I. Bachelet** ^1^, A. Munitz^1^, N. Linnenberg^2^, Y. J. Pollak^3^, F. Levi-Schaffer^1^; ^1^The Hebrew University of Jerusalem, Jerusalem, ISRAEL, ^2^Freescale, Herzliya Pituach, ISRAEL, ^3^Mobileye Vision Technologies, Jerusalem, ISRAEL.

**836**   **Regulation of Human Mast Cells by Fluticasone and Salmeterol**

**L. E. Erdos**, R. P. Schleimer, M. Kulka; Northwestern University, Chicago, IL.

**837**   **Effects of the Chinese Herbal Formula CUF2 on Cytokine Release from Human Mast Cell Line**

**Y. O. Wong**, R. Y. T. Sung, K. Li, Y. Zhao, A. M. C. Li, K. P. Fung; The Chinese University of Hong Kong, Hong Kong, HONG KONG.

**838**   **Pharmacological Cell and Tissue Models of Human Mast Cells for Compound Prioritization in Drug Development**

**C. Prothmann**; ALTANA Research Institute, Waltham, MA.

**839**   **Distinct Role Of Il-3 Promoter And Enhancer Region In Murine Mast Cells**

**A. Park**; Chonnam National university, Gwangju, REPUBLIC OF KOREA.

**840**   **Role of Mast Cell Mediators in Basal Cell Carcinoma**

**S. Z. Salim**, F. A. Sorour, E. B. Abdelal, H. M. Hussein, E. E. Fouda; Al-Azhar Allergy & immunology Centre, Cairo, EGYPT.

**841**   **Modulation of Histamine Release (HR) from Peripheral Blood Leukocytes (PBL) by Antioxidants**

**V. Windhorst**, C. Bauer, B. Przybilla; Ludwig-Maximilians-Universität, Munich, GERMANY.

**842**   **Ratio of IgE Receptor to TLR9 on Human Plasmacytoid Dendritic Cells Predicts Allergic Status and Cytokine Response to Innate and Adaptive Immune Stimuli**

**J. R. Tversky**, A. P. Bieneman, K. L. Chichester, J. T. Schroeder; Johns Hopkins University, Baltimore, MD.

**843**   **Circulating IgE and IgG Antigalectin - 1 Antibodies Associated with Asthma**

**J. Muino** ^1^, C. C. Castro^1^, M. A. Sanabria^1^, M. D. Romero^2^, M. Ferrero^2^, G. A. Rabinovich^3^; ^1^Fac Cs MED - Universidad Nacional de Córdoba, Cordoba, ARGENTINA, ^2^LIIDO, Cordoba, ARGENTINA, ^3^Instituto de Inmunogenética - Facultad de Medicina Universidad Nacional de Buenos Aires, Buenos Aires, ARGENTINA.
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**844**   **IL-5 and the *FIP1L1/PDGFRA* Fusion Gene Cooperatively Promote Eosinophil Development, Activation, and Signal Transduction**

**Y. YAMADA** ^1^, J. A. Cancelas^2,3^, D. A. Williams^2^, M. E. Rothenberg^1^; ^1^Division of Allergy and Immunology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^2^Division of Experimental Hematology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, ^3^Hoxworth Blood Center, University of Cincinnati, Cincinnati, OH.

**845**   **Pyk2 Signaling Events Mediate Eosinophil Chemotaxis Along Chemoattractant Gradients In The Lung**

**C. A. Lipinski** ^1^, R. Schubert^1^, Z. Yang^1^, R. S. Pero^1^, M. Russ^2^, S. Muller^2^, H. Kohler^3^, J. J. Lee^1^; ^1^Mayo Clinic Arizona, Scottsdale, AZ, ^2^ImmPheron, Lexington, KY, ^3^InNexus Biotechnology, Scottsdale, AZ.

**846**   **Kinetics of Cord Blood Eosinophil Lineage Biomarker mRNA: Co-expression of CysLTR1 with GATA-1**

**L. Crawford**, A. K. Ellis, J. A. Denburg; McMaster University, Hamilton, ON, CANADA.

**847**   **Cockroach Activates and Induces Degranulation of Human Eosinophils Through Protease-Activated Receptor-2**

**K. Wada**, Y. Matsuwaki, T. A. Bingemann, H. Kita; Mayo Clinic College of Medicine, Rochester, MN.

**848**   **Inhaled Budesonide At Low to Moderate Doses Is An Effective Treatment For Children With Eosinophilic Esophagitis**

**K. M. Maples**, M. Graham, A. Irani; Virginia Commonwealth University, Richmond, VA.

**849**   **Does Cigarette Smoke Modify Eosinophil Properties? Implications for Chronic Lung Disease**

**L. H. Bellehsen**; Hebrew University of Jerusalem, Jerusalem, ISRAEL.

**850**   **A Novel Method to Detect and Quantitate Pulmonary Eosinophils**

**W. W. Stevens** ^1,2^, T. S. Kim^1^, L. M. Pujanauski^1,3^, T. J. Braciale^1,4^; ^1^Beirne Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville, VA, ^2^Department of Microbiology, University of Virginia Health Sciences Center, Charlottesville, VA, ^3^Department of Biology, University of Virginia, Charlottesville, VA, ^4^Departments of Pathology and Microbiology, University of Virginia Health Sciences Center, Charlottesville, VA.

**851**   **IP-10 Augments Eosinophil Adhesion To ICAM-1**

**T. Kobayashi**, T. Soma, Y. Takaku, K. Hagiwara, M. Kanazawa, M. Nagata; Saitama Medical University, Saitama-ken, JAPAN.

**852**   **Interferon-γ Enhances Human Eosinophil Effector Functions Induced by Th2-type Cytokines**

**M. Kato** ^1,2^, T. Yamaguchi^1^, K. Kozawa^1^, H. Kimura^3^; ^1^Gunma Prefectural Institute of Public Health and Environmental Sciences, Maebashi, Gunma, JAPAN, ^2^Gunma Children\'s Medical Center, Shibukawa, Gunma, JAPAN, ^3^National Institute of Infectious Disease, Tokyo, JAPAN.

**853**   **Eosinophils Respond to Acidic environments with cAMP Generation in a TDAG8-Dependent Manner**

**L. C. Kottyan** ^1^, A. R. Collier^1^, K. A. Niese^1^, C. O. Radu^2^, O. N. Witte^2^, M. E. Rothenberg^1^, N. Zimmermann^1^; ^1^Cincinnati Children\'s Hospital, Cincinnati, OH, ^2^University of California Los Angeles, Los Angeles, CA.

**854**   **Inhibition of Eosinophil Survival by Peroxisome Proliferator-Activated Receptor (PPAR) alpha Agonists**

**T. Adachi** ^1^, S. Ueki^1^, H. Nagase^1^, J. Chihara^2^, K. Ohta^1^; ^1^Teikyo University School Medicine, Tokyo, JAPAN, ^2^Akita University School Medicine, Akita, JAPAN.

**855**   **L-plastin Interacts with Receptor for Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Transduces Antiapoptotic Signaling in Human Eosinophils**

**T. W. Young**, K. Pazdrak, C. Straub, S. Stafford, A. Kurosky; University of Texas Medical Branch, Galveston, TX.

**856**   **Human Airway Eosinophils Exhibit Differential Regulation of ERK and STAT5-Associated Signaling Responses to Interleukin-5 (IL-5) and Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF)**

**C. J. Koziol**, M. Bates, P. J. Bertics; University of Wisconsin-Madison, Madison, WI.

**857**   **Inhibitor of Apoptosis Proteins in the Regulation of Eosinophil Apoptosis in Allergic Disease**

**V. Mehta** ^1^, B. Moore^2^, A. Bewtra^1^, D. K. Agrawal^2^; ^1^Center for Allergy, Asthma and Immunology, Creighton University, Omaha, NE, ^2^Department of Biomedical Sciences, Creighton University, Omaha, NE.

**858**   **Molecular Markers of Eosinophilopoiesis: Multiplex Q-PCR Analysis of GATA-1, MBP and IL-5 Receptor mRNA Expression in Peripheral Blood**

**A. K. Ellis**, L. Crawford, J. A. Denburg; McMaster University, Hamilton, ON, CANADA.

**859**   **A3 Adenosine Receptors Modulate Eosinophil Function In Bleomycin-Induced Lung Injury**

**E. Morschl** ^1^, J. B. Volmer^1^, J. G. Molina^1^, J. J. Lee^2^, S. I. Ochkur^2^, M. R. Blackburn^1^; ^1^The Medical School at the University of Texas Houston, Houston, TX, ^2^Mayo Clinic Scottsdale, Scottsdale, AZ.

**860**   **Expression and Activation of Toll Receptor 7 (TLR7) In Human Eosinophils: Effect on Eosinophil Survival and Cytokine Production**

**K. Pazdrak**, C. Straub, V. Starosta, S. Stafford, T. W. Young, A. Kurosky; University of Texas Medical Branch, Galveston, TX.

**861**   **Differential Effects of Adhesion Molecules on Eosinophil Superoxide Anion Generation Induced by Leukotriene D4**

**M. Nagata**, M. Kushiya, T. Kobayashi, K. Hagiwara, M. Kanazawa; Saitama Medical University, Saitama, JAPAN.

**862**   **TGF-beta Regulation Of Bone Marrow Eosinophil Production**

**M. Hogan**, D. Piktel, L. F. Gibson, K. S. Landreth; West Virginia University, Morgantown, WV.

**863**   **Rapid Selective Priming Of FcαR On Eosinophils By Corticosteroids**

**M. Bracke** ^1,2^, W. ten Hove^1,2^, L. A. Houben^2^, J. A. M. Raaijmakers^1^, L. Koenderman^2^; ^1^Utrecht Institute for Pharmaceutical Sciences, Utrecht, THE NETHERLANDS, ^2^Dept. Pulmonary Diseases, University Medical Center, Utrecht, THE NETHERLANDS.

**864**   **Nonspecific Bronchial Hyperresponsiveness Caused by *T. canis* 2nd Stage Larval Infestation**

**S. Lee** ^1^, S. Kyung^1^, C. An^1^, S. Jeong^1^, Y. Kim^1^, M. Kim^1^, K. Ha^2^, D. Choi^3^, S. Kang^4^, Y. Chung^5^; ^1^Gachon University of medicine and science, Incheon, REPUBLIC OF KOREA, ^2^Sung Ae General Hospital, Seoul, REPUBLIC OF KOREA, ^3^Samsung Medical Center, Seoul, REPUBLIC OF KOREA, ^4^Chung Ang University, Seoul, REPUBLIC OF KOREA, ^5^Jeju National University, Jeju, REPUBLIC OF KOREA.

**865**   **Age-related Changes in Eosinophil Function in Asthma Subjects**

**S. K. Mathur**, E. A. Schwantes, R. L. Brandau; University of Wisconsin, Madison, WI.

**866**   **Retinoic Acids Induce Eosinophil Survival and MCP-1 Production**

**S. Ueki** ^1^, G. Mahemuti^2^, W. Ito^2^, Y. Kobayashi^2^, T. Chiba^2^, H. Oyamada^2^, Y. Kamada^2^, K. Yamaguchi^2^, M. Takeda^2^, H. Kayaba^2^, J. Chihara^2^; ^1^Teikyo University School of Medicine, Tokyo, JAPAN, ^2^Akita University School of Medicine, Akita, JAPAN.

**867**   **TGF-β1 Increases Chloride Channel Activity in and Migration of Human Blood Eosinophils via Intracellular Pathways involving Protein Kinase C**

**B. Moore** ^1^, G. Cheng^1^, M. Kim^1^, D. K. Agrawal^1,2^; ^1^Department of Biomedical Sciences, Creighton University School of Medicine, Omaha, NE, ^2^Department of Internal Medicine, Creighton University School of Medicine, Omaha, NE.

**868**   **Comparison Between Peripheral Blood and Nasal Polyp Eosinophils Reveals a Distinct Profile of Surface Receptors**

**A. H. Nissim Ben Efraim** ^1^, I. Bachelet^1^, A. Munitz^1^, R. Eliashar^2^, F. Levi-Schaffer^1^; ^1^The Hebrew University of Jerusalem, Jerusalem, ISRAEL, ^2^The Hadassah Ein-Karem University Hospital, Jerusalem, ISRAEL.

**869**   **Bovine Dural Graft: A Unique Cause of Unexplained Fever, Erythroderma and Eosinophilia**

**W. B. Cherry**, M. F. Hartz, M. T. McEvoy, S. T. Pittock; Mayo Clinic, Rochester, MN.

**870**   **A Comparison of Nasal Smear Eosinophil Count via Blow Technique vs the Nasal Scrape Method**

**M. Varghese**, P. Lieberman; University of Tennessee, Memphis, TN.

**871**   **Eosinophilic Leukemoid Reaction in a Woman with Spindle Cell Sarcoma of the Leg**

**C. B. Lauter** ^1^, M. Snyder^1^, A. Armin^2^, I. Jaiyesimi^3^, M. Kolins^4^, J. Burdakin^3^, K. Les^5^; ^1^William Beaumont Hospital-Division of Allergy/Immunology, Royal Oak, MI, ^2^William Beaumont Hospital-Department of Anatomic Pathology, Royal Oak, MI, ^3^William Beaumont Hospital-Division Hematology/Oncology, Royal Oak, MI, ^4^William Beaumont Hospital-Department of Clinical Pathology, Royal Oak, MI, ^5^William Beaumont Hospital-Department of Orthopedic Surgery, Royal Oak, MI.

**872**   **\[Withdrawn\]**

**873**   **The Effects of rhSCF on Human Eosinophil Chemokine Receptor Expression**

**R. W. Keeton, Jr.**, N. Lukacs; U. of Michigan, Ann Arbor, MI.

**874**   **PEG-Interferon after Interferon alfa-2b for Hypereosinophilic Syndrome**

**J. Butterfield**; Mayo Clinic, Rochester, MN.

**875**   **Eosinophilia and Adrenal Insufficiency**

**C. C. Hassett**, L. G. Wild; Tulane University, New Orleans, LA.

**876**   **Reactive Eosinophilia to Invasive Candidiasis Responding to Caspofungin**

**G. Shanmugam**, B. L. Buchmiller, D. A. Wierzbicki, M. T. de la Morena; UT Southwestern, Dallas, TX.

**877**   **Churg-Strauss Presenting as Pulmonary Embolism, Lymphadenopathy and Eosinophilia**

**T. Chacko**, R. Frank, D. Ledford, R. F. Lockey; University of South Florida Collge of Medicine, Tampa, FL.
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**878**   **Allergens Associated with Ocular and Nasal Symptoms: An Epidemiologic Study**

**K. Singh**, L. Bielory, E. Kavosh; UMDNJ, Newark, NJ.

**879**   **Prevalence of Rhinitis among Children and Teenagers in Quito Ecuador**

**S. F. Barba, Jr.**; Hospital General FF AA, Quito, ECUADOR.

**880**   **High Prevalence of Sensitization to Japanese Cedar Pollen and House Dust Mite in Young Children in Japan**

**S. Masuda** ^1,2^, T. Fujisawa^1,2^, M. Nambu^3,2^, Y. Suehiro^4,2^, A. Terada^5,2^, Y. Tohda^6,2^; ^1^Mie National Hospital, Tsu, JAPAN, ^2^Kinki-Hokuriku Airway Disease Conference (KiHAC), Osaka, JAPAN, ^3^Tenri-Yorozu General Hospital, Tenri, JAPAN, ^4^Saiseikai Nakatsu Hospital, Osaka, JAPAN, ^5^Daido Hospital, Nagoya, JAPAN, ^6^Kinki University School of Medicine, Osaka, JAPAN.

**881**   **Allergic Rhinitis and Immunoglobulin Deficiency in Preschool Children with Frequent Upper Respiratory Illness**

**S. Siriaksorn** ^1^, M. Trakultivakorn^1^, S. Suchaitanawanit^2^; ^1^Division of Allergy and Clinical Immunology, Department of Pediatrics, Faculty of medicine, Chiang Mai University, Chiang Mai, THAILAND, ^2^Section of Immunology, Central Laboratory, Faculty of Medicine, Chiang Mai University, Chiang Mai, THAILAND.

**882**   **The Trends of Prevalence of Allergic Rhinitis among Elementary School Children in Seoul from 1995 to 2005: Stable but Increased Recognition**

**Y. Ahn**; Eulji University School of Medicine, Seoul, REPUBLIC OF KOREA.

**883**   **Firstborn Status, Early Day Care Use and Allergen-Specific IgE, Hay Fever, and Asthma in Young Adults**

**C. C. Johnson** ^1^, G. R. Wegienka^1^, S. L. Havstad^1^, K. J. Woodcroft^1^, L. K. Williams^1^, C. L. M. Joseph^1^, D. R. Ownby^2^, E. M. Zoratti^3^; ^1^Dept of Biostatistics and Research Epidemiology, Henry Ford Hospital & Health System, Detroit, MI, ^2^Medical College of Georgia, Augusta, GA, ^3^Section of Allergy & Clinical Immunology, Henry Ford Hospital & Health System, Detroit, MI.

**884**   **Assessment Of A Rhinitis Questionnaire In A Seasonal Allergic Rhinitis Population**

**J. A. Bernstein** ^1^, D. Brandt^1^, P. Ratner^2^, W. Wheeler^3^; ^1^University of Cincinnati, Cincinnati, OH, ^2^Sylvana Research Associates, San Antonio, TX, ^3^MedPointe Pharmaceuticals, Somerset, NJ.

**885**   **Evaluation Of A Rhinitis Questionnaire In Different Regions Within The United States**

**D. Brandt** ^1^, A. El-Hag^2^, C. Abbott^3^, J. A. Bernstein^1,3^; ^1^University of Cincinnati, Cincinnati, OH, ^2^Allergy and Immunology, Plano, TX, ^3^Bernstein Allergy Group, Cincinnati, OH.

**886**   **The Burden Of Rhinitis In A Managed Care Organization (MCO)**

R. Zeiger^1^, **M. Schatz** ^1^, W. Chen^2^, S. Yang^2^, M. Corrao^3^, V. Quinn^2^; ^1^Kaiser Permanente, San Diego, CA, ^2^Kaiser Permanente, Los Angeles, CA, ^3^GlaxoSmithKline, Research Triangle Park, NC.

**887**   **Symptom Burden During the Winter for Allergic and Non-allergic Rhinitis Sufferers**

R. Nathan^1^, E. Meltzer^2^, J. Derebery^3^, P. Stang^4^, U. Campbell^4^, M. Corrao^5^, **R. Stanford** ^5^; ^1^Asthma & Allergy Associates, Colorado Springs, CO, ^2^Allergy and Asthma Medical Group and Research Center, San Diego, CA, ^3^House Ear Clinic, Los Angeles, CA, ^4^Galt Associates, Blue Bell, PA, ^5^GlaxoSmithKline, Research Triangle Park, NC.

**888**   **Allergies in Canada: AR Patient Perspectives on Prescription Nasal Sprays**

**M. Desrosiers** ^1,2^, P. Keith^3^, R. Schellenberg^4^, S. Waserman^5^; ^1^McGill University, Montreal, PQ, CANADA, ^2^Université de Montréal, Montreal, PQ, CANADA, ^3^McMaster University, Hamilton, ON, CANADA, ^4^University of British Columbia, Vancouver, BC, CANADA, ^5^University of Toronto, Toronto, ON, CANADA.

**889**   **Physicians\' Perspectives of Allergic Rhinitis (AR) in Canada**

**R. Schellenberg** ^1^, P. Keith^2^, M. Desrosiers^3^, S. Waserman^2^; ^1^University of British Columbia, Vancouver, BC, CANADA, ^2^McMaster University, Hamilton, ON, CANADA, ^3^McGill University, Montreal, PQ, CANADA.

**890**   **Subjective Effects of Allergic Rhinitis on Sleep Quality and Amount During the Winter**

E. Meltzer^1^, R. Nathan^2^, J. Derebery^3^, P. Stang^4^, U. Campbell^4^, M. Corrao^5^, **R. Stanford** ^5^; ^1^Allergy and Asthma Medical Group and Research Center, San Diego, CA, ^2^Asthma & Allergy Associates, Colorado Springs, CO, ^3^House Ear Clinic, Los Angeles, CA, ^4^Galt Associates, Blue Bell, PA, ^5^GlaxoSmithKline, Research Triangle Park, NC.

**891**   **The Burden Of Non-Allergic Versus Allergic Rhinitis In A Managed Care Organization (MCO)**

**M. Schatz** ^1^, W. Chen^2^, S. Yang^2^, M. Corrao^3^, V. Quinn^2^, R. Zeiger^1^; ^1^Kaiser Permanente, San Diego, CA, ^2^Kaiser Permanente, Los Angeles, CA, ^3^GlaxoSmithKline, Research Triangle Park, NC.

**892**   **Evaluation and Control of Allergic Rhinitis in Patients with Asthma (CARINA) in Korea**

**Y. Rha** ^1^, B. Son^2^; ^1^Department of Pediatrics, College of Medicine, Kyung Hee University, Seoul, REPUBLIC OF KOREA, ^2^Department of Pediatrics, College of Medicine, Inha University, Inchon, REPUBLIC OF KOREA.

**893**   **Burden of Illness of Allergic Rhinitis in Canada**

**P. K. Keith** ^1^, M. Desrosiers^2^, S. Waserman^1^, R. R. Schellenberg^3^; ^1^McMaster University, Hamilton, ON, CANADA, ^2^McGill University, Universite de Montreal, Montreal, PQ, CANADA, ^3^University of British Columbia, Vancouver, BC, CANADA.

**894**   **Characterization of Chronic Rhinitis in Children**

**R. Kachru**, J. Friedrich, J. Corren; Allergy Research Foundation, Los Angeles, CA.

**895**   **Clinical Characteristics of Allergic Rhinitis and Nonallergic Rhinitis in Pediatric Allergy Clinic at Siriraj Hospital, Thailand**

**C. Suratannon**, P. Lertbunnaphong, O. Jirapongsananuruk, N. Visitsunthorn, P. Vichyanond; Siriraj Hospital, Bangkok, THAILAND.

**896**   **Nasal Spray Device And Formulation Attributes May Contribute To Stopping Treatment With Prescription Nasal Sprays**

**R. Stanford** ^1^, E. Meltzer^2^, R. Nathan^3^, J. Derebery^4^, P. Stang^5^, U. Campbell^5^; ^1^GlaxoSmithKline, Research Triangle Park, NC, ^2^Allergy and Asthma Medical Group and Research Center, San Diego, CA, ^3^Asthma & Allergy Associates and Research Center, Colorado Springs, CO, ^4^House Ear Clinic, Los Angeles, CA, ^5^Galt Associates, Blue Bell, PA.

**897**   **US and European Perspective on the Burden of Chronic Sinusitis: Survey of Allergists and Otolaryngologists**

**L. Katz** ^1^, R. Casciano^1^, A. Stergious^1^, M. Memran^2^, J. Willet^1^; ^1^Accentia Biopharmaceuticals, New York City, NY, ^2^Analytica International, New York City, NY.
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**898**   **Efficacy and Safety of Mometasone Furoate Alone or With Concomitant Medication for Perennial and Seasonal Allergic Rhinitis**

**H. Ulmer**; Medizinische Universität Innsbruck, Innsbruck, AUSTRIA.

**899**   **A Real World Open-label Multicenter Single Group Study to Evaluate Patients\' Reactions to Mucinex**

**(Single Entity Long-acting Guaifenesin)**

**W. W. Storms** ^1^, M. A. Kaliner^2^, M. Javidi^3^, J. R. Farrar^4^, C. S. Efessiou^5^; ^1^The Williams Storms Allergy Clinic, Colorado Springs, CO, ^2^The Institute for Asthma and Allergy, Wheaton and Chevy Chase, MD, ^3^North Carolina State University, Raleigh, NC, ^4^SRxA Institute for Professional Education, Washington, DC, ^5^Strategic Pharmaceutical Advisors, Inc., Washington, DC.

**900**   **Patient Comparison of Sensory Attributes of Olopatadine and Azelastine Nasal Sprays**

**E. O. Meltzer** ^1^, W. E. Berger^2^, S. J. Chadwick^3^, G. Gross^4^, C. F. LaForce^5^, R. Garadi^6^, K. Crenshaw^6^, G. M. Wall^6^; ^1^Allergy & Asthma Medical Group & Research Center, San Diego, CA, ^2^Allergy & Asthma Associates of Southern California, Mission Viejo, CA, ^3^ENTA Allergy, Head & Neck Institute, Decatur, IL, ^4^Pharmaceutical Research and Consulting, Inc., Dallas, TX, ^5^North Carolina Clinical Research, Raleigh, NC, ^6^Alcon Research, Ltd., Fort Worth, TX.

**901**   **Acoustic Rhinometry And Symptoms Score Evaluation During The Treatment With Desloratadine In Pediatric Patients With Allergic Rhinitis**

**A. B. F. Fomin**, A. G. A. Oliveira, A. C. Pastorino, C. M. A. Jacob; Faculty of Medicine of University of Sao Paulo, Sao Paulo, BRAZIL.

**902**   **Fluticasone Furoate^∗^ (FF) Nasal Spray-Ergonomic Considerations for a Next Generation Delivery System**

**\[^∗^USAN approved name\]**

**J. W. Godfrey**, A. C. Grant, A. L. Slater; GlaxoSmithKline Research & Development, Ware, Hertfordshire, UNITED KINGDOM.

**903**   **Once-Daily Fluticasone Furoate^∗^ Nasal Spray (FFNS) Improves Quality of Life (QoL) in Subjects with Seasonal Allergic Rhinitis (SAR) during the mountain cedar pollen season**

**^∗^USAN approved name**

**J. H. van Bavel** ^1^, T. Toler^2^, A. Ellsworth^2^, R. Stanford^2^, E. Philpot^2^; ^1^Allergy & Asthma Associates Research Dept., Austin, TX, ^2^GlaxoSmithkline, RTP, NC.

**904**   **Do Allergic Rhinitis (AR) Patients Achieve Twenty-four Hour Symptom Control?**

**A. Dalal** ^1^, A. E. Williams^2^, S. Kay^3^; ^1^GlaxoSmithKline, Research Triangle Park, NC, ^2^GlaxoSmithKline R&D, London, UNITED KINGDOM, ^3^Adelphi Group Products, Macclesfield, UNITED KINGDOM.

**905**   **Buffered Hypertonic Saline Nasal Spray and Gel As Treatment Modifiers in Allergic and Vasomotor Rhinitis**

**J. N. Hausfeld**; George Washington University School of Medicine and Health Sciences, Washington, DC.

**906**   **Ocular Efficacy of a Novel, Enhanced Affinity Corticosteroid, Fluticasone Furoate^∗^ Nasal Spray, in Ragweed-Sensitive Patients**

**^∗^USAN-approved name**

**W. R. Lumry** ^1^, S. H. Cohen^2^, A. Levy^3^, E. Philpot^4^, T. Toler^4^, A. Ellsworth^4^; ^1^Allergy and Asthma Specialists, Dallas, TX, ^2^Allergic Diseases, Milwaukee, WI, ^3^Foot Hills Asthma & Allergy Association, Spartanburg, SC, ^4^GlaxoSmithKline, Research Triangle Park, NC.

**907**   **Fluticasone Furoate^∗^ (FF) Nasal Spray - Development of a Next-Generation Delivery System for Allergic Rhinitis**

**\[^∗^USAN approved name\]**

**W. Berger** ^1^, J. W. Godfrey^2^, A. C. Grant^2^, A. L. Slater^2^, S. J. Broughton^2^; ^1^Southern California Research, Mission Viejo, CA, ^2^GlaxoSmithKline Research & Development, Ware, Hertfordshire, UNITED KINGDOM.

**908**   **Once-daily Fluticasone Furoate^∗^ Nasal Spray (FF) Effectively Treats Ocular Symptoms Of Seasonal Allergic Rhinitis (SAR) Caused By Mountain Cedar Pollen**

**^∗^USAN Approved Name**

**P. Ratner** ^1^, C. Andrews^2^, J. van Bavel^3^, T. Toler^4^, A. Ellsworth^4^, E. Philpot^4^; ^1^Sylvana Research Associates, San Antonio, TX, ^2^Diagnostics Research Group, San Antonio, TX, ^3^Allergy and Asthma Associates, Austin, TX, ^4^GlaxoSmithKline, Research Triangle Park, NC.

**909**   **Lack of Effect on Hypothalamic-Pituitary-Adrenal (HPA)Axis Function by Once-daily Fluticasone Furoate^∗^ Nasal Spray (FFNS) 110 mcg in Children with Perennial Allergic Rhinitis (PAR)**

**^∗^USAN approved name**

**I. Tripathy** ^1^, R. Sterling^2^, D. Clements^3^, W. Wu^3^, M. Faris^3^, E. Philpot^3^; ^1^Clinical Research of the Ozarks, Rolla, MO, ^2^Carolina Research, Orangeburg, SC, ^3^GlaxoSmithKline, Research Triangle Park, NC.

**910**   **Once-daily Fluticasone Furoate^∗^ Nasal Spray (FFNS) is Effective for the Treatment of Seasonal Allergic Rhinitis (SAR) Caused by Ragweed**

**^∗^USAN-approved name**

**H. B. Kaiser** ^1^, R. Naclerio^2^, J. Given^3^, E. Philpot^4^, T. Toler^4^, A. Ellsworth^4^; ^1^Asthma and Allergy Specialists, Minneapolis, MN, ^2^University of Chicago Hospitals, Chicago, IL, ^3^Allergy and Respiratory Center, Canton, OH, ^4^GlaxoSmithKline, Research Triangle Park, NC.

**911**   **Rhinorrhea Not Responding to Nasal Corticosteroids**

**P. N. Patel** ^1^, B. Oyefara^1^, R. Aarstad^2^, S. L. Bahna^1^; ^1^Allergy/Immunology Section, Louisiana State University Health Sciences Center, Shreveport, LA, ^2^Otolaryngology Department, Louisiana State University Health Sciences Center, Shreveport, LA.
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**912**   **Viremia is Associated with Sleep Disturbances, Neurocognitive Disorders and Cytokine Dysregulation in Pediatric HIV Infection**

**S. B. Foster** ^1^, M. E. Paul^1^, D. G. Glaze^1^, J. M. Reuben^2^, L. L. Harris^1^, E. N. Cohen^2^, B. Lee^2^, C. A. Kozinetz^1^, H. L. Schwarzwald^1^, M. W. Kline^1^, C. D. Jackson^1^, A. J. Loeb^1^, P. E. Frerking^1^, J. E. Fehlis^1^, P. Y. Brouwers^1^, W. T. Shearer^1^; ^1^Baylor College of Medicine, Houston, TX, ^2^University of Texas, MD Anderson Cancer Center, Houston, TX.

**913**   **Epigallocatechin Gallate Inhibits HIV-1-gp120-Induced Immune Dysregulation and Apoptosis in Human Lymphocytes**

**C. L. Nance** ^1,2^, S. P. Westerfield^2^, V. C. Willis^2^, W. T. Shearer^1,2^; ^1^Texas Children\'s Hospital, Houston, TX, ^2^Baylor College of Medicine, Houston, TX.

**914**   **Characterization of Antigen Presenting Cells of Peripheral Blood in Patients with HCV infection During Immunotherapy**

**L. P. Titov** ^1^, U. V. Tarasiuk^1^, I. A. Karpov^2^, E. N. Yagovdik-Telezhnaya^2^, L. M. DuBuske^3^; ^1^Belarusian Research Institute for Epidemiology and Microbiology, Minsk, BELARUS, ^2^Belarusian State Medical University, Minsk, BELARUS, ^3^Immunology Research Institute of New England, Gardner, MA.

**915**   **Characterization of Peripheral Blood Mononuclear Cells and Dendritic Cells in Patients with Viral Hepatitis C**

**L. Titov** ^1^, U. V. Tarasiuk^1^, E. N. Yagovdik-Telezhnaya^2^, I. A. Karpov^2^, D. A. Charnashey^2^, L. M. DuBuske^3^; ^1^Belarusian Research Institute for Epidemiology and Microbiology, Minsk, BELARUS, ^2^Belarusian State Medical University, Minsk, BELARUS, ^3^Immunology Research Institute of New England, Gardner, MA.

**916**   **Inhibition of Respiratory Syncytial Virus (RSV) Replication in Cell Culture by Small Interfering RNA (siRNA)**

**M. R. Khaitov** ^1^, V. S. Akimov^1^, E. B. Faizuloev^1^, A. A. Nikonova^1^, L. P. Alexeev^1^, V. V. Zverev^1^, L. M. DuBuske^2^; ^1^Institute of Immunology, Moscow, RUSSIAN FEDERATION, ^2^Immunology Research Institute of New England, Gardner, MA.

**917**   **Diminished Airway Inflammation against Double-stranded RNA in Mast Cell-Deficient Mice**

**H. Nagase** ^1^, K. Noda^1^, M. Yamaguchi^2^, H. Yoshihara^1^, K. Yamamura^1^, T. Yano^1^, S. Ueki^1^, H. Ishida^1^, O. Ohbayashi^1^, M. Nakajima^1^, T. Adachi^1^, K. Ohta^1^; ^1^Teikyo University, Tokyo, JAPAN, ^2^University of Tokyo, Tokyo, JAPAN.
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**918**   **Characterization of Bet v 1 Specific CD4+ T cell Responses in Allergic and Non Allergic Individuals**

**M. Philippe**; Stallergenes SA, Antony, FRANCE.

**919**   **Interleukin-5 Receptor Endocytosis is Regulated by Two Distinct Pathways**

**M. Moczygemba**, J. T. Lei; Baylor College Of Medicine, Houston, TX.

**920**   **G-Protein Receptor Kinases (grKs) Play an Important Regulatory Role in the K/BxN Serum Transfer Model of Inflammatory Arthritis**

**T. K. Tarrant** ^1^, R. R. Rampersad^1^, C. G. Moore^1^, L. R. Rothlein^1^, R. M. Lefkowitz^2^, D. M. Lee^3^, D. D. Patel^4^; ^1^University of North Carolina, Chapel Hill, NC, ^2^Duke University, Durham, NC, ^3^Brigham and Women\'s Hospital, Boston, MA, ^4^Novartis, Basel, SWITZERLAND.

**921**   **Flt3 Ligand (FL) Treatment Generates Multiple Subsets of Myeloid Dendritic Cells (DCs) with Differential Phenotypic and Functional Properties in Mouse Model of Asthma**

**A. S. Bharadwaj**, D. K. Agrawal; Creighton University, Omaha, NE.

**922**   **Thymic Stromal Lymphopoietin (TSLP) and Receptor (TSLPR) and CD11c^+^ Dendritic Cells (DC) in Allergen-induced Cutaneous Late Phase Responses (LPR) in Atopic Subjects**

**S. Ying** ^1^, Y. H. Wang^2^, Y. J. Liu^2^, Q. Meng^1^, A. B. Kay^3^, S. Phipps^3^, T. H. Lee^1^, C. J. Corrigan^1^; ^1^King\'s College London, London, UNITED KINGDOM, ^2^Centre of Cancer Immunolgy, MD Anderson Cancer Centre, Houston, TX, ^3^Imperial College, London, UNITED KINGDOM.

**923**   **Atrial Natriuretic Peptide (ANP)-mediated Maturation and Cytokine Phenotype of Human Dendritic Cells (DCs) Involve Demethylation of the SOCS3 Promoter**

**W. Zhang**, X. Cao, G. Hellermann, R. F. Lockey, S. S. Mohapatra; USF, Tampa, FL.

Oral Abstract Session {#sec61}
=====================

4603

Monday, February 26, 2007

1:45 PM - 3:00 PM

The Health Effects of Air Pollutants In and Out of the Workplace {#sec61.1}
----------------------------------------------------------------

**924**   **Early Childhood Environmental Tobacco Smoke Exposure is Associated with Lower Serum Total IgE at 18 Years**

**K. J. Woodcroft** ^1^, S. Havstad^1^, D. R. Ownby^2^, C. C. Johnson^1^, E. M. Zoratti^1^; ^1^Henry Ford Health System, Detroit, MI, ^2^Medical College of Georgia, Augusta, GA.

**925**   **Children Demonstrate Diminished Antioxidant Defenses Against Diesel Exhaust Particles**

E. M. Lin, L. Zhang, **D. Diaz-Sanchez**; University of California at Los Angeles, Los Angeles, CA.

**926**   **Characterization of Diesel Exposure and Wheezing in Infants: the Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS)**

**P. H. Ryan** ^1^, G. K. LeMasters^1^, P. Biswas^2^, S. Hu^2^, D. I. Bernstein^1^, J. Lockey^1^, M. Villareal^1^, G. K. Khurana Hershey^3^, S. Grinshpun^1^; ^1^University of Cincinnati, Cincinnati, OH, ^2^Washington University, St. Louis, MO, ^3^Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**927**   **Th2 Cytokine Profiles Do Not Predict Antibody Responses and Respiratory Hyperresponsiveness Following Dermal Exposure To Isocyanates**

**M. J. K. Selgrade** ^1^, E. H. Boykin^1^, N. Haykal-Coates^1^, M. R. Woolhiser^2^, C. Wiescinski^2^, D. L. Andrews^1^, A. K. Farraj^1^, D. L. Doerfler^1^, S. H. Gavett^1^; ^1^U.S. Environmental Protection Agency, Research Triangle Park, NC, ^2^The Dow Chemical Company, Midland, MI.

**928**   **Occupational Latex Allergy in Non-Health Care Workers with Rubber Glove Exposure**

**R. Lleonart**, M. Corominas; Hospital Universitari de Bellvitge, L\'Hospitalet de Llobregat, Barcelona, SPAIN.

**929**   **Beta 2-Adrenergic Receptor Gene 46 A\>G Polymorphism May Confer Specific IgE Sensitization In Toluene Diisocyanate-Exposed Workers**

**Y. Ye** ^1^, H. Park^1^, S. Kim^1^, Y. Kang^1^, C. Kim^2^, H. Kim^3^, C. Hong^4^, A. Jang^5^, C. Park^5^, A. V. Wisnewski^6^, C. A. Redlich^6^; ^1^Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA, ^2^Inha University College of Medicine, Incheon, REPUBLIC OF KOREA, ^3^The Catholic University of Korea, Seoul, REPUBLIC OF KOREA, ^4^Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA, ^5^Soonchunhyang University Hospital, Bucheon, REPUBLIC OF KOREA, ^6^Yale School of Medicine, New Heaven, CT.
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**930**   **Probiotics in the Prevention of IgE-Associated Eczema: a Double Blind Randomised Placebo-Controlled Trial**

**T. Abrahamsson** ^1^, T. Jakobsson^1^, M. Fagerås Böttcher^1^, M. Fredrikson^2^, M. C. Jenmalm^1^, B. Björkstén^3^, G. Oldaeus^4^; ^1^Department of Molecular and Clinical Medicine, Division of Pediatrics, Linköping, SWEDEN, ^2^Department of Molecular and Clinical Medicine, Division of Occupational and Environmental Medicine, Linköping University, Sweden, Linköping, SWEDEN, ^3^Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SWEDEN, ^4^Department of Pediatrics, County Hospital Ryhov, Jönköping, SWEDEN.

**931**   **Role of CD4^+^CD25high T Cells in the Persistence of Atopic Dermatitis**

**A. Singh**, K. Burmeister, M. L. Jennes-Clough, R. Gangnon, M. Evans, K. A. Roberg, C. Tisler, D. DaSilva, T. Pappas, J. E. Gern, R. F. Lemanske, Jr., C. M. Seroogy; University of Wisconsin - Madison, Madison, WI.

**932**   **GM-CSF Pathway Defects May Account for Reduced Neutrophil Chemotaxis in Atopic Dermatitis**

**L. G. Bankova** ^1^, M. E. Brummet^2^, B. S. Bochner^2^, D. N. Grigoryev^2^, K. C. Barnes^2^, L. A. Beck^1^; ^1^Department of Dermatology and Division of Allergy/Immunology & Rheumatology, University of Rochester School of Medicine & Dentistry, Rochester, NY, ^2^Division of Allergy & Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD.

**933**   **Histamine H4 Receptor Antagonists are Superior to H1R Antagonists in the Attenuation of Experimental Allergic Pruritus**

**P. J. Dunford**, K. N. Williams, R. L. Thurmond; Johnson & Johnson PRD, San Diego, CA.

**934**   **Analysis of Discrete Regulatory T Cell Subsets in Patients with Atopic Dermatitis Reveals Th2-Promoting Properties**

**A. J. Reefer**, S. M. Satinover, J. Nguyen, M. D. Solga, J. Lannigan, B. Wilson, J. A. Woodfolk; University of Virginia, Charlottesville, VA.

**935**   **Histamine 4 Receptor (H4R) Antagonism Reduces Edema In A Th2 And IgE Dependent Model Of Atopic Dermatitis**

**J. M. Cowden**, M. Zhang, R. L. Thurmond, P. J. Dunford; Johnson and Johnson, San Diego, CA.
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**936**   **Dendritic Cell Subsets In The Development Of Allergic Sensitization To Food Allergens In Mice**

**A. Blazquez Gonzalez**, M. Berin; Mount Sinai School of Medicine, New York, NY.

**937**   **Effect of Partially Hydrolyzed Formula in Atopy Prevention of High Risk Infants Identified by Atopic Risk Score**

**N. Pitaksit**, P. Tansupapol, T. Tongkaew, P. Chatchatee, J. Ngamphaiboon; Allergy and Immunology Division, Department of Pediatrics, King Chulalongkorn Memorial Hospital, Bangkok, THAILAND.

**938**   **DBPCFCs In Children With A History Of Anaphylaxis To Foods: Are They Necessary And Safe?**

**B. J. Vlieg-Boerstra**, E. J. Duiverman, S. van der Heide, C. M. A. Bijleveld, J. Kukler, A. E. J. Dubois; University Medical Center Groningen, Groningen, THE NETHERLANDS.

**939**   **Examining Attitudes and Behaviors in Adolescents with Food Allergy: A Telephone Survey**

**A. S. Murthy** ^1^, R. Seshadri^1,2^, J. A. Pongracic^1^; ^1^Children\'s Memorial Hospital, Chicago, IL, ^2^The Mary Ann and J. Milburn Smith Child Health Research Program, Chicago, IL.

**940**   **Il-13 Is Overexpressed In Eosinophilic Esophagitis And Induces Eotaxin-3 Expression In Esophageal Epithelial Cells**

**C. Blanchard** ^1^, M. K. Mingler^1^, P. Putnam^1^, M. E. Rothenberg^1,2^; ^1^Cincinnati Children\'s Hospital, Cincinnati, OH, ^2^University of Cincinnati, College of Medicine, Cincinnati, OH.

**941**   **Gastrointestinal Priming and Recruitment of Th2 Lymphocytes in Food Allergy**

**A. K. Knight** ^1^, A. B. Blazquez^2^, S. Zhang^2^, L. Mayer^2^, H. A. Sampson^2^, M. C. Berin^2^; ^1^Louisiana State University Health Sciences Center, Shreveport, LA, ^2^Mount Sinai School of Medicine, New York, NY.
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**942**   **Overexpression of ClC-3 Channels Prevent TGF-β-induced Apoptosis in Human Airway Epithelial Cells**

**G. Cheng** ^1^, M. Kim^1^, B. Chaudhari^1^, D. K. Agrawal^1,2^; ^1^Dept. of Biomedical Science, Creighton University School of Medicine, Omaha, NE, ^2^Dept. of Internal Medicine, Creighton University School of Medicine, Omaha, NE.

**943**   **IL-4Ra, IL-13 and IL-10 Polymorphisms in Allergic Bronchopulmonary Aspergillosis**

**A. P. Knutsen**, B. Kariuki, M. R. Shah; St. Louis University Health Sciences, Saint Louis, MO.

**944**   **Lymphotacin (XCL1) Improves Suppressive Function of Regulatory T Cells from Allergic Asthmatics**

**S. W. Berquist**; Stanford University, Stanford, CA.

**945**   **A Synthetic Non-peptide Compound Targeting CCR5 Prevents the Development of Asthma in a Murine Model**

**Y. Suzaki**, K. Hamada, Y. Kai, H. Kimura; Nara Medical University, 840 Shijo Kashihara Nara, JAPAN.

**946**   **Allergy-driven Alternative Splicing of Interleukin-13 Receptor Alpha 2 Yields Distinct Membrane and Soluble Forms**

**Y. Tabata**, W. Chen, M. R. Warrier, A. M. Gibson, M. O. Daines, G. K. Khurana Hershey; Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**947**   **Inflammatory Cytokines Regulate Glucocorticoid Receptor \[gr\] via Differential Phosphorylation of Serine Residues In the AF1 Domain: Possible Role In Steroid Insensitive Asthma**

**R. J. Hasan**, B. T. Ameredes, W. J. Calhoun; Division of Allergy, pulmonary, Immunology, CCM and Sleep. University of Texas Medical Branch, Galveston, TX.
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**948**   **Analysis of the TLR2 Signaling Pathway in Nasal Epithelial Cells from Patients with Chronic Rhinosinusitis (CRS)**

**L. C. Grammer**, B. Tancowny, Q. Truong-Tran, J. Lee, A. Peters, K. Harris, D. Conley, R. Kern, R. Schleimer; Northwestern University Feinberg Sch. Med., Chicago, IL.

**949**   **Nasal Epithelial Gene Expression In Response To Cigarette Smoke Extract And Toll-Like Receptor Agonists: Relevance To Chronic Rhinosinusitis (CRS)**

**D. L. Hamilos**; Mass Gen Hospital/Harvard Med Sch, Boston, MA.

**950**   **B cell-activating Factor of the TNF Family (BAFF) Expression in Chronic Rhinosinusitis with Nasal Polyps**

**R. P. Schleimer** ^1^, A. Kato^1^, A. Tripathi^1^, B. Tancowny^1^, L. Suh^1^, R. Carter^1^, M. Agashe^1^, K. E. Harris^1^, D. Conley^2^, R. Kern^2^, L. C. Grammer^1^; ^1^Allergy-Immunology Division, Northwestern University Feinberg School of Medicine, Chicago, IL, ^2^Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, IL.

**951**   **Staphylococcus Aureus Enterotoxin B Stimulation In Nasal Polyps**

**J. Patou**, T. Van Zele, G. Holtappels, P. Gevaert, P. Van Cauwenberge, C. Bachert; Upper Airways Research laboratory, Department of Otorhinolaryngology, Ghent University, Ghent, BELGIUM.

**952**   **Histologic Examination Reveals Distinct Disease Subsets of Chronic Sinusitis**

**S. B. Early**, J. Han, L. Borish, J. Steinke; University of Virginia, Charlottesville, VA.

**953**   **Regulatory Cytokines In Chronic Rhinosinusitis With And Without Nasal Polyps**

**K. Scheckenbach**, A. Chaker, M. Wagenmann; Heinrich-Heine-University Duesseldorf, Duesseldorf, GERMANY.
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**954**   ***In Vitro* Metabolism of Ciclesonide in the Upper and Lower Airways**

**R. Nave** ^1^, H. Sato^2^, E. Mutch^3^, T. Nonaka^2^, S. Nishimura^2^, H. Muroga^2^, Y. Katsuura^2^, N. McCracken^1^; ^1^Altana Pharma AG, Konstanz, GERMANY, ^2^Teijin Pharma Limited, Tokyo, JAPAN, ^3^University of Newcastle, Newcastle upon Tyne, UNITED KINGDOM.

**955**   **The Preferred Regimen Of Corticosteroid Used By Practicing Community Physicians For Treatment Of Acute Asthma In Children**

**P. Britto-Williams** ^1^, C. Williams^2^, R. Thomas^1^, M. Pansare^1^; ^1^Wayne State University, Detroit, MI, ^2^Henry Ford Bon Secour Hospital, Detroit, MI.

**956**   **Efficacy of High-Dose Continuous Nebulized Levalbuterol for Pediatric Status Asthmaticus**

**T. Andrews**, E. McGintee, L. Tyler, M. Mittal, A. Chew, N. Pawlowski, J. Zorc; The Children\'s Hospital of Philadelphia, Philadelphia, PA.

**957**   **Effect of Gly16Arg β2-Adrenergic Receptor Variation on Response to Formoterol Administered Alone or in Combination With Budesonide in Patients With Moderate to Severe Persistent Asthma**

**M. Goldman** ^1^, R. Lawrance^2^, H. Ambrose^2^; ^1^AstraZeneca, Wilmington, DE, ^2^AstraZeneca, Alderley Park, UNITED KINGDOM.

**958**   **Effectiveness of, Adherence to and Satisfaction with Montelukast Treatment in Allergic Rhinitis Patients with Uncontrolled Asthma Symptoms while on Treatment with Low Dose Inhaled Corticosteroids**

**C. Koch** ^1^, A. Kaplan^2^, J. Sampalis^3^, E. Psaradellis^3^, A. McIvor^4^; ^1^Merck Frosst Canada Ltd., Pointe-Claire, PQ, CANADA, ^2^Investigator, Richmond Hill, ON, CANADA, ^3^JSS Research Inc., Montreal, PQ, CANADA, ^4^MacMaster University, Hamilton, ON, CANADA.

**959**   **Effects of Low Dose Fluticasone/Salmeterol Combination (Advair 100/50) on Surrogate Inflammatory Markers in Mild Persistent Asthma**

**M. A. Pasha** ^1^, S. Patel^1^, H. Jafri^2^, P. Feustel^1^, D. Sarathchandra^1^, T. Smith^1^, P. Malone^1^, F. Jourd\'heuil^1^, D. Jourd\'heuil^1^; ^1^Albany Medical College, Albany, NY, ^2^U.T. Southwestern Medical Center, Dallas, TX.

**960**   **Effects of KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor (CysLT1R) and Thromboxane A2 Receptor (TP), on Porcine Pancreas Elastase Induced Emphysema in Mice**

**S. Kurokawa**, T. Okuda, M. Amakawa, M. Suda, T. Murata, Y. Hiyama; Kaken Pharmaceutical CO.,LTD., Kyoto, JAPAN.

**961**   **Prevention of Exercise-induced Bronchoconstriction by a Single Dose of Montelukast or Salmeterol**

**D. S. Pearlman** ^1^, C. Villaran^2^, T. Loeys^3^, C. Legrand^3^, T. F. Reiss^3^, G. Philip^3^; ^1^Colorado Allergy and Asthma Centers, Denver, CO, ^2^Clinica Ricardo Palma, Lima, PERU, ^3^Merck Research Labs, Rahway, NJ.

**962**   **Soluble Adhesion Molecules And Cd40l In Asthma And Copd**

**J. V. Garmendia** ^1^, D. Moreno^2^, N. E. Larocca^1^, C. M. Tálamo^3^, J. B. De Sanctis^1^; ^1^Instituto de Inmunología. Universidad Central de Venezuela, Caracas, VENEZUELA, ^2^Cátedra de Fisiopatología del Instituto de Medicina Experimental y Servicio de Neumonología del Hospital Universitario de Caracas. Universidad Central de Venezuela, Caracas, VENEZUELA, ^3^Servicio de Neumonología del Hospital Universitario de Caracas. Facultad de Medicina. Universidad Central de Venezuela, Caracas, VENEZUELA.

**963**   **The Effect of Proton Pump Inhibitor on the Exhaled Breath Condensate pH and QOL in QUEST Questionnaire-Positive Asthmatics**

**T. Yano**, H. Nagase, J. Nakano, H. Yoshihara, K. Yamamura, S. Ueki, O. Ohbayashi, M. Nakajima, T. Adachi, K. Ohta; Teikyo University School of Medicine, Tokyo, JAPAN.

**964**   **Budesonide and Formoterol in One Metered-Dose Inhaler Improves Health-Related Quality of Life in Adults with Mild to Moderate Persistent Asthma Previously Treated with Inhaled Corticosteroids**

**H. Nelson** ^1^, K. Murphy^2^, B. Parasuraman^3^, R. Boggs^3^, C. Miller^3^, L. O\'Dowd^3^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^Midwest Allergy and Asthma Clinic, Omaha, NE, ^3^AstraZeneca, Wilmington, DE.

**965**   **Perceived Onset of Effect of Budesonide and Formoterol Administered via One Pressurized Metered-dose Inhaler in Patients With Asthma Previously Receiving Inhaled Corticosteroids**

**N. K. Leidy** ^1^, D. L. Patrick^2^, R. Boggs^3^, B. Parasuraman^3^, L. O\'Dowd^3^; ^1^United BioSource Corporation, Bethesda, MD, ^2^University of Washington, Seattle, WA, ^3^AstraZeneca, Wilmington, DE.

**966**   **Efficacy Of Ventolin^®^ HFA MDI Cumulative Dosing In Children**

**A. Davis**, W. Lincourt, R. Trivedi, A. Ellsworth, C. Crim; GlaxoSmithKline, RTP, NC.

**967**   **The Safety of Home Therapy with Subcutaneous Anti-Immunoglobulin E Antibody Omalizumab in Twenty-five Patients with Allergic Asthma**

**M. I. Liebhaber**, Z. Dyer; Sansum Santa Barbara Clinic, Santa Barbara, CA.

**968**   **Prophylactic Effects of the Chinese Herbal Formula, ASHMI, in a Murine Model of Late Onset Atopic Asthma**

**P. J. Busse** ^1^, T. Zhang^1^, K. Srivastava^1^, B. Schofield^2^, X. Li^1^; ^1^Mount Sinai School of Medicine, New York, NY, ^2^Bloomberg School of Publich Health, Baltimore, MD.

**969**   **How Potent Are Inhaled Steroids? Cushing\'s Syndrome Due To Interaction Between Inhaled Fluticasone And Ritonavir In A Child With Human Immunodeficiency Virus (HIV) Infection**

**I. S. Randhawa**, R. M. Ferdman, J. A. Church; Childrens Hospital Los Angeles, Los Angeles, CA.

**970**   **Effect of long acting β2 agonist patch, Asthma**

**H. Lee**; Cheil General Hospital, Seoul, REPUBLIC OF KOREA.

**971**   **Comparative Bronchodilatory Effects of Formoterol Dry-Powder Inhaler (DPI) Versus the Combination of Formoterol and Budesonide Pressurized Metered-Dose Inhaler (pMDI)**

**W. S. Mezzanotte** ^1^, C. J. Miller^1^, S. Senn^2^; ^1^AstraZeneca, Wilmington, DE, ^2^University of Glasgow, Glasgow, UNITED KINGDOM.

**972**   **Comparative Assessment of Asthma Control With Budesonide and Formoterol in One Pressurized Metered-Dose Inhaler (pMDI) Versus Budesonide and Formoterol in Individual Inhalers and Placebo**

**J. Corren** ^1^, P. E. Korenblat^2^, C. J. Miller^3^, C. D. O\'Brien^3^, W. S. Mezzanotte^3^; ^1^Allergy Research Foundation, Los Angeles, CA, ^2^The Clinical Research Center, St Louis, MO, ^3^AstraZeneca, Wilmington, DE.

**973**   **Cardiac Safety of Ventolin^®^ HFA in Children**

J. Hedrick^1^, **A. Davis** ^2^, W. Lincourt^2^, R. Trivedi^2^, A. Ellsworth^2^, C. Crim^2^; ^1^Kentucky Pediatric/Adult Research, Bardstown, KY, ^2^GlaxoSmithKline, RTP, NC.

**974**   **Measured Onset of Bronchodilation With Budesonide and Formoterol Administered via One Pressurized Metered-dose Inhaler (pMDI) in Patients With Asthma Previously Receiving Inhaled Corticosteroids**

**H. B. Kaiser** ^1^, C. J. Miller^2^, L. O\'Dowd^2^; ^1^Clinical Research Institute, Minneapolis, MN, ^2^AstraZeneca, Wilmington, DE.

**975**   **Effect of a Novel Medical Food (NMF) on Biomarkers of Inflammation and Airway Hyperresponsiveness in Children with Mild Persistent Asthma**

**R. Covar** ^1^, B. Macomber^1^, L. Stewart^1^, M. Gleason^1^, K. Engelhardt^1^, J. Murphy^1^, A. Liu^1^, S. Wood^2^, S. DeMichele^2^, E. Gelfand^1^, S. Szefler^1^; ^1^National Jewish Med Res Ctr, Denver, CO, ^2^Ross Products, Abbott Laboratories, Columbus, OH.

**976**   **The Significance of the Initiating Time of Inhaled Corticosteroid in Asthma Treatment**

**J. Jung** ^1^, J. Kim^2^, J. Lee^3^; ^1^Dong-A University Hospital, Busan, REPUBLIC OF KOREA, ^2^Ulsan University Hospital, Ulsan, REPUBLIC OF KOREA, ^3^Masan Samsung Hospital, Masan, REPUBLIC OF KOREA.

**977**   **Stability of IgE Levels during Acute Asthma: Implications for Initiation of Omalizumab Therapy after the Emergency Department Visit**

C. J. Ahn^1^, B. M. Baumann^2^, R. F. Kysia^3^, M. S. Radeos^4^, K. Stiffler^5^, **C. A. Camargo, Jr.** ^1^; ^1^Massachusetts General Hospital, Boston, MA, ^2^Cooper University Hospital, Camden, NJ, ^3^Cook County Hospital, Chicago, IL, ^4^Lincoln Medical and Mental Health Center, Bronx, NY, ^5^Summa Health System, Akron, OH.

**978**   **Prescribing of Fluticasone Propionate/Salmeterol Combinations as Initial Therapy for Patients With Asthma in a Commercially-Insured Population**

**H. S. Friedman** ^1^, T. K. Wilcox^2^, G. Reardon^3^, S. Crespi^4^, B. P. Yawn^5^; ^1^Analytic Solutions, LLC, New York, NY, ^2^United Biosource Corporation, Bethesda, MD, ^3^Informagenics, LLC, Worthington, OH, ^4^Schering-Plough Corporation, Kenilworth, NJ, ^5^Olmsted Medical Center, Rochester, MN.

**979**   **Management of Patients with Bronchial Asthma, Elevated IgE and Eosinophilia Including Patients with Churg Strauss Syndrome**

**V. V. Chopyak** ^1^, G. O. Potomkina^1^, K. O. Lishchuk-Yakymovych^1^, R. R. Holovyn^1^, I. V. DuBuske^2^, L. M. DuBuske^2^; ^1^Lviv National Medical University, Lviv, UKRAINE, ^2^Immunology Research Institute of New England, Gardner, MA.
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**980**   **Reversible Pan-hypogammaglobulinemia Associated With The Antiepileptic Levetiracetam (keppra)**

**A. E. Azar** ^1,2^, Z. K. Ballas^1,2^; ^1^University of Iowa Hospitals and Clinics, Iowa City, IA, ^2^Veterans Affairs Medical Center, Iowa City, IA.

**981**   **Efficacy of IGIV in Patients With IgG Subclass Deficiency and/or Antibody Deficiency in a One-Year Open Label Study of Quality of Life, Innate Immunity, and Correction of Subclass/Antibody Levels**

**C. A. Greenwell** ^1^, R. Mehta^2^, J. D. Hester^3^, G. V. Yamshchikov^3^, J. F. Halsey^3^, N. I. Abdou^1^; ^1^Center for Rheumatic Disease, Allergy, and Immunology, Kansas City, MO, ^2^University of Missouri Kansas City School of Medicine, Kansas City, MO, ^3^IBT Reference Lab, Lenexa, KS.

**982**   **Why Are Patients Referred to A Non HIV Adult Immunodeficiency Clinic?**

**J. B. Hagan**, R. S. Abraham, M. A. Park, G. W. Volcheck, D. E. Maddox, J. H. Butterfield, J. T. C. Li; Mayo, Rochester, MN.

**983**   **Autoimmune Lymphoproliferative Syndrome (ALPS) in a Patient with Common Variable Immunodeficiency (CVID): Fas Deficiency with Increased Apoptosis**

**M. B. Narra** ^1^, N. I. Abdou^2^; ^1^UMKC School of Medicine, Kansas City, MO, ^2^Center for Rheumatic Disease, Allergy and Immunology, Saint Luke\'s Hospital, Kansas City, MO.

**984**   **A Pilot Study of Quality of Life, Mood, Sleepiness and Fatigue in Patients with Primary Immunodeficiency Receiving IVIG**

**A. S. Kanani**, R. R. Schellenberg, D. F. Stark; University of British Columbia, Vancouver, BC, CANADA.

**985**   **11q Terminal Deletion Disorder (Jacobsen Syndrome) with Combined Variable Immunodeficiency (CVID)**

**G. Puglisi**, A. L. Cox, V. R. Bonagura; North Shore - Long Island Jewish Health System, Great Neck, NY.

**986**   **Absent B-cells and Decreased T-cells in a Family With Hypogammaglobulinemia: A Unique Form of Combined Immune Deficiency?**

**M. H. Land**, R. Tachdjian, E. Lin, M. Riedl, R. L. Roberts; UCLA Medical Center, Los Angeles, CA.

**987**   **Recurrent Facial Herpes Simplex Infections in a 4 year Old Female with a Functional Natural Killer Cell Deficiency**

**A. Marks**, R. Hostoffer, Jr.; Case Western Reserve University, Cleveland, OH.

**988**   **IgG Subclasses Deficiency\'s Clinical Expressions**

**G. Manfredi**, C. Derosa, E. Ventura, R. Caso; Religious Gen. Hospital "F. Miulli", Acquaviva (BA), ITALY.

**989**   **Partial DiGeorge Anomaly (DGA) with an Unusual Immune Phenotype is Diagnosed in an Adult Parent, after the Diagnosis of his Daughter**

**B. A. Becker**, A. P. Knutsen; Saint Louis University School of Medicine, Saint Louis, MO.

**990**   **Idiopathic CD4+ Lymphocytopenia in a Patient with Progressive Multifocal Leukoencephalopathy Treated with Cidofovir**

**S. J. McEldowney**, R. K. Bush; University of Wisconsin Hospital and William S. Middleton Memorial Veterans Hospital, Madison, WI.

**991**   **Griscelli Syndrome: A Case Report**

**J. Y. Zhang** ^1^, A. J. MacGinnitie^1^, B. Ackermann^2^, C. Galambos^3^; ^1^Children\'s Hospital of Pittsburgh, Allergy and Immunology, Pittsburgh, PA, ^2^Children\'s Hospital of Pittsburgh, Pittsburgh, PA, ^3^Children\'s Hospital of Pittsburgh, Pathology, Pittsburgh, PA.

**992**   **Hereditary Angioedema: An often Misdiagnosed Dsease**

**Y. X. Zhi**, h. y. Zhang; Peking Union Medical College Hospital, Beijing, CHINA.

**993**   **Heart Surgery Reverses Hypogammagolulinemia And CD4-cytopenia By Correcting Protein-losing Enteropathy**

**K. Y. Wang**, R. L. Roberts; UCLA Medical Center, Los Angeles, CA.

**994**   **A Child with WHIM Syndrome (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) and a Family History of Cervical Dysplasia Suggesting Generalized Susceptibility to Human Papilloma Virus Serotypes**

**L. E. Montelibano** ^1^, K. Paris^1^, R. Howes^2^, R. U. Sorensen^1^; ^1^LSU Health Sciences Center, New Orleans, LA, ^2^LSU Health Sciences Center - University Medical Center, Lafayette, LA.

**995**   **Autosomal Recessive Chronic Granulomatous Disease in a Two Week Old Arabic Female and Unusual Carrier State Detected on Flow Cytometry of Asymptomatic Siblings**

**N. Mireku**, E. A. Secord; Children\'s Hospital of Michigan, Detroit, MI.

**996**   **A Novel Case of Gaucher\'s Disease Associated with Hypogammaglobulinemia**

**S. Jariwala**, J. Fodeman, D. Rosenstreich, G. Hudes, K. Ahuja; Division of Allergy and Immunology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY.

**997**   **Major Histocompatibility Complex Class II (MHC II) Deficiency in a Child with Panhypogammaglobulinemia and Lymphopenia**

**A. E. Bailey** ^1^, J. J. H. Bleesing^2^, S. M. Jones^1^, T. T. Perry^1^, U. M. Nagarajan^1^, A. M. Scurlock^1^; ^1^UAMS/Arkansas Children\'s Hospital, Little Rock, AR, ^2^Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**998**   **Severe Mycobacterium Fortuitum Lung Disease Resembling Interstitial Pneumonitis in an 8 Year-old Child - Dilemmas in Diagnosis and Treatment**

**B. M. Peralejo**, H. Aguila, L. Geng, H. Jyonouchi; University of Medicine and Dentistry of New Jersey, Newark, NJ.

**999**   **Nonmyeloablative Matched Unrelated Donor Hematopoietic Cell Transplant for Late-Onset Omenn\'s with Novel RAG Mutation**

**D. A. Wierzbicki** ^1^, J. A. Cox^2^, I. R. Rainville^3^, R. P. Nelson, Jr.^4^, M. T. de la Morena^1^; ^1^Division of Allergy and Immunology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, ^2^Pediatric Hematology/Oncology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, ^3^Correlagen Diagnostics, Inc, Cambridge, MA, ^4^Division of Hematology/Oncology, Indiana University School of Medicine and the Indiana Cancer Center, Indianapolis, IN.

**1000**   **Infliximab Treatment For Common Variable Immunodeficiency (CVID) With Sarcoid-Like Granulomatous Disease: A Pediatric Case Report**

**R. J. Marchlewski**, L. Katz, A. Shende, B. Gottlieb, V. R. Bonagura; North Shore-Long Island Jewish Health System, Great Neck, NY.

**1001**   **Severe Hypogammaglobulinemia And Absent B Cells in an Adult Patient: A Case Report**

**S. R. Iyengar** ^1^, B. G. Blackburn^2^, D. B. Lewis^2^; ^1^Children\'s Hospital of Boston, Boston, MA, ^2^Stanford University Medical Center, Stanford, CA.

**1002**   **Sprue-like Disease Associated with T-Cell Clonality as a Cause of Death in a Patient with Common Variable Immunodeficiency**

**J. D. Mozena**; University of Virginia, Charlottesville, VA.

**1003**   **\[Withdrawn\]**

**1004**   **Granulomatous Disease Mimicking Angioedema in a Patient with Long-Standing Common Variable Immunodeficiency**

**D. S. Landa**, B. Kaplan; North-Shore Long Island Jewish Health System, Great Neck, NY.

**1005**   **A Novel Missense Mutation in CYBB gene in Chronic Granulomatous Disease**

**J. P. DeMore** ^1^, Y. Dong^2^, D. B. Lewis^2^, J. E. Gern^1^, C. M. Seroogy^1^; ^1^University of Wisconsin Hospital and Clinics, Madison, WI, ^2^Stanford School of Medicine, Stanford, CA.

**1006**   **Acquired C1 Esterase Inhibitor Deficiency in a Patient with Systemic Lupus Erythematosus (SLE)**

**J. V. Giannobile** ^1^, B. J. Fessler^2^, J. R. Bonner^1^; ^1^University of Alabama at Birmingham, Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Birmingham, AL, ^2^University of Alabama at Birmingham, Department of Medicine, Division of Immunology and Rheumatology, Birmingham, AL.

**1007**   **Glucocorticoid Receptor \[gr\] Translocation Regulation by Inflammatory Cytokines**

**N. Bulayeva**, B. T. Ameredes, W. J. Calhoun; University of Texas Medical Branch, Galveston, TX.
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**1008**   **TLR2 Activation By Supernatant From *Bifidobacterium Breve* Modulates Maturation And Survival Of Human DCs Via Differential Effects On PI3Kinase, p38 And ERK Pathways**

**C. Hoarau** ^1^, L. Martin^1^, F. Velge-Roussel^1^, C. Gontier^2^, Y. Lebranchu^1^; ^1^Public Hospital, Tours, FRANCE, ^2^Bledina, Stennvorde, FRANCE.

**1009**   **ANP-NPRA Signaling Modulates Immunity By Altering TLR-2 Expression In Human Dendritic Cells (DCs)**

**X. Cao**, W. Zhang, R. F. Lockey, S. S. Mohapatra; USF, Tampa, FL.

**1010**   **Interferon-a Alters IgE Receptor-dependent Cytokine Production by Human Circulating Monocytoid Dendritic Cells**

**T. V. Le**, B. A. Plunkett, R. A. Wood, S. K. Huang, J. T. Schroeder; Johns Hopkins School of Medicine, Baltimore, MD.

**1011**   **Role Of Dendritic Cells In Drug Metabolism**

**C. Mayorga** ^1^, R. R-Pena^1^, G. Perez-Cataldo^2^, M. Castell^2^, M. J. Torres^3^, C. Antunez^1^, P. Chaves^1^, J. V. Castell^2^, M. Blanca^3^; ^1^Research Laboratory, Fundacion IMABIS-Carlos Haya Hospital, Málaga, SPAIN, ^2^Experimental Hepathology Unit, University Hospital La Fe, Valencia, SPAIN, ^3^Allergy Service, Carlos Haya Hospital, Málaga, SPAIN.

**1012**   **Are the Pro-Allergic Properties of House Dust Mite Allergen Explained by the Adjuvant Effects of Mite DNA?**

**S. Satinover**, A. Reefer, K. Hulse, H. Carper, T. Platts-Mills, J. Woodfolk; University of Virginia, Charlottesville, VA.

**1013**   **Gene Expression Profiles in The Plasmacytoid Dendritic Cells Stimulated with *Lactobacillus GG* or *E.coli***

**S. Toki**, H. Saito, K. Matsumoto; National Research Institute for Child Health and Development, Tokyo, JAPAN.

**1014**   **Elucidating the Mechanisms of IL-12 Mediated Alterations of the Tumor Microenvironment**

**E. W. Sorensen**; University of Rochester, Rochester, NY.

**1015**   **Allergen and Antibody Mediated Desensitisation for Mucosal-Induced Respiratory Allergy**

**W. R. Thomas**, P. T. Cunningham, C. E. Elliot, J. C. Lenzo, P. G. Holt; Telethon Institute for Child Health Research, West Perth, AUSTRALIA.

**1016**   **Measurement of Enterovirus-Specific IgG in Intravenous Immunoglobulin Preparations**

**M. R. Kaplan** ^1^, R. Arora^2^, M. R. Nelson^1^; ^1^Walter Reed Army Medical Center, Washington, DC, ^2^William Beaumont Army Medical Center, El Paso, TX.

**1017**   **New Treatment Strategy for Systemic Mastocytosis**

**R. Sullivan**, D. J. Stechschulte; University of Kansas, Kansas City, KS.

**1018**   **Rituximab in Lupus Pneumonitis: Breathe Easier**

**A. L. B. Hersh**, P. Efthimiou; UMDNJ - Newark, NJ, Newark, NJ.

**1019**   **Peptide Immunotherapy: The Use of Bovine Colostrum Proline-Rich Polypeptides in Cytokine Modulation for the Alternative Relief of Allergic Symptoms**

**A. M. Keech**; Advanced Protein Systems, Phoenix, AZ.

**1020**   **Mast Cells co-cultured with Astrocytes Evokes the Releases of Mediators via Intracellular Calcium Signal Pathway**

D. Kim^1,2^, Y. Ahn^3^, Y. Lee^1,2^, **J. Ro** ^1,2^; ^1^Sungkyunkwan University School of Medicine, Suwon, REPUBLIC OF KOREA, ^2^Samsung Biomedical Research Institute, Suwon, REPUBLIC OF KOREA, ^3^Eulji University School of Medicine, Seoul, REPUBLIC OF KOREA.

**1021**   **(1) The Plasma Membrane Shuttling of CAPLI in Mast Cell Activation**

**M. NAKANISHI**; Aichi Gakuin University, Nagoya, JAPAN.

**1022**   **The Role of Innate Immunity in Otitis Media**

**M. L. Hernandez**; University of California, San Diego, La Jolla, CA.

**1023**   **Identification of Protein Related with Maturation of Mouse Bone Marrow-Derived Mast Cells**

S. Ryu^1,2^, D. Kim^1,2^, B. Lee^3^, **J. Ro** ^1,2^; ^1^Sungkyunkwan University School of Medicine, Suwon, REPUBLIC OF KOREA, ^2^Samsung Biomedical Research Institute, Suwon, REPUBLIC OF KOREA, ^3^Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA.

**1024**   **Basic Fibroblastic Factor-induced Neurite Outgrowth Suppressed by Nicotine via Inhibition of Nitric Oxide Synthesis in H19-7 Cells**

**H. Lee**, J. Oh, J. Han, Y. Koh, S. Park, J. Cho, D. Oh; Hanyang University Medical Center, Seoul, REPUBLIC OF KOREA.

**1025**   **Activity Of TLR Pathways In Healthy Children And Adults And Patients Taking Immunosuppressive Drugs**

N. Khan, M. Helbert, **P. D. Arkwright**; University of Manchester, Manchester, UNITED KINGDOM.

**1026**   **CATERPILLERS R US: Novel Regulators of Inflammation and Apoptosis Preserved from Plants to Humans**

**J. P. Y. Ting**; Lineberger Comprehensive Cancer Center CB\#7295, Chapel Hill, NC.

**1027**   **Characterisation of a New Intravenous Immunoglobulin**

**M. López**, P. Ristol, J. I. Jorquera; INSTITUTO grIFOLS, S.A., Parets del Vallès, Barcelona, SPAIN.

**1028**   **Human Keratinocytes Secrete TNFa Stimulated With Cytomix and *D. Pteronyssinus* Extract**

**M. Frieri**, A. Capetandes; Nassau University Medical Center-North Shore Long Island Jewish Health Care System, East Meadow, NY.

**1029**   **Capacity of Human Intravenous Immunoglobulin (IGIV3I) Production Process to Eliminate an Experimental TSE-Model Agent**

**J. M. Diez**, H. Biescas, S. Caballero, R. Gajardo, J. I. Jorquera; Instituto Grifols, Barcelona, SPAIN.

**1030**   **Sophorolipids Decrease IgE Production in U266 Cells by Downregulation of BSAP (Pax5), TLR-2, STAT3 and IL-6**

M. Hagler^1^, T. A. Smith-Norowitz^1^, S. Chice^1^, S. R. Wallner^2^, D. Viterbo^1^, C. M. Mueller^1^, R. Gross^2^, M. Nowakowski^1^, R. Schulze^1^, M. E. Zenilman^1^, **M. H. Bluth** ^1^; ^1^SUNY Downstate Medical Center, Brooklyn, NY, ^2^Polytechnic University, Brooklyn, NY.

**1031**   **Viral Safety Studies of a New Human Intravenous Immunoglobulin (IGIV3I)**

**H. Biescas**, S. Caballero, N. Domingo, R. Gajardo, J. I. Jorquera; Instituto Grifols, Parets del Vallès. Barcelona, SPAIN.

**1032**   **Cytokine and Chemokine Responses of Type II Alveolar Epithelial Cells (AEC) in Monocrotaline-Induced Pulmonary Fibrosis**

**R. N. Kamal** ^1^, A. Molteni^1^, M. Zoubine^1^, M. Norkin^1^, S. Reppert^2^, Y. Xue^2^, R. Baybutt^2^, B. Herndon^2^, A. Shnyra^1^; ^1^University of Missouri - Kansas City School of Medicine, Kansas City, MO, ^2^Kansas State University, Manhattan, KS.
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**1033**   **Prevalence and Titer of Specific IgE Antibodies in Relation to Total Serum IgE: Evaluation of Sensitization to Allergens Derived from Domestic Mice**

L. Naccara^1^, P. Heymann^1^, M. Carter^2^, A. Litonjua^3^, E. Peters^4^, S. Satinover^1^, E. Erwin^1^, **T. A. E. Platts-Mills** ^1^; ^1^University VA Medical Center, Charlottesville, VA, ^2^NIH/NIAID, Bethesda, MD, ^3^Harvard Medical Center, Boston, MA, ^4^Allergy and Asthma Consultants, Austin, TX.

**1034**   **Sequence Analysis of Monoclonal Antibodies Against Group 1 Dust Mite Allergens**

**K. T. Williams**, M. D. Chapman, A. Pomés; INDOOR Biotechnologies, Inc., Charlottesville, VA.

**1035**   **Gender and Age Differences in Component Resolved Sensitization Pattern to Grass Pollen Allergens**

**A. Marknell DeWitt** ^1^, C. Nordenhall^2^, T. Lundgren^1^, M. Nordlund^2^, G. Lilja^2^, J. Lidholm^1^; ^1^Phadia AB, Uppsala, SWEDEN, ^2^Department of Paediatrics, Sachs\' Children\'s Hospital, Stockholm, SWEDEN.

**1036**   **Bcg\'s Scar and Allergic Sensitization in High Risk Atopic Children**

**C. S. K. La Scala**, V. V. E. Rullo, L. C. L. de Oliveira, D. Solé; Sao Paulo Federal University, Sao Paulo, SP, BRAZIL.

**1037**   **Simultaneous Detection of Total and Allergen-specific IgE Using Fluorescent Multiplex Array Technology**

**E. M. King**, C. Earle, A. Tsay, L. Vailes, M. D. Chapman; INDOOR Biotechnologies Inc., Charlottesville, VA.

**1038**   **Settled Barn and Home Dust Induces Distinct Airway Inflammation in Mice not Explained by Endotoxin**

**M. S. Leino** ^1^, H. Alenius^1^, T. Haahtela^2^, L. von Hertzen^2^, H. Wolff^3^, M. Salkinoja-Salonen^4^, M. A. Andersson^4^, O. Saris^4^, L. Pylkkänen^1^, K. Reijula^1^, M. Mäkelä^2^; ^1^Finnish Institute of Occupational Health, Helsinki, FINLAND, ^2^Department of Allergy, Helsinki University Central Hospital, Helsinki, FINLAND, ^3^Department of Pathology, Helsinki University Central Hospital, Helsinki, FINLAND, ^4^Department of Applied Chemistry and Microbiology, University of Helsinki, Helsinki, FINLAND.

**1039**   **Microbial Contaminants Contribute to the Inflammatory Effect of Metal Working Fluid in a Murine Model**

**M. C. Zacharisen** ^1^, C. S. Barrios^2^, V. P. Kurup^1,2^, J. N. Fink^1^; ^1^Medical College of Wisconsin, Milwaukee, WI, ^2^Zablocki VA Medical Research Center, Milwaukee, WI.

**1040**   **Effects of Oral Monosodium Glutamate (MSG) in Mouse Models of Asthma and Atopic Dermatitis**

**J. Yoneda**; Ajinomoto co., INC. Institute of Life Sciences, Kawasaki-shi., JAPAN.

**1041**   **Botanical Combination Product Reduces Late-Phase Response To Nasal Allergen Challenge**

**M. Lemay** ^1^, Y. Lin^1^, R. K. Randolph^1^, L. Rozga^1^, D. Diaz-Sanchez^2^, D. Krempin^1^, J. Corren^3^; ^1^Nutrilite Health Institute, Buena Park, CA, ^2^Department of Medicine, University of California, Los Angeles, CA, ^3^Allergy Research Foundation, Los Angeles, CA.

**1042**   **Comparative Analysis of Extract-based Skin Test and IgE detection, Singleplexed Molecule-based IgE Detection and a Molecule-based Microarray System**

**A. Mari** ^1^, P. Palazzo^1^, D. Pomponi^1^, M. Helmer-Citterich^1^, D. Zennaro^2,1^, M. Giani^1^, E. Scala^1^; ^1^Center for Clinical and Experimental Allergology. IDI-IRCCS, Rome, ITALY, ^2^Campus-Biomedico University, Rome, ITALY.

**1043**   **Development of a Microarray Assay to Determine the Potency of Allergenic Extracts Using Recombinant Antibodies**

**N. C. deVore**, J. E. Slater; Food and Drug Administration, Rockville, MD.

**1044**   **Exposure To Formaldehyde In Asthmatic And Control Dwellings In The Area Of Strasbourg (France)**

**C. Marchand** ^1^, S. Le Calvé^1^, P. Mirabel^1^, N. Glasser^2^, A. Casset^3^, N. Schneider^3^, F. de Blay^3^; ^1^CNRS - Louis Pasteur University, Strasbourg, FRANCE, ^2^Faculty of Pharmacy, Illkirch, FRANCE, ^3^Asthma and Allergy Division, Department of Chest Diseases, University Hospital, Strasbourg, FRANCE.

**1045**   **Measurement of Airway Hyperresponsiveness May Be a Incomplete Outcome Parameter in Occupational Asthma**

**C. Kim**, B. Park, J. Cho; Inha University Hospital, Incheon, REPUBLIC OF KOREA.

**1046**   **Occupational Rhinitis and Asthma Caused by Tampico Fibers in a Brush Maker**

**S. Quirce**, M. Fernández-Nieto, C. Pastor, J. Torres, A. Enríquez, J. Sastre; Fundación Jiménez Díaz, Madrid, SPAIN.

**1047**   **Lower Airway Inflammation Assessed by Induced Sputum in a Cluster of Cases Suggestive of Organic Dust Toxic Syndrome**

**R. Castano**, J. L. Malo, C. Lemiere, M. Labrecque, A. Cartier; Hoˆpital du Sacré-Coeur de Montréal, Montréal, PQ, CANADA.
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**1048**   **Is there Adequate Regulation in the Use of Complementary and Alternative Medicines (CAM)?**

**H. C. G. Wong** ^1,2^; ^1^University of British Columbia, Vancouver, BC, CANADA, ^2^Vancouver General Hospital, Vancouver, BC, CANADA.

**1049**   **Moxifloxacine-induced Drug Hypersensitivity Syndrome**

**S. Lee**; Dong-A University, Busan, REPUBLIC OF KOREA.

**1050**   **Successful Transcatheter Closure of an Atrial Septal Defect in a Nickel-Allergic Patient**

**B. Vickery**, P. Askenase, F. Kantor, J. Asnes; Yale University, New Haven, CT.

**1051**   **Risk Factors For Adults with a History of Penicillin Allergy**

**A. J. Apter** ^1^, F. Wan^1^, J. Chittams^1^, B. Adelsberg^2^, S. Andrew^3^, M. Blaiss^4^, M. Columbo^5^, A. Davidson^6^, P. Detjen^7^, B. De Cotiis^8^, D. Dvorin^9^, L. Ford^10^, S. Gawchik^11^, S. Gillman^12^, M. Grijnsztein^13^, G. Gross^14^, M. Hoffman^15^, M. Lanz^16^, A. Stillerman^17^, P. Takach^18^, T. Rebbeck^1^; ^1^University of Pennsylvania, Philadelphia, PA, ^2^Connecticut Medical Group, Hamden, CT, ^3^Mainland Allergy Clinic, Dickinson, TX, ^4^Allergy & Asthma Care, Germantown, TN, ^5^Rohr &Columbo Asthma, Allergy & Immunology Specialists, Bryn Mawr, PA, ^6^Allergy & Asthma Consultants, Mt. Pleasant, TN, ^7^Adult & Pediatric Asthma & Allergy, Kenilworth, IL, ^8^De Cotiis & Grijnszstein, Brick, NJ, ^9^Allergy and Asthma Research of New Jersey, Forked River, NJ, ^10^Asthma & Allergy Center, Papillion, NE, ^11^Crozer Chester Medical Center, Chester, PA, ^12^Sherwin Gillman, Orange, CA, ^13^DeCotiis & Grijnsztein, Brick, NJ, ^14^Atlantic Allergy Asthma & Immunology Associates, Ashbury Park, NJ, ^15^Allergy, Asthma, and Immunology Associates, Lincoln, NE, ^16^Allergy, Asthma, Atopic Dermatitis, Rhinitis, and Sinusitis Clinical Research Center, Coral Gables, FL, ^17^Allergy and Asthma Specialists, Minneapolis, MN, ^18^Allergy Associates, Chico, CA.

**1052**   **Evidence for Cross-Reactivity Among Proton Pump Inhibitors (PPIs): A Case Report of Hypersensitivity to Three PPIs**

**A. L. Cox**, B. Kaplan; North Shore-Long Island Jewish Health System, Great Neck, NY.

**1053**   **Iodinated Contrast Media Hypersensitivity Diagnosis - Skin Tests and Limphoblastic Transformation Test**

**A. F. F. Ferrão**, R. P. Reis, L. A. Patricio, M. R. Viseu, S. H. Correia, S. H. Correia, M. J. Peres, E. M. Tomaz, F. C. Inácio; Hospital S. Bernardo, Setubal, PORTUGAL.

**1054**   **Desensitization to High-dose Methotrexate (mtx) After Anaphylactoid Reaction, Without Premedication Phase**

**S. R. Abouhassan** ^1^, S. Alexander^2^, A. Chouksey^2^; ^1^University Hospitals of Cleveland, Cleveland, OH, ^2^Rainbow Babies & Children\'s Hospital, Cleveland, OH.

**1055**   **Human Insulin Allergy of Immediate Type and Insulin-induced Vasculitis In a Patient With Diabetes Mellitus Type 1**

**D. C. Hatzis** ^1^, C. Larmou^2^, I. Ioannou^2^, A. Anagnostou - Keramida^3^, C. Bartsocas^1^; ^1^Mitera General Hospital, Athens, grEECE, ^2^Limassol General Hospital, Limassol, CYPRUS, ^3^Evangelismos General Hospital, Athens, grEECE.

**1056**   **Oral Aspirin Challenge In Acute Myocardial Infarction**

**D. S. Walia**, D. J. Stechschulte; Kansas University Medical Center, Kansas City, KS.

**1057**   **A Case Study of a Lichenoid Drug Eruption due to Oral Cyclosporine**

**J. S. Swartz**, M. Budev, A. Mehta; Cleveland Clinic, Cleveland, OH.

**1058**   **Allergenic Cross-Reactivity between Echinacea and Ragweed**

**M. B. Fasano**; Universtiy of Iowa, Iowa City, IA.

**1059**   **Assessment of Irritant Skin Test Reactions to Common Vaccines**

**R. A. Wood**, R. Setse, N. Halsey; Johns Hopkins University, Baltimore, MD.

**1060**   **Penicillin Skin Testing and Challenges in the Absence of the Major Penicillin Determinant**

**P. A. Greenberger**, A. T. Peters; Northwestern University, Chicago, IL.

**1061**   **Cytokine and Chemokine Expression in the Skin from Patients with Maculopapular Exanthema to Drugs**

**T. D. Fernández** ^1^, C. Mayorga^1^, J. A. Cornejo-García^1^, M. J. Torres^2^, C. Rondon^2^, R. R-Pena^1^, S. López^1^, E. Martín^2^, M. Blanca^2^; ^1^Research Laboratory. Fundacion IMABIS-Carlos Haya Hospital, Málaga, SPAIN, ^2^Allergy Service. Carlos Haya Hospital, Málaga, SPAIN.

**1062**   **Predicting Severity of Reactions During Aspirin Desensitization in Patients with Aspirin Exacerbated Respiratory Disease (AERD)**

**A. P. Hope**, R. A. Simon, D. D. Stevenson; Scripps Clinic/Green Hospital, La Jolla, CA.

**1063**   **Cytokine and Transcription Factors Expression in Patients with Delayed Allergic Reactions to Drugs**

**J. A. Cornejo-Garcia** ^1^, T. D. Fernandez^1^, C. Mayorga^1^, M. J. Torres^2^, M. Carballo^3^, I. Hernan^3^, C. Rondon^2^, J. L. Rodriguez-Bada^1^, E. Martin^2^, M. Blanca^2^; ^1^Research Laboratory, Fundacion IMABIS-Carlos Haya Hospital, Málaga, SPAIN, ^2^Allergy Service, Carlos Haya Hospital, Málaga, SPAIN, ^3^Laboratory Service, Tarrasa Hospital, Barcelona, SPAIN.

**1064**   **Rapid Desensitization with Imipenem in Penicillin Allergic Patient**

**M. R. Aquino**, A. Wolff, A. Hersh, L. Bielory; UMDNJ Newark, Newark, NJ.

**1065**   **Prompt Recognition And Timely Diagnosis Of Stevens-Johnson Syndrome**

**S. J. Schuval** ^1^, G. Schwarz^1^, A. Cox^1^, P. Ponda^1^, W. Li^2^; ^1^Schneider Children\'s Hospital, New Hyde Park, NY, ^2^North Shore University Hospital, Manhasset, NY.

**1066**   **Exaggerated Neurogenic and Allergic Inflammation in the Skin of Rats Treated with Systemically Administered Indomethacin**

**T. Sakamoto**, M. Miyake, R. Kimura, S. Morii, K. Ito; Nagoya University Graduate School of Medicine, Nagoya, JAPAN.

**1067**   **Allergy to Marijuana: Case report**

**S. Perez-Bustamante**, M. Vazquez de la torre, A. Villanueva, R. Pelta, M. Rubio, M. Baeza; Hospital General Universitario Gregorio Marañon, Madrid, SPAIN.
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**1068**   **Hereditary Angioedema and Pancreatitis**

**D. Chung**, P. Busse, M. Oh; Mount Sinai Medical Center, New York, NY.

**1069**   **Hereditary Angioedema: Clinical Aspects in a Brazilian Family**

M. Ferraro, M. Thiesen, **L. Arruda**, W. Sarti; School of Medicine of Ribeirão Preto-University of São Paulo, Ribeirão Preto, BRAZIL.

**1070**   **Fresh Frozen Plasma for the Treatment of Hereditary Angioedema**

**M. Prematta**, J. Gibbs, T. J. Craig, E. Pratt, T. Stoughton; Penn State University, Hershey, PA.

**1071**   **Absolute Bioavailability of Subcutaneously Administered Icatibant, a Selective and Potent Bradykinin B2 Receptor Antagonist**

**F. Wagner** ^1^, B. Rosenkranz^2^, J. Knolle^2^; ^1^Charite Research Organisation GmbH, Berlin, GERMANY, ^2^Jerini AG, Berlin, GERMANY.

**1072**   **Successful Treatment of Chronic Idiopathic Urticaria & Angioedema (CIU), With Xolair (Omalizumab)**

**C. A. Shapiro** ^1^, N. S. Kapetanos^2^, E. Sarmiento^2^; ^1^Flushing Hospital Med Ctr, Flushing, NY, ^2^Advanced Allergy & Asthma Assessment & Diagnostics, P.C., Bayside, NY.

**1073**   **Resolution of Angioedema with Omalizumab**

**J. W. Blume**, S. Kiratseavee, M. F. Sands; University at Buffalo, Buffalo, NY.

**1074**   **Angioedema from Angiotensin I-Converting Enzyme Inhibitors May Have a Genetic Basis in African-American Families**

**A. Shah**, D. Shats, V. Rajput; UMDNJ-Robert Wood Johnson Medical School. Cooper University Hospital, Camden, NJ.

**1075**   **Hereditary Angioedema: Clinical Characteristics and Outcome of 36 Patients**

L. K. Tanno, L. H. Pinto, A. A. Motta, J. Kalil, **P. Giavina-Bianchi**; FMUSP, São Paulo, BRAZIL.

**1076**   **Facial Skin Splitting due to Hereditary Angioedema**

**G. V. Marcotte**; Asthma & Allergy Care of Delaware, Wilmington, DE.

**1077**   **Side Effects Of Long-Term Treatment With Danazol And Stanozolol In Hereditary Angioedema**

**K. Bork** ^1^, L. Zingale^2^, H. Farkas^3^, A. Bygum^4^, L. Bouillet^5^, C. Bucher^6^, T. Caballero^7^, H. Longhurst^8^, E. Nielsen^9^, M. Cicardi^2^; ^1^Department of Dermatology, University of Mainz, Mainz, GERMANY, ^2^University Hospital, Milano, ITALY, ^3^University Hospital, Budapest, HUNGARY, ^4^University Hospital, Odense, DENMARK, ^5^University Hospital, Grenoble, FRANCE, ^6^University Hospital, Zurich, SWITZERLAND, ^7^University Hospital, Madrid, SPAIN, ^8^University Hospital, London, UNITED KINGDOM, ^9^University Hospital, Tromso, NORWAY.

**1078**   **Plasmatic Markers Of Coagulation And Fibrinolysis In Patients With C1 Inhibitor Deficiency During Acute Attacks Of Angioedema**

**A. Zanichelli** ^1^, M. Cugno^1,2^, L. C. Zingale^1^, D. Lambertenghi Deliliers^1^, L. Maggioni^1^, S. Griffini^1,2^, M. Cicardi^1^; ^1^University of Milan, Milano, ITALY, ^2^Ospedale Maggiore Policlinico, Mangialgalli e Regina Elena, Fondazione IRCCS, Milan, ITALY.

**1079**   **The European Register of Hereditary Angioedema: Experience and Preliminary Results**

**L. C. Zingale** ^1^, K. Bork^2^, H. Farkas^3^, A. Bygum^4^, L. Bouillet^5^, T. Caballero^6^, H. Longhurst^7^, E. Waage Nielsen^8^, B. Bilo^9^, C. Bucher^10^, R. Perricone^11^, M. Cicardi^1^; ^1^University of Milan, Milan, ITALY, ^2^University of Mainz, Mainz, GERMANY, ^3^Semmelweis, Budapest, HUNGARY, ^4^University of Odense, Odense, DENMARK, ^5^CHU de Grenoble, Grenoble, FRANCE, ^6^University Hospital La Paz, Madrid, SPAIN, ^7^St Bartholomew\'s Hospital, London, UNITED KINGDOM, ^8^Dept. of Anesthesiology, Bodø, NORWAY, ^9^University of Cracow, Cracow, POLAND, ^10^University of Zürich, Zürich, SWITZERLAND, ^11^University of Rome Tor Vergata, Rome, ITALY.

**1080**   **A New Variant of Hereditary Angioedema Involving Macular Edema With Transient Loss of Vision**

**A. M. Deener**, A. Rubinstein; Albert Einstein College of Medicine, Bronx, NY.

**1081**   **Interim Open-Label Results of EDEMA3sm: A Study of Subcutaneous Ecallantide in Patients with Hereditary Angioedema**

**H. H. Li** ^1^, R. J. Levy^2^, D. L. McNeil^3^, T. K. Schmalbach^4^; ^1^Institute for Asthma and Allergy, Wheaton, MD, ^2^Family Allergy & Asthma Center, PC, Atlanta, GA, ^3^Optimed Research, LLC, Columbus, OH, ^4^Dyax Corp., Cambridge, MA.

**1082**   **Unnecessary Abdominal Surgeries Secondary to Undiagnosed Hereditary Angioedema**

**K. J. Bowie**, M. D. Scarupa, H. H. Li; Institute for Asthma & Allergy, PC, Wheaton, MD.

**1083**   **Diagnosis, Clinical Manifestation and Therapy in Children with Hereditary Angiooedema**

**I. Martinez-Saguer**, E. Rusicke, E. Aygören-Pürsün, T. Klingebiel, W. Kreuz; J.-W. Goethe University Hospital Frankfurt, Germany, Frankfurt, GERMANY.

**1084**   **New Mutations of C1 inhibitor (*SERPING1/C1NH)* Gene Associated with Hereditary Angioedema in a European Population**

**C. Drouet** ^1^, M. Cicardi^2^, E. Pappalardo^2^, N. Monnier^1^, O. Roche^3^, A. Tordai^4^, I. Wagenaar-Bos^5^, R. Perricone^6^, A. Bygum^7^, K. Bork^8^, M. Tosi^9^, M. López-Trascasa^3^; ^1^University Joseph Fourier, Grenoble, FRANCE, ^2^University of Milan, Milan, ITALY, ^3^University Hospital La Paz, Madrid, SPAIN, ^4^National Medical Center, Budapest, HUNGARY, ^5^Sanquin Research Center, Amsterdam, THE NETHERLANDS, ^6^University Tor Vergata, Rome, ITALY, ^7^University of Odense, Odense, DENMARK, ^8^Johannes Gutenberg University, Mainz, GERMANY, ^9^University of Rouen, Rouen, FRANCE.

**1085**   **Treatment With Pasteurized C1 Inhibitor Concentrate In Skin Swelling Attacks Of Patients With Hereditary Angioedema**

**P. Staubach**, K. Bork; Department of Dermatology, University of Mainz, Mainz, GERMANY.

**1086**   **Icatibant, a Potent and Selective Bradykinin B2 Receptor Antagonist, is Effective in Treating Patients with Hereditary Angioedema (HAE)**

**R. J. Levy**, S. Goodman; Family Allergy and Asthma Center, P.C., Atlanta, GA.

**1087**   **Prodromal Symptoms Before Exacerbations of Hereditary Angioedema**

**J. G. Gibbs**, T. J. Craig; Penn State College of Medicine, Hershey, PA.

**1088**   **Treatment Of Acute Edema Attacks In Hereditary Angioedema With A Bradykinin Receptor-2 Antagonist (Icatibant)**

**B. Grundt** ^1^, K. Bork^1^, J. Frank^2^, P. Schlattmann^3^, J. Nussberger^4^, B. Rosenkranz^5^, L. Dong^5^, J. Knolle^5^, W. Kreuz^6^; ^1^Department of Dermatology, University of Mainz, Mainz, GERMANY, ^2^Department of Dermatology, University Hospital Maastricht, Maastricht, THE NETHERLANDS, ^3^Institute of Medical Informatics, Biostatistics and Epidemiology, Charite, University of Berlin, Berlin, GERMANY, ^4^Department of Medicine, CHUV, University of Lausanne, Lausanne, SWITZERLAND, ^5^Jerini AG, Berlin, GERMANY, ^6^Center of Pediatrics, University of Frankfurt, Frankfurt, GERMANY.

**1089**   **Discoid Lupus Erythematosus Presenting as Lower Facial Angioedema**

**N. J. Nam**; Columbia University Medical Center, New York, NY.

**1090**   **Episodic Angioedema Associated with Eosinophilia: Successful Treatment with Imatinib Mesylate**

**S. E. Scranton** ^1^, C. A. Wild^2^, R. W. England^1^; ^1^Wilford Hall Medical Center, Lackland AFB, TX, ^2^David Grant Medical Center, Travis AFB, CA.

**1091**   **Different Causes of Angioedema**

**P. Nordenfelt**, L. Maroti, U. Malkolmsson, J. Björkander; Lansjukhuset Ryhov, Jonkoping, SWEDEN.

**1092**   **Resolution of Symptoms in a Patient with Hereditary Angioedema (HAE) Following Treatment with Icatibant, a Potent and Selective Bradykinin-2 Receptor Antagonist**

**T. Boehm** ^1^, W. R. Lumry^2^; ^1^Jerini AG, Berlin, GERMANY, ^2^AARA Research Center, Dallas, TX.

**1093**   **Lymphoproliferative disease and Acquired C1 inhibitor (C1-INH) deficiency**

**M. Cicardi**, D. Lambertenghi Deliliers, A. Zanichelli, L. C. Zingale, R. Castelli; University of Milan, Milan, ITALY.
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**1094**   **Cutaneous Colonization of *Staphylococcus aureus* at 4 Months of Age and Eczema at 18 Months of Age**

**S. Suzuki**, N. Shimojo, Y. Inoue, T. Arima, M. Tomiita, Y. Kohno; Department of Pediatrics, Graduate School of Medicine and School of Medicine, Chiba University, Chib, Chiba City, JAPAN.

**1095**   **Altered Expression of Epidermal Differentiation Proteins in Atopic Dermatitis compared to Psoriasis or Nonatopic, Healthy Controls**

**A. De Benedetto** ^1^, L. Y. McGirt^2^, M. Brummet^3^, C. Cheadle^3^, K. C. Barnes^3^, L. A. Beck^1^; ^1^Department of Dermatology and Division of Allergy/Immunology and Reumatology, University of Rochester School of Medicine and Dentistry, Rochester, NY, ^2^Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, ^3^Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD.

**1096**   **Association Of Interleukin-10 Gene Promoter Polymorphism In Korean Children With Atopic Dermatitis**

**K. Kim**, J. Hong, J. Park, K. Kim, E. Kim, M. Sohn; Department of Pediatrics, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA.

**1097**   **Transepidermal Water Loss As A Biological Marker In Atopic Dermatitis In Children**

**J. Gupta** ^1,2^, E. Grube^2^, A. Lucky^2^, A. Sheth^2^, A. Assa\'ad^2^, G. K. Khurana Hershey^2^; ^1^University of Cincinnati, Cincinnati, OH, ^2^Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**1098**   **The Relationships among Severity Score, Behavioral Problem, Parental Stress, Maternal Depression, and Social Support in Children with Atopic Dermatitis**

**M. Shin** ^1^, S. Chung^2^, S. Lee^2^; ^1^Soonchunhyang university hospital, Bucheon, REPUBLIC OF KOREA, ^2^Samsung seoul hospital, Seoul, REPUBLIC OF KOREA.

**1099**   **Properties of Circulating Regulatory T Cells Associated with Nascent IgE Responses in Children with Atopic Dermatitis**

**M. Moloney**, S. Satinover, A. Reefer, P. Heymann, D. Murphy, J. Woodfolk; University of Virginia, Charlottesville, VA.

**1100**   **Colonization Of Staphylococcus Aureus On The Cheeks Of 4 Month-old Children At Local Health Centers In Chiba, Japan**

**N. Shimojo** ^1^, S. Suzuki^1^, M. Tomiita^1^, Y. Inoue^1^, Y. Arima^1^, Y. Kohno^1^, Y. Akiba^2^; ^1^Chiba University, Chiba, JAPAN, ^2^Chiba city institute for enviroment and hygiene, Chiba, JAPAN.

**1101**   **Effect of House Dust Mite (HDM) Avoidance Measure on The Clinical Symptoms in Dogs with Atopic Dermatitis (AD)**

**S. Kawarai** ^1^, H. Shirai^2^, M. Sakaguchi^3^, K. Ohmori^1^, N. Yasuda^1^, H. Yasuda^4^, K. Ikeda^5^, H. Tsujimoto^1^; ^1^Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, JAPAN, ^2^Yamasei corporation, Tokyo, JAPAN, ^3^Division of Otorhinolaryngology, Graduate School of Medicine and School of Medicine, Chiba University, Chiba, JAPAN, ^4^National Hospital Organization, Sagamihara National Hospital, Kanagawa, JAPAN, ^5^National Institiute of Public Health, Saitama, JAPAN.

**1102**   **Objective Measurement of Sleep Quality, Scratching, and Cytokine Response in Atopic Dermatitis (AD)**

**B. G. Bender**, R. D. Ballard, D. Y. M. Leung; National Jewish Medical and Research Center, Denver, CO.

**1103**   **Development of a Classification System for Atopic Dermatitis (AD): Correlation Between Subjective Symptoms and Disease Extent or Intensity**

**A. DiDario** ^1^, E. Yousef^2^; ^1^Thomas Jefferson University, Philadelphia, PA, ^2^A.I. duPont Hospital for Children, Wilmington, DE.

**1104**   **The Effects of Breast-milk Feeding on Severe Atopic Dermatitis In Korean Infant and Toddler**

**D. Lim**, J. Kim, B. Son, Y. Oh; Inha University, Incheon City, REPUBLIC OF KOREA.

**1105**   **Evaluation of Passive Smoking as a Risk Factor for Severity and Allergic Sensitization Among Atopic Dermatitis Children**

**A. A. C. Leite** ^1^, R. M. S. Leite^2^, I. M. C. Costa^3^, G. M. de Paula^2^, L. O. Rezende^2^; ^1^Instituto Saint Louis, Brasilia, BRAZIL, ^2^Universidade Catolica de Brasilia, Brasilia, BRAZIL, ^3^Universidade de Brasilia, Brasilia, BRAZIL.

**1106**   **TARC(CCL17) Augments TNF-α Induced CTACK(CCL27) Production in Infantile Atopic Dermatitis**

**J. Nakazato**, J. Fujiwara, M. Inoue, M. Kishida, N. Shinomiya; Toho University Medical Center, Tokyo, JAPAN.

**1107**   **Effectiveness and Safety Of Recombinant Human Interferon γ Therapy for Moderate to Severe Atopic Dermatitis in Childhood**

**J. Oh** ^1^, H. Lee^2^, E. Mo^3^, J. Lee^4^; ^1^Hanyang University Guri Hospital, Kyunggi-do, REPUBLIC OF KOREA, ^2^Hanyang University, Seoul, REPUBLIC OF KOREA, ^3^Choongnam National University, Daejeon, REPUBLIC OF KOREA, ^4^Choongnam University, Daejeon, REPUBLIC OF KOREA.

**1108**   **Modulation of Filaggrin by Th2 Cytokines in the Skin of Atopic Dermatitis (AD)**

**M. D. Howell** ^1^, B. E. Kim^2^, M. Boguniewicz^1^, D. Y. M. Leung^1^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^Sanggye Paik Hospital and Inje University, Seoul, REPUBLIC OF KOREA.

**1109**   **Influence Of Cetirizine On Cytokine Production In Patients With Atopic Dermatitis**

**G. N. Drannik** ^1^, A. Kurchenko^1^, L. M. DuBuske^2^; ^1^Ukrainian Center for Clinical Immunology, Kiev, UKRAINE, ^2^Immunology Research Institute of New England, Gardner, MA.

**1110**   **Quantitative Real-time PCR of Staphylococcus aureus DNA Reveals High Levels in Bed, Floor, and Vacuum Dust in Children with Severe Atopic Dermatitis (AD)**

**A. D. Leung** ^1^, A. M. Schiltz^1^, C. F. Hall^1^, A. A. Harris-Deutch^1^, A. H. Liu^1,2^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^University of Colorado School of Medicine, Denver, CO.

**1111**   **Severe Refractory Atopic Dermatitis (AD) in Adult Patients, as Compared to Quiescent and Moderate AD is Highly Atopic**

**B. H. Salt**, M. Boguniewicz, D. Y. M. Leung; National Jewish Medical and Research Center, Denver, CO.

**1112**   **The Atopic Dermatitis Questionnaire (ADQ): A 5-minute, Easy-to-use Parent Administered Atopic Dermatitis (AD) Scoring Tool For Home-based Follow Up Compares Well With The SCORAD**

**K. D. Carel**, M. D. Klinnert, K. Kelsay, A. Kelley-Day, N. Miyazawa, E. Gyorkos, K. Walsh, S. Solanyk, E. W. Gelfand, D. L. Bratton; National Jewish Medical and Research Center, Denver, CO.

**1113**   **The Role Of Stat6 In The Murine Model Of Atopic Dermatitis**

**H. Alenius** ^1^, T. Savinko^1^, S. Lehtimäki^1^, N. Fyhrquist-Vanni^1^, H. Wolff^1,2^, A. Lauerma^1^; ^1^Finnish Institute of Occupational Health, Helsinki, FINLAND, ^2^Helsinki University Central Hospital, Helsinki, FINLAND.

**1114**   **Immunologic Phenotype in the Atopic March (AM)**

**J. M. Spergel** ^1,2^, M. Boguniewicz^3^, V. Tsai^1^, R. Harbeck^3^, K. Pinzone^1^, S. B. Leung^3^, D. Y. M. Leung^3^; ^1^Children\'s Hospital of Philadelphia, Philadelphia, PA, ^2^University of Pennsylvania School of Medicine, Philadelphia, PA, ^3^National Jewish Medical and Research Center, Denver, CO.
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**1115**   **Reasons Why Patients Leave Against Medical Advice (AMA) Following an Asthma Hospitalization**

**R. Arora**, I. Warrier, A. P. Baptist; Wayne State University, Detroit, MI.

**1116**   **Asthma Controller Awareness, Knowledge, Health Beliefs and Behaviors**

**M. Tsoukleris** ^1,2^, V. Hsu^1^, C. L. Vibbert^2^, M. E. Bollinger^2^, A. M. Butz^3^; ^1^University of Maryland School of Pharmacy, Baltimore, MD, ^2^University of Maryland School of Medicine, Baltimore, MD, ^3^The Johns Hopkins University School of Medicine, Baltimore, MD.

**1117**   **Curriculum Development for the Theory-driven, Research-guided, School-based *Staying Healthy-Asthma Responsible & Prepared* Education and Counseling Program**

**E. K. Kintner**, M. Clary, G. D. Cook; Michigan State University, East Lansing, MI.

**1118**   **Adolescents\' Disease Empowerment and Persistency Technology (ADEPT) Increases Asthma Knowledge among Inner City African American Teenagers Using MP3 Players**

**G. S. Mosnaim** ^1^, C. Rhoads^2^, M. Cohen^3^; ^1^Rush University Medical Center, Chicago, IL, ^2^Northwestern University, Chicago, IL, 367Khz Inc., Chicago, IL.

**1119**   **Educational Asthma Summer Camp Including Exercise Challenge Test Improved Adherence**

**N. Kojima** ^1^, Y. Takeda^2^, M. Akashi^1^, A. Akasawa^1^; ^1^National Center for Child Health and Devepolment, Tokyo, JAPAN, ^2^Division of Health and Welfare, Kita Ward, Tokyo, JAPAN.
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**1120**   **Modulation of Nitric Oxide (NO) production by Histamine Receptor Antagonists**

**R. A. Khanferyan** ^1^, D. V. Lesik^1^, L. M. DuBuske^2^; ^1^Kuban State Medical University, Krasnodar, RUSSIAN FEDERATION, ^2^Immunology Research Institute of New England, Gardner, MA.

**1121**   **Activation of Mast Cells Induces PKC-dependent Phosphorylation of Serine-273 of the LILRB4 Inhibitory Receptor that is Self-Regulated**

**D. I. Hong**, T. R. Murphy, K. F. Austen, H. R. Katz; Brigham & Women\'s Hospital, Boston, MA.

**1122**   **Neutralization of CD86 Reduced the Th2 Immune Response in Murine Allergic Aspergillosis**

**C. Barrios** ^1^, B. Johnson^1^, J. Fink^1^, V. Kurup^1,2^; ^1^Medical College Of Wisconsin, Milwaukee, WI, ^2^V A Medical Center, Milwaukee, WI.

**1123**   **Paracrine Involvement of LTD4-induced TGFbeta1 Secretion by Epithelial Cells in Bronchial Smooth Muscle Cell proliferation**

**Y. Bossé**, C. Thompson, S. McMahon, C. M. Dubois, J. Stankova, M. Rola-Pleszczynski; Université de Sherbrooke, Sherbrooke, PQ, CANADA.

**1124**   **Parthenolide, a Sesquiterpene Lactone From the Medicinal Plant, Feverfew, Inhibits IκB kinase, Nuclear Factor-κB activation and Inflammatory response in CF cell lines and Mice**

**A. Saadane** ^1^, S. Masters^1^, J. DiDonato^2^, J. Li^1^, M. Berger^1^; ^1^CWRU, Cleveland, OH, ^2^Lerner Research Institute, Cleveland Clinic, Cleveland, OH.

**1125**   **Constitutive Association of Lyn A and B Kinases with the High Affinity IgE Receptor (FceRI) Positively Regulates Mast Cell Secretion**

**S. J. Killedar**, S. Gibbons, Jr., H. Chang, E. Lin, B. M. Vonakis; Johns Hopkins Asthma and Allergy Center, Baltimore, MD.

**1126**   **Activation of Effector Memory CD8^+^ T Cells Following Ligation of BLT1 by Leukotriene B4**

H. Ohnishi^1^, N. Miyahara^1^, C. H. Swasey^1^, K. Takeda^1^, A. Dakhama^1^, J. Domenico^1^, J. J. Lucas^1^, S. Mathis^2^, B. Haribabu^2^, **E. W. Gelfand** ^1^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^James Graham Brown Cancer Center, Louisville, KY.

**1127**   **MK2 Controls the Level of Negative Feedback in the NFκB Pathway and is Essential for Endothelial Permeability and Airway Inflammation**

**M. M. Gorska** ^1^, Q. Liang^1^, S. J. Stafford^2^, N. Goplen^1^, N. Dharajiya^2^, L. Guo^1^, S. Sur^2^, M. Gaestel^3^, R. Alam^1^; ^1^National Jewish Medical and Research Center, Denver, CO, ^2^University of Texas Medical Branch, Galveston, TX, ^3^Hannover Medical School, Hannover, GERMANY.

**1128**   **Interleukin-4 Receptor Alpha Chain ITIM Motif Mutant Mice Potentiate Stat6 Activation and IgE Production**

**R. Tachdjian**, N. Truong, T. A. Chatila; UCLA School of Medicine, Los Angeles, CA.

**1129**   **Signaling Interactions Between IL-4 or IL-13 and Leukotrienes in Allergic Inflammation**

**M. O. Daines**, P. A. Zornes, G. K. Khurana Hershey; Cincinnati Children\'s Hospital, Cincinnati, OH.

**1130**   **Inhibitory Functions of Siglec-8 in Transfected RBL-2H3 Cells**

**H. Lee** ^1^, S. Ryu^2^, S. A. Hudson^2^, C. Bikel^2^, O. H. Choi^2^, B. S. Bochner^2^; ^1^Kwandong University College of Medicine, Goyang, REPUBLIC OF KOREA, ^2^Johns Hopkins University School of Medicine, Baltimore, MD.

**1131**   **Lipoxin A4 Antagonizes Granulocyte and Macrophage Activation Evoked by Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) by Inhibition of Protein Phosphorylation**

**V. Starosta**, K. Pazdrak, A. Kurosky; UTMB, Galveston, TX.

**1132**   **Surfactant Protein D (SP-D) Inhibits TNF-α Production In CpG-induced Alveolar Macrophages Via Irak-1 Inactivation**

**K. Yeh** ^1,1^, L. Wang^2^, C. Liu^3^, W. Chang^1^, J. Wang^1^, C. Shieh^1^; ^1^Dept of Microbiology&Immumology, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, ^2^Dept of Biochemistry, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, ^3^Institude of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, TAIWAN.

**1133**   **A Phospho-site Screen Identifies Baseline Activation of PKR As a Survival-limiting Factor For Eosinophils**

**N. P. Goplen** ^1^, S. J. Stafford^2^, Q. Liang^1^, M. Gorska^1^, S. Rozario^1^, R. Alam^1^; ^1^National Jewish Medical Research Center, Denver, CO, ^2^University of Texas Medical Branch, Galveston, TX.

**1134**   **Effect of Chitinase on Il-8 Gene Expression in Human Respiratory Epithelial Cells**

**J. Y. Hong** ^1^, K. E. Lee^2^, K. W. Kim^1^, E. S. Kim^1^, J. Y. Park^1^, M. H. Sohn^1^, K. E. Kim^1^; ^1^Department of Pediatrics, Severance Children\'s Hospital,Yonsei University College of Medicine Brain Korea 21 Project for Medical Science, Yonsei University, Seoul, REPUBLIC OF KOREA, ^2^Department of Pediatrics, Severance Children\'s Hospital,Yonsei University College of Medicine Brain Korea 21 Project for Medical Science, Yonsei University, Seoul, REPUBLIC OF KOREA.

**1135**   **Scavenging of Reactive Oxidative Species (ROS) Generated by Pollen NADPH Oxidases Inhibits Th2 and Th17 Cytokine Production from Johnson Grass (JG)Sensitized Human Peripheral Blood Mononuclear Cells (PBMCs)**

**M. C. Saavedra**, N. G. Dharajiya, D. R. Redding, I. Boldogh, C. Y. Lee, S. Sur; UTMB, Galveston, TX.

**1136**   **Multiple Granulocyte Priming Phenotypes In Peripheral Blood Of Allergic Asthmatics**

**L. Koenderman** ^1^, W. Ten Hove^2^, B. Luijk^1^, B. Leufkens^2^, J. Lammers^1^, J. Raaijmakers^2^, M. Bracke^2^; ^1^University Medical Center Utrecht, Utrecht, THE NETHERLANDS, ^2^Utrecht Institute for Pharmaceutical Sciences, Utrecht, THE NETHERLANDS.

**1137**   **The Effect of Daily Apolipoprotein A-I Mimetic Therapy on Pro-Inflammatory High Density Lipoprotein in a Murine Model of Asthma**

**S. D. Nandedkar** ^1^, K. S. Konduri^1^, J. Wang^1^, H. Xu^1^, Y. Shi^1^, D. A. Rickaby^1^, N. Duzgunes^2^, K. A. Pritchard^1^; ^1^Medical college of Wisconsin,Children\'s Research Institute, and Zablocki VA Medical Center, Milwaukee, WI, ^2^University of Pacific School of Dentistry, San Franscisco, CA.

**1138**   **NADPH Oxidases in Johnson Grass Extract (JGE) Induce Intracellular ROS (iROS) in Bronchial Epithelial Cells**

**D. R. Redding**, M. C. Saavedra, J. G. Patel, N. Dharajiya, I. Boldogh, S. Sur; University of Texas Medical Branch at Galveston, Galveston, TX.

**1139**   **Leukocyte and Eosinophil Progenitor Cells in Peripheral Blood Correlate with Asthma Severity**

**J. S. Makowska**, J. Grzegorczyk, B. Bienkiewicz, M. Cieslak, M. L. Kowalski; Medical University of Lodz, Poland, Lodz, POLAND.

**1140**   **Exhaled Bronchial Nitric Oxide in Chronic Nasal Inflammation**

**M. F. Kramer** ^1^, H. Dressel^2^, A. Bihler^2^, F. Jund^1^, D. de la Motte^2^, R. Joerres^2^, D. Nowak^2^; ^1^Oto-Rhino-Laryngology, Head and Neck Surgery; Ludwig-Maximilians-University, Munich, GERMANY, ^2^Institute and Outpatient Clinic for Occupational and Environmental Medicine; Ludwig-Maximilians-University, Munich, GERMANY.

**1141**   **Increased Leukotriene B4 In Exhaled Breath Condensate From Asthmatic Children**

**J. Y. Park** ^1^, K. W. Kim^1^, E. S. Kim^1^, J. Y. Hong^1^, C. H. Kim^2^, M. H. Sohn^1^, K. E. Kim^1^; ^1^Department of Pediatrics, Severance Children\'s Hospital, Yonsei University College of Medicine, seoul, REPUBLIC OF KOREA, ^2^Department of Pediatrics, Kwandong University College of Medicine, Goyang, REPUBLIC OF KOREA.

**1142**   **A Novel Mouse Model of Whole Pollen Grain Induced Rhinitis**

**J. Brimnes**, J. Kildsgaard, H. Jacobi, K. Lund; ALK-Abello, Hoersholm, DENMARK.

**1143**   **Effect of Forced Swimming Exercise Stress on Allergic Pulmonary Inflammation in Mice**

**G. P. Shome**, L. E. Hulbert, N. Krebs, M. A. Sutherland, M. Watchell, J. J. McGlone; Texas Tech University, Lubbock, TX.

**1144**   **Formaldehyde Exposure Induces Airway Inflammation *Via* Regulation Of The Production Of Eotaxin And Reactive Oxygen Species**

**H. Yoon**; Chonnam national university, Gwang-ju, REPUBLIC OF KOREA.

**1145**   **Lack of Filaggrin Expression in the Human Bronchial Mucosa**

**T. H. Lee**, S. Ying, Q. Meng, C. J. Corrigan; King\'s College London, London, UNITED KINGDOM.

**1146**   **Age-Dependent Ontogeny of TLR4 Expression on Peripheral Lymphocytes and their Modulation by Interleukin-4**

**J. An**, A. Banville-Langelier, P. O. Fiset, D. Prefontaine, M. B. Mazer, J. Guay, O. Hajoui, Q. Hamid, B. D. Mazer; Meakins Christie Laboratories, Montreal, PQ, CANADA.
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**1147**   **Effect of Fluticasone on Airway Smooth Muscle (ASM) in Mice Treated with IL-13**

**J. Evans**, P. R. Gendapodi, P. Abel, F. Romero, R. G. Townley; Creighton University, Omaha, NE.

**1148**   **Different Roles of Aspirin during Antigen Challenge in Murine Model of Asthma**

**S. Kim** ^1^, Y. Kim^2^, J. Lee^1^, T. Kim^1^, J. Sohn^1^, H. Yoon^1^, D. Shin^1^, S. Park^1^, S. Chang^3^, D. Choi^4^; ^1^Hanyang University College of Medicine, Seoul, REPUBLIC OF KOREA, ^2^Postech Biotech Center, Pohang University of Science and Technology, Pohang, REPUBLIC OF KOREA, ^3^Sungae Hospital, Seoul, REPUBLIC OF KOREA, ^4^Sungkyunkwan University School of Medicine, Seoul, REPUBLIC OF KOREA.

**1149**   **Ngf (Nerve Growth Factor) Regulates Collagen Deposition Independent Of Tgf-β**

**A. Kilic**, S. Sonar, D. Schwinge, A. Yildirim, S. Achenbach, H. Fehrenbach, A. Nockher, H. Renz; Hospital of the Philipps University, Marburg, GERMANY.

**1150**   **Role of Endogenous Estrogen in Regulating Airway Hyperresponsiveness Induced by Allergen Inhalation Without Adjuvant**

S. Matsubara, C. H. Swasey, A. Dakhama, J. E. Loader, H. Ohnishi, A. Joetham, A. Balhorn, N. Miyahara, K. Takeda, **E. W. Gelfand**; National Jewish Medical and Research Center, Denver, CO.

**1151**   **Increase of CD25 and RLA II Positive-Cells Population in Perivascular Infiltrate in Lungs from Ovalbumin (OVA) Sensitized and Challenged Rabbits**

**M. A. Vinuesa, Sr.**, G. Fontanella, Sr., N. Bassan, Sr., O. Soldano, Sr., S. Chaparro, Sr., N. Caviglia, Sr.; Facultad de Ciencia Medicas, Rosario, ARGENTINA.

**1152**   **Grass Hypersensitivity Causing Bronchopulmonary Obstruction In A Patient With Cystic Fibrosis**

**L. Ree-Kim**, J. El-Dahr; Tulane University Health Sciences Center, New Orleans, LA.

**1153**   **Effect of Fluticasone and/or β-agonists on Airway Hyperresponsiveness (AHR) In Mice Either Sensitized to Allergen or Pre-treated with IL-13**

**R. G. Townley**, P. R. Gendapodi, J. Evans, F. Romero; Creighton University, Omaha, NE.

**1154**   **Type-I Allergic Reaction In Recently Diagnosed Untreated Pulmonary Tuberculosis**

H. M. Elboshy, A. M. Nafei, E. N. Ali, A. I. Ali, T. A. Attia, M. S. Abdalla, **E. E. Fouda**; Al-Azhar University Allergy & Immunology Center, Cairo, EGYPT.

**1155**   **Analysis of a LAM-derived Cell Transcriptome Identifies Similarity to Other Pulmonary Diseases**

**T. J. Whitney** ^1^, M. Brandon^1^, L. Ma^2^, B. Camoretti-Mercado^2^; ^1^Idaho State University, Pocatello, ID, ^2^University of Chicago, Chicago, IL.

**1156**   **Nasal Fibroblasts Derived from Allergic Patients Retain Their Typical Gene Expression Profile In Culture**

**M. Yoshikawa** ^1^, T. Yoshimura^1^, N. Okada^2^, H. Saito^2^, H. Moriyama^1^; ^1^Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, JAPAN, ^2^Department of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, JAPAN.

**1157**   **Micro Flora Associated Characteristics and Changes in Allergic Sensitization During the First Four Years of Life**

**A. Sandin** ^1^, E. Norin^2^, B. Björkstén^3^, L. Bråbäck^4^; ^1^Department of Clinical Science, Paediatrics, Umeå, SWEDEN, ^2^Department of Cellular and Microbial Biology, Division of Microbial Ecology, Karolinska Institute, Stockholm, SWEDEN, ^3^The National Institute of Environmental Medicin, Division of Physiology, Karolinska Institute, Stockholm, SWEDEN, ^4^Mid-Sweden Research and Development Center, Sundsvall Hospital, Sundsvall, SWEDEN.

**1158**   **Modulation of Effects of Albuterol Enantiomers on IL-6 Release in Human Airway Smooth Muscle Cells as a Function of Cell Stimulation**

**E. A. Duru**, J. L. Parks, IV, W. J. Calhoun, B. T. Ameredes; Unuversity of Texas Medical Branch, Galveston, TX.

**1159**   **Regulation of Dendritic Cell Function by Surfactant Protein D**

**S. Kierstein**, L. Hortobagyi, K. Krytska, A. Haczku; University PA School Medicine, Philadelphia, PA.

**1160**   **Glucocorticoid Induced Leucine Zipper Mediates the Anti-Inflammatory Effects of Dexamethasone in Airway Epithelial Cells**

**J. Eddleston** ^1,2^, J. Herschbach^2^, A. L. Wagelie-Steffen^1^, S. C. Christiansen^1,3^, B. L. Zuraw^1,2^; ^1^UCSD, La Jolla, CA, ^2^VMRF, San Diego, CA, ^3^Kaiser Permanente, San Diego, CA.

**1161**   **Analysis of Chemokine and Cytokine Production by a Human Alveolar Epithelial Cell Line in Response to Pollen Surface Proteins**

**J. M. Ward**; The University of Chicago, Chicago, IL.

**1162**   **Oral Sulforaphane Induces Antioxidant Phase II Enzymes in the Human Airway**

**M. A. Riedl**, A. Saxon, D. Diaz-Sanchez; UCLA - David Geffen School of Medicine, Los Angeles, CA.

**1163**   **Increased Plasma Levels Of Vascular Endothelial Growth Factor And Plasminogen Activator Inhibitor-1 In Children With Frequent Asthma Exacerbations**

**H. Chung**, S. Kim, S. Kim; School of Medicine, Catholic University of Taegu, Taegu, REPUBLIC OF KOREA.

**1164**   **Identification of Allergen-Susceptibility Genes Using Recombinant Inbred Mouse Model of Allergic Asthma**

**D. N. Grigoryev** ^1^, E. P. Hoffman^2^, M. Wills-Karp^3^, K. C. Barnes^1^; ^1^Johns Hopkins University, School of Medicine, Baltimore, MD, ^2^Children\'s National Medical Center, Washington, DC, ^3^Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**1165**   **Effect Of ISS And TGF-β1 On MLg Lung Fibroblast Proliferation In Vitro**

**S. Deane**, M. Miller, J. Cho, D. H. Broide; UC San Diego, San Diego, CA.

**1166**   **A Novel Inducible Transgenic Histamine Releasing Factor Construct**

**L. Xie**, Z. Zhu, S. M. MacDonald; JHUSM, Baltimore, MD.

**1167**   **A Neuroactive Steroid Inhibits Guinea-pig Airway Sensory Nerves via Maxi-K^+^ Channels Activation**

**S. Yoshihara** ^1^, H. Morimoto^2^, M. Ohori^2^, Y. Yamada^1^, T. Abe^1^, O. Arisaka^1^; ^1^Dokkyo University School of Medicine, Mibu,Tochigi, JAPAN, ^2^Department of Pharmacology, Medical Biology Research Laboratories,Fujisawa Pharmaceutical Co., Ltd., Osaka, JAPAN.

**1168**   **The effect of Kawasaki Disease on Allergy in childhood**

**W. K. Liew** ^1^, T. C. W. Lim^2^, H. V. Bever^2^, S. C. Quek^2^, T. H. Tan^1^, K. Y. Wong^1^; ^1^Kerdang Kerbau Hospital, Singapore, SINGAPORE, ^2^National University Hospital, Singapore, SINGAPORE.

**1169**   **Relation of Elevated Plasma Complement Split Product Levels to Their Peripheral Blood Leukocyte Receptors and Asthma Severity**

**H. Solomon**, I. Kalampokis, D. Dure, S. Chice, M. Nowakowski, H. G. Durkin, R. Joks; Center for Allergy and Asthma Research, SUNY Downstate, Brooklyn, NY.

**1170**   **Ligands for Siglec-8 and Siglec-F: Binding Characteristics and Tissue Distribution**

**J. P. Guo** ^1^, A. C. Myers^1^, O. Choi^1^, H. S. Lee^1^, Z. Zhu^1^, S. A. Hudson^1^, M. Brummet^1^, N. V. Bovin^2^, P. R. Crocker^3^, B. S. Bochner^1^; ^1^Johns Hopkins Asthma and Allergy Center, Baltimore, MD, ^2^Russian Academy of Sciences, Moscow, RUSSIAN FEDERATION, ^3^University of Dundee, Dundee, UNITED KINGDOM.

**1171**   **Ngf (nerve Growth Factor): A Key Player In Events Ensuing Lung Epithelium Injury And Repair**

**S. Sonar**, D. Schwinge, A. Kilic, A. Yildirim, S. Achenbach, H. Fehrenbach, A. Nockher, H. Renz; Hospital of the Philipps University, Marburg, GERMANY.

**1172**   **Association Between Thromboxane A2 Receptor Gene Polymorphisms (+924T\>C, +795T\>C) and Asthma in Korean Children**

**J. Kim** ^1^, H. Kim^2^, M. Kang^3^, S. Lee^4^, B. Kim^5^, S. Jang^3^, S. Hong^3^; ^1^Ulsan University Hospital, Ulsan, REPUBLIC OF KOREA, ^2^Inje University Sanggye Paik Hospital, Seoul, REPUBLIC OF KOREA, ^3^Asan Medical Center, Seoul, REPUBLIC OF KOREA, ^4^Hallym University College of Medicine, Hangang Sacred Heart Hospital, Seoul, REPUBLIC OF KOREA, ^5^Gangneung Asan Hospital, Gangneung, REPUBLIC OF KOREA.

**1173**   **Is CRP a Useful Marker for Inflammation in Different Forms of Rhinitis?**

**A. Baccιoglu**, F. Kalpaklioglu; Kirikkale University Faculty of Medicine, Kirikkale, TURKEY.

**1174**   **Expression of the Novel ER-α36 Variant of Estrogen Receptors in Murine Lung: Effects of Antigen Sensitization**

**S. Jia**, X. Zhang, Z. Wang, T. B. Casale; Creighton University, Omaha, NE.

**1175**   **Airway Fibroblasts Isolated from Mouse Model of Allergic Asthma Display Distinct Cellular and Phenotypic Characteristics as Compared to Normal Fibroblasts**

**A. I. Berro** ^1^, H. Sugiura^2^, X. Liu^2^, F. Duan^2^, S. Kawasaki^2^, S. Togo^2^, K. Kamio^2^, X. Q. Wang^2^, L. Mao^3^, Y. Ahn^2^, R. F. Ertl^2^, T. B. Casale^1^, S. I. Rennard^2^; ^1^Creighton University, Omaha, NE, ^2^University of Nebraska Medical Center, Omaha, NE, ^3^Third Hospital of Peking University, Beijing, CHINA.

**1176**   **Effect Of Cetirizine On Early- And Late-phase Airway Responses In A Brown Norway Rat Model Of Allergic Asthma**

**X. Zhang**, P. Siegel; Centers for Disease Control and Prevention, Morgantown, WV.

**1177**   **Nor-nordihydroguaiaretic Acid (NDHGA) Ameliorates C5a-Induced Acute Peritonitis**

**P. N. Pushparaj** ^1^, S. D. Kumar^1^, J. J. Aarthi^2^; ^1^National University of Singapore, Singapore, SINGAPORE, ^2^Singapore General Hospital, Singapore, SINGAPORE.

**1178**   **Biochemical Efficacy and Tolerability of a New Augmentation Preparation in Two Patients with MMALTONZ Alpha1-Antitrypsin Deficiency**

**J. M. Stocks** ^1^, M. Brantly^2^; ^1^The University of Texas Health Center at Tyler, Tyler, TX, ^2^University of Florida College of Medicine, Gainesville, FL.
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**1179**   **Fungal Etiology of Chronic Sinusitis: Knowledge and Attitudes Survey in the US and Europe**

**A. Stergious** ^1^, R. Casciano^1^, L. Katz^1^, M. Memran^2^, J. Willet^1^; ^1^Accentia Biopharmaceuticals, New York City, NY, ^2^Analytica International, New York City, NY.

**1180**   **Differences in Treatment Practices of Chronic Sinusitis in Europe and US**

**R. Casciano** ^1^, A. Stergious^1^, L. Katz^1^, M. Memran^2^, J. Willet^1^; ^1^Accentia Biopharmaceuticals, New York City, NY, ^2^Analytica International, New York City, NY.

**1181**   **Oral Itraconazole in the Treatment of Chronic Rhinosinusitis**

**A. Y. Kung**, H. Kita, J. C. Guarderas, R. O. Gustafson, M. A. Park; Mayo Clinic, Rochester, MN.

**1182**   **Aspirin Desensitization: The University Of Michigan Experience**

**T. A. Miller** ^1,2^, J. L. Baldwin^1^; ^1^University of Michigan, Ann Arbor, MI, ^2^Capital Allergy & Respiratory Disease Center, Sacramento, CA.

**1183**   **Relationship Between IFN-γ Genotypes and the Development of Otitis Media (OM) During Respiratory Syncytial Virus (RSV) Infection in Young Children**

**J. M. Koehrsen**, D. P. Skoner, D. A. Gentile, A. Patel, M. Varga, T. J. Schaffner, C. A. Schad; Allegheny General Hospital, Pittsburgh, PA.

**1184**   **Inflammation And Remodelling Parameters In Induced Sputum Of Nonasthmatic Seasonal Allergic Rhinitis**

**A. B. Dursun** ^1^, G. Celik^1^, M. Melli^2^, Z. Misirligil^1^; ^1^Ankara University, School of Medicine, Department of Respiratory Medicine, Allergic Diseases Division, Ankara, TURKEY, ^2^Ankara University, School of Medicine, Department of Clinical Pharmacology, Ankara, TURKEY.

**1185**   **Comparison of ICAM-1, HLA-DR, TLR2, and TNFR1 Expression in Response to *Staphylococcus aureus* and Pro-Inflammatory Cytokines between Primary Conjunctival Epithelial Cells and the Cell Line, IOBA-NHC**

**J. L. Stahl**, E. B. Cook, N. P. Barney, F. M. Graziano; University of Wisconsin-Madison, Madison, WI.

**1186**   **Effect of Treatment with Montelukast on Otitis Media (OM) in Children**

**D. A. Gentile**, J. M. Koehrsen, D. P. Skoner, A. Patel, M. Varga, C. A. Schad, T. J. Schaffner; Allegheny General Hospital, Pittsburgh, PA.

**1187**   **Knemometric Assessment of Short-Term Lower-Leg Growth in Children with Allergic Rhinitis (AR) treated with Fluticasone Furoate^∗^ (FF) Nasal Spray**

**^∗^USAN approved name**

**J. Gradman** ^1^, M. Caldwell^2^, O. Wolthers^1^; ^1^Asthma and Allergy Clinic, Children\'s Clinic Randers, Randers, DENMARK, ^2^GlaxoSmithKline, Greenford, UNITED KINGDOM.

**1188**   **Once-Daily Fluticasone Furoate^∗^ Nasal Spray (FFNS) 110mcg Improves Quality of Life (QoL) in Subjects with Seasonal Allergic Rhinitis (SAR) during the ragweed season**

**^∗^USAN approved name**

**J. Given** ^1^, T. Toler^2^, A. Ellsworth^2^, R. Stanford^2^, E. Philpot^2^; ^1^Allergy Respiratory & Sleep Center, Canton, OH, ^2^GlaxoSmithkline, RTP, NC.

**1189**   **Once-daily Fluticasone Furoate^∗^ Nasal Spray (FF) is Safe and Effective in The Long-term Treatment of Perennial Allergic Rhinitis (PAR) in Children Ages 2 to 11 Years**

**^∗^USAN approved name**

**J. F. Maspero** ^1^, A. Rosenblut^2^, A. Finn, Jr.^3^, J. Lim^4^, W. Wu^4^, M. Faris^5^, E. Philpot^4^; ^1^Allergy and Clinical Immunology Buenos Aires University, Buenos Aires, ARGENTINA, ^2^Hospital Dr. Sotero del Rio, Santiago, CHILE, ^3^National Allergy, Asthma, Urticaria Center of Charleston, Charleston, SC, ^4^GlaxoSmithKline, RTP, NC, ^5^GlaxoSmithKline, Greenfort, UNITED KINGDOM.

**1190**   **Once-daily Fluticasone Furoate^∗^ Nasal Spray (FF) Provides 24-hour Symptom Relief In Subjects With Seasonal Allergic Rhinitis (SAR) Caused By Mountain Cedar Pollen**

**^∗^USAN approved name**

**F. C. Hampel, Jr.** ^1^, R. Jacobs^2^, B. Martin^3^, T. Toler^4^, A. Ellsworth^4^, E. Philpot^4^; ^1^Central Texas Health Research, New Braunfels, TX, ^2^Biogenics Research Institute, San Antonio, TX, ^3^Southwest Allergy and Asthma Research, San Antonio, TX, ^4^GlaxoSmithKline, Research Triangle Park, NC.

**1191**   **Lack of Effect on Hypothalamic-Pituitary-Adrenal (HPA) Axis Function by Once-daily Fluticasone Furoate^∗^ Nasal Spray(FFNS) 110 mcg in Adolescents and Adults with Perennial Allergic Rhinitis (PAR)**

**^∗^USAN approved name**

**D. Patel** ^1^, P. Ratner^2^, D. Clements^3^, W. Wu^3^, M. Faris^3^, E. Philpot^3^; ^1^Allied Research International Inc, Mississauga, ON, CANADA, ^2^Sylvana Research Associates, San Antonio, TX, ^3^GlaxoSmithKline, Research Triangle Park, NC.

**1192**   **Effect Of Desloratadine On The Bronchial Reactivity During Allergen Provocation Tests In Rhinitics Allergic To Grass Pollen**

**A. Purohit** ^1^, C. Donnay^1^, A. Casset^1^, M. Kopferschmitt^1^, I. Dreyfus^2^, F. Sevenier^3^, F. de Blay^1^; ^1^Asthma and Allergy Division, Department of Chest Diseases, University Hospital Strasbourg, Strasbourg, FRANCE, ^2^Schering-Plough laboratories, Levallois-Perret, FRANCE, ^3^Fovea, Paris, FRANCE.

**1193**   **Once-daily Fluticasone Furoate^∗^ Nasal Spray (FF) Provides 24-hour Relief of the Nasal Symptoms of Seasonal Allergic Rhinitis (SAR) in Children ages 2-11 Years**

**^∗^USAN approved name**

**E. O. Meltzer** ^1^, I. Tripathy^2^, J. Lee^3^, J. Lim^4^, A. Ellsworth^4^, E. Philpot^4^; ^1^University of California, San Diego, San Diego, CA, ^2^Clinical Research of Ozarks, Rolla, MO, ^3^Advance Care Research Center, Dallas, TX, ^4^GlaxoSmithKline, RTP, NC.

**1194**   **Lack of Correlation Between Physical Exam(PE), Mini RQLQ (MRQLQ), and Nasal Peak Inspiratory Flow (nPIF) as Measures of Nasal Congestion in Obstructive Sleep Apnea (OSA) Patients With Rhinitis**

**M. R. Rupp, Jr.** ^1^, A. S. Baran^2^, G. D. Marshall, Jr.^2^; ^1^Allergy and Asthma Clinic of Southern New Mexico, Las Cruces, NM, ^2^University of Mississippi Medical Center, Jackson, MS.

**1195**   **Videophone Technology, a Novel Measure of True Treatment Compliance in a 6-week Pediatric Safety Study of Fluticasone Furoate^∗^ Nasal Spray**

**^∗^USAN approved name**

**D. Clements**, W. Wu, E. Philpot; GlaxoSmithKline, Research Triangle Park, NC.

**1196**   **Positron Emission Tomography of the Airway Distribution of Intranasal Challenge Solutions**

**L. Conejero** ^1^, M. L. Soto^1^, J. J. Vaquero^1^, M. L. Baeza^1^, E. Lage^1^, I. Varela-Nieto^2^, M. Desco^1^, J. M. Zubeldia^1^; ^1^Hospital Gregorio Maranon, Madrid, SPAIN, ^2^Instituto Investigaciones Biomedicas Alberto Sols. CSIC-UAM, Madrid, SPAIN.

Oral Abstract Session {#sec77}
=====================

5601

Tuesday, February 27, 2007

2:00 PM - 3:15 PM

Pharmacotherapy of Asthma {#sec77.1}
-------------------------

**1197**   **VEGF Receptor 2 (KDR) is Up-regulated in the Nasal Mucosa of Seasonal Allergic Rhinitics**

A. Tarun^1^, **D. Shusterman** ^2^; ^1^Seattle Biomedical Research Institute, Seattle, WA, ^2^University of Washington, Seattle, WA.

**1198**   **Andolast, a Novel Calcium-activated Potassium-channel Opener, Inhibits AMP and Exercise Induced Bronchoconstriction in Asthma**

**S. H. Arshad** ^1^, M. D\'Amato^2^, L. Rovati^2^, S. T. Holgate^1^; ^1^University of Southampton, Southampton, UNITED KINGDOM, ^2^Rotta Research Laboratorium/Rottapharm, Monza, ITALY.

**1199**   **Differential Contribution Of Cysteinyl Leukotriene Receptor Type 1 Gene In Patients With Aspirin Hypersensitivity**

**S. Kim** ^1^, E. Yang^1^, J. Choi^2^, H. Lee^1^, C. Suh^1^, D. Nahm^1^, H. Park^1^; ^1^Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA, ^2^Bundang Jesaeng general Hospital, Seongnam, REPUBLIC OF KOREA.

**1200**   **Modulation Of Cysteinyl Leukotriene (CysLT) Production And Responsiveness By Corticosteroids (CCS)**

**J. A. Negri**, L. Borish, J. W. Steinke; University Of Virginia Health Systems, Charlottesville, VA.

**1201**   **Exploring the Effect on Asthma Control of Omalizumab Reduction After 28 Weeks Treatment**

**R. Slavin** ^1^, P. Lowe^2^, C. Ferioli^2^, H. Fox^3^, L. Carpenter^3^, C. Martin^3^, W. Sallas^4^; ^1^Saint Louis University School of Medicine, Saint Louis, MO, ^2^Novartis Pharmaceuticals AG, Basel, SWITZERLAND, ^3^Novartis Horsham Research Centre, Horsham, UNITED KINGDOM, ^4^Novartis Pharmaceuticals Corporation, East Hanover, NJ.

**1202**   **Exploring the Relationship Between Asthma and Rhinitis Response Following Omalizumab Therapy: Patients who Achieve Greatest Benefit for their Asthma Experience Greatest Benefit for Rhinitis**

**L. Boulet** ^1^, Z. Panahloo^2^, M. Blogg^2^, G. Ayre^2^; ^1^Institut de Cardiologie et de Pneumologie de l\'Université Laval, Hoˆpital Laval, Sainte-Foy, PQ, CANADA, ^2^Novartis Horsham Research Centre, Horsham, UNITED KINGDOM.
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**1203**   **CD4^+^CD25^+^ T cells Regulate TLR4 Signaling in Pulmonary Dendritic Cells**

**H. Chen**, D. A. Piggott, L. Xu, K. Bottomly; Yale University, New Haven, CT.

**1204**   **Th2 Inflammation reduces Toll-Like Receptor 4 Expression and Regulatory Functions of T Cells**

**D. Préfontaine**, M. Mazer, A. Banville-Langelier, P. Fiset, B. D. Mazer, Q. Hamid; Meakins-Christie Laboratories, McGill University, Montreal, PQ, CANADA.

**1205**   **TGF-beta Stimulated Human CD4+CD25-FOXP3- Cells Express FOXP3, But Lack Regulatory Function**

**D. Tran**, E. M. Shevach; NIH/NIAID, Bethesda, MD.

**1206**   **Suppression Induced By In Vitro Expanded Human Tregs Is Antigen-independent And Is Partly Abrogated By GITR Signalling**

A. Domdey^1^, A. H. Millner^1^, K. Lund^1^, I. Søndergaard^2^, **P. A. Würtzen** ^1^; ^1^ALK-Abello, Hørsholm, DENMARK, ^2^BioCentrum-DTU, Technical University of Denmark, Lyngby, DENMARK.

**1207**   **Kinetics of Gene Related to Anergy in Lymphocytes (grAIL) expression in CD4+ CD25+ T Regulatory Cells and Correlation with Suppression and T:APC Conjugate Formation**

**J. M. Schartner**, A. Timmel, W. Simonson, M. Jennens-Clough, A. Huttenlocher, C. M. Seroogy; University of Wisconsin - Madison, Madison, WI.

**1208**   **The Functional Insufficiency of Natural Regulatory T Cells in Allergic Asthma May Due to TNF Downregulation**

**Y. Lin** ^1,2^, J. Wang^1^; ^1^Dept of Ped, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, ^2^Institute of Microbiology and Immunology, National Cheng Kung University, Tainan, TAIWAN.
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**1209**   **Cat Ownership Is A Risk Factor For Developing Sensitization To Cat But Not Wheeze By Age 5 In A Low Income New York City Birth Cohort**

**M. S. Perzanowski** ^1,2^, G. L. Chew^1^, A. Divjan^1^, A. Johnson^1^, K. Panjwani^1^, B. J. Sheares^1^, T. A. Platts-Mills^3^, F. P. Perera^1^, R. L. Miller^1^; ^1^Columbia Children\'s Center for Environmental Health (CCCEH), New York, NY, ^2^Department of Environmental Health Sciences, Columbia University, New York, NY, ^3^Asthma and Allergic Diseases Center, University of Virginia, Charlottesville, VA.

**1210**   **Is the Attenuation in Risk of Sensitisation and Wheezing observed at High Allergen Exposures due to a Modified Th Response?**

**M. G. Jones**, J. Harris, W. Atkinson, P. Mills, S. A. Moffat, C. W. White, A. Newman Taylor, P. Cullinan; NHLI

**1211**   **Immunomodulatory Effects of Allergen-specific Sublingual Immunotherapy in a Rat Model of Allergic Sensitization**

**L. A. Rosenthal** ^1^, X. Su^1^, R. J. Szakaly^1^, R. L. Sorkness^1,2^; ^1^University of Wisconsin School of Medicine and Public Health, Madison, WI, ^2^School of Pharmacy, University of Wisconsin-Madison, Madison, WI.

**1212**   **Sensitization to Mouse Allergen and Asthma Morbidity in a Population of Boston Women**

**W. Phipatanakul** ^1,2^, A. A. Litonjua^2^, T. A. E. Platts-Mills^3^, L. Naccara^3^, J. C. Celedon^2^, H. Abdulkerim^2^, S. T. Weiss^2^, D. R. Gold^2^; ^1^Children\'s Hospital, Boston, Harvard Medical School, Boston, MA, ^2^Channing Laboratory, Brigham and Women\'s Hospital, Boston, MA, ^3^University of Virginia, Charlottesville, VA.

**1213**   **Changes in IgE and IgG Antibody Responses to Cat with Decreased Exposure to Cat Allergen**

**E. A. Erwin**, S. M. Satinover, A. J. Reefer, J. A. Woodfolk, T. A. E. Platts-Mills; University VA, Charlottesville, VA.

**1214**   **Dog Exposure at Birth through Age 3 Reduces the Risk of Asthma at Age 6**

**N. A. Hallett**, K. A. Roberg, E. L. Anderson, L. E. P. Salazar, R. A. Grabher, D. F. DaSilva, J. D. Bufford, K. T. Sullivan Dillie, R. Gangnon, M. D. Evans, J. E. Gern, R. F. Lemanske, Jr.; University of Wisconsin School of Medicine and Public Health, Madison, WI.
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**1215**   **Over 10 Years Of Experience With The Use Of C1-inhibitor Concentrate In Hereditary Angioedema, In Retrospect**

**H. Farkas** ^1^, G. Temesszentandrási^1^, B. Visy^2^, G. Harmat^2^, L. Varga^1^, G. Füst^1^, G. Széplaki^1^, I. Karádi^1^, B. Fekete^1^, L. Jakab^1^; ^1^Semmelweis University, Budapest, HUNGARY, ^2^Madarász street Hospital of the Heim Pál\' Pediatric Hospital, Budapest, HUNGARY.

**1216**   **Functional Study Of Histamine N-methyltransferase (hnmt) Genetic Polymorphisms In Patients With Aspirin-intolerant Chronic Urticaria**

**Y. KANG** ^1^, S. Kim^1^, Y. Ye^1^, G. Hur^1^, S. Lee^2^, H. Lee^1^, C. Suh^1^, D. Nahm^1^, H. Park^1^; ^1^Ajou university, Su-won, REPUBLIC OF KOREA, ^2^Dong-A University, Busan, REPUBLIC OF KOREA.

**1217**   **Longitudinal Examination of Basophil Functional Phenotypes and Disease Activity in Chronic Idiopathic Urticaria (CIU)**

**L. M. Gober**, P. M. Sterba, R. Baker, K. Vasagar, B. M. Vonakis, S. S. Saini; Johns Hopkins University, Baltimore, MD.

**1218**   **Discovery of Ecallantide: A Potent and Selective Inhibitor of Plasma Kallikrein**

**R. Ladner**, R. Kent, A. Ley, A. Nixon, D. Sexton; Dyax Corp., Cambridge, MA.

**1219**   **Efficacy of Omalizumab for the Treatment of Allergic Urticaria and Angioedema**

**A. Rafi**, L. Do, R. Mangat, S. Sender, R. M. Katz; Allergy Asthma Care Center of Santa Monica, Santa Monica, CA.

**1220**   **Intraindividual And Interindividual Variations Of Symptoms In Patients With Hereditary Angioedema**

**E. Rusicke**, I. Martinez-Saguer, E. Aygören-Pürsün, T. Klingebiel, W. Kreuz; JWG-University Hospital Frankfurt/Germany, Frankfurt/Main, GERMANY.
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**1221**   **Intestinal Expression of Interleukin 9 (IL-9) Induces Mast Cell-Mediated Intestinal Permeability**

**K. R. Groschwitz**, E. E. Forbes, E. B. Brandt, R. Ahrens, F. D. Finkelman, P. Abonia, M. E. Rothenberg, S. P. Hogan; Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH.

**1222**   **Treatment of RSV-Infected Newborn Mice With Anti-IgE Antibody Attenuates the Subsequent Enhancement of Airway Hyperresponsiveness on Re-Infection**

A. Dakhama, Y. Lee, A. Balhorn, A. Joetham, **E. W. Gelfand**; National Jewish Medical and Research Center, Denver, CO.

**1223**   **Human recombinant Histamine Releasing Factor (HrHRF) Induced Histamine Release (HR) is Associated with SHIP Knockdown (k/d) in both the Cultured Human Mast Cell (MC) and Basophil Models**

**J. M. Langdon**, J. T. Schroeder, A. P. Bieneman, B. M. Vonakis, S. M. MacDonald; JHUSM, Baltimore, MD.

**1224**   **The Immunosuppressant Drug FTY720 Inhibits Cytosolic Phospholipase A2 Independently of Sphingosine-1-Phosphate Receptors**

**S. Spiegel**, S. Payne, C. Oskeritzian, S. Milstien; VCU School of Medicine, Richmond, VA.

**1225**   **Activation of Protein Kinase D1 (PKD1) in Mast Cells by TLR, Kit, and FcepsilonRI ligands**

**T. R. Murphy**, H. R. Katz; Harvard Med. Sch./Brigham & Women\'s Hosp., Boston, MA.

**1226**   **CysLT2 Receptors Negatively Regulate CysLT1 Receptor Functions on Mast Cells Through Heterodimerization**

**J. A. Boyce**, Y. Jiang; Brigham and Women\'s Hospital, Boston, MA.
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**1227**   **The Ability of the Nose to Warm and Humidify Inspired Air is Heritable**

J. Pinto, A. Sahin-Yilmaz, **F. Baroody**, M. deTineo, S. Elwany, C. Ober, R. M. Naclerio; The University of Chicago, Chicago, IL.

**1228**   **Positive Nasal Allergen Provocation Test and Nasal Specific-IgE to Grass Pollen in Patients with Idiopathic Rhinitis**

**C. Rondon** ^1^, J. J. Romero^1^, S. Lopez^2^, R. R-Pena^2^, J. L. Rodriguez-Bada^2^, P. Chaves^2^, I. Doña^1^, M. Blanca^1^; ^1^Allergy Service, Carlos Haya Hospital, Málaga, SPAIN, ^2^Research Laboratory, Fundacion IMABIS-Carlos Haya Hospital, Málaga, SPAIN.

**1229**   **Importance of Both Allergen-Specific (ANR) and Non-Specific Nasal Reactivity (NNR) in the Development of Early- and Late-Phase Nasal Responses**

S. Miyahara, N. Miyahara, S. Matsubara, A. Joetham, **E. W. Gelfand**; National Jewish Medical and Research Center, Denver, CO.

**1230**   **Effect of Montelukast on Nasal Secretion Weights During Naturally Acquired vURIs in Adults**

**D. P. Skoner**, D. A. Gentile, J. M. Koehrsen, A. Patel, M. Varga, T. J. Schaffner, C. A. Schad; Allegheny General Hospital, Pittsburgh, PA.

**1231**   **Influence of Allergen Immunotherapy on Substance P Release by Nasal Challenge of Grass Pollen Sensitized Allergic Rhinitis Patients**

**R. Gawlik** ^1^, B. Jawor^1^, B. Rogala^1^, L. M. DuBuske^2^; ^1^Silesian University School of Medicine, Zabrze, POLAND, ^2^Immunology Research Institute of New England, Gardner, MA.
